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ABSTRACT 
Extensively and pan antibiotic resistant Acinetobacter baumannii belonging to the global clone 
GC2 present a significant challenge in the treatment of infections worldwide. This study aimed 
to analyse the causes of antibiotic resistance in a selection of 20 extensively antibiotic resistant 
GC2 isolates from Singapore. One isolate was from 1996 and others were from 2004-2011. All 
carried multiple antibiotic resistance genes including the carbapenem resistance gene oxa23.  
 
To determine the relationships between these isolates the structures of the AbGRI1, AbGRI2 
and AbGRI3 resistance islands were examined, along with ISAba1 locations and MLST 
profiles (Oxford scheme). Plasmid diversity was also examined. Most isolates were ST208 or 
a single locus variant and one was a triple locus variant. All had ISAba1 upstream of ampC 
(resistance to third generation cephalosporins) and a version of AbGRI1 and AbGRI2. 
However, AbGRI3 including the armA gene (resistance to all clinically relevant 
aminoglycosides) was present in 15 isolates.  
 
Shared features allowed evolutionary lineages to be inferred. The 1996 ST208 isolate shared 
many features with most Australian isolates including AbGRI2-1, and 11 of 12 conserved 
ISAba1 positions, and hence is closely related to their progenitor. Four other isolates had 
AbGRI2-1 but ISAba1 in only 8 conserved positions. The remaining 15 isolates contain an 
AbGRI3 variant and an IS26-derived deletion variant of AbGRI2-1. They share 3 of the 
conserved ISAba1s and 2 more ISAba1 positions specific to the AbGRI3 lineage. Six AbGRI3 
variants were detected. One was associated with 6 extra ISAba1 positions. 
 
RepAci6 plasmids of 2 known backbone types and 2 novel types were found in the collection; 
most were transfer proficient. Of the 14 plasmids, 2 were cryptic, 4 carried aphA6 (amikacin 
	 VII	
resistance) in TnaphA6, 10 had oxa23 in Tn2006 in AbaR4 and one had oxa23 in Tn2008. Two 
novel transposons were also identified. All AbGRI3 isolates had a small RepAci1 plasmid with 
no mobilisation genes and one carrying Tn2006 was mobilised by a RepAci6 plasmid enabling 
a shared putative oriT to be found.  
 
The tet39 tetracycline resistance determinant and the macrolide resistance gene pair msrE-
mphE were found in a novel plasmid in one isolate. These resistance genes are in dif modules, 
bounded by inversely-oriented XerC-XerD binding sites, termed pdif sites. Numerous dif 
modules containing many different orfs, including various toxin/antitoxin systems, were 
identified in Acinetobacter plasmids. Two types of dif modules, C and D modules, that usually 
alternate were defined. 
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ABBREVIATIONS 
 
Units 
 
bp Base pair 
kb Kilo base 
Mb Mega base 
M Molar 
Mol Moles 
U Units of activity (of enzyme) 
v/v Volume per volume 
w/v Weight per volume 
 
Terms 
 
aa Amino acid 
AbaR A. baumannii resistance island 
AbGRI A. baumannii genomic resistance island 
CDS Calibrated Dichotomous Sensitivity 
CLSI Clinical and Laboratory Standards Institute 
CR Common region 
5`-CS 5`-conserved segment 
3`-CS 3`-conserved segment 
DNA Deoxyribonucleic acid 
dNTP Deoxynucleotide triphosphate 
DR Direct repeat 
EC European clone 
GC Global clone 
EDTA Ethylenediaminetetraacetic acid 
EtBr Ethidium bromide 
HGT Horizontal gene transfer 
ICU Intensive care unit 
In Integron 
IS Insertion sequence 
IR Inverted repeat 
LB Luria Bertani 
MAR Multiply antibiotic resistant 
MARR Multiple antibiotic resistance region 
MIC Minimum inhibitory concentration 
MLST Multi-locus sequence typing 
MQ Milli-Q water 
NCBI National Centre for Biotechnology information 
nt Nucleotide 
orf Open reading frame 
PCR Polymerase chain reaction 
PFGE Pulse-field gel electrophoresis 
RI Resistance island 
SDS Sodium dodecyl sulfate 
SNP Single nucleotide polymorphism 
sp. Species 
ST Sequence type 
TBE Tris-borate EDTA 
TE Tris-EDTA 
Tn Transposon 
Tris Tris(hydroxymethyl)aminomethane 
UV Ultra-violet 
V Volts 
	 IX	
 
Antibiotics 
 
IPM Imipenem 
MER Meropenem 
Dor Doripenem 
Ap Ampicillin 
SAM Ampicillin/sulbactam 
TIM Ticarcillin-clavulanic acid 
TZP Piperacillin-tazobactam 
CTX Cefotaxime 
CAZ Ceftazidime 
CRO Ceftriaxone 
FEP Cefepime 
Sm Streptomycin 
Sp Spectinomycin 
Su Compound sulphonamides 
Tc Tetracycline 
Mc Minocycline 
Dc Doxycycline 
Tp Trimethoprim 
Cl Chloramphenicol 
Fl Florfenicol 
Km Kanamycin 
Nm Neomycin 
Gm Gentamicin 
Ne Netilmicin 
Ak Amikacin 
Tm Tobramycin 
Nx Nalidixic acid 
CIP Ciprofloxacin 
LVX Levofloxacin 
Rif Rifampicin 
CLAV Clavulanic acid 
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General Introduction 
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1.1 The genus Acinetobacter 
The genus Acinetobacter and its species have had a complicated history of taxonomic change. 
The first description of bacteria from this genus was from 1911 by a Dutch microbiologist 
Beijerinck, who isolated an organism from soil using an enriched calcium-acetate medium (15). 
He called the organism Micrococcus calcoaceticus (15). Over the next 40 or so years similar 
bacteria have been assigned many different names and the sub-committee on the taxonomy of 
Moraxella and Allied Bacteria officially acknowledged the Acinetobacter genus in 1971 (19, 
122).   
 
Acinetobacter is located within the family of Moraxellaceae in the order of 
Gammaproteobacteria (19). The genus of Acinetobacter comprises gram negative, aerobic, 
catalase positive, oxidase negative, non-fermenting, non-fastidious bacteria that have a GC 
content of 39-47% (19, 122, 207). They are typically rod-shaped during exponential phase but 
are more coccoid in shape at stationary phase (122). On solid media they usually form smooth, 
sometimes mucoid, gray-white colonies (207). Species of Acinetobacter have been recovered 
from virtually all soil and water samples, can be members of the normal flora and some have 
roles as human pathogens (9, 13, 258, 271). 
 
Today there are 49 validly named species of Acinetobacter (43). Phenotypic methods of 
speciation were unreliable and even genotypic methods used in the 1980s such as DNA-DNA 
hybridisation separated 12 genospecies of Acinetobacter that were themselves composed of 
several species (30). One group, called the A. calcoaceticus – A. baumannii complex (Acb) 
(77, 78), included A. baumannii, A. calcoaceticus, A. pittii (genomic species 3) and A. 
nosocomialis (genomic species 13 TU) (185). The grouping of clinically relevant 
Acinetobacter species (A. baumannii, A. pittii and A. nosocomialis) with the environmental 
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species A. calcoaceticus is undesirable. In addition, accurate identification of the three 
clinically relevant Acb species is important for epidemiology and for effective infection 
control. Many methods have been used in clinical laboratories to distinguish these species 
including amplification of species-specific regions including the gyrB gene (114, 117), or for 
the specific A. baumannii oxaAb carbapenemase gene (263). More recently, MALDI-TOF MS 
(matrix assisted laser desorption ionisation – time of flight mass spectrometry) instruments 
have been used to effectively distinguish these species (257).  
 
1.2 A. baumannii  
A. baumannii causes the majority of clinical infections caused by Acinetobacter species and is 
an important nosocomial pathogen that causes opportunistic infections. These infections 
commonly occur in patients who are immunocompromised or in intensive care units (ICUs). 
Other predisposing factors that increase the likelihood of A. baumannii infection include old 
age, premature birth, the heavy use of antibiotics following surgery, indwelling catheters, 
wounds and length of hospital and/or ICU stay (75). A. baumannii is an important cause of 
hospital acquired pneumonia particularly in patients requiring mechanical ventilation (207). 
This bacterium is also commonly associated with skin infections, particularly burn wounds or 
surgical wounds and serious wound infections can lead to bacteraemia (9). A. baumannii can 
also be associated with secondary meningitis and is occasionally the cause of urinary tract 
infections. Rarely, community acquired A. baumannii infections have been reported and 
excessive alcoholism is a risk factor (8).  
 
Unlike other species of Acinetobacter, A. baumannii is rarely isolated from non-clinical 
environmental sources and the natural reservoir of this bacterium is not known (258, 271). 
During an outbreak`, A. baumannii can be recovered from hospital surfaces and the skin of 
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patients and hospital personnel (14). During an outbreak, A. baumannii can be recovered from 
hospital surfaces and the skin of patients and hospital personnel (14). Once these bacteria are 
present in the hospital environment they are very hard to eradicate due to their high level of 
resistance to desiccation and disinfection (258). 
 
The success of A. baumannii as a nosocomial pathogen is likely due to its ability to persist in 
the hospital environment and its high level of antibiotic resistance, though it was this second 
characteristic that lead to specific studies of A. baumannii in the 1990s, particularly those that 
were carbapenem resistant (258). Current isolates frequently only remain susceptible to colistin 
(9) and ominously, isolates resistant to all antibiotics have been detected (84).  The severity of 
antibiotic resistance in A. baumannii, has lead its inclusion in the ESKAPE group of bacteria 
(224). This group includes Enterococcus faecium, Staphylococcus aureus, Klebsiella 
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa and Enterobacter species, 
which are able to effectively ‘escape’ the effects of antibiotics (224). Increasingly, the 
therapeutic options for these pathogens are so limited that older previously discarded drugs that 
are associated with significant toxicity, such as colistin are being used (29). A 2017 report from 
the World Health Organisation, classified the threat of carbapenem-resistant A. baumannii as 
critical with the urgent need for the developments of new treatments.  
 
The development of standardised terminology to classify and describe antibiotic resistance in 
A. baumannii in 2011 enabled accurate comparison of surveillance data world-wide (166). This 
classification system was based on the resistance to 9 useful categories of antibiotic for 
treatment of Acinetobacter infections listed in Table 1.1 (166). Multiple antibiotic resistance 
(MAR) was defined as being resistant to one or more antibiotics in at least 3 categories, 
extensively antibiotic resistance (XAR) means the bacteria were resistant to an antibiotic in 7 
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out of the 9 categories, and resistance to all antibiotics means that the bacteria are pan antibiotic 
resistant (PAR) (166).  
 
Table 1.1 Antibiotic categories and antibiotics used to define resistance in Acinetobacter 
sp.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3 Antibiotic resistance in A. baumannii 
Antibiotic resistance in A. baumannii can be due to both intrinsic and acquired resistance. 
Bacteria can acquire resistance to an antibiotic by enzymatically altering or degrading the 
antibiotic, modifying the target site, or via decreased antibiotic accumulation either through 
decreased uptake or increased efflux, overproduction of the target enzyme or acquiring an 
alternate pathway to those inhibited by an antimicrobial agent (170, 246, 276). Antibiotic 
Antibiotic category Antibiotics 
Aminoglycosides Gentamicin  
Tobramycin  
Amikacin 
Netilmicin 
Carbapenems Imipenem  
Meropenem  
Doripenem 
Fluoroquinolones Ciprofloxacin 
Levofloxacin 
Antipseudomonal penicillins 
+ b-lactamase inhibitors 
Piperacillin-azobactam 
Ticarcillin-clavulanic acid 
Extended-spectrum 
cephalosporins 
Cefotaxime 
Ceftriaxon 
Ceftaxidime 
Cefepime 
Folate pathway inhibitors Trimethoprim-
sulphamethoxazole 
  
Penicllins + b-lactamase 
inhibitors 
Ampicillin-sulbactam 
Polymyxins Colistin 
Polymyxin B 
Tetracyclines Tetracycline 
Doxycycline 
Minocycline 
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resistance can be acquired through chromosomal DNA mutations, which alter existing bacterial 
proteins or through the acquisition of new DNA carrying resistance genes from other bacteria 
(170). This transfer of genetic material between bacteria, known as horizontal gene transfer 
(HGT), increases the genetic flexibility of these organisms. 
 
1.3.1 Intrinsic resistance  
Based on early studies of Acinetobacter isolates (237, 266), it has been reported that A. 
baumannii are intrinsically resistant to aminopenicillin, 1st and 2nd generation cephalosporins 
and chloramphenicol (52). From these studies, it is difficult to determine if the genes conferring 
this resistance are intrinsic or acquired but it is likely that they are due to the chromosomally 
encoded AmpC cephalosporinase and CraA efflux pump (described below). A recent study has 
identified a novel aminoglycoside nucleotidyltransferase, intrinsic to most species of 
Acinetobacter, an ant(3``)-II or aadA gene, which confers resistance to spectinomycin and 
streptomycin (283).  
 
1.3.2 Resistance to cephalosporins 
A. baumannii usually contain a chromosomally-encoded cephalosporinase, called AmpC (27, 
211). The ampC gene encoding this protein is constitutively expressed at low levels and does 
not confer resistance to 3rd generation cephalosporins including ceftazidime and cefotaxime 
(27, 165). However, increased expression of this gene, usually by the insertion of an ISAba1 
upstream providing a promoter stronger than the intrinsic one, results in high level resistance 
to these antibiotic (89, 165, 211). Despite being located upstream of many different ampC 
alleles, ISAba1 is always found in the same position, 9 bp upstream of the start codon of the 
ampC gene (89). Insertion of ISAba125 upstream of ampC has also been shown to increase 
expression and contribute resistance to 3rd generation cephalosporins (95, 165).  
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However, increasing the expression of their own native ampC gene is not the only way isolates 
of A. baumannii have become resistant to 3rd generation cephalosporins. There is evidence that 
some isolates have acquired an activated ampC region (with ISAba1 or ISAba125 already 
upstream) from another isolate by homologous recombination (91, 95). A composite 
transposon, named Tn6168, containing the ampC gene flanked by two directly orientated 
copies of ISAba1, has also been identified (92).  
 
Some A. baumannii have also acquired extended-spectrum b-lactamases (ESBLs) including 
blaPER, blaVEB, blaCTX-M and rarely blaSHV or blaTEM type genes (211).  
  
1.3.3 Carbapenem resistance 
Carbapenem antibiotics have historically been the first line of treatment of multiply antibiotic 
resistant infections. Resistance to carbapenems can be conferred by several b-lactamases but 
the most common are Class D b-lactamases (oxacillinases) (215). In general, these enzymes 
hydrolyse imipenem faster than meropenem (215).  
  
A. baumannii isolates encode an intrinsic class D b-lactamase, often referred to as OXA-51 
(31, 61) that is specific to the species of A. baumannii. This gene has been used to identify the 
organism (263) although there are many variants of this gene. The gene encoding all the 
different alleles of OXA-51 will be referred to as oxaAb. Like the intrinsic ampC gene, the 
oxaAb gene does not confer clinical levels of resistance to carbapenems, however upregulation 
of this gene either by ISAba125 or ISAba1, can result in reduced susceptibility to carbapenems 
(194, 211).  
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The most commonly acquired and hence most well studied of class the D b-lactamases in A. 
baumannii include the OXA-23, OXA-24 (and the identical OXA-40) and the OXA-58 b-
lactamases (61, 215). Recently, two other Class D beta-lactamases have been identified in A. 
baumannii, OXA-143 (116) and OXA-235 (115).  
 
The oxa23 gene, and its numerous variants, have been detected worldwide and has been found 
as part of various transposon structures located both in the chromosome and in plasmids (61, 
194, 215). OXA-23 was first identified in Scotland, 1985, in an imipenem resistant A. 
baumannii, though it was originally called ARI 1 (205). The oxa23 gene has been detected in 
Tn2006, Tn2007, Tn2008, Tn2008B, Tn2009 (194, 215) (Fig 1.1). All of these transposons, 
except Tn2007 which has ISAba4 upstream, have ISAba1 upstream of oxa23 (194). The oxa23 
gene has been mobilised from the chromosome of Acinetobacter radioresistens, in which it is 
intrinsic (212). In the A. radioresistens sequences to date, there is no IS upstream of the oxa23 
gene and these isolates are susceptible to carbapenems, indicating that an overexpression of 
OXA-23 is required to confer resistance (194). 
 
 
Figure 1.1 The five structures harbouring oxa23 in A. baumannii. Arrows indicate orientations and extents of 
genes and open reading frames and the oxa23 gene is in orange. The blue box is ISAba1 and the green box is 
ISAba4 and the internal arrows indicate the orientation of the transposase. The curved arrow below indicates the 
distance between the IS and the start codon of the oxa23 gene. The arrow designated ‘P’ indicates the position 
and orientation of the strong promoter in ISAba1. Figure adapted from Nigro et al. (194). 
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|||||||||||||||||||||||||| |||||||||||||||||||||||||||||||||||||||||||       ||||||||||||||||||||||||||||||||| 
GTATTCGTCGTTAGAAAACAATTATTGTGACATTATTTCAATGAGTTATCTATTTTTGTCGTGTACAGAG-------TTATTTTCTATTGATCTGGTGTTTAAAATGAAT 
|      | | | |      |   || | |     | | | |   || | |      |   |    |             ||||||||| |||||||||||||||||||| 
GAGCCTTTGGGTTGTGTCGTAACTTTCTAAATGGCTCTAACTACCTTTTTTTCAAGGGCTTTTCTTATCCGTAATTCGGGTTTTCTATTCATCTGGTGTTTAAAATGAAT Tn2007
Tn2008B
Tn2008
NIPH 2130
2
oxaAr
A. radioresistens
P
P
P
P
50 20
1
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ATCCTGATAGGATAAGGGTTCTGTGAAATTTGTCGTGTACAGAG 
 |     ||    || |  |     |  |||||||||||||||| 
GTGACATTATTTCAATGAGTTATCTATTTTTGTCGTGTACAGAG 
    |||    |    || |   | |   ||||||||||    | 
ACATCATTGGCTGGCAGATTCTGCAAAAATTGTCGTGTATTTTG 
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ACATCATTGGCTGGCAGATTCTGCAAAAATTGTCGTGTATTTTG 
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(a)
(b)
500 bp
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Only Tn2006 and Tn2009 are true class I or composite transposons, with two copies of ISAba1 
flanking the internal segment containing oxa23 (Fig 1.1). Tn2006 has been experimentally 
proven to transpose, and like ISAba1, produces a 9 bp target site duplication (TSD) (181). A 
characteristic TSD surrounding Tn2008, Tn2008B and Tn2009 in different locations indicates 
that these transposons are also mobile (180, 194). Tn2006, is often located within a larger 
transposon Tn6022 and this entire structure is named AbaR4 (3). AbaR4 itself is mobile and 
has been seen in both the chromosome and on plasmids of A. baumannii (3, 88, 99, 140, 232, 
238). 
 
The OXA-24 group was the second group of class D b-lactamases in A. baumannii, identified 
in 1997 in an outbreak in Spain (28). Most isolates containing OXA-24 are resistant to 
carbapenems although this is likely due a number of factors including efflux pumps (215). 
Genes encoding OXA-24 or related enzymes (OXA-40 and OXA-72) have been detected in 
plasmids from various species of Acinetobacter (46, 85, 172) and unlike oxa23, it is not usually 
associated with any IS. Instead, an internal segment encoding OXA-24 is found flanked by 
conserved inverted repeats of 28 bp that were found to be homologous to XerC-XerD binding 
sites (46). These sites contain the 11 bp binding sites for the XerC and XerD recombinase 
separated by a 6 bp spacer (46). The segment containing the oxa24 gene and surrounded by 
XerC-XerD binding sites has also been detected in two locations in the RepAci1 plasmid 
pAB120 (220), as well as in plasmids of novel Rep types (85, 172). It has been suggested that 
this module is mobile and the XerC-XerD binding sites may have a role in its mobilisation (46, 
172). 
 
The first OXA-58 enzyme was identified in France in 2003 (214) and similar to OXA-24 
enzymes it only hydrolyses carbapenems at low levels, so clinical levels of resistance in isolates 
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encoding these enzymes is usually multifaceted (61, 215). Variants of OXA-58 have since been 
identified including OXA-96, OXA-97 and OXA-164 (61, 215). The genes encoding OXA-58 
variants have been detected in many different contexts. Most are often associated with the 
ISAba3, though this is often interrupted by other insertions sequences such as ISAba2, IS1008 
and IS18 (61, 216). Genes encoding the OXA-58 enzymes have mostly been identified in 
plasmids (20, 64, 168, 216, 281).  
 
Class B b-lactamases (metallo-b-lactamases) are powerful carbapenemases. Four types of 
these enzymes have been reported in A. baumannii, IMP-like, VIM-like, SIM-1 and NDM-
type enzymes (211). The genes encoding the first three are found in gene cassettes in class 1 
integrons (211) and NDM is associated with ISAba125, which provides the gene with a strong 
promoter (58). Rarely, class A carbapenemases including KPC (226) and GES-type enzymes 
(26) have been detected.  
 
1.3.4 Aminoglycoside resistance 
A variety of aminoglycoside resistance genes have been detected in Acinetobacter and are 
listed in Table 1.2. Most of these genes confer resistance to a subset of aminoglycoside 
antibiotics through enzymatic modification and encode phosphotransferases, acetyltransferases 
and adenyltransferases (239). However, the armA gene is a 16S rRNA methyltransferase that 
provides ribosomal protection through methylation of 16S rRNA, which impedes the binding 
of aminoglycosides to the 30S subunit (54, 72). This gene confers resistance to all clinically 
relevant aminoglycosides (72).  
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Table 1.2 Aminoglycoside resistance genes, their typical phenotypes and context 
Gene Confers resistance to Context 
aacC1 Gentamicin Gene cassette 
aacC2 Gentamicin, netilmicin, tobramycin  
aadA1 Streptomycin, spectinomycin Gene cassette 
aphA1b Kanamycin, neomycin Tn6020, Tn4352 
aphA6 Amikacin, kanamycin, neomycin TnaphA6 
aacA4a1 Amikacin, netilmicin, tobramycin Gene cassette 
aacA4b1 Gentamicin, netilmicin, tobramycin Gene cassette 
aadB Gentamicin, kanamycin, tobramycin Gene cassette in secondary site 
aac(6’)-Im Amikacin, netilmicin, tobramycin Gene cassette 
armA Amikacin, gentamicin, netilmicin, 
tobramycin, kanamycin 
Tn1548-like 
1The substrate specificity of the aacA4 changes based on a single base change that results in an amino acid change.  
 
Many of the aminoglycoside resistance determinants listed in Table 1.2 are located in gene 
cassettes in class 1 integrons and are often located within specific cassette arrays (211). The 
aacC1 and aadA1 genes are often found together in the cassette array of aacC1-orfP-orfP-
orfQ-aadA1 or aacC1-orfP-orfQ-aadA1 in a class 1 integron, with the sulphonamide resistance 
gene sul1 in the 3`-conserved segment (3`-CS) (Fig 1.2) (3, 183, 188, 217, 219, 262, 265). 
Previously, the orfP and orfQ gene cassettes have been referred to as orfX and orfX’(217, 219, 
265). 
 
 
Figure 1.2 Typical cassette array found in class 1 integrons in A. baumannii. Arrows indicate extent and 
orientation of genes and open reading frames. The aadA1 gene is orange, aacC1 is green and the sul1 gene is 
mauve. The sequence of the 5`-CS, gene cassettes and 3`-CS are indicated by the bars above. The attI site is shown 
by the open box and the black bars indicate the attC site of each gene cassette. The location and orientation of the 
promoter is indicated by Pc.  
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Isolates containing either of these two cassette arrays commonly also contain the aphA1b gene 
(127, 183, 265), which was later shown to be located in Tn6020 (188, 217), a 3.07 kb compound 
transposon flanked by IS26s.  
 
Another frequently detected cassette array found in a class 1 integron includes the aacA4-
catB8-aadA1 array (232, 262), that in addition to conferring resistance aminoglycosides also 
contains the chloramphenicol resistance gene catB8. This array is often found associated with 
the armA gene within a Tn1548-like transposon that is flanked by IS26s (136, 285, 286).  
 
Rarely, other cassette arrays containing aacA4-orfO-blaOXA-20 (129) or aac(6`)-Im-aadA1 genes 
(105) have been detected in other class 1 integrons. The aadB gene cassette is inserted in a 
secondary site in the small plasmid pRAY (236). The original sequence of pRAY contained a 
number of errors and a correct sequence pRAY* was released (100). A number of different 
variants eg. pRAY*-v1 and pRAY*-v2 have been detected (100).  
 
The aphA6 gene (147, 148) in Acinetobacter is most commonly located within TnaphA6, a 
composite transposon flanked by copies of ISAba125 (Fig 1.3) (197). It is thought that the 
aphA6 gene originated in A. guillouiae, an amikacin susceptible environmental species and has 
been mobilised by ISAba125, resulting in over-expression of the aphA6 gene and high level 
resistance (279). This transposon is frequently found on plasmids (90, 97, 148, 192, 277). 
 
 
Figure 1.3 Structure of TnaphA6. The purple arrow indicates the extent and orientation of the aphA6 gene. The 
green boxes represent ISAba125 and the internal arrow indicates the orientation of the transposase 
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1.3.5 Quinolones and fluoroquinolones 
Resistance to quinolones and fluoroquinolones can occur through mutations in the genes 
encoding the bacterial gyrase (gyrA and gyrB) and topoisomerase IV (parA and parC), that 
lower the binding affinity of these antibiotics to the enzyme-DNA complex (211). The most 
commonly reported mutations that have been experimentally shown to confer resistance to 
fluoroquinolones such as ciprofloxacin are those that result in a Ser-81-Leu substitution in 
GyrA and a Ser-84-Leu substitution in ParC (267, 268).  
 
1.3.6 Tetracycline resistance 
Tetracycline resistance in A. baumannii is commonly due to the presence of the TetA and TetB 
resistance determinants which are efflux pumps that specifically remove tetracycline from the 
cell (169, 211). The TetB determinant additionally confers resistance to minocycline (225). 
Another efflux pump, the Tet39 determinant, has been detected in A. baumannii isolates and 
like TetA, only confers resistance to tetracycline (5, 98). The TetM determinant has also been 
seen and confers resistance through ribosomal protection (223). Resistance to tigecycline, a 
modified tetracycline known as a glycycline, is often associated with overexpression of 
AdeABC and AdeIJK efflux pumps (described below) (209).  
 
1.3.7 Sulphonamide and trimethoprim resistance 
Sulphonamide resistance is frequently detected in A. baumannii (207, 211). Class 1 integrons 
which harbour the sul1 resistance gene in the 3`-CS are frequently detected (36, 86, 120, 128, 
193, 219, 252). Sulphonamide resistance in Acinetobacter can also be conferred by the sul2 
gene (191, 198), which is usually adjacent to a full or partial CR2, in a fragment derived from 
GIsul2 (189). Resistance to trimethoprim can be associated with dfr genes located in gene 
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cassettes in integrons (86, 259) or overexpression of intrinsic efflux pumps (described below) 
(44).  
 
1.3.8 Colistin resistance 
The main mechanism of polymyxin resistance involves modification of lipid A (LPS) which 
reduces that net negative charge of the outer membrane (211). Point mutations and frameshift 
in the pmrA and pmrB genes, that form a two-component system involved in regulating the 
modification of LPS, have been shown to cause an increase in colistin MICs (4, 221). There is 
also evidence that resistance to colistin may also be attributed by complete loss of LPS by 
mutations in genes involved in lipid A biosynthesis (lpxA, lpxC and lpxD) (245, 270).  
 
1.3.9 Rifampicin resistance 
Resistance to rifampicin is most frequently due to mutations leading to amino acid changes in 
the active site of bacterial RNA polymerase and a number of different mutations have been 
associated with increase in MICs (80). Rarely, the acquired arr-2 resistance gene which 
enzymatically inactivates rifampicin, has been detected in a cassette in class 1 integrons (121, 
154).  
 
1.3.10 Chloramphenicol resistance 
An intrinsic efflux pump of the major facilitator superfamily, CraA (‘chloramphenicol 
resistance Acinetobacter’), was identified in A. baumannii (227). This efflux pump has high 
affinity to chloramphenicol and has been shown to confer high levels of resistance (227). 
Despite intrinsic resistance, chloramphenicol resistance genes encoding efflux pumps such as 
cmlA genes or those encoding a chloramphenicol-modifying enzyme such as cat genes, have 
been detected in A. baumannii (44, 217, 286).   
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1.3.11 Macrolide resistance 
Although A. baumannii are intrinsically resistant to macrolides, acquired resistance genes 
conferring resistance to this class of antibiotics have been detected. These include the msrE 
and mphE resistance genes (285, 286).  
 
1.3.12 Additional efflux pumps involved in antibiotic resistance 
Efflux pumps from a number of different families including three efflux pumps from the 
resistance-nodulation-cell division (RND) family, AdeABC, AdeIJK and AdeFGH, as well as 
AbeM, from the multidrug and toxic compound extrusion family (MATE) and AbeS, a member 
of the major facilitator superfamily (MFS) have been detected in A. baumannii (44). Over 
expression of AdeABC efflux pump contributes to resistance to a broad-range of antibiotics 
including aminoglycosides, b-lactams, fluoroquinolones, erythromycin, chloramphenicol, 
tetracycline and tigecycline (278). Overexpression of AdeABC has been shown to provide a 
strong synergistic effect with aminoglycoside and carbapenem resistance genes (44). 
Upregulation of the AdeFGH pump also contributes to resistance to fluoroquinolones, 
chloramphenicol, trimethoprim and sulphonamides (44). The AdeIJK pump is constitutively 
expressed (47) and contributes to intrinsic resistance against b-lactams, fluoroquinolones, 
tetracyclines, tigecycline, erythromycin, chloramphenicol, trimethorprim, sulphonamides and 
rifampicin. AbeS has been shown to contribute to resistance against chloramphenicol, 
fluoroquinolones and erythromycin (247) and in addition the substrate range of AbeM also 
includes kanamycin and trimethoprim (250).  
 
1.4 A. baumannii clones 
Early analysis of different outbreaks of A. baumannii isolates were performed by a variety of 
molecular methods including ribotyping, pulsed-field gel electrophoresis (PFGE), randomly 
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amplified polymorphic DNA (RAPD) and amplified fragment length polymorphism (AFLP) 
(271). These older methods successfully differentiated isolates but they have limitations as they 
can be quite cumbersome, time consuming and expensive to perform. Studies employing these 
methods recognised that isolates from unrelated outbreaks shared similar characteristics (52). 
Typing of isolates from Northern Europe found that most of the outbreak and MAR isolates 
were members of two clones, I and II (182, 184). By the early 2000’s, studies had detected 
isolates belonging to clone I and clone II across numerous countries across Europe including 
Spain, Italy, Greece, Portugal, Turkey and South Africa (182). Hence, these two clones became 
known as European clones (EC) I and II. Evidence of a third clone, EC III was also identified 
by ribotyping, though isolates belonging to this group were less common (182).  
 
In 2007, a PCR typing scheme was developed that distinguished isolates into 3 groups which 
corresponded to the three clonal complexes (261). This scheme was based on the sequences of 
the ompA, csuE and oxaAb genes and sequence group (SG) 1 corresponded to EC II and SG2 
corresponded to EC I (261). EC III corresponded to SG3. Other new and simple PCR and 
sequence based methods facilitated the analysis of larger, more diverse strain collections from 
around the world. Publications from 2009-2010 showed that EC I and II could be detected in 
hospitals on different continents (51, 70, 113, 180, 208, 217, 219), and henceforth these clones 
will be called global clones (GC) 1 and 2.  
 
Two multi-locus sequence typing (MLST) schemes have been developed for A. baumannii (12, 
51) and use the sequence of seven house-keeping genes, some of which are shared (indicated 
on Fig 1.4). In the Instiut Pasteur (IP) scheme ST1 correlates with GC1 isolates and ST2 with 
GC2 isolates, with closely related isolates being a single or double locus variants (SLV, DLV) 
(51). Profiles of GC1 and GC2 isolates can be quite variable using the Oxford Scheme (104) 
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and this is due to the high levels of variation in the gyrB allele and in the gpi allele which is 
located in the capsule locus which has been shown to frequently switch (119, 137). The A. 
baumannii MLST database (http://pubmlst.org/abaumannii) currently contains 2,227 unique 
sequences (Aug, 2017).  
 
 
Fig 1.4 Schematic of the A. baumannii chromosome showing the location of genes used in the Pasteur and 
the Oxford MLST schemes. White circles in a black box show genes used in both schemes while the genes 
indicated by the green squares are used in the Pasteur Scheme and the red dots indicate genes used in the Oxford 
Scheme.  
 
Most carbapenem resistant isolates are members of the global clones and the majority of these 
are GC2 (113, 131). The carbapenemase gene most frequently associated with resistance in 
GC2 isolates is the oxa23 gene. Other problematic STs that are not members of the global 
clones have been reported including ST25 and ST78 (50), and ST85 (25).  
 
1.5 A. baumannii genomics  
Whole genome sequence data has enabled in-depth comparison of bacterial isolates. The first 
A. baumannii genome was sequenced in 2006 (67), and at the advent of this project there were 
17 completed genomes, 9 of which were GC2. However, as of July 2017 there are now 71  
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Figure 1.5 Completed A. baumannii genomes in GenBank. A. Year of submission of genome. B. Geographic 
density of isolation. C. Isolation by country.  
 
!
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completed genomes in GenBank (Fig 1.5A) and 39 of them are GC2 isolates (Appendix I; 
Table A1.1). 
 
There are also over 2,000 draft A. baumannii genomes 
(https://www.ncbi.nlm.nih.gov/genome/403). At first these genomes were sequenced using 
less accurate and cumbersome sequencing technologies including 454 and Sanger whole shot-
gun sequencing, but as sequencing technology improved, Illumina HiSeq and MiSeq platforms 
were used. In general, the HiSeq and MiSeq genomes were more accurate than the earlier 
genomes, but many may have suffered from assembly errors. From 2013 onwards, genomes 
sequenced by PacBio, a third-generation technology, began to be released and are the most 
accurate due to the long reads produced. A description of the differences between these 
sequencing technologies is provided in Section 1.11.  
 
The Fig 1.5B and C show the location of isolation of the completed genomes and A. baumannii 
from 16 countries have been sequenced. Most countries have below 5 sequenced genomes (Fig 
1.5C). China and USA have 9 and 10 genomes respectively, but South Korea currently has the 
highest count of 23 (Fig 1.5C), and all but one of them released prior to 2016 (Appendix I; 
Table A1.1). 
 
The genome of A. baumannii isolates ranges from 3.7 Mb to 4.3 Mb. Whole genome 
phylogenies reveal separate clusters for GC1 and GC2 isolates and are consistent with MLST 
data (130, 162, 228, 254). Attempts to define the core genome of A. baumannii varied based 
on number and identity of strains analysed, but overall evidence suggests that it lies between 
1,455 and 2,688 genes (3, 63, 130). This is around 60% of the average strain genome content 
and mostly encodes proteins involved in metabolic and cellular processes (9). However, the 
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pan genome, including both the core and accessory genome for A. baumannii is impressively 
large (over 8,800 genes) (9) and will likely continue to grow as more sequences become 
available. This accessory genome includes prophage regions, siderophore clusters, heavy metal 
resistance clusters and resistance islands and other mobile genetic elements (3, 130). Variation 
in gene content within chromosomal islands carrying antibiotic resistance genes has been a 
large focus of the analysis of the accessory genome of A. baumannii.  
 
1.6 Chromosomal resistance islands  
Both GC1 and GC2 isolates contain their own characteristic resistance islands located in the 
chromosome that contain clusters of antibiotic resistance genes. These regions are composed 
of fragments of transposons, IS, integrons and other mobile elements such as common region 
(CR) elements that either contain or are associated with specific antibiotic resistance genes.  
 
1.6.1 GC1 AbaR islands 
Most antibiotic resistant GC1 isolates contain a resistance island, named AbaR (A. baumannii 
resistance island) inserted in a chromosomal ATPase, later renamed comM, and surrounded by 
the 5 bp TSD of 5`-ACCGC-3` (Fig 1.6) (3, 67, 217). The first multi-antibiotic resistant GC1 
isolate analysed was AYE, from France in 2001, and it was found to contain an 86 kb island in 
comM, designated AbaR1 (67). AbaR1 contains genes conferring resistance to various 
antibiotics and heavy metals and these genes were often in fragments of transposons (67). All 
of the antibiotic resistance genes in AbaR1 are located in a central region designated MARR 
(multiple antibiotic region) that is flanked by two copies of Tn6018 (previously named ISPu12-
like elements) (217) and forms a transposon (Fig 1.6). This transposon is inserted in the uspA 
gene of Tn6019 and it is Tn6019 that is inserted in the comM gene and forms the backbone of 
this island (217). An addition, a region containing arsenate/asenite resistance genes is located 
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between tniE and the uspA gene of Tn6019. The transposon Tn6019 has imperfect 26 bp IRs 
and the first 5 genes likely encode its transposition functions and have been called tniA, tniC, 
tniB, tniD and tniE (88). The gene named sup in Tn6019 (217) encodes a sulphate permease 
which had previously been incorrectly annotated as sul1. 
 
 
Figure 1.6 Structure of AbaR. The arrows indicate the extents and orientations of genes. The grey arrows are 
the fragments of the chromosomal comM gene. IRs are shown by vertical lines and the vertical arrow above 
indicates the insertion point of the Tn6018 flanked MARR, while the vertical arrow below so the position of genes 
involved in arsenic resistance.  
 
 
Many variants of AbaR islands have since been discovered, but AbaR1 is still the largest (3, 
145, 146, 198, 217, 219), and it appears that relative to other AbaRs, AbaR1 has acquired an 
additional region of antibiotic resistance genes. A comparison of AbaR1, AbaR3 (AB0057, 
isolated in America) (3) and AbaR5 (characterised in the Australian isolate 3208) (217) showed 
that a portion of the MARR region present in AbaR3 was missing in the other two islands. 
Hence, it was concluded that AbaR3 was ancestral (217). However, recent analysis has 
revealed that AbaR3 cannot be the ancestral to AbaR1 and AbaR5, as AbaR3 contains a 108 
bp deletion in the 5`-CS of the integron, and this sequence was present in the other islands 
(103). The ancestor of AbaR3, AbaR1 and AbaR5 is AbaR0. This structure, characterised in 
an Australian isolate (WM98), does not contain the 108 bp deletion but in all other ways is 
identical to AbaR3 (103).  
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The MARR region of AbaR0, shown in Fig 1.7 is made up of fragments of known transposons 
which are indicated above. These include the mercury resistance module of Tn1696, the tet(A) 
resistance determinant in a fragment of Tn1721, the catA1 gene in a partial Tn2670, blaTEM 
within a partial Tn1 and a complete Tn6020 containing the aphA1b gene (Fig 1.7). A class 1 
integron containing aacC1-orfP-orfP-orfQ-aadA1 gene cassettes with sul1 in the 3`-CS is also 
present (Fig 1.7) (67, 217). An additional fragment of the 3`-CS is present containing a second 
copy of sul1. Within the MARR of AbaR0, there are three copies of IS26 and much of the 
variation reported in other AbaR structures is due to IS26 mediated deletions. 
 
 
Figure 1.7 Structure of the Tn6018 flanked MARR of AbaR0. Arrows indicate the extents and orientations of 
genes and open reading frames. The sul1 gene is purple, the tet(A) determinant is in pink, the catA1 gene is yellow, 
the blaTEM genes is blue, the aphA1b gene is red-orange and aacC1 gene and aadA1 gene are orange and green 
respectively. Coloured boxes indicate insertion sequences and the internal arrow indicates the transposase gene. 
Vertical bars indicate IRs and the open box indicates the attI site. The lines above represent the regions derived 
from known transposons with vertical lines indicate the boundaries between segments and X showing a 
recombination crossover.  
 
1.6.2 AbaR4, Tn6022 and Tn6021 
In a GC1 isolate another transposon has been detected in the comM gene and surrounded by 
the same 5 bp direct repeat as AbaR islands (88). This island is called AbaR4, consists of the 
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backbone transposon Tn6022 with Tn2006 containing the oxa23 gene inserted in the sup gene 
(3, 88). AbaR4 was first identified in a secondary location in the GC1 isolate AB0057, which 
had AbaR3 in comM (3). Tn6022 is related to Tn6019 but is more closely related to another 
transposon, Tn6021 (88) that was identified in the comM gene of ATCC 17978 (244). Hence, 
Tn6019, Tn6021 and Tn6022 are part of the same family of transposons that target the comM 
gene.  
 
1.6.3 Chromosomal resistance islands in GC2 
1.6.3.1 Resistance islands in comM 
GC2 isolates also contain a resistance island inserted in the comM gene and surrounded by the 
same 5 bp TSD as AbaR islands. The first completed GC2 genome was of an Italian isolate 
ACICU (129). This isolate had part of an AbaR island and that was called AbaR2. AbaR2 is 
lacking the left end of most AbaR islands and contains Tn6020 and a class 1 integron 
containing the aacA4-orfO-blaOXA-20 cassette array, followed by Tn6018 and the right end of 
Tn6019 (129). ACICU is the only sequenced GC2 that contains an AbaR type resistance island 
in comM and hence appears to be of a separate lineage to all of the other sequenced GC2 
isolates.  
 
The majority of GC2 isolates contain a different island in this position. Early analysis of the 
island in comM of GC2 isolates differentiated it from the AbaR islands of GC1 isolates as 
Tn6022 rather than Tn6019 could be detected at the left end and the uspA gene was intact as 
no copies of Tn6018 were present (217). Furthermore, the resistance content of the island 
differed from that found in AbaR islands. Most GC2 isolates contain the tet(B) determinant, 
the strB-strA genes (190, 238, 260, 285) and some also include the sul2 gene (125, 191, 193). 
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Many of these structures have been assigned AbaR numbers or called AbaR4-like islands in 
the literature, though most do not resemble to AbaR islands.  
 
Broadly, there appear to be two main types of these islands in GC2 isolates. The first type, 
named Tn6166 and later AbGRI1-2 (A. baumannii genomic island 1), has the structure shown 
in Fig 1.8 (191). This 37 kb island contains Tn6022∆1 at the left end (has a 2.85 kb deletion in 
respect to Tn6022), followed by an orf region, and a fragment of a transposon 86% identical to 
that of Tn6022 (191) and recently this has been named Tn6173 (94). Another portion of this 
transposon, containing orf4b bounds the right end of this island (94). These two fragments of 
Tn6173 are separated by a region derived from GIsul2 with a fragment of Tn10 containing the 
tetA(B) determinant within it, adjacent to a segment of Tn5393 containing the strB and strA 
genes (Fig 1.8) (191). Interestingly, a large portion of this island has recently been discovered 
in the conjugative plasmids pD4, pA293-10, pAB3 and the resistance island in these plasmids 
is likely the origin of AbGRI1 (94). In addition, AbGRI1-2 also contains ISAba17 inserted in 
the orf between the delta tniE and uspA genes in Tn6022∆1 and Tn2006 containing the oxa23 
gene in the orf region (Fig 1.8) (191). So far, this arrangement appears to be unique to 
Australian isolates from the East Coast (193).  
 
Figure 1.8 Structure of AbGRI1-2. Arrows indicate extents and orientations of genes and open reading frames. 
The sul2 gene is pink, the tetA(B) and tetR(B) genes are dark blue and the strB and strA genes are light green. The 
light blue box represents ISAba1, the yellow boxes indicate CR2 elements and the arrows inside represent the 
orientation of the transposase and rolling circle replicase, respectively. Vertical bars indicate IRs. Bars above 
indicate the origin of segments and vertical arrows indicate the deletion (∆) and location of insertions. Figure 
made to scale from GenBank accession number JN96883.  
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The second group of these islands appear to have derived from a structure that has acquired a 
second copy of Tn6022, which is inserted in the last 6 bp of the tetA(B) gene. The 41.6 kb 
resistance island in comM of MDR-TJ, called RIMDR-TJ, is an example of this (Fig 1.9A) (125). 
The stop codon for the tetA(B) gene now lies 18 bp within the IRr of Tn6022 and these 
additional bases do not appear to alter the function of the protein. A closely-related version of 
this island, called AbaR24, was assembled from isolates from Latvia and had AbaR4 instead 
of Tn6022 in this position (Fig 1.9A) (232).  
 
 
Figure 1.9 AbGRI1 variants. Arrows indicate extents and orientations of genes and open reading frames. The 
sul2 gene is pink, the tetA(B) and tetR(B) genes are dark blue and the strB and strA genes are light green. The 
light blue box represents ISAba1, the yellow boxes indicate CR2 elements and the arrows inside represent the 
orientation of the transposase and rolling circle replicase, respectively. Vertical bars indicate IRs. Bars above 
indicate the origin of segments and vertical arrows indicate the deletion (∆) and location of insertions. Figure 
made to scale from GenBank accession number CP003500 for RIMDR-TJ and from GenBank accession number 
JN247441 for AbGRI1-1.  
 
The variant detected in A320, the type strain for GC2 isolates and the oldest known isolate 
from 1982 was named AbGRI1-1 (previously referred to as Tn6166) (190) (Fig 1.9B). This 
variant was only 17.6 kb and has likely derived from an island related to RIMDR-TJ as the tetA(B) 
gene in AbGRI1-1 is also missing 6 bp (190). It is likely that recombination between Tn6022∆1 
and Tn6022 of RIMDR-TJ has removed the orf region, the fragment of Tn6173 and the sul2 gene 
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to form AbGRI1-1. Variants of AbGRI1-1 containing Tn2006 in exactly same the position in 
the sup gene as in AbaR4, was detected in the isolate AB210 from the UK (260), as well as in 
isolates from Lithuania where it was called AbaR4b (238) (Fig1.9B). Another variant detected 
in another Lithuanian isolate is virtually identical to AbGRI1-1 but instead of Tn6022∆1, it 
contains a full Tn6022 at the left end of the island. It is likely that a slightly different 
recombination event between Tn6022∆1 and Tn6022 from RIMDR-TJ has resulted in the 
evolution of this structure.  
 
Another variant detected in 1656-2 (202), an isolate from South Korea, has evolved from 
RIMDR-TJ, through the acquisition of an additional of a region containing the blaPER gene 
between strA and orf4b, as well as the loss of the full Tn6022 and the tetA(B) determinant, 
likely through recombination between the partial and full CR2. The structure present in the 
Chinese isolates MDR-ZJ06 (285), named AbaR22, has a full copy of Tn6022 the left end of 
the island, followed by the orf region and the Tn6173 fragment. However, the tniBb gene in 
∆Tn6173 has recombined with the tniB gene of the second copy of Tn6022, forming a hybrid 
transposon, and the sul2 region has been lost. The right end of the island is the same as RIMDR-
TJ. This implies that variants of this island with two full copies of Tn6022 may also be 
circulating.  
 
1.6.3.2 AbGRI2 resistance island 
This resistance island was only discovered and characterised in 2013 and is located in another 
region of the chromosome (Fig 1.10B) (188), however it was noted that a segment of the 
surrounding chromosome was missing. Unlike the islands in the comM gene, this resistance 
island was not located in a backbone transposon but was bounded by two copies of IS26 (Fig 
1.10A). 
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Figure 1.10 AbGRI2. A. Structure of AbGRI2-1. B. Schematic of the GC2 chromosome indicating the location 
of AbGRI1 and AbGRI2. In A. the arrows indicate extents and orientations of genes and open reading frames. 
The blaTEM gene is blue, the aphA1b gene is red-orange, the sul1 gene is purple and the aadA1 and aacC1 gene 
are green and orange, respectively. The IS are represented by coloured boxes and the internal arrow indicates the 
orientation of the transposase gene. IS26, IS1 and IS6100 are shown by the green, dark blue and light blue boxes 
respectively. Vertical bars indicate IRs and the bars above indicate the origin of segments. The dashed lines and 
the black triangle indicate sequence missing in AbGRI2-1. Figure made to scale from GenBank accession number 
JX869489 for AbGRI2-1. In B. the arrows indicate the location of AbGRI1 and AbGRI2.  
 
The first characterised version of this resistance island was AbGRI2-1 and assembled from the 
draft genome of two Australian isolates, A91 (2004) and WM99c (1999) (188). AbGRI2-1 was 
19.5 kb and was composed of fragments of known transposons containing resistance genes as 
well as three internal copies of IS26 (Fig 1.10A). This island contains the aphA1b gene in 
Tn6020 (217), a fragment of Tn1 containing the blaTEM gene and a class 1 integron containing 
the cassette array aacC1-orfP-orfP-orfQ-aadA1 and the sul1 gene in the 3`-CS (Fig 1.10A) 
(188). It was noted that a segment of AbGRI2-1 matched the MARR of AbaR islands. Two 
other variants of AbGRI2 were described in this work (188), AbGRI2-2 from the complete 
genome of MDR-TJ and AbGRI2-3 found in the complete genome of MDR-ZJ06. Both of 
these variants could have arisen from AbGRI2-1 via IS26 mediated deletions in addition to 
cassette switching for AbGRI2-3.  
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Recently, the structure of the AbGRI2 region in the GC2 type strain A320, isolated in 1982, 
was published (24). The AbGRI2 region in A320 had been separated into two separate islands, 
AbGRI2-0a and AbGRI2-0b by an IS26 mediated inversion (24). Reversal of this inversion in 
silico revealed a 32.4 kb resistance island AbGRI2-0 (Fig 1.11) that was inserted in the gene 
corresponding the ABA1_01225 in A1 (GenBank accession number CP010781) and 
surrounded by an 8 bp TSD (5`-CGCCAACT-3`) (24). This is the original insertion site of 
AbGRI2 and alludes to the important role of IS26 in its acquisition of this island into the GC2 
chromosome.  
 
 
Figure 1.11 AbGRI2-0 is ancestral to AbGRI2-1. Arrows indicate extents and orientations of genes and open 
reading frames. The blaTEM gene is blue, the aphA1b gene is red-orange, the catA1 gene is yellow, the sul1 gene 
is purple and the aadA1 and aacC1 gene are green and orange, respectively. The IS are represented by coloured 
boxes and the internal arrow indicates the orientation of transposase. IS26, IS1 and IS6100 are shown by the 
green, dark blue and light blue boxes, respectively. Vertical bars indicate IRs and the bars above indicate the 
origin of segments. The dashed lines and the black triangle indicate sequence missing in AbGRI2-1. Figure made 
adapted from Blackwell et al. (24).    
 
In addition to the resistance genes found in AbGRI2-1, AbGRI2-0 also contains the catA1 gene 
located in a fragment from Tn2670 and a mercury resistance module from Tn1696 (Fig 1.11) 
(24). AbGRI2-0 is ancestral to AbGRI2-1, and AbGRI2-1 can be derived from AbGRI2-0 via 
a number of events. An IS26 mediated deletion has removed a 12.7 kb central fragment from 
the island, that includes the catA1 gene and the mer module. The IS26 at the left end of 
AbGRI2-1 has switched orientation and 223 bp of AbGRI2-0 next to it is missing. In addition, 
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compared to AbGRI2-0, AbGRI2-1 has 47.2 kb of chromosomal sequence to the left of the 
island missing.  
 
The events detailed above that lead to the construction of AbGRI2-1 from AbGRI2-0 are quite 
specific and most of the reported structures from America and Asia have an island derived from 
AbGRI2-1 (24, 188, 193, 277). The island present in 1656-2 in Korea (202), has gained an 
addition IS26 bounded segment that includes the aac6`Im gene cassette (24).  
 
1.6.3.3 The origin of AbGRI2  
Recently, a resistance island from the M1 plasmid R1215 was assembled (top line in Fig 1.12) 
(22). R1215 was isolated from Serratia marcesencs, prior to 1980. The resistance region in 
R1215 is 37.8 kb in size and interrupts the mucB gene. This region is made up of the same 
fragments of transposons as both AbGRI2-0 and the centre of the MARR region of AbaR0 
(22).  
 
Figure 1.12 Relationship of the resistance island of R1215 to AbGRI2-0*. The R1215 resistance island is 
shown above and AbGRI2-0* is shown below. Arrows indicate extents and orientations of genes and open reading 
frames. The blaTEM gene is blue, the aphA1b gene is red-orange, the catA1 gene is yellow, the sul1 gene is purple 
and the aadA1 and aacC1 gene are green and orange respectively. The IS are represented by coloured boxes and 
the internal arrow indicates the transposase gene. IS26, IS1 and IS6100 are shown by the green, dark blue and 
light blue boxes respectively. Vertical bars indicate IRs. Figure adapted from Blackwell et al. (22).   
 
A comparison of AbGRI2-0*, which is a predicted precursor structure of AbGRI2-0 produced 
by the in silico reversal of two IS26 mediated inversions (24), displays the strong relationship 
between these two regions (Fig 1.12). The orientation of a segment including the aphA1b gene 
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is different in the two islands but as this segment is located between inversely-oriented copies 
of IS26, it could have inverted through homologous recombination (Fig 1.12). The R1215 
resistance island is also lacking ∆IS6100 adjacent to IS6100 but this has been shown to be lost 
by recombination (32, 204). Hence, the resistance island in R1215 is closely related to the 
progenitor of AbGRI2-0* and this region was likely acquired into the GC2 chromosome 
through the action of IS26 (22). It appears that a single GC2 A. baumannii cell became 
multiply-antibiotic resistant in a single step, prior to 1982, and all modern isolates have evolved 
from this cell as they all contain a remnant of the AbGRI2 island (22, 194). Current evidence 
does not indicate whether 1 or 2 was first.  
 
The centre of the MARR of AbaR0 can also be constructed from the resistance island in R1215, 
through its evolution is more complex. This involves inversions through homologous 
recombination, TU formation followed by TU integration by homologous recombination 
between a sul1 gene already present in the AbaR precursor (22). Hence, GC1 isolates also 
became resistant in a single step to multiple antibiotics.  
 
1.6.3.4 A third chromosomal resistance island 
Recently, a third chromosomal island has been identified in some American isolates. This 
island was reported to be located between the reading frames corresponding to ACICU_02398 
and ACICU_02399 in ACICU (GenBank accession number CP000863) (277). This resistance 
island contains the armA gene which encodes a 16S RNA methyltransferase which confers 
resistance to all clinically relevant aminoglycosides (72). The armA gene is located in an IS26 
bounded transposon that is related to Tn1548 (73) and hence is a second IS26 bounded 
resistance island in these isolates. In addition to the armA gene, this region is also associated 
with macrolide resistance genes msrE-mphE, a class 1 integron containing the aacA4, catB8 
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and aadA1 gene cassettes (conferring resistance to amikacin, tobramycin and netilmicin; 
chloramphenicol; streptomycin and spectinomycin) with the sulphonamide resistance gene 
sul1 in the 5`-CS and sometimes also with aphA1b gene (resistance to kanamycin and 
neomycin) (277). The authors also noted that this resistance island was present in the completed 
genome of TYTH-1 from China, indicating that this region was not just specific to American 
GC2 isolates (277). The armA gene has been detected in other GC2 isolates, but the location 
of these gene was not determined (53, 136).  
 
1.7 Tn6019, Tn6021 and Tn6022 family 
The transposons Tn6019, Tn6021 and Tn6022 (and AbaR4) all appear to target the same 
position in the comM gene and are surrounded by a 5 bp TSD of 5` ACCGC 3` (88). These 
transposons are all bounded by approximately 25 bp inverted repeats (IR) that end with 5`-
TGT-3` and a fragment of this IR is repeated multiple times at both ends of the transposon. 
They also share a conserved structure with 5 genes, tniC, tniA, tniB, tniD and tniE, that likely 
encode the transposition functions.  
 
The size and outer sequence of the IR, the size of the TSD and targeted mode of transposition 
of these A. baumannii transposons is similar to Tn402, Tn5053 and Tn7 (45), and for ease these 
transposons will be called Class III transposons. In addition, TniA and TniB of the A. 
baumannii transposons show homology with those of Tn402 and Tn5053. Transposon Tn402 
is both a transposon and a class 1 integron (176, 222). The transposition module of Tn402 
encodes four proteins, TniA, TniB, TniQ and TniR. TniA of Tn402 is 25% identical to TnsB 
of Tn7, (222) and encodes a transposase. However, instead of encoding a restriction enzyme 
like TnsA, Tn402 instead contains a resolvase, TniR (222) and a res site.  
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The transposition module of Tn7 encodes five proteins called TnsA, TnsB, TnsC, TnsD and 
TnsE, which facilitate transfer of this element (45, 210). The essential TnsA and TnsB proteins 
resemble a restriction enzyme and a transposase, respectively (210). Transposition of Tn7 can 
occur in a targeted manner using TnsD, where Tn7 moves to its preferred single site in a 
bacterial chromosome (45), or in a non-specific manner, utilising TnsE, where the transposon 
preferentially moves to a random site in a conjugative plasmid (210).  
 
1.8 IS elements 
1.8.1 IS26 
IS26 plays a key role in the evolution of resistance islands in A. baumannii. IS26 is a member 
of the IS6 family and is 820 bp in length with perfect 14 bp terminal IR, contains a single gene 
(tnp26) that encodes a 234 aa transposase and generates an 8 bp TSD upon insertion (177). 
IS26 has two modes of transposition, replicative and conservative mode. The replicative mode 
involves the formation of a cointegrate between the DNA molecule it resides in and the target 
molecule, duplicating an IS26 copy and generating a TSD (177). In the replicative mode, when 
the target of IS26 transposition is on the same DNA molecule as the donor IS, i.e. 
intramolecular transposition, either a deletion or inversion reaction occurs (10) depending on 
which strand is attacked by each end of the IS (Fig 1.13). Sequence deletion or inversion by 
IS26 has contributed to the evolution and rearrangement of many plasmids and chromosomes 
(22, 24, 109, 193, 218). 
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Figure 1.13 IS26 intramolecular transposition. Show the two outcomes of transposition of IS26 within the 
same DNA molecule, A. a deletion event, or B. an inversion event. These two outcomes are determined based on 
what strands are attacked. The pink arrow indicates a gene and different coloured lines are different segments of 
DNA sequence. The green box is IS26 and the internal arrow indicates the orientation of the transposase. The 
flags indicate the TSD.  
 
The recent discovery of the conservative mode of IS26 transposition invokes a circular 
translocatable unit (TU) consisting of a single IS26 and a unique DNA segment (potentially 
carrying an antibiotic resistance gene), which then preferentially inserts itself adjacent to 
another IS26 in the target sequence so that both IS26s are in the same orientation, with no 
duplication of the IS26 or of target bases (107). The result of this transposition reaction has the 
same structure as a class I transposon (107) and accounts for the structures of tandem arrays of 
the same DNA fragment flanked by IS26s (20, 163, 171, 287) as well as ‘overlapping’ IS26 
compound transposons with too few IS26s (32, 106, 217). Formation of TUs can occur via the 
replicative mode of IS26 transposition (deletion reaction) or through homologous 
recombination between two IS26s flanking a DNA sequence.  
 
1.8.2 ISAba1 
ISAba1 was first identified in A. baumannii isolates (111) and is frequently detected in multiple 
copies in the chromosome. ISAba1 is 1,180 bp in size and includes two overlapping open 
reading frames that encode the transposase. ISAba1 is a member of the IS4 family (167) and 
B. A. 
+
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causes a 9 bp TSD at the site of transposition (111). This IS is able to affect the expression of 
neighbouring genes as it contains an outwardly facing promoter that includes both the -35 and 
-10 sequence (111). This IS is frequently detected upstream of the chromosomal ampC gene in 
clinical isolates, increasing its expression and contributing to third generation cephalosporin 
resistance (42, 89). ISAba1 is frequently associated with the oxa23 gene and is a component 
the oxa23-containing transposons Tn2006, Tn2008 and Tn2009 (Fig 1.1) (194).  
 
1.9 Plasmids 
In general, plasmids are circular double-stranded DNA molecules that replicate independently 
of the host chromosome (16, 69). Most plasmids do not encode functions that are vital for the 
cell so can be lost and gained without any deleterious effect (69). Plasmids can exhibit broad 
host range, where they can transfer and survive in vastly different bacterial species, such as 
those found in the family of Enterobacteriaceae, or narrow host range where they are limited 
to a small number of similar bacterial species (16).  
 
Some plasmids encode the functions required for transfer between cells and these plasmids are 
termed conjugative or self-transmissible. Conjugative plasmids have their own relaxase (and 
helper protein), origin of transfer (oriT site), type four coupling protein (T4CP) and type four 
secretions system (T4SS) conjugative apparatus so are generally required to be larger than 30 
kb (69, 242). Some smaller plasmids are termed mobilisable (242), as they are able to be 
transferred by conjugation when a suitable helper conjugative plasmid is present in the same 
cell. Mobilisable plasmids can have their own oriT and relaxase but are recognised by the T4CP 
of a suitable conjugative plasmid, termed mobilisation in cis (242). However, in mobilisation 
in trans, the small plasmid has an oriT sequence that mimics the co-residing conjugative 
plasmid and relies on the conjugative plasmids relaxase, T4CP and T4SS (200).  
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1.9.1 Acinetobacter plasmids 
The plasmids of Acinetobacter are specific to the genus and other plasmids found in 
Enterobacteriaceae are unable to replicate in Acinetobacter (21). Acinetobacter plasmids range 
from small cryptic plasmids, small plasmids containing one or two resistance genes, and large 
plasmids that may carry a number of resistance genes. Three different sets of conjugative 
transfer genes have been detected in Acinetobacter plasmids (87, 97, 126) and many of the 
small plasmids carry homologues of mobilisation genes (relaxase and helper proteins).  
  
So far, Acinetobacter plasmids have been characterised based on their replication initiation 
protein. In 2010 Bertini et al. (21) analysed 18 A. baumannii plasmids available in GenBank 
and characterised 9 different replicase types which were designated RepAci1-9 as well as 
identifying a number of other Rep types that were not assigned Aci numbers (21). Some 
plasmids contained two different replication initiation proteins. A limitation of the replicon 
typing (21) was that, by definition, it did not include plasmids without a known replication 
initiation gene. The small plasmid pRAY (6 kb), containing the aadB gene (tobramycin, 
gentamicin and kanamycin resistance), contains no replication initiation protein but does 
encode mobilisation proteins. 
 
Due to the decrease in the cost of genome sequencing over the last 7 years many more plasmid 
sequences are now available. As of July of 2017, there are now over 183 sequenced A. 
baumannii plasmids in GenBank and the analysis of Bertini et al. (21) likely under represents 
the diversity of the plasmids found in this species.  
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1.9.1.1 Bertini PCR-based plasmid replicon typing scheme 
This scheme characterised 9 different replicase types but all of the Rep proteins belonged to 
one of two protein families, Pfam03090 or Pfam0105. The RepAci6 protein was the only 
representative of Pfam03090 and does not contain any iterons (21). The other replicase types 
detected were members of the Rep-3 superfamily, Pfam0105, and all of these plasmids  
included iteron sequences upstream of the rep gene (21). A number of these plasmids contain 
orthologues of the MobA or MobS-MobL mobilisation proteins indicating that they may be 
mobilised by a suitable, self-transmissible plasmid (21). The RepAci9 plasmid pMAC (9,540 
bp), isolated from ATCC 19606, has been well characterised (56). The genes and regions 
performing replication functions, plasmid mobilisation as well as involved in organic peroxide 
resistance were shown experimentally (56).  
 
1.9.1.2 RepAci1 and RepAci2 plasmids 
The cryptic RepAci1 plasmid pAB0057 (3) is detected quite frequently in sequenced isolates 
and the pAb-G7-1 variant (97) is seen in GC1 isolates from Australia. Most Australian GC2 
isolates contain a cryptic RepAci2 plasmid, represented by pD72-1 (192, 193). However, 
RepAci1 and RepAci2 plasmids carrying the oxa24 resistance gene have also been reported 
(46, 179, 220).  
 
1.9.1.3 RepAci6 plasmids 
RepAci6 plasmids are common in sequenced isolates and oxa23 containing transposons, 
Tn2008, Tn2006 and AbaR4, as well as aphA6, located in TnaphA6 have been detected in these 
plasmids (90, 97, 99, 192, 195, 277). These plasmids carry an MPFF type transfer region and 
have been shown to conjugate (97). The mobilisation proteins encoded by RepAci6 plasmids 
are closest to those of IncW and hence have been named TrwB and TrwC (97).  Within this 
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family of plasmids, two slightly different backbone types have been detected (192). The two 
backbones are distinguished based on SNPs throughout the backbone and differ by more than 
1 % over the majority of the sequence but some small regions are up to 80 % different (192). 
The type 2 backbone also contains a small insertion. The type 1 backbone is represented by 
pAb-G7-2 (97) and the type 2 backbone by pA85-3 (99).   
 
1.9.2 Conjugative plasmids not included in the Bertini PCR-based replicon typing 
scheme 
A second group of conjugative plasmids were identified as they carried the NDM-1 
carbapenemase resistance gene. These include pNDM-BJ01 (46 kb) (123) and pNDM-AB (47 
kb) (284). These plasmids contain a novel Rep type and a VirB type 4 secretion system. 
Interestingly, both conjugated into and were maintained in E. coli (123, 284). This is the only 
type of Acinetobacter plasmid that has been shown to replicate outside the genus.  
 
Recently, a group of related large plasmids, pAB3, pAB04-1 (272), pIOMTU433 (240), pD4-
1 (93) and pA297-1 (87) were reported. Despite their large size (>130 kb), these plasmids do 
not contain any gene encoding a homologue of a protein known to be involved in replication 
initiation (87). However, they do contain a full set of genes encoding conjugative transfer 
functions and pAB3, pAB04-1 and pA297-1 have been shown to conjugate (87, 272).  
 
1.10 Epidemiology of GC2 A. baumannii from Australia and South-east 
Asia 
1.10.1 GC2 A. baumannii in Australia 
The majority of the genomic analysis of GC2 A. baumannii in Australia has focused on isolates 
from the east coast of the country. A study analysing 61 isolates, from 6 different hospitals, 
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revealed that they form a homogeneous group based on sharing a number of unique 
characteristics (193). All but one was ST208 (gltA-1, gyrB-3, gdhB-3, recA-2, cpn60-2, gpi-97 
and rpoD-3) and one was ST425 (SLV of ST208 in the gpi allele). Every isolate contained the 
AbGRI1-2 structure including the characteristic ISAba17 and Tn2006 location (Fig 1.8) (193). 
All of the isolates contained either AbGRI2-1 or an island structure that could be derived 
AbGRI2-1 through IS26 mediated deletions or inversions. None of these isolates contained the 
armA resistance gene. Based on the close homology between the isolates from the east coast 
of Australia it is likely that all of these isolates stem from a common ancestor (193). This 
suggests a single import event and that all of the current isolates have evolved from this 
ancestor creating the different sub-lineages detected.  
 
1.10.2 GC2 A. baumannii in South-east Asia 
A. baumannii is a major cause of hospital acquired infection in South-east Asia and was the 
dominant cause of hospital-acquired pneumonia or ventilator assisted pneumonia (VAP) in 
Thailand and Malaysia from a report in 2010 (38). A recent study indicates that carbapenem-
resistant A. baumannii were the major cause of VAP in Vietnam, causing 46% of infections 
(187).  
 
Isolates reported as CC92 or ST92 are predominant in South-East Asian countries including 
Malaysia, Singapore, Thailand and Vietnam (134). However, ST92 is actually ST208 and the 
discrepancy is due to the inclusion of the primer sequence in the gpi allele (101). ST195, a SLV 
of ST208, has been frequently detected in Maylasia and Thailand (139, 150). The oxa23 gene, 
or one of its variants, was commonly associated with ST208 or one of its SLVs (134, 139, 143). 
The armA gene has been detected in isolates from Vietnam (253), and Malaysia (150). 
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Completed genomes of isolates from Malaysia have been released but little is currently known 
about the structures of resistance islands in isolates from Singapore, Thailand or Vietnam.  
 
1.11 Sequencing technologies 
Sequencing technologies have advanced rapidly over the last 50 years, increasing from the 
ability to sequence short oligonucleotides to millions of bases. Over this time there has been 
arguably 3 generations of sequencing technologies and the third generation has only become 
commercially available over the last 3 years.  
 
Sanger sequencing was one of the first generation of sequencing technology. This method relies 
on synthesizing DNA on a single-stranded template while randomly incorporating chain 
terminators (230). The sequencing of overlapping fragments, which are then aligned into one 
contiguous sequence or contig in silico is referred to as shot-gun sequencing and was how the 
first bacterial genome, that of Haemophilus influenza was determined (65). This technology is 
still used today to sequence small DNA sequences such as a PCR amplicons but the maximum 
read length from Sanger sequencing is just under 1 kb (110).    
 
1.11.1 Second generation sequencing technology 
These technologies are grouped together based on the kind of template used for sequencing 
reactions (164). Platforms of the second generation depend on the production of libraries of 
clonally amplified templates and include 454 and Illumina (originally Solexa) platforms. Each 
of these technologies have the same work flow but may perform each step differently 
particularly in their chemistry of sequencing and the approach to used read the sequence (164). 
Firstly, libraries are produced from template DNA that has been fragmented, tagged, 
immobilized and amplified, followed by sequencing (48, 110, 164).  
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The Roche 454 system used the luminescent method for measuring pyrophosphate synthesis, 
also called pyrosequencing (199). High-end instruments of this technology produced long reads 
of 700-800 bp but with a relatively high error rate in terms of poly-bases longer than 6 bp (164). 
Illumina use Solexa chemistry, which includes reversible termination of sequencing products 
(17). HiSeq platforms produce large amounts of reads at an average length of 150 bp and the 
sequencing process can take up to a week (164). MiSeq sequencing on the other hand, produces 
fewer reads than HiSeq but with a larger read length of 300 bp (164). Despite the relatively 
short-read length of HiSeq and MiSeq, they have the advantage of producing paired-end (PE) 
data, in which the sequence at both ends of each DNA cluster is recorded (142, 164).  
 
1.11.2 Assembly of second generation sequencing 
Assembly of the short reads produced by second generation sequencing are often best 
assembled by programs involving De Bruijn graphs (40). These programs, such as Velvet and 
the newer SPAdes, work by splitting reads into even shorter units of a particular length k (k-
mers) (40). The k-mer length that will best fit different read sets will vary (59). The programs 
builds a graph representing each k-mer prefixes and suffixes as nodes then draws edges that 
represent k-mers having a particular prefix and suffix (40). It then finds paths through the graph 
by alignment of overlapping k-mers and these paths form contigs (40, 282). Paired-end data is 
also incorporated correcting paths through the graph. Unlike Velvet, which uses a fixed k-mer 
value (282), SPAdes iterates over values of k-mer sizes and is able to incorporate paired-end 
data earlier in the assembly (11).  
 
One of the major limitations of second generation sequencing is the length of the reads that are 
produced. No matter how good the assembly programs is, it is not able to resolve repeated 
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sequences larger than the read size, and as most repeats are longer, this results in breaks in the 
assembly where draft genomes of many contigs are produced. In addition, regions with 
repeated sequence, such as resistance islands, are often the focus of analysis, making their 
correct assembly critical for subsequent studies. Assembly of draft genomes is often laborious 
and expensive requiring manual confirmation of each junction via PCR and Sanger sequencing 
of the amplicons. Also, some repeat sequences are much larger than the lengths that can be 
resolved reliably by PCR.  
 
1.11.3 Third generation sequencing technology 
Pacific Biosciences (PacBio) single molecule real-time sequencing or SMRT sequencing is the 
most established of this generation. This method of sequencing has no amplification step and 
involves imaging the continuous incorporation of dye-labelled nucleotides during DNA 
synthesis (60). Zero-mode waveguide detectors (ZMW) obtain sequence information as 
phospholinked nucleotides are incorporated into the growing primer strand (48, 60). 
Improvements in the chemistry used in this technology now produces large reads (average of 
10 kb) and although the individual read error is 10-15%, increased coverage allows for high 
cumulative accuracy rates (>99.99%) (152). Assembly of long read data is different to that of 
short read data. SMRT HGAP assembly program is the package released by Pacific 
Biosciences which first preassembles the longest reads as ‘seed’ reads, then corrects errors by 
tilling the small reads to these (37). These corrected ‘seed’ reads are then assembled together 
into a genome (37). Alternatively, the SMRT reads can combined with shorter reads produced 
by second generation techniques in a hybrid assembly. The detection of DNA methylation data 
from SMRT sequencing has been well-established (66). Currently, the main limitation of 
SMRT is the cost-relative to second generation technologies but this will likely continue to 
drop with time.  
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The idea for Nanopore sequencing was proposed 20 years ago but significant hurdles have had 
to be overcome. Useable devices, such as GridION or MiniION have only been produced 
recently and the technology is still evolving and improving (48). Nanopores use voltage 
variation produced when ssDNA is fed through the nanopore via an enzyme (233). The run 
time is short and as there is no amplification step the direct examination of DNA sequence 
modifications (such as methylation) can be examined, however this has only recently emerged 
as an application for Nanopore (48). The reads produced are super long but have a high error 
rate. However, they are useful to tile low error rate short-read data against and programs such 
as UniCycler (273) are designed for this.  
 
1.12 Aims and scope 
Extensively and pan antibiotic resistant Acinetobacter baumannii belonging to the global clone 
GC2 present a significant challenge in the treatment of infections worldwide. The GC2 
populations from Australia and certain areas in USA have been studied in depth but the 
examination of populations from China are only beginning to emerge and little is known about 
those from Singapore, Korea or Taiwan. This study aimed to analyse the causes of antibiotic 
resistance in a selection of 20 extensively antibiotic resistant GC2 isolates from Singapore 
General Hospital to increase the understanding of A. baumannii from this region. These isolates 
were from a period of 15 years, from 1996 to 2011, and all were known to carry the carbapenem 
resistance gene oxa23. The in-depth understanding of antibiotic resistance in this group could 
then underpin a broader analysis of GC2 A. baumannii from Singapore and South-east Asia.  
 
Specific aims were to: 
• Determine the complete resistance profiles and compliment of antibiotic resistance 
genes in a collection of 20 GC2 isolates 
• Determine the contexts of all acquired antibiotic resistance mutations or genes 
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• Determine the structure(s) of the known chromosomal islands AbGRI1 and AbGRI2 
• To determine if any isolates contain the more recently acquired third chromosomal 
resistance island AbGRI3 and characterise it and its variants in detail  
• Examine the plasmids that contribute to antibiotic resistance and to define the structure 
of any regions containing antibiotic resistance genes  
• Explore the relationships between the isolates using MLST and mapping of the 
positions of ISAba1. 
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Materials and methods
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2.1 Materials 
2.1.1 Chemicals and reagents 
The chemicals utilised throughout this project were of molecular biology grade and 
were purchased from Promega (Madion, MI, USA), Sigma-Aldrich (St Louis, MO, 
USA) and Bio-Rad (Hercules, CA, USA).  
 
2.1.2 Buffers and other solutions 
The buffers and solutions were made up with H20 treated by reverse osmosis (Milli-Q 
H20), according to the protocols in Sambrook et al. (229) (Table 2.1).  
 
Table 2.1 Buffers and solutions 
Buffer/solution Components 
0.5X TBE buffer 45 mM Tris  
45 mM boric acid 
1mM EDTA 
1X TAE buffer 40mM Tris 
20mM acetic acid 
1mM EDTA 
TE buffer 10mM Tris-HCl, pH 7.5 
1mM EDTA, pH 8 
Loading dye  0.1% (w/v) bromophenol blue 
0.2% (w/v) xylene 
20 mg/mL ficoll 
Saline 0.9% (w/v) NaCl 
Elution Buffer (EB) 10 mM Tris-HCl, pH 8.5  
Solution 1 (plasmid preparation) 50mM glucose 
25mM Tris-HCl (pH 8.0)  
10mM EDTA (pH 8.0) 
Solution II (plasmid preparation) 0.2 N NaOH and 1% SDS 
Solution III (plasmid preparation) Potassium acetate (3M potassium 
5M acetate) 
 
2.1.3 Growth media 
Media purchased from Becton Dickinson (Cockeysville, MD, USA) included BactoTM 
Yeast Extract and BactoTM Agar, while Tryptone and Sensitest Agar were acquired 
from Oxoid (Basingstocke, Hampshire, UK). Growth media was prepared according to 
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the instructions provided by the manufacturer and autoclaved at 121°C at 130 kPa for 
20 minutes.  
 
Table 2.2 Growth media 
Media Components 
Luria-Bertani Broth (LB) 1% (w/v) tryptone 
0.5% (w/v) yeast extract 
1% NaCl 
Luria-Bertani Agar (LA) LB containing 1.5% (w/v) agar 
Sensitest Agar 3.2% (w/v) Sensitest Agar in H2O  
Mueller Hinton Agar (MHA) 3.8% (w/v) Mueller Hinton Agar in H20 
Mueller Hinton Broth 
(cation-adjusted) 
2.2% (w/v) Mueller Hinton Broth (cation 
-adjusted) in H20 
 
When necessary, antibiotics were added after the media had cooled to 60°C. The final 
concentration of antibiotics in the media are provided in Table 2.3. Most antibiotics 
were added to LB or LA, however when sulphamethoxazole or erythromycin were 
supplemented, MHA or MHB was used.  
 
Table 2.3 Antibiotics used in this study and the final concentrations 
Antibiotic 
or inhibitor 
Abbreviation Diluent Stock conc. 
(mg/mL) 
Final 
conc. 
(µg/mL) 
Tetracycline1 Tc 50% ethanol 10 4 
Kanamycin Km MQ H20 50 20 
Ticarcillin TIC MQ H20 100 1002 
Clavulanic acid CLAV MQ H20 25 25 
Sulphamethoxazole Su MQ H20, NaOH  25 100 
Rifampycin1 Rif 100% methanol 10 100 
Nalidixic acid Nx 0.5M NaOH 25 25 
Erythromycin Ery 100% ethanol 40 var3 
1Tetracycyline and rifampicin were stored in a lightproof container to prevent degradation. 
2Was reduced to 40 µg/mL when selecting for pBAL_204-1.  
3Concentration tested varied from 2 µg/mL to up to 128 µg/mL. 
 
2.1.4 Enzymes  
Taq polymerase and all restriction endonucleases with the appropriate buffers were 
obtained from New England Biolabs (Ipswich, USA). High fidelity PhusionTM 
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polymerase was acquired from Finnzymer (Vantaa, Finland). Proteinase K was 
obtained from Promega (Madison, MI, USA). RNase A and lysozyme were purchased 
from Sigma-Aldrich (St Louis, MO, USA).  
 
2.2 Bacterial isolates 
Experimental work was conducted on twenty GC2 Acinetobacter baumannii isolates 
(listed in Table 2.4), isolated between 1996 and 2011 from Singapore General Hospital 
that were kindly supplied by Dr Li Yang Hsu (National University Health System, 
Singapore).  
 
Table 2.4 GC2 isolates from Singapore used for experimental work in this study  
Isolate1 Name2 Source3 Year 
SGH96011 S21 Unknown 1996 
SGH0402 S22 ETTA 2004 
SGH0403 S23 ETTA 2004 
SGH06011 S24 Trach 2006 
SGH0602 S25 ETTA 2006 
SGH0604 S26 ETTA 2006 
SGH07011 S27 Blood 2007 
SGH0702 S28 Blood 2007 
SGH07031 S29 Blood 2007 
SGH0823 S30 ETTA 2008 
SGH0825 S31 Trach 2008 
SGH0905 S32 Blood 2009 
SGH0907 S33 Blood 2009 
SGH09081 S34 Blood 2009 
SGH1010  S35 Sputum 2010 
SGH1011 S36 Blood 2010 
SGH1012 S37 ETTA 2010 
SGH11111 S38 Sputum 2011 
SGH11121 S39 Sputum 2011 
SGH1113 S40 Blood 2011 
1Draft genome sequence was available at the start of the project. 
2For ease, this is the name by which the isolate will be referred to from here on. 
3Abbreviations include tracheal aspiration (Trach) and Endotracheal aspiration (ETTA). 
 
Seven isolates, S21, S24, S27, S29, S34, S38, S39, had draft sequences available at 
upon the commencement of this project. Genomic DNA for these isolates had been 
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sequenced using Illumina HiSeq at the Wellcome Trust Sanger Institute. Dr Kathryn 
Holt (University of Melbourne) assembled the paired-end reads of 100 bp into contigs 
using Velvet (282). 
  
Additional isolates that all had draft genome sequence available were examined 
throughout the course of this study. This included D86, isolated from Royal North 
Shore Hospital in 2006 and was kindly provided by Peter Huntington. RCH51-1 (102) 
was isolated from Royal Children’s Hospital (no isolation date) in Brisbane was kindly 
supplied by Dr Mohammad Katouli. The isolate BAL_204 (235), from Vietnam was 
isolated in 2010 and was kindly provided by Dr Steven Baker. Draft genome sequence 
were available for each of these isolates. 
 
Features of strains used for conjugation and transformation recipients are listed in Table 
2.5 and include ATCC 19606 (234) which was isolated prior to 1948, ATCC 17978 (3) 
which was isolated in 1951 and AB307_0294 (3) which was isolated in 1994 in Buffalo, 
USA. A25, which was isolated in 1987 in the United Kingdom, was kindly provided 
by Dr Kevin Towner, was also used in the project.  
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Table 2.5 Features of recipient strains 
Strain Resistance Plasmids 
ATCC 179781 Su, Ap,  pAB1 (CP000522), pAB2 
(CP000523), pAB3 (SuR) 
(CP012005) 
ATCC 17978Rif Su, Ap, Rif pAB1, pAB2, pAB3 (SuR) 
ATCC 17978-A Ap pAB1, pAB2  
ATCC 17978Rif-
A 
Ap, Rif pAB1, pAB2 
ATCC 19606Rif Ap, Sm, Su, Rif pMAC (AY541809)2 
 
AB307_0294 Ap, Sp, CTX, CAZ, CRO, Nx  - 
AB307_0294Rif Ap, Sp, CTX, CAZ, CRO, Nx, Rif - 
A25 Ap, Sm, Sp, Su, CTX, CAZ, Tc, Tp  - 
Ampicillin, Ap; Ceftazidime, CAZ; Cefotaxime, CTX; Ceftriaxone, CRO; Nalidixic acid, Ns; 
Rifampicin, Rif; Spectinomycin, Sp; Specintomycin, Sm; Sulphamethoxazole, Su; Tetracycline, Tc; 
Trimethroprim, Tm.  
1GenBank accession for completed genome is CP012004 
2Plasmid profile indicates that there may be another but no sequence has been confirmed.  
 
Rifampicin resistant mutants of ATCC 17978 and ATCC 19606 were already in the 
Hall laboratory collection. In addition, a variant of ATCC 17978 that had spontaneously 
lost pAB3 (containing sulphonamide resistance) and was now sulphonamide 
susceptible is designated ATCC 17978-A (Table 2.5). A rifampicin resistance version 
of this strain, ATCC 17978Rif-A had also been constructed previously.  
 
2.3 Bacterial characterisation and manipulation 
2.3.1 Bacterial growth  
Isolates of A. baumannii were routinely cultured overnight in LB supplemented with 
appropriate antibiotics at the final concentrations listed in Table 2.3. To store isolates 
long-term, an equal volume of overnight culture (750 µL) was mixed with 50% glycerol 
in a Cryovial (Thermo Scientific, Rochester, USA) and stored at -80°C. 
 
 
Chapter 2 50	
2.3.2 Antibiotic resistance phenotype determination using disk diffusion 
The Calibrated Dichotomous Sensitivity (CDS) (http://web.med.unsw.edu/cdstest) disk 
diffusion assay was used to quantify the resistance of each isolate to a set of 30 
antibiotics. Plates were made up with 20 mL Sensitest agar. Saline (4 mLs) was 
inoculated with single colonies from an isolate of A. baumannii and successively 
poured onto 5 plates. Once dry, each plate was stamped with 6 antibiotic disks, for a 
total of 30 different antibiotic disks tested. Following overnight incubation at 37°C, the 
annular radius of the zone clearing was measured from the edge of each disk. According 
to the CDS guidelines, resistance to an antibiotic is indicated by an annular radius of 
less than or equal to 6 mm. The antibiotics used were; ampicillin (25 µg), streptomycin 
(25 µg), spectinomycin (25 µg), trimethoprim (5 µg), tetracycline (30 µg), minocycline 
(30 µg), doxycycline (30 µg), compound sulphonamides (300 µg), chloramphenicol (30 
µg), florfenicol (30 µg), kanamycin (30 µg), neomycin (30 µg) amikacin (30 µg), 
tobramycin (10 µg), netilmicin (30 µg), gentamicin (10 µg), ciprofloxacin (5 µg), 
nalidixic acid (30 µg), levofloxacin (5 µg), imipenem (10 µg), meropenem (10 µg), 
doripenem (10 µg), piperacillin-tazobactam (110 µg), Timentin (ticarcillin-clavulanic 
acid; 85 µg), ampicillin-sulbactam (20 µg), cefotaxime (30 µg), ceftazidime (30 µg), 
ceftriaxone (30 µg) , cefepime (30 µg)  and rifampicin (30 µg) (Oxoid, Basingshire, 
UK).  
 
2.3.3 Antibiotic resistance phenotype determination using Etest 
Minimal inhibitory concentrations (MIC) were determined for colistin (BioMérieux). 
Single colonies from an isolate of A. baumannii were resuspended in 2 mL saline and 
then used to inoculate a plate made up with 20 mL cation-adjusted MHA. Once dry, a 
single Etest strip was placed on the surface of the agar and incubated overnight at 37°C. 
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The MIC was measured, according to the reading guidelines from bBioMérieux 
(www.biomerieux.com), from the point where the ellipse intersects the scale on the 
strip.  
 
2.3.4  Conjugation 
Equal volumes of donor and recipient cells were mixed on a LA plate and incubated 
overnight at 37°C. Cells were harvested in 0.9% saline and serially diluted to 10-8. 100 
µL of each dilution was plated onto LA plates supplemented with an antibiotic to select 
for the recipient (most commonly rifampicin, 100 µg/mL) and an antibiotic, at the 
concentrations listed in Table 2.3, that the target plasmid confers resistance to in order 
to isolate transconjugants. Conjugation frequency was calculated as transconjugants per 
donor with experiments repeated in triplicate. To ensure the randomly selected 
transconjugants were not spontaneous rifampicin mutants of the donor, colonies were 
purified and screened for growth on LA supplemented with antibiotics that the donor 
was resistant to and the recipient was susceptible to. Further confirmation was 
performed via PCR screening of boil preparations (Section 2.4.1.2) and at least two 
transconjugants from each conjugation were frozen at -80°C (Section 2.3.1). 
 
2.3.5 Transformation 
An overnight culture (Section 2.3.1) was diluted 1:100 in fresh LB. Following growth 
at 37°C to exponential phase (OD600: 0.5-0.7) the cells were pelleted by centrifugation 
at 4500 rpm for 10 minutes at 4°C. 10 mL of pre-chilled (0°C on ice) 10% glycerol 
(v/v) was used to resuspend the pellet, followed by centrifuged at 12,000 rpm for 10 
minutes at 4°C. This washing step of resuspension in ice-cold 10% glycerol followed 
by centrifugation was repeated (3 times), concentrating the cells and the final 
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resuspension was in 300 µL of pre-chilled 10% glycerol. This was separated into 60µL 
aliquots which were stored at -80°C or kept on ice for immediate use. This protocol 
follows a slight modification to the Manufacturer’s Instructions (Biorad, California). 
 
Electroporation was performed by adding 2 µL of Genomic DNA (Section 2.4.1.1) or 
Plasmid DNA (Section 2.4.1.4.2) to an aliquot of electro-competent A. baumannii cells. 
The transformation mixture was transferred into a pre-chilled (0°C on ice) 
electroporation cuvette and electroporation was performed using a BioRad gene pulser 
unit with the following parameters, 0.2 cm cuvettes, 2.5 kV, 25 µF, 200 Ω. One mL of 
LB was added to the transformation mix and was recovered for 1 hour at 37°C with 
shaking at 200 rpm. 100 µL and 10 µL of transformation reaction were plated on LA 
plates supplemented with the appropriate antibiotics (concentrations listed in Table 2.3) 
to select for transformants, subsequently screened by PCR with at least three 
transformants frozen at -80°C (Section 2.3.1). 
 
2.3.6 Plasmid stability assay 
Starter cultures of the strain containing both pS21-1 (kanamycin resistant) and pS32-1 
(ticarcillin resistant) with the appropriate selections for both plasmids were grown 
overnight at 37°C. 100 µL of the 10-5 dilution of starter culture (approximately 1,000 
cells) was used to inoculate LB without antibiotic selection and grown overnight 
(approximately 22 generations). Cultures were diluted, and a fresh LB inoculated with 
approximately 1,000 cells, and this was performed daily for five cycles. The CFU/mL 
of cells resistant to kanamycin, ticarcillin and both kanamycin and ticarcillin, was 
calculated daily by plating serial dilutions on LA plates containing the three different 
combinations of antibiotics as well as LA alone to determine the total concentration. 
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Following the 5th subculture, 50 colonies grown on LA were patched onto LA plates 
containing kanamycin, ticarcillin and both kanamycin and ticarcillin to see if pS21-1 
and pS32-1 had both been retained. PCR screening from boil preparations (Section 
2.4.1.2) of the patches were used to confirm the presence of the two plasmids.  
 
2.4 DNA preparation and analysis 
2.4.1 DNA extraction 
2.4.1.1 Genomic DNA for PCR and sequencing 
The CTAB (Cetyltrimethyl ammonium bromide) genomic DNA purification method 
was used to extract chromosomal DNA. 1.5 mL of an overnight culture of an A. 
baumannii isolate (Section 2.3.1) was harvested by centrifugation (23,000 rpm, 30 
seconds) and resuspended in 500 µL of TE. Lysozyme (20 µL of 10 mg/mL), RNase 
(20 µL of 10 mg/mL) and Proteinase K (5 µL of 10 mg/mL) was added to the cell 
suspension, followed by 100 µL of 10% SDS solution. The samples were incubated for 
1 hour at 37°C followed by a second incubation at 50°C for another hour. 200 µL of 
5M NaCl followed by 100 µL of 10% CTAB was added and incubated at 65°C for a 
further 10 minutes. The solution was extracted with and equal volume of 
chloroform:isolamyl alcohol (24:1) solution, followed by a second extraction in a 
Heavy Phase Lock Gel (5prime, Gaithersburg, USA) tube using an equal volume of 
phenol:chloroform:isoamyl alcohol (25:24:1). The DNA was then precipitated using 
0.6 volumes of isopropanol, followed by a wash with 70% ethanol. Once the ethanol 
was removed, the dried pellet was resuspended in TE buffer and stored at 4°C. Gel-
electrophoresis and the Thermo Scientific Nanodrop spectrophotometer (Thermo 
Fisher Scientific, Wilmington, Delaware, USA) was used to verify the concentration 
and purity of the extracted DNA. An A260/A280 of 1.8-1.9 was considered suitable for 
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DNA sequencing. For use in PCR, the DNA was diluted in sterile Milli-Q water to a 
concentration of 10-50 ng/µL (Section 2.4.2).  
 
2.4.1.2 Boil preparation 
To screen potential transformants, transconjugants as well colonies of specific AbGRI3 
containing isolates, DNA was obtained by boiled preparation methods. A single colony 
or a single colony size of cell mass from patch plates were picked and placed into an 
eppendorf tube containing 200 µL of sterile Milli-Q water with a pre-sterilised loop. 
Following a 10 minute incubation at 100°C, the contents of the tube were centrifuged 
at high speed and stored at 4°C.  
 
2.4.1.3 DNA purification technique of PCR products 
PCR products to be used for sequencing were cut from agarose gels using a clean 
scalpel and purified using the QIAquick Gel Extraction Kit (Qiagen, Hilden, Germany). 
The spin column protocol was followed according to the manufacturer’s instructions 
(QIA quick spin Handbook, 2007). The Thermo Scientific Nanodrop 
spectrophotometer (Thermo Fisher Scientific, Wilmington, Delaware, USA) was used 
to determine the concentration of the purified DNA.  
 
2.4.1.4  Plasmid DNA 
2.4.1.4.1  Plasmid DNA isolated from E. coli  
1.5 mL of overnight culture (Section 2.3.1) was harvested by centrifugation, and the 
pellet was resuspended in 100 µL of solution I. 200 µL of freshly made solution II was 
added to the suspension and left on ice for 10 mins. 150 µL of solution III was added 
followed by a further 3-5 minutes incubation on ice. Following centrifugation the 
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supernatant was extracted with an equal volume of phenol:chloroform:isoamyl alcohol 
(25:24:1). The DNA was then precipitated using 2 volumes of 100% ethanol, followed 
by a wash with 70% ethanol. Once the ethanol was removed, the dried pellet was 
resuspended in TE buffer containing 20 µg/mL RNase. The plasmid DNA was then 
stored at 4°C. Whole plasmid DNA was visualised using gel electrophoresis (Section 
2.4.4.2).  
  
2.4.1.4.2  Plasmid DNA isolated from A. baumannii 
A 20 mL volume of LB was inoculated with 1/100 volume of overnight culture 
(Section 2.3.1) and shaken at 37°C to an OD600 of 0.4-0.5 was reached. 15mL of the 
culture was harvested by centrifugation and then the preparation was performed as 
described in Section 2.4.1.2.1 with the volumes scaled up ten-fold.  
 
2.4.2 Polymerase Chain Reaction (PCR) 
2.4.2.1  Primers 
All primers were synthesised by Integrated DNA Technologies (Coralville, Iowa, 
USA). The lyophilised primers were resuspended in TE to a concentration of 500 µM 
and stored at -20°C. 50 µM working stocks were prepared by dilution with sterile Milli-
Q water and were also stored at -20°C. The Primer 3 program 
(htttp://bioinfo.ut.ee/primer3-0.4.0/primer3/) was used to design primers made 
throughout this project. All primers were designed to have a standard annealing 
temperature of 60°C and be approximately 20-23 bp in length. All primers used in this 
project are listed in Appendix III. 
 
 
Chapter 2 56	
2.4.2.2  Standard PCR  
PCR amplification reactions were performed in a total volume of 12.5 µL of 1x 
ThermoPol PCR reaction buffer containing 200 µM dNTP mix, 1 µM of each primer, 
1U Taq polymerase and template DNA. If the DNA template was derived from Section 
2.1.1.1, 0.5 µL of diluted DNA was added. However, if the DNA template was derived 
from boil preparation (Section 2.4.1.2), 5 µL of template was used. Eppendorf 
Mastercycler, Eppendorf Mastercycler Nexus (Eppendorf, Hamburg, Germany) or a 
Biorad MyCyclerTM (BioRad, Hercules, USA) series machines were used to perform 
PCR reactions. The general cycling conditions are as follows; an initial denaturation 
time of 3 minutes at 94°C, followed by 30 cycles of denaturation at 94°C (30 seconds), 
primer annealing at 60 °C (30 seconds) and extension at 72°C (extension time varied 
based on expected amplicon size, where 1 minute was allowed for 1 kb of sequence) 
and a final extension time of 5 minutes for 72 °C. Gel electrophoresis (Section 2.4.4.1) 
was used to visualise amplicons and the products were identified by comparison to 
known standards. A DNA-free control was always included and when available a 
known control for the target region was used and. If the PCR amplicon was used for 
sequencing, the reaction was scaled up to 25 µL. 
 
2.4.2.3  Long-range PCR 
A high fidelity polymerase was used for PCR amplicons that were predicted to be 3 kb 
or larger. This reaction was made up to a total volume of 10 µL of 1x HF buffer 
containing 200 µM dNTP mix, 0.5 µM of each primer and 0.02 U of Phusion 
polymerase and template DNA. For template DNA derived from Section 2.4.1.1, 0.5 
µL of diluted DNA was added, while if derived from Section 2.4.1.2, 5 µL of DNA 
template was used. Eppendorf Mastercycler, Eppendorf Mastercycler Nexus 
Chapter 2 57	
(Eppendorf, Hamburg, Germany) or a Biorad MyCyclerTM (BioRad, Hercules, USA) 
series machines were used to perform PCR reactions.  The general cycling conditions 
are as follows; an initial denaturation time of 3 minutes at 98°C, followed by 35 cycles 
of denaturation at 98°C (10 seconds), primer annealing at 60 °C (30 seconds) and 
extension at 72°C (extension time varied based on expected amplicon size, where 1 
minute was allowed for 1 kb of sequence) and a final extension time of 5 minutes for 
72 °C. Gel electrophoresis (Section 2.4.4.1) was used to visualise amplicons and the 
products were identified by comparison to known standards. A DNA-free control was 
always included and when available a known control for the target region was used and 
a DNA-free control was always included. If the PCR amplicon was used for 
sequencing, the reaction was scaled up to 20 µL.  
 
2.4.3 Restriction endonuclease digestion 
PCR amplicons and plasmid DNA were used as templates for digestion with 5-10 U of 
restriction endonuclease in 1x buffer and if recommended by the Manufacturer 1x BSA, 
in a total volume of 20-30 µL. The digestion mixture was incubated in a water bath for 
1-4 hours at the optimal temperature for the enzyme used. Agarose gel electrophoresis 
was used to separate and visualise the digestion. However, the gel electrophoresis 
protocol varied depending upon predicted product size, between Section 2.4.4.1 
(product smaller that 23 kb) and Section 2.4.4.2 (larger than 23 kb).  
 
2.4.4 Agarose gel electrophoresis 
2.4.4.1 PCR products and enzyme digestions 
The gels used were 1% (w/v) molecular grade agarose (Bioline) dissolved by heating 
in 0.5x TBE. For visualisation of the DNA, ethidium bromide was added to the cooled 
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liquid gel at a final concentration of 0.1 µg/mL. DNA (5-25 µL) mixed with 2 µL of 
loading dye, was loaded into the wells of the set gel and allowed to run at 180 V for 
approximately 30-45 minutes. The bands on the gel were then visualised using a UV 
transilluminator and imaged with the Gel Doc XR program (BioRad, Hercules, USA). 
For comparison, each gel was loaded with 4 µL of 100 bp or 1 kb ladder (New England 
BioLabs, Ipswich, USA). l DNA-HindIII Digest (heated at 60°C for 3 minutes before 
loading 2.5 µL) was also used as a standard when digests were examined.  
 
2.4.4.2 Plasmid DNA 
The gels used were 0.7% (w/v) agarose dissolved in 1x TAE for 1 minute. 15 µL of the 
sample mixed with 2 µL of loading dye was added to the wells of the set gel and allowed 
to run at 120 V for 1.5-3 hours (depending on the size of the gel). Gels were post-stained 
with an ethidium bromide solution (0.5 µg/mL) for 20 minutes, then de-stained in water 
for an hour before visualisation with an UV transilluminator and imaged using a 
Molecular Imager Gel Doc XR System. The sizing standard for these experiments was 
a plasmid preparation of the Escherichia coli strain 39R861+ (178) that contains 6 
plasmids of known or estimated size (2, 7, 38, 66, 95, 155 kb, with the largest unable 
to enter the gel under the conditions used).  
 
2.5 DNA sequencing and sequence assembly 
2.5.1 Sanger sequencing  
The sequencing reaction mixture was made up to a total volume of 12 µL and contained 
12-18 ng (PCR product <500 bp) or 30-70 ng (PCR product >500 bp) of purified DNA 
(Section 2.4.1.3). Automated sequencing was performed on an Applied Biosystems 
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AB3730xl DNA Analyzer using the Big Dye system at the Sydney node of the 
Australian Genome Research Facility (AGRF).  
 
2.5.2 Whole genome sequencing and sequence assembly 
2.5.2.1 Illumina MiSeq 
DNA was isolated as per the process outlined in Section 2.4.1.1. 100 µL aliquots, 
containing 2-5 µg of DNA, were then sent to the Sydney node of the AGRF and were 
sequenced using Illumina MiSeq, generating paired-end reads of 150 bp.  
 
2.5.3.2 SPAdes assembly 
Paired-end reads from MiSeq sequencing were assembled using SPAdes (v.3.5.0) (11) 
using k-mers of 21, 33, 55, 77, 99 and 127, and a coverage cut-off of 5. Assembly 
quality was assessed by QUAST (http://quast.sourceforge.net/quast).  
 
2.6 Bioinformatics analysis 
The contigs assembled from the Illumina HiSeq paired end sequencing and the contigs 
from Illumina MiSeq paired end sequencing were used to form a database of genomic 
data for used with the stand-alone BLAST command line application version 2.2.25+ 
(33). In addition, DNA and amino acid sequencers were analysed using the online 
BLAST facility (http://blast.ncbi.nlm.nih.gov/BLAST.cgi). Pairwise or multiple 
sequence alignments were performed using ClustalW2 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) or using the Artemis Comparison Tool 
version 12.0.0 (34). The Multi-Locus Sequence Typing (MLST) of each sequence in 
both the Institut Pasteur and the Oxford scheme was determined online 
(https://pubmlst.org) or by employing a python script, mlstBLAST 
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(htt://sourceforge.net/projects/srst/files/mlstBLAST/), which uses blastn to extract 
profiles from assembled contigs. Resistance genes were identified in assemblies online 
using ResFinder (https://cge.cbs.dtu.dk/services/ResFinder/) (280). ISMapper (108) 
was used to find the locations of insertion sequences in the paired end Illumina HiSeq 
short read sequences, while ISseeker (1) was used to locate insertion sequences in draft 
genomes assembled from Illumina MiSeq sequencing. DNA chromatograms from 
Sanger sequencing runs were viewed using Sequencher 5.1 (Gene Codes Corp, Ann 
Arbor, MI, USA) and then trimmed manually. Sequences were assembled using 
Sequencher and then visualised and annotated using Gene Construction Kit version 
4.0.3 (Textco, West Lebanon, NH, USA). SnapGene viewer version 3.3.3 (GSL 
Biotech LLC, Chicago, USA) was used to annotate circular plasmid sequences.  
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CHAPTER  
  3 
 
Phenotypic and genotypic 
characterisation
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3.1 Introduction 
Dr Li Yang Hsu kindly supplied a diverse collection of 20 GC2 A. baumannii from Singapore 
General Hospital (SGH) (Table 3.1). One isolate was from 1996 and the remaining 19 were 
isolated from 2004 to 2011. All isolates had been determined to be resistant to carbapenems 
and the draft genomes of 7 that had been sequenced at the Wellcome Trust Sanger Institute by 
Illumina HiSeq were available (bold in Table 3.1). Further information on these isolates are 
listed in Chapter 2; Table 2.2. 
 
Table 3.1 GC2 isolates from Singapore General Hospital 
Isolate Source1 Year GC oxa23 
S21 Unknown 1996 2 + 
S22 ETTA 2004 2 + 
S23 ETTA 2004 2 + 
S24 Trach 2006 2 + 
S25 ETTA 2006 2 + 
S26 ETTA 2006 2 + 
S27 Blood 2007 2 + 
S28 Blood 2007 2 + 
S29 Blood 2007 2 + 
S30 ETTA 2008 2 + 
S31 Trach 2008 2 + 
S32 Blood 2009 2 + 
S33 Blood 2009 2 + 
S34 Blood 2009 2 + 
S35 Sputum 2010 2 + 
S36 Blood 2010 2 + 
S37 ETTA 2010 2 + 
S38 Sputum 2011 2 + 
S39 Sputum 2011 2 + 
S40 Blood 2011 2 + 
The draft genome of those in bold are available. 
1Tracheal aspiration (Trach) and Endotracheal aspiration (ETTA). 
 
The initial screening of these isolates was performed by Matthew Wynn and showed that all 
isolates belonged to Turton group 1 (261) confirming that they were members of GC2. They 
were all found to contain the oxa23 gene, which accounted for the detected carbapenem 
resistance and preliminary resistance phenotype determination using disk diffusion was 
performed (Appendix I; Table A1.2). 
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The work described in this chapter aimed to complete the phenotypic and genotypic analysis 
of antibiotic resistance in these isolates. This included completing the full spectrum of 
antibiotic resistance phenotypes to determine their level of resistance. Genes involved in 
antibiotic resistance were first detected by PCR screening and then by searching the draft 
genome sequences as they became available. The relationships between the isolates was 
examined through MLST.  
 
3.2 Phenotypic resistance profiles 
3.2.1 Antibiotic resistance phenotype determination using disk diffusion 
Each isolate was screened for resistance 30 different antibiotics listed in Table 3.2 using 
calibrated Dichotomous Sensitivity (CDS) disk diffusion. The full results showing the annular 
radii of the zone of inhibition are listed in Appendix I; Table A1.2. Resistance to most 
antibiotics had been tested previously (by Matthew Wynn and shown in black in Appendix I; 
Table A1.2) but others were performed during this project (shown in red in Appendix I; Table 
A1.2). According to the CDS guidelines (http://web.med.unsw.edu.au/cdstest), resistance to an 
antibiotic is indicated by an annular radius of less than 6 mm.  
 
The 20 isolates were all resistant to imipenem, meropenem and doripenem, consistent with the 
presence of the oxa23 gene (Table 3.2). They were all also resistant to every extended spectrum 
cephalosporin, antipseudomonal penicillin with b-lactamase inhibitor, penicillin and b-
lactamase inhibitor, quinolone, fluoroquinolone, tetracycline and folate pathway inhibitor 
tested (Table 3.2). As expected for A. baumannii, the isolates were all resistant to both phenicol 
antibiotics tested. A single isolate, S35, was resistant to rifampicin.  
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Table 3.2 Antibiotics tested by disk diffusion  
Class Antibiotics 
Carbapenems Imipenem, meropenem, doripenem 
Extended-spectrum cephalosporins Cefotaxime, ceftriaxone, ceftazidime, cefepime 
Antipseudomonal penicillins + b-lactamase 
inhibitors 
Piperacillin-tazobactam, ticarcillin-clavulanic acid 
Penicillins and b-lactamase inhibitors Ampicillin/sulbactam, ampicillin  
Quinolones Nalidixic acid 
Fluoroquinolones Ciprofloxacin, levofloxacin 
Tetracyclines Tetracycline, doxycycline, minocycline 
Aminoglycosides Gentamicin, tobramycin, amikacin, netilmicin, kanamycin, 
neomycin, streptomycin, spectinomycin 
Folate pathway inhibitors Trimethoprim, sulphamethoxazole 
Phenicols Chloramphenicol and florfenicol  
Rifampin Rifampicin 
Those in red are a part of the antibiotic categories and antibiotics used to define resistance in Acinetobacter 
(Chapter 1; Table 1.1)  
 
 
The aminoglycoside resistance profile of the 20 isolates varied and these profiles distinguished 
four groups in the collection (Table 3.3).  
 
Table 3.3 Aminoglycoside resistance profiles 
Isolates Aminoglycoside resistance  
Ak Gm Km Net Nm Tm Sm Sp 
S21, S24, S26, S29, S30 + + + - + - + + 
S22, S23, S27, S31-S33, S40 + + + + + + + + 
S25, S28, S35-S39 + + + + - + + + 
S34 + + + + + + + - 
Ak, amikacin; Gm, gentamicin; Net, netilmicin; Nm, neomycin; Sm, streptomycin; Sp, spectinomycin; Tm, 
tobramycin.  
 
Eight of the nine classes of antibiotics used to define antibiotic resistance in A. baumannii are 
highlighted in red in Table 3.2. As each of the 20 isolates are resistant to all relevant antibiotics 
in the eight classes, they are at least classified as extensively antibiotic resistant (XAR) (166). 
If they are additionally found to be resistant to the antibiotics in the ninth class they would be 
considered pan resistant. The ninth class of applicable antibiotics is polymyxins, which 
includes colistin and polymyxin B, but due to poor agar diffusion, the determination of 
resistance to these antibiotics by disk diffusion is not reliable (71). Instead, susceptibility to 
colistin was measured using Etest.  
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3.2.3 Colistin resistance  
The MIC of colistin was determined for each isolate using Etest strips (bioMerieux) and the 
CLSI breakpoints of ≤ 2µg/mL as susceptible and >2 µg/mL as resistant were applied (255). 
All but S35 had an MIC of ≤0.75 µg/mL of colistin, and were classed as susceptible (Table 
3.4). Hence these 19 isolates are XAR. However, the MIC of S35 was 3 µg/mL, indicating that 
this isolate was resistant to colistin (Table 3.4). To be classed as pan resistant S35 would have 
to be also resistant to polymixin B, but this was not available for testing, hence, S35 is still 
classified as XAR.  
 
Table 3.4 Colistin MIC 
 
 
 
 
 
3.3 Genotypic resistance profile 
3.3.1 IS upstream of ampC 
The isolates were screened for ISAba1 upstream of the ampC gene (Fig 3.1), which is known 
to increase the expression of ampC and confer resistance to third generation cephalosporins 
(42, 89). The published primer pair RH581 and RH582 (92) produced an amplicon of 
approximately 2.5 kb in all isolates, consistent with the predicted amplicon size of 2,583 bp for 
ISAba1 upstream of ampC. If ISAba1 was not present, the amplicon would only be 1,403 bp. 
Resistance to third generation cephalosporins in these 20 isolates is likely due to the increased 
expression of ampC by ISAba1.  
Isolates Colistin MIC 
(µg/mL) 
S37 0.25 
S21, S23, S28, S31-S34, S36, S38-S40 0.38 
S22, S24, S30 0.5 
S25-S27, S29 0.75 
S35 3 
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Figure 3.1 ISAba1 upstream of ampC. Arrows indicate extent and orientation of genes and open reading frames. 
The ampC gene is shown in purple. The blue box is ISAba1 and the internal arrows indicate the transposase 
orientation. The bent arrow indicates the orientation and location of the promoter. Primers used to detect if ISAba1 
is upstream of ampC are shown by the bars above along with the PCR amplicon size.  
 
3.3.2 Resistance gene screening 
In an attempt to account for the resistance profiles detected, the presence of nine resistance 
genes were screened for in each isolate using the gene specific primer combinations shown in 
Appendix III; Table A3.1. These included the sulphonamide resistance genes sul1 and sul2, 
tetracycline resistance gene tetA(B), an ampicillin resistance gene blaTEM and a selected group 
of aminoglycosides resistance genes including aacC1, aadA1, aacA4, aphA1b, strA-strB, 
aphA6, and armA. All of these genes have previously been detected in GC2 A. baumannii 
isolates.  
 
The different combinations of resistance genes that were detected are shown in Table 3.5. In 
addition to the oxa23 gene, all isolates contained the tetA(B) gene, accounting for resistance to 
tetracycline, doxycycline and minocycline, and the strA-strB resistance genes, causing 
resistance to streptomycin. Sulphonamide resistance was accounted for by sul1 or sul2 genes, 
though some isolates contained both. Some isolates included the blaTEM gene, but this did not 
appear to affect their ampicillin resistance to profiles if absent. The aminoglycoside resistance 
gene content varied between isolates (Table 3.5) and is described in Section 3.3.2.1. 
 
 
 
ISAba1 ampCfolE orf
P
RH581-RH582
2,583 bp
500 bp
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Table 3.5 Resistance genes detected in addition to oxa23, tetA(B) and strA-strB  
Isolates sul1 sul2 blaTEM 
Aminoglycoside resistance genes 
aacC1 aadA1 aphA6 armA aacA4 strA-strB aphA1b 
S21, S24, S26, 
S29  
+ + + + + + - - + + 
S30 + - + + + + - - + + 
S22, S23 + + + + + - + + + + 
S25, S28 + + + + + - + + + - 
S27 + + - - + - + + + - 
S31 + - - + + - + + + - 
S32-S34, S40 - + + - - - + - + + 
S35-S37 - + - - - - + - + - 
S38, S39 + - - + + - + + + - 
 
Acquired resistance genes do not fully account for resistance to trimethoprim and some of the 
b-lactam combinations (Table 3.5). They also do not account for resistance to quinolone and 
fluoroquinolone antibiotics or for rifampicin, however, in Acinetobacter, mutational resistance 
is the most common mechanism of resistance. Mutational resistance to these antibiotics is 
examined further in Section 3.4.2.1 and Section 3.4.2.2, after the genome sequence became 
available.  
 
3.3.2.1 Aminoglycoside resistance 
Aminoglycoside resistance determinants usually only confer resistance to a subset of 
aminoglycosides (shown in Table 3.6), so combinations of these genes would be required to 
confer the spectrum of aminoglycoside resistance detected in the 20 Singapore isolates (Table 
3.2). Even the armA gene on its own, which confers resistance to all clinically relevant 
aminoglycoside antibiotics (Table 3.6), does not account for resistance to neomycin, 
streptomycin and specintomycin. 
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Table 3.6 Phenotypes conferred by aminoglycoside resistance genes 
Gene Confers resistance to 
aacC1 Gm 
aphA1b Km, Nm 
aphA6 Ak, Km, Nm 
aacA4 Ak or Gm1, Net, Tm 
aadB Km, Gm, Tm 
armA Ak, Gm, Net, Tm, Km 
aadA1 Sm, Sp 
strA-strB Sm 
Ak, amikacin; Gm, gentamicin; Net, netilmicin; Nm, neomycin; Sm, streptomycin; Sp, spectinomycin; Tm, 
tobramycin.  
1The substrate specificity of aacA4 changes based on a single base difference that results in an amino acid change.  
 
The 20 isolates fall into two groups based on the presence or absence of armA and aphA6 
(Table 3.7). The isolates in the first group, S21, S24, S26, S29 and S30, lack armA but contain 
aphA6 (orange in Table 3.7). The aphA6 gene confers resistance to amikacin which is a 
clinically important antibiotic, as well as to kanamycin and neomycin. They all also contain 
the aphA1b gene, which also confers resistance to kanamycin and neomycin. Gentamicin 
resistance is conferred by the aacC1 genes in these isolates and streptomycin and 
spectinomycin resistance can be accounted for by the aadA1 and strA and strB genes. The 
absence of any genes conferring resistance to tobramycin or netilmicin in these isolates is 
consistent with their phenotype (Table 3.2).  
 
Table 3.7 Two groups based on the armA and aphA6 resistance genes 
G1 Isolates oxa23, 
tetA(B), 
strA-strB 
aphA6 armA aphA1b aacC1 aadA1 aacA4 sul1 sul2 blaTEM 
1 S21, S24, S26, 
S29  
+ + - + + + - + + + 
 S30 + + - + + + - + - + 
2 S22, S23 + - + + + + + + + + 
 S25, S28 + - + - + + + + + + 
 S27 + - + + - + + + + - 
 S31 + - + + + + + + - - 
 S32-S34, S40 + - + - - - - - + + 
 S35- S37 + - + - - - - - + - 
  S38, S39 + - + - + + + + - - 
Orange box indicates isolates with aphA6 and are group 1, while the green box shows isolates with armA that are 
group 2.  
1Group.  
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The second group, with 15 isolates, all contain the armA gene (green in Table 3.7), which 
accounts for their resistance to amikacin, gentamicin, tobramycin and netilmicin, which are all 
clinically relevant antibiotics. In addition, some isolates also included the aacA4 and/or the 
aacC1 genes but as these confer resistance to a subset of the same antibiotics as armA, their 
presence cannot be inferred from phenotype alone. The subgroup that are neomycin resistant 
contain the aphA1b gene, as resistance to this antibiotic is not conferred by armA.  
 
Most isolates, regardless of its group, include the aadA1 gene, which confers resistance to 
streptomycin and spectinomycin, though they are not used clinically in humans (144). A sub-
group within the 15 isolates consisting of S32, S33, S34 and S40 lack the aadA1 gene (Table 
3.7), but only S34 is susceptible to spectinomycin (Table 3.2).  
 
3.3.3 Tn2006 screening 
The oxa23 gene is commonly located in Tn2006, a transposon bounded by inversely oriented 
copies of ISAba1 (61, 194, 215). All isolates were screened for Tn2006 using published primer 
pairs (88), ISAba1B paired with oxa23F and oxa23R paired with ISAba1B (Fig 3.2A). This 
screening confirmed that each isolate had an ISAba1 upstream of oxa23 (Fig 3.2B) and all but 
one isolate produced an amplicon of the expected size for the ISAba1 position downstream of 
oxa23 in Tn2006 (Fig 3.2C). Thus, in 19 of the isolates the oxa23 gene is located in Tn2006. 
The amplicon for the downstream ISAba1 for S30 was not as crisp and as strong as the others 
(Fig 3.2C). As the left end of Tn2006 is conserved in S30, the oxa23 gene in this isolate may 
be located within another oxa23 containing transposon (194).  
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 Figure 3.2 Tn2006 screening. A. Location of primers for detection of Tn2006. The orange arrow indicates the 
oxa23 gene and the blue boxes represent ISAba1 with the internal arrows showing the direction of the transposase. 
Primers used to detect Tn2006 are shown by the bars above along with the predicted amplicon size. B. Screening 
the left end of Tn2006 using primers ISAba1B and oxa23F to amplify a 1,558 bp amplicon. C. oxa23R and 
ISAba1B were paired to amplify the right end of Tn2006. The sizes of molecular markers on the left and right are 
in kb and isolate numbers are shown above their lanes.  
 
3.3.4 TnaphA6 screening 
The aphA6 gene is most commonly located in TnaphA6, which is a class 1 transposon bounded 
at each end by ISAba125 (Fig 3.3) (197). Two previously designed primer pairs, RH577 and 
aphA6R (703 bp amplicon), and aphA6F and RH576 (1,001 bp amplicon) (Fig 3.3) (197), were 
used screen for TnaphA6 in the five aphA6 containing isolates. S21, S24, S26, S29 and S30 
produced amplicons consistent with the expected sizes for both PCRs, indicating that the aphA6 
gene was located in TnaphA6 in these isolates.  
oxa23
Tn2006
ISAba1 ISAba1
ISAba1B-oxa23F
1,558 bp oxa23R-ISAba1B
2,725 bp
500 bp
A. 
B. 
C. 
21 22 23 24 25 26 27 28 29 30 32 34 3635 37 38 39 4031 33 +veM
3
2
1.5
21 22 23 24 25 26 27 28 29 30 32 34 3635 37 38 39 4031 33 M+ve-ve
3
2
1.5
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Figure 3.3 Structure of TnaphA6. The purple arrow indicates the extent and orientation of the aphA6 gene. 
ISAba125 are shown as green boxes with the internal arrows indicating the orientation of the transposase. Primer 
combinations used to detect TnaphA6 are shown by the black bars above, along with the amplicon size.  
 
3.4 Detection of resistance gene content using the draft genome 
sequences 
The draft genomes of S21, S24, S27, S29, S34, S38 and S39 which were available at the start 
of this project had been sequenced using Illumina HiSeq and assembled using Velvet and 
summary of these assemblies and accession numbers are provided in Appendix I, Table A1.3. 
Draft genomes of the remaining 13 of these isolates were not available until the end of 2016. 
The Illumina MiSeq platform was used to sequence the latter isolates and their draft genomes 
were assembled using SPAdes (details of the assemblies can be found in Appendix I, Table 
A1.4). The analysis described in the following sections was first performed on the seven 
sequences, but was completed on the remaining 13 once their sequences were available.  
 
3.4.1 Resistance genes detected using ResFinder 
Analysis of the draft genomes of the 20 isolates confirmed the presence of the resistance genes 
detected by PCR screening, and revealed that 16 isolates had additional resistance genes (blue 
in Table 3.8). All of the armA containing isolates (those in group 2 in Table 3.7) also included 
the msrE and mphE macrolide resistance genes. When present, the armA, msrE, mphE, sul1, 
aphA6
TnaphA6
ISAba125ISAba125
500 bp
RH577-aphA6R
703 bp
aphA6F-RH576
1,001 bp
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aadA1, catB8 and aacA4 genes were always on the same contig (underlined in Table 3.8). The 
isolate S30 from the aphA6 group also had the msrE and mphE genes, but they were not 
associated with armA. Instead, it was seen on the same contig as the tet39 tetracycline 
resistance determinant (underlined in Table 3.8). Examination of the draft genome sequence of 
S30 revealed that oxa23 was in fact located in Tn2008. This transposon only contains the 
upstream ISAba1 and no downstream ISAba1 (194), which is consistent with earlier screening 
(Section 3.3.3).  
 
Table 3.8 Resistance genes detected using ResFinder 
Group Isolates Detected resistance genes 
1 S21, S24, S26, S29  sul2, strA-strB, tetA(B), blaTEM, aphA1b, aacC1, aadA1, 
sul1, aphA6, oxa23 
 S30 strA-strB, tetA(B), blaTEM, aphA1b, aacC1, aadA1, sul1, 
aphA6, oxa23, msrE-mphE, tet39 
2 S22, S23 sul2, strA-strB, tetA(B), blaTEM, aphA1b, aacC1, oxa23 
armA, msrE-mphE, sul1, aadA1, catB8, aacA4 
 S25, S28 sul2, strA-strB, tetA(B), blaTEM, aacC1, oxa23 
armA, msrE-mphE, sul1, aadA1, catB8, aacA4 
 S27 sul2, strA-strB, tetA(B), aphA1b, oxa23 
armA, msrE-mphE, sul1, aadA1, catB8, aacA4 
 S31 strA-strB, tetA(B), aphA1b, aacC1, oxa23 
armA, msrE-mphE, sul1, aadA1, catB8, aacA4 
 S32, S33, S34, S40 sul2, strA-strB, tetA(B), blaTEM, aphA1b, oxa23,  
armA, msrE-mphE 
 S35, S36, S37 sul2, strA-strB, tetA(B), oxa23, armA, msrE-mphE 
 S38, S39 strA-strB, tetA(B), aacC1, oxa23 
armA, msrE-mphE, sul1, aadA1, catB8, aacA4 
Blue genes indicate addition resistance genes identified by ResFinder and underlined genes are on the same contig.   
 
Interestingly, the presence of catB8 would not have affected the phenotypic characteristics of 
the isolates that contain them, as all isolates are intrinsically resistant to chloramphenicol. 
Macrolide antibiotics such as erythromycin are not used to treat Gram-negatives because they 
are slow to traverse the cell wall and are only effective against Gram-positives (170). The 
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ability of the msrE and mphE genes to confer resistance to erythromycin was examined further 
in Chapter 10; Section 10.3.  
 
3.4.2 Mutations leading to antibiotic resistance  
3.4.2.1 Quinolone and fluoroquinolone resistance 
Mutations in gyrA and parC were detected using standalone BLAST searches with the 
sequence of the fluoroquinolone susceptible A320 as a query. All isolates had the single base 
mutation that leads to the Ser81Leu substitution in GyrA. All but S24, also had the single base 
change that leads to Ser84Leu in ParC. These mutations have been shown to be equivalent to 
those in E. coli (Ser83Leu in GyrA and Ser80Leu in ParC), which are known to cause high 
levels of resistance (267, 268). Hence, these mutations account for the quinolone and 
fluoroquinolone resistance in 19 of the 20 isolates.  
 
3.4.2.2 Rifampicin resistance in S35 
Mutations in the rpoB gene have been shown to confer resistance to rifampicin in A. baumannii 
(79). Sequence comparison to rpoB in the rifampicin susceptible isolate A320 using standalone 
BLAST revealed that all but S35 had an rpoB sequence identical to that of A320, consistent 
with their susceptible phenotype. However, the sequence of rpoB in S35 had two single base 
differences that cause the changes Leu520Ser and Asp525Gly in RpoB. The Asp535Gly 
mutation has previously been detected in rifampicin resistant A. baumannii (79) and likely 
accounts for S35 resistance to this antibiotic.  
 
3.5 MLST 
The pubMLST website (https://pubmlst.org/Abaumannii) was used to determine the ST of 
each isolate using both the Institut Pasteur and the Oxford schemes.  
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3.5.1 Institut Pasteur scheme 
A total of 18 isolates were ST2 when the Institut Pasteur scheme was used (Table 3.9). 
However, the two remaining isolates S24 and S34, were each a single locus variant (SLV) of 
ST2 differing at the fusA and cpn60 allele, respectively (Table 2.9). In both isolates, the 
different allele present is the ST1 (GC1) allele, indicating that recombination may have 
occurred in these isolates, incorporating DNA from a GC1 isolate. Despite the two differences 
at the single alleles, the 20 isolates are all GC2.  
 
Table 3.9 MLST profiles using the Institut Pasteur scheme 
Isolates Year ST 
(IP)  
Alleles 
cpn60 fusA gltA pyrG recA rplB rpoB 
18 isolates 1996-2011 2 2 2 2 2 2 2 2 
S24 2006 641 2 1 2 2 2 2 2 
S34 2009 98 1 2 2 2 2 2 2 
 
3.5.2 Oxford scheme 
Using the Oxford scheme there was much more variation within the collection, particularly in 
the gpi allele (Table 3.10). Seven different STs were detected including ST208 (five isolates), 
ST218 (four isolates), ST195 (six isolates) and a single example of ST369 and ST1128. In 
addition, two novel STs were detected, submitted to the pubMLST website, and assigned 
ST1165 (S26 and S29) and ST1166 (S34). All of the ST variants, except S34, are SLVs of 
ST208 with the variation confined to the gpi allele. However, ST1166 is a triple locus variant 
(TLV) of ST208 in the cpn60, gpi and rpoD alleles indicating that additional recombination 
has occurred in this isolate (Table 3.10).  
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Table 3.10 MLST profiles using the Oxford scheme 
Isolate Year ST 
(IP) 
ST 
(Ox) 
Oxford alleles 
gltA gyrB gdhB recA cpn60 gpi rpoD 
S21 1996 2 208 1 3 3 2 2 97 3 
S22 2004 2 218 1 3 3 2 2 102 3 
S23 2004 2 218 1 3 3 2 2 102 3 
S24 2006 641 208 1 3 3 2 2 97 3 
S25 2006 2 218 1 3 3 3 2 102 3 
S26 2006 2 1165 1 3 3 2 2 164 3 
S27 2007 2 218 1 3 3 2 2 102 3 
S28 2007 2 1128 1 3 3 2 2 260 3 
S29 2007 2 1165 1 3 3 2 2 164 3 
S30 2008 2 369 1 3 3 2 2 106 3 
S31 2008 2 208 1 3 3 2 2 97 3 
S32 2009 2 195 1 3 3 2 2 96 3 
S33 2009 2 195 1 3 3 2 2 96 3 
S34 2009 98 1166 1 3 3 2 4 106 2 
S35 2010 2 195 1 3 3 2 2 96 3 
S36 2010 2 195 1 3 3 2 2 96 3 
S37 2010 2 195 1 3 3 2 2 96 3 
S38 2011 2 208 1 3 3 2 2 97 3 
S39 2011 2 208 1 3 3 2 2 97 3 
S40 2011 2 195 1 3 3 2 2 96 3 
 
As the gpi allele lies in the capsule locus (KL), variation in this allele generally accompanies a 
replacement of the capsule gene cluster (3, 119, 137). The KL present in each isolate was kindly 
determined by Dr Johanna Kenyon (personal communication) and each change in the gpi allele 
is consistent with a different capsule being produced (Table 3.11).  
 
Table 3.11 Connection between the gpi allele and capsule locus replacement 
Isolates ST (Oxford) gpi allele KL 
S21, S24, S31, S38, S39 208 97 2 
S22, S23, S25, S27 218 102 7 
S26, S29 1165 164 73 
S28 1128 260 32 
S30, S34 369, 1166 106 49 
S32, S33, S35, S36, S37, S40 195 96 3 
The isolates in the aphA6 group are underlined.  
 
3.6 Discussion 
The 20 GC2 A. baumannii isolates from Singapore General Hospital were all classed as XAR 
and all but one isolate remains susceptible to colistin. The majority of the antibiotic resistance 
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in these isolates can be accounted for by intrinsic resistance, acquired antibiotic resistance 
genes, specific mutations in chromosomal genes as well as increased expression of the 
chromosomal ampC gene.  
 
However, resistance to some antibiotics was not able to be accounted for by the analysis in this 
chapter. This included the isolates resistance to trimethoprim and some of the b-lactam 
combinations. It is possible that a combination of resistance genes and efflux pumps such as 
AdeABC, AdeIJK, AdeFGH and AbeM (44) are contributing to these resistances. The 
resistance of S24 to fluoroquinolones could be accounted for by mutations in gyrB and parE 
(133, 141) or increased expression of efflux pumps (44, 247, 278) have been shown to 
contribute to resistance to these antibiotics. The cause of colistin resistance in S35 was also not 
examined during the course of this project but mutations in pmrACB locus have been shown to 
contribute resistance to this antibiotic (211).  
 
The lack of resistance of S34 to spectinomycin is quite unusual, despite this isolates lack of an 
aadA1 gene. Recently, an aminoglycoside nucleotidyltransferase (AadA) intrinsic to A. 
baumannii, ANT(3``)-II, has been identified and shown to contribute to resistance to 
streptomycin and spectinomycin (283). Expression of the gene encoding ANT(3``)-II in E. coli 
showed an increase in specintomycin MIC from 32 to 2,048 µg/mL (283). A gene matching 
ant(3``)-II was present in all 20 isolates and raises the question of why S34 is susceptible to 
spectinomycin. S32, S33 and S40 encode the same ant(3``)-II gene which is 98% identical 
(770/786) to that in S34. These SNPs cause 6 aa substitutions in the protein of S34 which may 
have a deleterious effect on the functioning of the protein and could potentially account for the 
spectinomycin susceptibility in this isolate. 
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Within the antibiotic resistance gene content of these isolates, there is also a high amount of 
redundancy. Many isolates contain both sul1 and sul2, when one of these genes alone confers 
high levels of sulphonamide resistance. The isolate, S30, also contains two tetracycline 
resistance gene and many of the armA containing isolates contain additional aminoglycoside 
resistance genes which are already covered by the spectrum of armA. Furthermore, some 
isolates have also acquired the chloramphenicol resistance gene catB8 which is superfluous as 
A. baumannii are intrinsically resistant to this antibiotic.  
 
Two main populations can be distinguished in this collection based on aminoglycoside 
resistance genes. Isolates in the first group lack the armA gene and carry the aphA6 gene located 
in TnaphA6 (Table 3.12), while in the second group isolates contain armA but no aphA6 gene 
(Table 3.12).  
 
Table 3.12 Characteristics of group 1 isolates containing aphA6 
Isolate Year ST (IP) ST (Ox) KL Resistance genes and likely location 
S21 
S24 
S26 
S29 
1996 
2006 
2006 
2007 
2 
641 
2 
2 
208 
208 
1165 
1165 
2 
2 
73 
73 
AbGRI1: sul2, strA-strB, tetA(B) 
AbGRI2: blaTEM, aphA1b, aacC1, aadA1, sul1 
Other:      aphA6, oxa23 
S30 2008 2 369 49 AbGRI1: strA-strB, tetA(B) 
AbGRI2: blaTEM, aphA1b, aacC1, aadA1, sul1 
Other:      aphA6, oxa23, tet39, msrE-mphE 
 
The majority of the antibiotic resistance genes in group 1 isolates are those characteristically 
found in the AbGRI1 or AbGRI2 resistance islands, and will likely assemble into these regions 
(Table 3.12). In addition to these resistance islands, they all have TnaphA6, which has been 
detected on RepAci6 plasmids and the oxa23 gene has been detected in many locations either 
in plasmids or in the chromosome. However, in this group there was lots of deviation when the 
sequence type in both the Institut Pasteur and the Oxford scheme were considered (Table 3.12). 
Only S29 and S26 appear to potentially be siblings.  
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Some of the resistance genes present in the armA positive isolates can be assigned to AbGRI1 
and AbGRI2 island, though S35-S37 lack all of the characteristic AbGRI2 genes (Table 3.13).  
 
Table 3.13 Characteristics of group 2 containing armA 
Isolate Year ST (IP) ST (Ox) KL Resistance genes and likely location 
S22 
S23 
 
 
2004 
2004 
2 
2 
218 
218 
7 
7 
 
AbGRI1:  sul2, strA-strB, tetA(B) 
AbGRI2:  blaTEM, aphA1b, aacC1 
3rd island: armA, aacA4, catB8, msrE-mphE. aadA1, sul1 
Other:       oxa23 
S25 
S28 
2006 
2007 
2 
2 
218 
1128 
7 
32 
AbGRI1:  sul2, strA-strB, tetA(B) 
AbGRI2:  blaTEM, aacC1 
3rd island: armA, aacA4, catB8, msrE-mphE, aadA1, sul1 
Other:      oxa23 
S27 2007 2 218 7 AbGRI1:  sul2, strA-strB, tetA(B) 
AbGRI2:  aphA1b 
3rd island: armA, aacA4, catB8, msrE-mphE, aadA1, sul1 
Other:      oxa23 
S31 2008 2 208 2 AbGRI1:   strA-strB, tetA(B) 
AbGRI2:   aphA1b, aacC1 
3rd island: armA, aacA4, catB8, msrE-mphE, aadA1, sul1 
Other:       oxa23 
S32 
S33 
S34 
2009 
2009 
2009 
2 
2 
98 
195 
195 
1166 
3 
3 
49 
AbGRI1:  sul2, strA-strB, tetA(B) 
AbGRI2:  blaTEM, aphA1b 
3rd island: armA, msrE-mphE 
Other:      oxa23 
S35 
S36 
S37 
2010 
2010 
2010 
2 
2 
2 
195 
195 
195 
3 
3 
3 
AbGRI1:  sul2, strA-strB, tetA(B) 
AbGRI2:  - 
3rd island: armA, msrE-mphE 
Other:      oxa23 
S38 
S39 
2011 
2011 
 
2 
2 
208 
208 
2 
2 
AbGRI1:  strA-strB, tetA(B) 
AbGRI2:  aacC1 
3rd island: armA, aacA4, catB8, msrE-mphE, aadA1, sul1 
Other:       oxa23 
 
However, quite a large portion of these genes were contiguous with one another and had the 
same gene content as a third chromosomally located resistance island described recently (277). 
Hence, these isolates may also contain a version of this resistance island. Some isolates in this 
group contain the aphA1b (red in Table 3.13) which has been associated with both AbGRI2 
(24, 188) and this new resistance island (277), and could potentially be in either region or both. 
Again, they all contain the oxa23 gene in Tn2006 which could be potentially located in the 
chromosome or in RepAci6 plasmids. The diversity in the Oxford MLST profiles of these 15 
isolates provided further evidence of the variation present in this collection. 
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4.1 Introduction 
The oxa23 carbapenemase resistance gene in A. baumannii has been detected in a number of 
different transposons, including Tn2006, Tn2007, Tn2008, Tn2008B and Tn2009 (194, 215). 
All but Tn2007, which has ISAba4 upstream, have ISAba1 upstream of oxa23, and Tn2006 
and Tn2009 also have a copy of ISAba1 downstream of this gene (61, 194, 215). Tn2006 has 
been experimentally shown to transpose and like ISAba1 it creates a 9 bp TSD (181). The 
oxa23 gene is commonly detected in carbapenem resistant A. baumannii, both in the 
chromosome and in plasmids (194).  
 
Tn2006 can also be found in a larger transposon Tn6022 and the entire structure was named 
AbaR4 (3). Tn6022 is an 11,998 bp transposon that encodes five genes likely involved in its 
transposition; tniC, tniA, tniB, tniD and tniE, as well as the uspA and sup genes (Fig 4.1) (88). 
In AbaR4, Tn2006 interrupts the sup gene and is surrounded by the 9 bp TSD 5`-
CCCGCGAAT-3` (Fig 4.1). AbaR4 has been detected in the comM gene (88), but it was first 
identified in a different chromosomal location in AB0057 which already had AbaR3 in comM 
(AB57_0566, GenBank accession number CP001182) (3).  
 
Figure 4.1 AbaR4 structure. Arrows indicate the extent and orientation of genes and open reading frames. The 
oxa23 gene is orange. ISAba1 are shown as light blue boxes and the internal arrows represent the transposase. 
Vertical bars indicate IRs. Bars above and below indicate extents of transposons. Figure made to scale from 
GenBank accession number JN96883.  
 
Most GC2 isolates contain a resistance island in comM, and in all but one of the genomes 
completed so far, the resistance island contains Tn6022 or a specific deletion derivative 
Tn6022∆1 at one end (190). Tn6022∆1 (190) is missing 2.85 kb of the transposition module, 
orf4sup∆oxa23∆supuspAtniEtniDtniBtniAtniC
Tn2006
500 bp
Tn6022 Tn6022
ISAba1 ISAba1
IRl IRr
AbaR4
CCCGCAAT CCCGCAAT
orf
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including part of tniB and tniE and all of tniD (260) (Fig 4.2A). Hence, to distinguish it from 
the AbaR islands present in comM GC1 isolates, the island variants containing Tn6022 or 
Tn6022∆1 in the comM gene in GC2 isolates are called AbGRI1 and variants are numbered 
(191).  
 
 
Figure 4.2. Variants of AbGRI1. Structure of A. AbGRI2-1, B. RIMDR-TJ and C. AbGRI1. Arrows indicate extent 
and orientation of genes and open reading frames. The sul2 gene is pink, the tetA(B) and tetR(B) genes are dark 
blue and the strB and strA genes are light green. Adjacent chromosomal genes are grey. The light blue box 
represents ISAba1, the yellow boxes indicate CR2 elements and the internal arrows indicate the orientation of the 
transposase and rolling circle replicase, respectively. Vertical bars indicate IRs. Bars above indicate the origin of 
segments and vertical arrows indicate the deletion (∆) and location of insertions. Figures made to scale from 
GenBank accession number JN968483 for AbGRI1-2, GenBank accession number CP003500 for RIMDR-TJ and 
GenBank accession number JN247441 for AbGRI1-1.  
 
Most Australian GC2 isolates contain AbGRI1-2 (37 kb in size and originally named Tn6167) 
(193), which is composed of Tn6022∆1, an orf region, part of the transposition module of 
Tn6173 (94), a fragment originating from GIsul2, including the sul2 resistance gene, the tetB 
Tn6022∆1AbGRI1-2
ISAba17∆
Tn6173 GIsul2 Tn10 Tn5393 Tn6173
CR2∆CR2
1 2 3 4 5 6 7tniC tniA tniB∆ ∆tniE uspA sup
tniCb tniAb tniBb∆ sul2 tetA(B) tetR(B) strAstrB orf4b
orf4
Tn2006
ISAba1
rcr2
∆comM
500 bp
IRl IRr
IRl IR5393 IRr
orf
comM∆
RIMDR-TJ
Tn6022∆1
∆
CR2∆CR2
1 2 3 4 5 6 7tniC tniA tniB∆ ∆tniE uspA sup
tniCb tniAb tniBb∆ sul2 tetA(B) tetR(B) strAstrB orf4b
orf4
ISAba1
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∆comM
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IRl IRr
IRl IR5393 IRr
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tniC tniA uspA sup orf4
orf
orftniB tniD tniE
 
∆
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orf
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tetracycline resistance determinant from Tn10 and the strA and strB genes (conferring 
resistance to streptomycin) from Tn5393 (Fig 2A) (191). In addition, AbGRI1-2 has two 
unique insertions that are not seen in any other known AbGRI1 variant. The first is ISAba17 
downstream of ∆tniE and the second is Tn2006 inserted in orf 8 (vertical arrows Fig 4.2A) 
(191).  
 
A larger island (41.6 kb), called RIMDR-TJ, was found in the completed genome of MDR-TJ 
(125) and has the same basic structure as AbGRI1-2 but lacks ISAba17 and Tn2006 (Fig 2B). 
In addition, RIMDR-TJ has a complete copy of Tn6022 inserted in the end of the tetA(B) gene 
separating the last 6 bases. A replacement stop codon for the tetA(B) gene is found 16-18 bp 
into the IR of Tn6022 (Fig 4.2B). A closely-related version of this island, originally called 
AbaR24, was assembled from isolates from Latvia but had AbaR4 instead of Tn6022 in the 
same position (Fig 4.2B) (232). 
 
The variant detected in A320, the oldest GC2 isolate from 1982, was AbGRI1-1 (originally 
named Tn6166) (190). AbGRI1-1 is only 17.6 kb and has likely derived from an island related 
to RIMDR-TJ as the tetA(B) in AbGRI1-1 is also missing 6 bp (190) (Fig 4.2C). AbGRI1-1 could 
arise from RIMDR-TJ through recombination between Tn6022∆1 and the full Tn6022. 
Interestingly, AbGRI1-1 containing Tn2006 in exactly the same position in the sup gene as in 
AbaR4, had been detected earlier in the isolate AB210 from the UK (260) as well as in isolates 
from Lithuania, where it was called AbaR4b (238). For clarity, I will refer to Tn2006 inserted 
in Tn6022∆1 as AbaR4∆1.  
 
The work in this chapter focuses on determining the location of the oxa23 gene in the 
chromosome of the 20 GC2 isolates from Singapore. Previous screening (Chapter 3; Section 
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3.3.3) had shown that the oxa23 gene was located in Tn2006 in all isolates except S30. The 
Tn2006 containing isolates were screened to determine if this transposon was located in AbaR4 
or AbaR4∆1. As both AbaR4 and AbaR4∆1 have been detected in AbGRI1, this island was 
assembled in all isolates. Further locations of transposons containing oxa23 in the chromosome 
were also determined.  
 
4.2 Screening for Tn6022 and AbaR4 
4.2.1 Detection of Tn6022 and/or Tn6022∆1 
Tn2006 has been seen in both Tn6022 as AbaR4 or in Tn6022∆1 as AbaR4∆1. The 20 isolates 
were screened for Tn6022 and Tn6022∆1 using the published primers RH910 and RH587 
(191). These primers bind to either side of the 2.85 kb deletion in Tn6022∆1 and distinguish 
these two forms based on size (Fig 4.3A). For a full Tn6022, a product 3,410 bp is amplified, 
while for Tn6022∆1 the amplicon is only 560 bp. The majority of the isolates contain both a 
full Tn6022 and Tn6022∆1 (Fig 4.3B), but S24, S26 and S29 contain only Tn6022 and S30 
contains only Tn6022∆1. 
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Figure 4.3. Screening for Tn6022 and/or Tn6022∆1 A. Location of primers to detect Tn6022 and Tn6022∆1. 
Arrows indicate extent and orientation of genes and open reading frames. Primers used to detect version of Tn6022 
are shown by the bars above along with the PCR amplicon size. Vertical bars indicate IRs and the triangle indicates 
the position of the 2.85 kb deletion in Tn6022∆1. B. The primers RH910 and RH587 were paired to amplify over 
a 3,410 bp region in Tn6022 and a 560 bp region in Tn6022∆1. Isolate numbers are shown above the lanes and 
sizes of the molecular marker on the left and right are in kb.   
 
4.2.2 Detection of AbaR4 or AbaR4∆1 
The isolates were screened for Tn2006 in AbaR4 or AbaR4∆1 using a primer in Tn2006, 
RH743, with RH910 in the start of the tniB gene that is present in both Tn6022 and Tn6022∆1 
(Fig 4.4A). The isolates S21-S29 and S34, produced an amplicon between 9 to 10 kb, consistent 
with the 9,363 bp predicted amplicon size of Tn2006 in Tn6022 (Fig 4.4B, lanes 2 and 3). 
Hence, Tn2006 is located in AbaR4 in these isolates. However, in S31, S32, S33, S35, S36, 
S37 and S40, a 9-10 kb amplicon and an amplicon between 6 to 8 kb, were produced indicating 
that Tn2006 was present in both AbaR4 and AbaR4∆1 were present (Fig 4.3B, lanes 4 and 5). 
An amplicon was not produced for S30, and this is consistent with the absence of Tn2006 in 
this isolate (Fig 4.4B, lane 1).  
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Figure 4.4 Screening for Tn2006 in AbaR4 and AbaR4∆1. Arrows indicate extent and orientation of genes and 
open reading frames. The oxa23 gene is orange. The light blue box represents ISAba1 and the internal arrows 
indicate the orientation of the transposase. Vertical bars indicate IRs. Primers used to detect Tn2006 in AbaR4 or 
AbaR∆1 are shown by the bars above along with the PCR amplicon size. B. The primers RH743 and RH910 were 
paired to amplify a 9,363 bp region in AbaR4 and a 6,513 bp region in AbaR4∆1. Isolate numbers are shown 
above the lanes and sizes of the molecular marker on right are in kb. The blue and red dots indicate the amplicon 
for AbaR4 or AbaR4∆1, respectively.  
 
4.2.3 Is an intact sup gene present? 
The 20 isolates were screened for an intact sup gene to determine if they contained a copy of 
Tn6022 or Tn6022∆1 without Tn2006. A set of primers, RH2523 and RH2509 were designed 
in the sup gene, on either side of the insertion site of Tn2006. The isolates S21-S30, 34, S38 
and S39 produced an amplicon of approximately 200 bp, consistent with the predicted product 
size of 209 bp for an intact sup gene (Table 4.1). Thus, these isolates contain at least one copy 
of Tn6022 or Tn6022∆1 without Tn2006. However, S31-S33, S35-S37 and S40 failed to 
produce an amplicon, indicating that every copy of Tn6022 or Tn6022∆1 in these isolates likely 
has Tn2006 inserted in the sup gene (Table 4.1).  
 
The screening results are summarised in Table 4.1. Included in Table 4.1 is the presence of 
sul2 gene in each isolate as this feature distinguishes AbGRI1-1 or RIMDR-TJ. Six groups were 
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differentiated based on the pattern of their screening results, but only three of these groups 
included isolates that were sequenced by Illumina HiSeq that were available at the start of the 
project (isolates in bold, Table 4.1).  
 
Table 4.1 Groups based on screening results   
Group Isolate sul2 Tn2006 Tn6022 Tn6022∆1 AbaR4 AbaR4∆1 Intact 
sup 
1 S21, S22, S23, S25, 
S27, S28, S34  
+ + + + + - + 
2 S24, S26, S29 + + + - + - + 
3 S32, S33, S35, S36, 
S37, S40 
+ + + + + + - 
4 S38, S39 - + + + + - + 
5 S31 - + + + + + - 
6 S30 - - - + - - + 
Isolates in bold has draft genome sequence available from the start of the project.  
 
As both AbaR4 and AbaR4∆1 had been detected in the AbGRI1 island of GC2 A. baumannii, 
this island was assembled in the 20 isolates either from HiSeq data or PCR mapping with later 
confirmation from MiSeq data.   
 
4.3 AbGRI1 assembly 
S30, S31, S38 and S39 do not contain the sul2 gene and are likely to contain a resistance island 
resembling the shorter AbGRI1-1 (Fig 4.2C). The other isolates have the sul2 gene and were 
more likely to resemble RIMDR-TJ. The AbGRI1 regions in the seven isolates sequenced by 
HiSeq (those in bold in Table 4.1) were assembled using the appropriate scaffold of RIMDR-TJ 
or AbGRI1-1. Through this process contigs indicating additional locations of AbaR4 were 
identified and their locations are further examined in Section 4.5.  
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4.3.1 AbGRI1-3 in S21 and AbGRI1-4 in S27 and S34 
The draft genomes of the three group 1 isolates (Table 4.1), S21, S27 and S34, had 10 contigs 
that were retrieved using RIMDR-TJ as query (Table 4.2). Eight of these contigs tiled to RIMDR-
TJ, spanning the entire region (Fig 4.5A). Two further contigs of all three isolates (listed in Table 
4.2) had either the left or right IR of Tn6022 at one end, but the rest of the sequence matched 
the RepAci6 plasmid backbone. The increased coverage of the contig containing the oxa23 
gene in these isolates indicates that AbaR4 may be present in a RepAci6 plasmid and these 
contigs are further examined in Chapter 8. 
 
Table 4.2 Contigs of S21, S27 and S34 matching RIMDR-TJ  
 
The AbGRI1 region of S21, S27 and S34 was mapped using the linkage PCRs indicated by 
maroon bars in Fig 4.5A. The amplicons produced were of the expected size for the left end of 
RIMDR-TJ. However, differences arose at the right end of the resistance island. When RH583 
(located in tniD) was combined with a primer in tetA(B), tetB-F, only S21 produced an 
amplicon around 8 kb, consistent with the predicted size of 8,074 bp (orange bar in Fig 4.5A). 
Hence S21, had the same AbGRI1 island as RIMDR-TJ. For consistency, this structure has been 
assigned an AbGRI1 number and is called AbGRI1-3.  
S21 contigs 
(bp) 
S27 contigs 
(bp) 
S34 contig 
 (bp) 
Content Edges 
L R 
17 (31,877) 27 (31,874) 46 (31,869) LH flank ND IRl Tn6022 
51 (3,281) 21 (3,282) 58 (3,282) tniC, tniA, tniB∆ IRl Tn6022 tniB∆ 
34 (3,640) 12 (3,640) 45 (3,640) ∆tniE, uspA, sup∆ tniE∆ sup∆ 
11 (2,235) 10 (2,236) 33 (2,236) ∆sup, orf4  sup∆ IRr Tn6022 
27 (9,581) 43 (9,569) 53 (9,578) orf region, ∆Tn6173 IRr Tn6022 ISAba1-IRr 
105 (1,617) 88 (1,617) 104 (1,620) sul2, CR2∆ ISAba1-IRl IRl Tn6022 
66 (3,012) 17 (3,009) 59 (3,009) ∆tniB, tniD, tniE∆ ∆tniB ∆tniE 
52 (65,573) 46 (65,569) 73 (65,569) tetA(B), tetR(B), CR2, strB, 
strA, orf4b, RH flank 
IRr Tn6022 ND 
10 (63,797) 50 (9,882) 22 (37,778) RepAci6 plasmid backbone ND IRl Tn6022 
38 (12,151) 19 (40,921) 8 (13,024) RepAci6 plasmid backbone IRr Tn6022 ND 
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Figure 4.5 AbGRI1 mapping for S21, S27 and S34. A. AbGRI1 contigs in S21, S27 and S34 and PCRs used to 
assemble them. Arrows indicate extent and orientation of genes and open reading frames. The sul2 gene is pink, 
the tetA(B) and tetR(B) genes are dark blue and the strB and strA genes are light green. Adjacent chromosomal 
genes are grey. The light blue box represents ISAba1, the yellow boxes indicate CR2 elements and the internal 
arrows indicate the orientation of the transposase and rolling circle replicase, respectively. Vertical bars indicate 
IRs and the triangle indicates the position of the 2.85 kb deletion in Tn6022∆1. Grey lines above indicate S21, 
S27 and S34 contigs and the blue bars indicate ISAba1 fragments. The primers used to link sequences are shown 
above by the maroon bar and orange bars along with the predicted amplicon size. B. Tn2006 is inserted in the 
AbaR4 position in Tn6022 in S27 and S34. The oxa23 gene in orange and grey arrows indicate the position of 
primers.  
 
The isolates S27 and S34 failed to amplify a product when RH583 and tetBF were combined. 
However, they did produce an amplicon when RH743, an internal primer of Tn2006, was 
combined with tetBF (Fig 4.5B). Both isolates produced an amplicon between 5 and 6 kb, 
consistent with the predicted size of 5,205 bp. Sequence of the amplicon confirmed that Tn2006 
was inserted directly adjacent to 5`-CCCGCAAT-3` which is the 9 bp TSD of AbaR4 (Fig 4.1). 
Hence, there is strong evidence that AbaR4 was present in S27 and S34 instead of the full copy 
of Tn6022 in the AbGRI1 of S21. However, primers linking Tn2006 to the sul2 gene (RH743 
and RH603) failed to amplify a product of the predicted size of 12,907 bp. This is not surprising 
tetA(B) tetR(B)
∆
CR2
∆CR2
1 2 3 4 5 6 7tniC tniA tniB∆ ∆tniE uspA sup
tniCb tniAb tniBb∆ sul2
strAstrB orf4b
orf4
ISAba1
rcr2
∆comM
comM∆
IRl IRr
IRl
IR5393 IRr
orf
500 bp
tniC tniA uspAorftniB tniD tniE
sup orf4
17/27/46
51/21/58
34/12/45 11/10/33
27/43/53
27/43/53
105/88/104
105/27/46 66/17/59 34/12/45
34/12/45 52/46/73
RH791-RH771
6,288 bp
RH772-RH596
4,768 bp
RH597-RH955 
5,586 bp
RH597-RH955 
5,586 bp
RH603-RH934 
8,423 bp
RH583-tetBF 
8,074 bp
RH583-tetBF 
8,074 bp
11/10/33
A. 
B. 
sup
oxa23ISAba1 ISAba1
oxa23R
Tn2006
tetA(B) tetR(B)
CR2
strAstrB orf4brcr2 comM∆
IR5393 IRr
orf4
tetBF
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due to the predicted amplicon size, and sequencing S27 and S34 using long read technology 
such as PacBio or Oxford nanopore will be required to confirm the correct assembly of AbGRI1 
in these isolates. The structure of AbGRI1 deduced from the genome data by PCR mapping of 
S27 and S34 is the same as that of one called AbaR24 (232). To avoid confusion with the 
AbaR-type islands in GC1 isolates, AbaR24 has been assigned AbGRI1-4.  
 
4.3.2  AbGRI1-5 in S24 and S29 
Nine and 10 contigs that had sequence matching AbGRI1-3 were retrieved from the draft 
genomes of S24 and S29, respectively (Table 4.3). These two isolates were in group 2 of Table 
4.1. As for S21, S27 and S34, two of the contigs from S24 and S29 contained sequence 
matching RepAci6 plasmid backbone with IRl or IRr of Tn6022 at one end. Hence, it is likely 
that AbaR4 is located only in a RepAci6 plasmid in these isolates and the increased coverage 
of the oxa23 containing contig supports this. These plasmids are examined further in Chapter 
8.  
 
Table 4.3 Contigs of S24 and S29 matching AbGRI1-3  
 
 
 
 
 
 
 
The remainder of the contigs of S24 and S29 in Table 4.3 tiled to AbGRI1-3 (Fig 4.6A). 
Consistent with the earlier screening (Table 4.1) there were no contigs for Tn6022∆1. There 
were also no contigs matching the orf region or tniCb (Fig 4.6A). However, there was a smaller 
S24 contigs 
(bp) 
S29 contigs 
(bp) 
Content Edges 
L R 
24 (31,874) 22 (31,862) LH flank ND IRl Tn6022 
138 (1,657) 91 (1,583) tniC, tniA∆ IRl Tn6022 tniA∆ 
64 (1,677) 51 (1,665) ∆tniAb, tniBb∆ ∆tniAb ISAba1-IRr 
97 (1,618) 70 (1,604) sul2, CR2∆ ISAba1-IRl IRl Tn6022 
49 (8,114) 18 (8,188) ∆tniA, tniD, tniE, tniE, uspA, sup∆ ∆tniA sup∆ 
51(2,236) 92 (2,237) ∆sup, orf4 ∆sup IRr Tn6022 
69 (65,570) - tetA(B), tetR(B), CR2, strB, strA, 
orf4b, RH flank 
IRr Tn6022 ND 
- 46 (65,569) tetA(B), tetR(B), CR2, strB, strA IRr Tn6022 ISAba1-IRl 
- 6 (59,219) orf4b, RH flank ISAba1-IRr ND 
14 (9,864) 50 (9,882) RepAci6 plasmid backbone ND IRl Tn6022 
65 (1,752) 19 (40,921) RepAci6 plasmid backbone IRr Tn6022 ND 
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contig 138/91, that at one edge had IRl of Tn6022 and ∆tniA at the other, and another contig 
64/51, that contained sequence of ∆tniAb, tniBb∆ and a fragment of ISAba1 (Fig 4.6A).  
 
Figure 4.6 Assembly of AbGRI1-5 in S24 and S29. A. AbGRI1 contigs in S24 and S29. B. Structure of AbGRI1-
5a. C. Site of recombination AbGRI1-5. In A. and B. arrows indicate extent and orientation of genes and open 
reading frames. The sul2 gene is pink, the tetA(B) and tetR(B) genes are dark blue and the strB and strA genes are 
light green. Adjacent chromosomal genes are grey. The light blue box represents ISAba1, the yellow boxes 
indicate CR2 elements and the internal arrows indicate the orientation of the transposase and rolling circle 
replicase, respectively. Vertical bars indicate IRs and the triangle indicates the position of the 2.85 kb deletion in 
Tn6022∆1.  Grey lines above indicate S24 and S29 contigs and the blue bars indicate ISAba1 fragments. The 
primers used to link sequences are shown above by the maroon bar and orange bars along with the predicted 
amplicon size. Some primer locations are indicated by grey arrows. The asterisk indicates the site of 
recombination. In C. the orange box indicates the 23 bp where recombination has occurred.  
 
A primer in the sequence flanking AbGR1 on the left, RH791, combined with a primer in the 
sul2 gene (Fig 4.6A), successfully amplified a 5 kb product, indicating that part of Tn6022∆1, 
the orf region and a fragment of ∆Tn6173 had been lost at the left end of AbGRI1 in S24 and 
S29 (Fig 4.6B). As tniA (1,911 bp) and tniAb (1,911bp) share 94% nucleotide identity 
(1805/1912, 2 gaps), it is likely that recombination between these two genes has removed the 
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∆
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strA-out RH1366
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tniC tniA hybrid tniBb∆ sul2
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IR5393 IRr
500 bp
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(ISAba1 in AbGRI1-5b)
A. 
B. AbGRI1-5a
 
 
 
 
 
 
TATTGAAATCGTGGATGACGAGTTTAGAGAAGCGATTGGAAAACCTCATTTAACCTTGGCAATCGATGTTTTCAGTCGGATGATCGTAGGGTATTACCTA 
|||||||||||||||||||||||||||||||||||||||||||||||| ||||||||||||||||||||||||||||||||||| || || ||||||||| 
TATTGAAATCGTGGATGACGAGTTTAGAGAAGCGATTGGAAAACCTCACTTAACCTTGGCAATCGATGTTTTCAGTCGGATGATTGTTGGATATTACCTA 
|||||||||||||||||||||||| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
TATTGAAATCGTGGATGACGAGTTCAGAGAAGCGATTGGAAAACCTCACTTAACCTTGGCAATCGATGTTTTCAGTCGGATGATTGTTGGATATTACCTA 
tniA
tniA/tniAb
tniAb
C. 
*
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intervening sequence. Sequence of the amplicon revealed a 23 bp region where the 
recombination has occurred (orange box in Fig 4.6C) and created a hybrid tniA (1,911 bp) 
composed of at least the first 768 bp of tniA (Tn6022) and at least the last 1,120 bp of tniAb 
(Tn6179).  
 
The mapping PCRs RH603 with RH934 (8,423 bp) and RH58 with tetBF (8,074 bp), confirmed 
that a full copy of Tn6022, without Tn2006, was located between the sul2 gene and the tetB 
determinant in S24 and S29. These PCRs completed the assembly of the AbGRI1 region in 
S24 as the contig containing the tet(B) determinant (contig 69), also contained the remainder 
of the right end and junction of AbGRI1. This AbGRI1 structure has been named AbGRI1-5a 
(Fig 4.6B).  
 
 However, in S29, the tetB containing contig, contig 46, ends with a fragment of ISAba1 just 
after the strA gene (Fig 4.6A). Contig 6 also has a fragment of ISAba1 adjacent to the orf4b 
gene and includes sequence to the right of AbGRI1 (Fig 4.6A). The primer strA-out was 
combined with RH1366 in comM and amplified a product just above 4 kb, consistent with the 
predicted amplicon size of 4,122 bp if an ISAba1 was present in this region in S29 (Fig 4.6B). 
The amplicon sequence confirmed the presence of an ISAba1 inserted 132 bp upstream of the 
start codon of strA and was surrounded by the 9 bp TSD 5`-ATATTAATT-3`. The acquisition 
of this extra copy of ISAba1 is the only difference between the AbGRI1 in S24 and S29, and 
thus the variant in S29 has been called AbGRI1-5b (Fig 4.6B).  
 
4.3.3 AbGRI1-1 in S38 and S39 
Eight contigs matching AbGRI1 were retrieved from both of the draft genomes of S38 and S39 
(Table 4.4). None of these contigs contained the sul2 gene or the orf region indicating that S38 
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and S39 contained AbGRI1-1 and five of the contigs tiled successfully to this island variant 
(Fig 4.7). However, two of the remaining contigs from these two isolates matched a segment 
of chromosome distant from AbGRI1 (Table 4.4) and had either IRl or IRr of Tn6022 at one 
end. The remaining additional contig, contig 48 in S38 and contig 16 in S39 contained the 
segment of Tn6022 missing in Tn6022∆1. Each of these three contigs from S38 and S39 were 
examined further in Section 4.5.2.  
 
Table 4.4 Contigs of S38 and S39 matching AbGRI1-1 
 
 
 
 
 
 
The sequence to the left of AbGRI1 was linked to sup and produced an amplicon slightly larger 
than 6 kb, consistent with the predicted product size of 6,288 bp for a Tn6022∆1 (Fig. 4.7). 
Hence, Tn6022∆1 is at the left end of AbGRI1 in S38 and S39. Using the primers RH910 and 
tetBF (Fig 4.7), Tn6022∆1 was linked to tetA(B), amplifying a product between 6 to 8 kb, 
consistent with the predicted size of 7,120 bp. Hence, S38 and S39 contained AbGRI1-1.  
 
S38 contigs 
(bp) 
S39 contigs 
(bp) 
Content Edges 
L R 
7 (31,878) 13 (31,874) LH flank ND IRl Tn6022 
57 (3,282) 37 (3,640) tniC, tniA, tniB∆ IRl Tn6022 tniB∆ 
27 (3,640) 35 (3,282) ∆tniE, uspA, sup∆ ∆tniE sup∆ 
12 (2,236) 11 (2,236) ∆sup, orf4 ∆sup IRr Tn6022 
48 (3,013) 16 (3,009) ∆tniB, tniD, tniE∆ ∆tniB tniE∆ 
11 (65,574) 8 (65,490) tetA(B), tetR(B), CR2, strB, strA, 
orf4b, RH flank 
IRr Tn6022 ND 
20 (40,066) 18 (40,100) Chromosome ND IRl Tn6022 
31 (10,482) 27 (10,398) Chromosome IRr Tn6022 ND 
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Figure 4.7 Assembly of AbGRI1-1 in S38 and S39. Arrows indicate extent and orientation of genes and open 
reading frames. The sul2 gene is pink, the tetA(B) and tetR(B) genes are dark blue and the strB and strA genes are 
light green. Adjacent chromosomal genes are grey. The light blue box represents ISAba1, the yellow boxes 
indicate CR2 elements and the internal arrows indicate the orientation the transposase and rolling circle replicase, 
respectively Vertical bars indicate IRs and the triangle indicates the position of the 2.85 kb deletion in Tn6022∆1. 
Grey lines above indicate S38 and S39 contigs. The primers used to link sequences are shown above by the maroon 
bars along with PCR amplicon size.  
 
4.3.4 Prediction of AbGRI1 variant forms in isolates not sequenced by Illumina HiSeq 
The mapping strategies used per Nigro et al. (191) and used to assemble the AbGRI1 variants 
in the isolates sequenced by Illumina HiSeq were applied to the 13 isolates without genome 
sequence data to predict their AbGRI1 structure. Two additional screening PCRs were used to 
confirm the structure at the right end of AbGRI1 (Fig 4.8). The primers tetBF and strBout 
(4,616 bp) and strAout and RH1366 (2,942 bp), were used to link the tet(B) determinant to strB 
and strA to the chromosome to the right of AbGRI1, respectively (Fig 4.8) (191). Whether the 
sul2 gene was present was also considered (Table 4.1).  
 
 
Figure 4.8 Screening PCRs for the right end of AbGRI1. Arrows indicate extent and orientation of genes and 
open reading frames. The tetA(B) and tetR(B) genes are dark blue and the strB and strA genes are light green. 
Adjacent chromosomal genes are grey. CR2 is shown by the yellow box and the internal arrow indicates the 
rolling circle replicase. Vertical bars indicate IRs. The primers used to link sequences are shown above by black 
bars along with the predicted amplicon size.  
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4.3.4.1 Isolates without the sul2 gene 
Both S30 (group 6) and S31 (group 5) did not contain the sul2 gene and so the mapping 
strategies for AbGRI1-1 were applied to these isolates (Table 4.5). The amplicons produced 
for S30 perfectly matched the predicted sizes for AbGRI1-1 and hence this isolate contained 
this version of AbGRI1. However, for S31, an amplicon matching the predicted size was 
produced for all primer pairs, except for RH910 and tetBF that link tniB to tetA(B). From 
previous screening, S31 does not contain an intact sup gene, and has a copy of AbaR4∆1. A 5 
kb amplicon for oxa23R with tetBF, linking Tn2006 to tetA(B), was produced and was 
consistent with the predicted size of 5,016 bp if AbaR4∆1 is present. Hence, AbGRI1 in S31 
differed to AbGRI1-1 by the presence of Tn2006 in AbaR4∆1. The structure in S31 is identical 
to that of AB210 (Fig 4.2C) (260) and this version of AbGRI1 has been named AbGRI1-6.  
 
Table 4.5 Mapping AbGRI1 for the isolates without sul2  
Isolate LH flank-sup 
(Tn6022∆1) 
tniB-
tetA(B) 
(Tn6022∆1) 
Tn2006-
tetA(B) 
tetA(B)-
strB 
strA-  
RH flank 
AbGRI1 
version 
RH791-
RH771 
(6,288 bp) 
RH910-
tetBF 
(7,120 bp) 
oxa23R-
tetBF 
(5,016 bp) 
tetBR-
strBout 
(4,616 bp) 
strAout-
RH1366 
(2,942 bp) 
S30 + + ND + + 1 
S31 + - + + + 6 
 
4.3.4.2 Isolates containing the sul2 gene 
The mapping strategies attempted on the isolates with sul2 are shown in Table 4.6. Previous 
screening had revealed that S26 did not contain Tn6022∆1 (Fig 4.3), so the failure of this isolate 
to produce an amplicon linking the left flank of AbGRI1 to the sup gene (RH791-RH771) was 
not surprising (Table 4.6). S26 belonged to the same group (group 2, Table 4.1) as S24 and 
S29 which contained AbGRI2-5 and so S26 was screened for this structure. S26 gave a product 
round 5 kb for RH791 (comM gene) and sul2R (sul2 gene), consistent with the predicted 
amplicon size for recombination between tniA and tniAb present in AbGRI1-5. A copy of 
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Table 4.6 Mapping AbGRI1 for isolates with sul2  
Isolate LH flank-
sup 
(Tn6022∆1) 
LH flank-
sul2  
sup-orf 
region 
Tn2006-
orf region 
orf region-
tniCb 
∆Tn6173-
sul2 
sul2-uspA 
(Tn6022) 
tniD-
tetA(B) 
oxa23-
tetA(B) 
tetA(B)-
strB 
strA-RH 
flank 
AbGRI1 
version 
RH791-
RH771 
(6,288 bp) 
RH791-
sul2R 
(5,099 bp) 
RH772-
RH596 
(4,768 bp) 
oxa23R-
RH596 
(7,720 bp) 
RH792-
RH597 
(1,566 bp) 
RH597-
RH955  
(5,596 bp) 
RH603-
RH934 
(8,423 bp) 
RH583-
tetBF 
(8,074 bp) 
oxa23R-
tetBF 
(5,019 bp) 
tetBR-
strBout  
(4,616 bp) 
strAout-
RH1366 
(2,942 bp) 
S26 - + ND ND ND ND + + ND + +1 5 
S22 + ND + ND + + + + ND + + 3 
S23 + ND + ND + + + + ND + + 3 
S25 + ND + ND + + + + ND + + 3 
S28 + ND + ND + + + - - + - ? 
S32 + ND - + + + + - + + + 7 
S33 + ND - + + + + - + + + 7 
S35 + ND - + + + + - + + + 7 
S36 + ND - + + + + - + + + 7 
S37 + ND - + + + + - + + + 7 
S40 + ND - + + + + - + + + 7 
ND denotes that this arrangement was not tested as conflicting arrangements had already been confirmed in this isolate.  
1Product was approximately 1 kb larger than the predicted size.
Chapter 4 96	
ISAba1 was present between strA and orf4b, indicating that S26 likely contained AbGRI1-5b 
(Table 4.6).  
 
Three of the four remaining group 1 isolates (Table 4.1), S22, S23 and S25, produced 
amplicons consistent with AbGRI1-3 (Table 4.6). The fourth isolate, S28, failed to produce 
amplicons of the predicted sizes for two of the assembly PCRs for AbGRI1-3 (Table 4.6).  
These were linking Tn6022 to tetA(B) (RH583 and tetBF) and linking strA to the right flanking 
sequence of AbGRI1 (strAout with RH1366). The structure present S28 was examined further 
in Section 4.4.1 after the draft genome became available.  
 
4.3.4.2.1 AbGRI1-7 
The six remaining isolates in Table 4.6 were all group 3 in Table 4.1 and were found to contain 
a novel AbGRI1 structure AbGRI1-7 (Fig 4.9). Like AbGRI1-4, AbaR4 instead of the full 
length Tn6022 was inserted in the end of the tetA(B) gene. However, AbGRI1-7 harboured 
AbaR4∆1 instead of Tn6022∆1 at the left end of the island. The presence of AbGRI1-7 in these 
6 isolates is consistent with results of earlier screening including the presence of both AbaR4 
and AbaR4∆1, as well as not containing a full sup gene (Table 4.1).  
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Figure 4.9 Structure of AbGRI1-7. Arrows indicate extent and orientation of genes and open reading frames. 
The oxa23 gene is orange, the sul2 gene is pink, the tetA(B) and tetR(B) genes are dark blue and the strB and strA 
genes are light green. Adjacent chromosomal genes are grey. The light blue boxes represent ISAba1, the yellow 
box indicates CR2 elements and the internal arrows represent the transposase and rolling circle replicase, 
respectively. Vertical bars indicate IRs and the triangle indicates the position of the 2.85 kb deletion in Tn6022∆1. 
 
4.4 Examination of the draft genomes from Illumina MiSeq sequencing 
When the draft genome sequences of the isolates in Table 4.5 and Table 4.6 became available 
at the end of 2016, they were compared to the AbGRI1 regions assembled by PCR mapping. 
The draft genomes of S22, S23, S25, S26, S30, S31 S32, S33, S35, S36, S37 and S40 were 
consistent with predicted AbGRI1 structures. Additional information from the draft genome of 
S28 facilitated further assembly of the AbGRI1 region in this isolate (described in Section 
4.4.1).  
 
Analysis of the draft genomes of several isolates revealed additional copies of AbaR4. S31 
contained two contigs matching chromosomal sequence, similar to those in S38 and S39 (Table 
4.4), that had the IRs of Tn6022 at one end and these are examined in further detail in Section 
4.5.2. The draft genomes of S22 and S23 had two additional chromosomal contigs that 
contained the IRl and IRr of Tn6022 at one end and these are examined in more detail in Section 
4.5.1. The draft genomes of S22, S23, S25, S28, and S40 each included a pair contigs matching 
RepAci6 plasmids that had a copy of IRl or IRr of Tn6022 at one end, and these contigs are 
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further analysed in Chapter 8. The oxa23 gene in Tn2008 was located on a contig containing 
sequence matching RepAci6 plasmid in the draft genome of S30 (Chapter 8). 
 
4.4.1 AbGRI1-8 in S28 
The contigs of the draft genome of S28 indicated that Tn2006 had inserted in the intergenic 
region between strA and orf4b, accounting for the amplification failure using the primers strA 
out and RH1366 (Table 4.6). Primers that anneal to the internal segment of Tn2006 were 
combined with strA-out and RH1366 to orientate the transposon (Fig 4.10). Amplicons of the 
expected size were amplified when oxa23R and strA-out (predicted amplicon size of 2,517 bp), 
and RH743 and RH1366 (5,023 bp predicted amplicon size) were paired. A 9 bp target site 
duplication of 5`-AAAAAAAGG-3` surrounded Tn2006. As this is a new Tn2006 insertion 
position, the structure of AbGRI1 in S28 is assigned AbGRI1-8.  
 
 
Figure 4.10 Structure of AbGRI1-8 in S28. Arrows indicate extent and orientation of genes and open reading 
frames. The oxa23 gene is orange, the sul2 gene is pink, the tetA(B) and tetR(B) genes are dark blue and the strB 
and strA genes are light green. Adjacent chromosomal genes are grey. The light blue box represents ISAba1, the 
yellow boxes indicate CR2 elements and the internal arrows indicate the orientation of the transposase and rolling 
circle replicase, respectively. Vertical bars indicate IRs and the triangle indicates the position of the 2.85 kb 
deletion in Tn6022∆1. The primers used to link sequences are shown above by the maroon and orange bars along 
with the PCR amplicon size. The binding sites of some primers are indicated by grey arrows.  
 
The draft genome of S28 did not provide any indication of why the primer combination of 
RH583 and tetBF failed to amplify a product (orange bars in Fig 4.10) (Table 4.6). However, 
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when RH1310 and tetBF were paired, a product of the predicted size was amplified (maroon 
bars in Fig 4.10). As the region spanned by this PCR, overlaps with the amplicon produced 
using RH603 and RH934 (maroon bars Fig 4.10), it was assumed that a full Tn6022 was 
inserted at the end of tetA(B) and the failure of RH583 to tetBF to amplify was not examined 
further. Sequencing S28 using Oxford nanopore or PacBio could confirm the structure of 
AbGRI1-8 in this isolate. AbGRI1-8 has the same structure as AbGRI1-3, but with a new 
insertion of Tn2006.  
 
4.4.2 AbGRI1 variants 
The AbGRI1 variants assembled in the 20 isolates are listed in Table 4.7 and compared in Fig 
4.11. All of the variants detected can be derived from AbGRI1-3 either by addition of Tn2006 
or through deletions of segments by recombination. In fact, the only difference between 
AbGRI1-3, AbGRI1-4, AbGRI1-7 and AbGRI1-8 is presence of Tn2006 in different locations 
(Fig 4.11, Table 4.7). Homologous recombination between tniA and tniAb has removed the 
intervening sequence in AbGRI1-5. AbGRI1-1 and AbGRI1-6 have lost a large internal 
segment of AbGRI1-3, likely through recombination between Tn6022∆1 and Tn6022, but 
AbGRI1-6 also contains Tn2006 (Table 4.7).  
 
Table 4.7 AbGRI1 variants detected 
Isolates AbGRI1 
version 
oxa23 oxa23 location 
S21, S22, S23, S25,  3 -  
S27, S34 4 +  AbaR4 
S32, S33, S35, S36, S37, S40 7 + AbaR4∆1, AbaR4 
S28 8 + Tn2006 
S24 5a -  
S26, S29 5b -  
S30, S38, S39 1 -  
S31 6 + AbaR4∆1 
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Figure 4.11 AbGRI1 variants. Coloured lines indicate different segments of AbGRI1 as shown the key. Labelled arrows above the line indicate insertion position of Tn2006 
and ISAba1 and the triangle indicates the position of the 2.85 kb deletion. Dashed lines indicate missing segments.  
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4.5 Additional chromosomal locations of oxa23 containing transposons 
The coverage of the contig containing oxa23 in some isolates indicated that multiple copies of 
this gene may present and/or that they may located in plasmids that have a higher sequence 
coverage. These draft genomes contained additional contigs that indicated that oxa23 
containing transposons may be located elsewhere in the genome. A subset of these contigs 
matched RepAci6 plasmids and these will be addressed in Chapter 8. The work in this section 
is focused on finding the location of oxa23 containing transposons Tn2006 or AbaR4 in the 
chromosome at locations outside of AbGRI1.  
 
4.5.1 AbaR4 in S22 and S23 
Examination of the draft genomes of S22 and S23 revealed that both of these isolates contained 
an additional contig with the IRl of Tn6022 at one end (contig 39 in S22 and contig 44 in S23) 
and another contig with IRr of Tn6022 at one edge (contig 17 and contig 24 in S22 and S23, 
respectively). These contigs matched chromosomal sequence present in the completed genome 
of XH386 (GC2 isolate that is ST208 in the Oxford scheme and sequenced by PacBio, 
GenBank accession number CP010779) and hence were investigated as a chromosomal 
location of AbaR4. The presence of AbaR4 was confirmed by PCR mapping as indicated in 
Fig 4.12A. AbaR4 in S22 and S23 was not surrounded by a 5 bp TSD and compared to XH386, 
a 26.3 kb region was missing (Fig 4.12A). The approximate position of AbaR4 is indicated in 
a schematic of the chromosome of XH386 (Fig 4.12B).  
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Figure 4.12 Location of AbaR4 in the chromosome of S22 and S23. Assembly and location of AbaR4 in S22 
and S23. Arrows indicate extent and orientation of genes and open reading frames. The oxa23 gene is orange and 
adjacent chromosomal genes are grey. ISAba1 are shown as light blue boxes and the internal arrows indicate the 
orientation of the transposase. Vertical bars indicate IRs. Locus tags of XH386 (GenBank accession number 
CP010779) are provided. B. Location of AbaR4 on a schematic of the chromosome. Arrows indicate the 
approximate location of resistance islands.  
 
4.5.2 AbaR4 in S31, S38 and S39 
The two additional contigs of S38 and S39 that contained IRl or IRr at one edge (contig 20 and 
31 of S38 and 18 and 27 of S39) indicated that these isolates may also contain a copy of AbaR4 
in the chromosome. The draft genome of S31 also included similar contigs. PCR mapping 
(indicated in Fig 4.13A) confirmed the presence of AbaR4, surrounded a 5 bp TSD 5`-
CACAG-3`and inserted in the intergenic region between TE32_00030 and TE32_00035 in 
XH386 just prior to the gyrB gene in these three isolates (Fig 4.13B).  
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Figure 4.13 Location of AbaR4 in the chromosome of S31, S38 and S39. Assembly and location of AbaR4 in 
S31, S38 and S39. Arrows indicate extent and orientation of genes and open reading frames. The oxa23 gene is 
orange and adjacent chromosomal genes are grey. ISAba1 are shown as light blue boxes and the internal arrows 
indicate the orientation of the transposase. Vertical bars indicate IRs. Locus tags of XH386 (GenBank accession 
number CP010779) are provided. B. Location of AbaR4 on a schematic of the chromosome. Arrows indicate the 
approximate location of resistance islands.  
 
4.5.3 Tn2006 in S34 
Bioinformatic pairing of contigs containing fragments of ISAba1 with matching 9 bp target 
site duplication from the draft genome of S34 revealed two contigs (contig 21 and contig 148) 
containing chromosomal sequence that had the same TSD (5`-CGCAAACAC-3`) adjacent to 
a fragment of ISAba1, but both fragments of ISAba1 were from the 5`- end of this IS. This is 
indicative of Tn2006 and PCR mapping confirmed that it was present at this position (Fig 
4.14A). The sequence of the chromosome surrounding this transposon in S34 was found only 
in a subset of GC1 and GC2 isolates and was present in the complete genome of A85, a GC1 
sequenced by PacBio (GenBank accession CP021782). Tn2006 is inserted between two open 
reading frames CBI29_00939 and CBI29_0090 of A85 and the approximate position of this 
transposon is indicated in Fig 4.14B.  
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Figure 4.14 Location of Tn2006 in the chromosome of S34. Assembly and location of Tn2006 in S34. Arrows 
indicate extent and orientation of genes and open reading frames. The oxa23 gene is orange and adjacent 
chromosomal genes are grey. ISAba1 are shown as light blue boxes and the internal arrows represent the 
transposase. Vertical bars indicate IRs. Locus tags of A85 (GenBank accession number CP021782) are provided. 
B. Tn2006 location on a schematic of the chromosome. Figure made using genome sequence of A85 and the 
arrows in indicate the approximate location the GC2 resistance islands, AbGRI1, AbGRI2 and AbGRI3, and 
Tn2006.  
 
4.6 Discussion 
A version of AbGRI1 was detected in each of the 20 isolates examined and 7 different variants 
of this island were characterised (Table 4.8). A number of these variants matched those that 
had been published previously AbGRI1-1, AbGRI1-3, AbGRI1-4 and AbGRI1-6, but the later 
three island structures had been called other names. These variants were renamed here for 
consistency and to distinguish them from the unrelated AbaR islands and Tn6019 backbone. 
However, the variants AbGRI1-5, AbGRI1-7 and AbGRI1-8 were first characterised in this 
project. AbGRI1 variants -1 and -3 were found in both isolates containing armA and those 
where armA is absent (bold in Table 4.8).  
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Table 4.8 Location of oxa23 containing transposons 
Isolate AbGRI1 
version 
Context of oxa23 
in AbGRI1 
Additional 
chromosomal locations 
RepAci6 
plasmid? 
S21, S25 3   AbaR4 
S22, S23 3  AbaR4 (1) AbaR4 
S27 4 AbaR4  AbaR4 
S34 4 AbaR4 Tn2006 AbaR4 
S24, S26, S29 5   AbaR4 
S28 8 Tn2006  AbaR4 
S31 6 AbaR4∆1 AbaR4 (2)  
S38, S39 1  AbaR4 (2)  
S32, S33, S35, S36, 
S37 
7 AbaR4, AbaR4∆1   
S40 7 AbaR4, AbaR4∆1  AbaR4 
S30 1   Tn2008 
Those in bold are the five isolates without the armA gene.  
 
The first three isolates, S21, S22 and S23 contain AbGRI1-3. The only difference between this 
variant and AbGRI1-4, AbGRI1-7 and AbGRI1-8 is the addition of the oxa23 containing 
transposon Tn2006. AbGRI1-4 and AbGRI1-7 have acquired AbaR4 instead of the full length 
Tn6022 and AbGRI1-7 also contains AbaR4∆1 instead of Tn6022∆1. The switch between 
Tn6022 and AbaR4 has likely arisen by recombination as these transposons are located in the 
same position within the tetA(B) gene. As it is unlikely that Tn2006 has jumped into the same 
position in the sup gene of both AbaR4∆1 and AbaR4, it is probable that recombination also 
accounts for the formation of AbaR4∆1. However, AbGRI1-8 differs to AbGRI1-3 by a new 
acquisition of Tn2006. Tn2006 in AbGRI1-8 is in a different location to AbGRI1-2 (191) and 
represents a second transposition event of Tn2006 into AbGRI1.  
 
Recombination in the AbGRI1-3 structure between tniA of Tn6022∆1 and tniAb of Tn6173 
accounts for the segment missing from AbGRI1-5. An AbGRI1 structure with the same 
recombination junction has been detected some Australian isolates from Melbourne and 
Adelaide that have different characteristics to those originating from hospitals from the East-
coast of Australia (Dr Steven Nigro, personal communication). AbGRI1-1 is likely derived 
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from AbGRI1-3 by recombination between Tn6022∆1 and Tn6022. AbGRI1-6 differs from 
AbGRI1-3 as AbaR4∆1 instead of Tn6022∆1 is present.  
 
In addition, two other chromosomal locations for AbaR4 were detected, as was another 
insertion of Tn2006. Isolates that share the same chromosomal AbaR4 location are likely 
closely-related. There was also evidence from the draft genomes that 8 of the isolates may also 
harbour an RepAci6 plasmid carrying AbaR4 or Tn2008 (Table 4.8). The AbaR4 transposon 
has previously been detected on pA85-3 (97) and Tn2008 has been seen in other RepAci6 
plasmids (277).  
 
All isolates carry at least one copy of the oxa23 gene, while most contain two or even three 
copies of this gene. A recent publication has shown that an increase in the copy number of 
oxa23 does not appear to enhance carbapenem resistance (124).  
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5.1 Introduction 
The AbGRI2 resistance island is bounded by copies of IS26 and contains variable resistance 
gene content. The first variant of this island, AbGRI2-1, was characterised in the Australian 
isolates WM99c (1999) and A91 (2004). AbGRI2-1 is 19.5 kb and composed of fragments 
from a number of transposons carrying resistance genes along with three internal copies of 
IS26 (second line in Fig 5.1). AbGRI2-1 contains the aphA1b gene (kanamycin resistance) in 
Tn6020 (217), blaTEM (ampicillin resistance) and a class 1 integron with cassettes aacC1-orfP-
orfP-orfQ-aadA1 (conferring resistance to gentamicin, and spectinomycin and streptomycin) 
and sul1 (sulphonamide resistance) in the 3`-CS (188). Two other variants of AbGRI2 were 
identified in this work, AbGRI2-2 from MDR-TJ and AbGRI2-3 found in MDR-ZJ06 (188). 
Both of these variants could have arisen from AbGRI2-1 via IS26 mediated deletions, in 
addition to cassette switching for AbGRI2-3. 
 
 
Figure 5.1 Structure of AbGRI2-0 and AbGRI2-1. Arrows indicate the extent and orientation of genes and 
open reading frames. The blaTEM gene is blue, the aphA1b gene is red-orange, the sul1 gene is mauve and the 
aadA1 and aacC1 genes are light green and orange, respectively. Adjacent chromosomal genes are grey. The dark 
green box represents IS26 and the light blue box is IS6100, with internal arrows indicating the transposase 
orientation. IS26* is 3 bp different to the standard sequence of IS26. Vertical bars indicate IRs and the TSD 
surrounding AbGRI2-0 is shown above. Dashed lines represent the extent of deletions relative to AbGRI2-0 and 
the size is indicated above. Figure made to scale from GenBank accession number JN247441 for AbGRI2-0 and 
GenBank accession number JX869489 for AbGRI2-1 and has been adapted from Blackwell et al. (24)  
 
Recently, the AbGRI2 region of A320 (RUH134), the GC2 type strain from 1982, was 
assembled (24). The resistance island in A320 had been separated into two pieces, AbGRI2-0a 
and AbGRI2-0b, by an IS26 mediated inversion. Reversal of this inversion in silico revealed a 
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larger 32.4 kb resistance island, AbGRI2-0 (24) (top line Fig 5.1). As AbGRI2-0 was 
surrounded by an 8 bp TSD, the original location of this resistance island in the gene 
corresponding to ABA1_01225 in A1 (GenBank accession number CP010781) was revealed. 
The GC1 chromosome of A1 (isolated in 1982 and sequenced by PacBio) was used as a 
reference genome for this region as all GC2 genomes to date contain deletions of various sizes 
in this location.  
 
In addition to the genes in AbGRI2-1, AbGRI2-0 contained the catA1 chloramphenicol 
resistance gene and a mercury resistance region from Tn1696 (24). A comparison revealed that 
AbGRI2-0 is ancestral to AbGRI2-1 and AbGRI2-1 can be derived from AbGRI2-0 through a 
small number of events (Fig 5.1). An internal IS26 mediated deletion has removed 12.7 kb of 
AbGRI2-0, including the catA1 gene and the mercury resistance module. The IS26 bounding 
the left end of AbGRI2-1 has switched orientation and 223 bp of AbGRI2-0 sequence next to 
it is missing. AbGRI2-1 retains the original right boundary of AbGRI2-0 but 47,197 bp is 
missing from the chromosome flanking the left of AbGRI2-1 (Fig 5.1). The events that have 
resulted in the configuration at the left end of AbGRI2-1 are quite specific, and most of the 
reported AbGRI2 structures found in isolates from Asia and America have an AbGRI2 island 
derived from AbGRI2-1 (24, 193, 277).  
 
The work in this chapter focused on the assembly and analysis of the AbGRI2 region in the 20 
GC2 isolates from Singapore. The relationship of these AbGRI2 versions to AbGRI2-1 was 
also examined.  
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5.2 Assembly of AbGRI2 regions 
In draft genomes assembled from short read data, the sequence of AbGRI2 would be 
fragmented into several contigs due to the multiple copies of IS26. If AbGRI2-1 is present in 
any of these isolates it would likely be in four fragments, shown in Fig 5.2 (labels a-d). 
Published primer combinations (extents and product sizes indicated in Fig 5.2) had already 
been designed to map the AbGRI2-1 region (188). The available draft genomes of S21, S24, 
S26, S27, S29, S34, S38 and S39 were queried for IS26 sequence and the contigs retrieved 
were tiled to AbGRI2-1. Additional contigs containing IS26 fragments were also retrieved 
from the draft genomes S27, S34, S38 and S39 as these isolates contain the armA gene in 
another IS26 bounded resistance island, which is the focus of Chapter 6.  
 
Figure 5.2 Expected contigs for the AbGRI2-1 structure. Arrows indicate the extent and orientation of genes 
and open reading frames. The blaTEM gene is blue, the aphA1b gene is red-orange, the sul1 gene is mauve and the 
aadA1 and aacC1 genes are light green and orange, respectively. The dark green box represents IS26 and the light 
blue box is part of IS6100, with internal arrows indicating the transposase orientation. IS26* is 3 bp different to 
the standard sequence of IS26. Vertical bars indicate IRs. Grey lines above indicate the different fragments of 
AbGRI2-1. Primer combinations able to join the segments in this order are shown above by the black bars, along 
with the amplicon size.  
 
5.2.1 AbGRI2-1 in S21, S24 and S29 
The draft genome of S24 contained 6 contigs (Table 5.1) that tiled perfectly to AbGRI2-1 and 
its flanking chromosome (Fig 5.3A) while S21 and S29 each contained 7 contigs (Table 5.1) 
that matched all of AbGRI2-1 with the exception of the sequence covering segment d (over the 
integron) which had split at the orfP cassettes of the integron (Fig 5.3B). The presence of two 
copies of the orfP cassette was confirmed in the three isolates as they produced a 4.5 kb 
amplicon using primers RH754 and R1 (Fig 5.3B), consistent with the predicted amplicon size 
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of 4,549 bp, compared to the 4,011 bp amplicon produced for the case where only one orf P is 
present.  
 
Table 5.1 Contigs of AbGRI2 in S24, S21 and S29 
AbGRI2-1 
fragment 
Contig (size in bp) 
S24  S21 S29 
LF 197 (72,159) 253 (72,157) 134 (85,447) 
a 63 (1,734) 74 (1,738) 133 (1,722) 
b 38 (3,727) 37 (3,731) 110 (3,716) 
c 77 (1,586) 71 (1,590) 95 (1,574) 
d 95 (8,420)            -  - 
d1 - 110 (3,918) 65 (3,902) 
d2 - 24 (4,126) 15 (4,110) 
RF 25 (25,215) 23 (24,119) 59 (25,203) 
 
 
Figure 5.3 AbGRI2-1 contigs in S21, S29 and S24. A. Contigs of S21 and S29 tiled to AbGRI2-1. B. S24 contigs 
tiled to AbGRI2-1. Arrows indicate the extent and orientation of genes and open reading frames. The blaTEM gene 
is blue, the aphA1b gene is red-orange, the sul1 gene is mauve and the aadA1 and aacC1 genes are light green 
and orange, respectively. The dark green box represents IS26 and the light blue box is part of IS6100, with internal 
arrows indicating the transposase orientation. IS26* is 3 bp different to the standard sequence of IS26. Vertical 
bars indicate IRs. Grey lines above indicate the extents of different contigs in S21, S29 and S24. In A. the primer 
combination spanning the integron is shown above by the black bar, along with two predicted amplicon sizes.  
 
Primers described previously (188) and indicated in Fig 5.2, were used to link segments. Each 
amplicon was consistent with the predicted product size for AbGRI2-1, where by sequencing 
these amplicons confirmed which IS26 isoform was present. Similar to AbGRI2-1, all but one 
copy of IS26 had the standard sequence, and the variant form IS26* (differs from IS26 at three 
nucleotide positions, G459A, G613A and G614A) was located between tnpR5393c and aphA1b. 
Hence, these three isolates contain AbGRI2-1.  
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5.2.2 AbGRI2-12 in S34 
The draft genome of S34 contained 7 contigs that end with fragments of IS26 (Table 5.2), but 
two of these did not tile to AbGRI2-1 and were later assembled into a third chromosomal 
resistance region (Chapter 6).  
 
Table 5.2 Contigs of AbGRI2 in S34 
AbGRI2-1 
fragment 
Contig  
(size in bp) 
LF 136 (83,830)1 
a 71 (1,734) 
b 47 (3,648) 
c 61 (1,412)2 
d - 
RF 6 (21,880)3 
130,672 bp of sequence is missing compared to the left flank of AbGRI2-1.  
2Missing the 175 bp of ∆IS26. 
33,333 bp of sequence is missing compared to the right flank of AbGRI2-1. 
 
The draft genome of S34 contained contigs matching fragment a, b and c, but no contig 
matched fragment d (containing the integron) (Table 5.2). Fragment a and b (contig 71 and 47) 
were linked using the published primer combination (indicated in Fig 5.4A). Published primers 
were also used to link fragment b with c (contig 47 and 61), but in S34 the amplicon was about 
approximately 200 bp smaller than the predicted size of 2,122 bp (Fig 5.4B). Sequencing of 
this smaller amplicon revealed that IS26* was directly adjacent to aphA1b, and that IS26∆ (175 
bp) was missing in S34. IS26∆ could have been lost by homologous recombination. 
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Figure 5.4 Assembly of AbGRI2-12 in S34. A. Contigs of S34 tiled to AbGRI2-1. Arrows indicate the extent 
and orientation of genes and open reading frames. The blaTEM gene is blue, the aphA1b gene is red-orange, the 
sul1 gene is mauve and the aadA1 and aacC1 genes are light green and orange, respectively. The dark green box 
represents IS26 and the light blue box is part of IS6100, with internal arrows indicating the transposase orientation. 
Vertical bars indicate IRs. Grey lines above indicate the extent of different contigs in S34 and grey arrows indicate 
the position and orientation of new primer pairs. Known primer combinations used to link sequences are shown 
above by the black bars, along with PCR amplicon size. B. Screening results of RH520 and RH880. Isolate 
numbers are shown above the lanes and sizes of the molecular marker on the left are in kb. C. Structure of 
AbGRI2-12. Dashed lines represent the extent of deletions relative to AbGRI2-1 and the deletion size is indicated 
above.  
 
The contigs containing sequence matching the chromosome to the left and right of AbGRI2 
(123 and 6 in Table 5.2), revealed that deletions in both flanks had occurred in S34 relative to 
AbGRI2-1. Hence, a new primer RH1563 was used with RH539 to join the contigs 136 and 
71, allowing for detection of the left junction (Fig 5.4A). The amplicon was approximately 1 
kb, consistent with the predicted product size of 1,046 bp. The right junction of AbGRI2 in 
S34 was confirmed by sequencing the 1.5 kb amplicon produced using RH881 and another 
new primer RH2008 (1,581 bp predicted product size) (Fig 5.4A). 
 
The variant of AbGRI2 in S34 has been named AbGRI2-12 (Fig 5.4C). Compared to AbGRI2-
1, AbGRI2-12 is missing IS26∆ and has a 9.6 kb deletion in the resistance region that has 
removed all of segment d and a further 3.3 kb of sequence to the right of the island. There is 
also an additional 30.7 kb deletion of sequence flanking on the left of AbGRI2-12. Most of this 
variation has likely been caused by IS26 deleting adjacent sequence.  
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IS26 IS26 IS26* IS26 IRiIRtIR1000
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5.2.3 AbGRI2-13 in S38 and S39 
Using IS26 as a query, 7 contigs were retrieved from the draft genomes of S38 and S39. Only 
three of these contigs tiled on to AbGRI2-1 and adjacent chromosome (Table 5.3, Fig 5.5A), 
with none of them matching fragment a or c. The remaining four contigs were assembled into 
a different resistance island (Chapter 6).  
 
Table 5.3 Contigs of AbGRI2 in S38/S39 
AbGRI2-1 
fragment 
Contig (size in bp) 
S38 S39 
LF 41 (33,756)1 42 (33,750)1 
a - - 
b 41 (33,756)1 42 (33,750)1 
c - - 
d 56 (4,492) 65 (4,458) 
RF 33 (25,218) 29 (25,214) 
1This appears to be a hybrid contig and sequence from a directly adjacent to sequence from c.  
 
Contig 41 in S38 and contig 42 in S39 appeared to be a hybrid of the left flanking sequence of 
AbGRI2 and fragment b (Fig 5.5A). A large section of the sequence matched chromosomal 
sequence to 1,935 bp to the left of AbGRI2-1, then continued directly into sequence matching 
a part of a fragment b, containing a partial tnpA1000 and then tnpR5393c∆ and a fragment of IS26 
(Fig 5.5A).  
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Figure 5.5 Assembly of AbGRI2-13 in S38 and S39. A. Location of AbGRI2 contigs in S38 and S39. Arrows 
indicate the extent and orientation of genes and open reading frames. The blaTEM gene is blue, the aphA1b gene is 
red-orange, the sul1 gene is mauve and the aadA1 and aacC1 genes are light green and orange, respectively. The 
dark green box represents IS26 and the light blue box is part of IS6100, with the internal arrows indicating the 
transposase orientation. Vertical bars indicate IRs. Grey lines above indicate the extent of different contigs in S38 
and S39 and grey arrows indicate the binding sites and orientations of new primer pairs. Known primer 
combinations used to link sequences are shown above by the black bars, along with amplicon size. B. Structure 
of AbGRI2-13. Dashed lines represent the extent of deletions relative to AbGRI2-1 and the deletion size is 
indicated above. C. Putative site of recombination of AbGRI2-13. The pink box highlights the 10 bp region with 
7 of 8 bp identical that could have facilitated the recombination.  
 
To confirm the correct assembly of these contigs, the region was amplified using a new primer 
RH2009 with RH781 Fig 5.5A. This combination yields a product around 1.2 kb (consistent 
with the predicted product size of 1,223 bp) and the amplicon sequence confirmed the contig 
assembly. Comparison between the sequences of chromosome on the left of AbGRI2, contig 
41/42 and tnpA1000, revealed a 10 bp region with 7 or 8 bp identical (pink box in Fig 5.5C). 
This short region of homology could have facilitated recombination, removing 4,767 bp of the 
left end of the resistance island and 1,935 bp of the flanking chromosomal sequence relative to 
AbGRI2-1, a total deletion of 6,702 bp.  
 
S38 and S39 each had a contig (56 or 65 for S38 and S39, respectively) matching a part of 
fragment d (Table 5.3 and Fig 5.5A). The primer RH520 was combined with RH935 to link 
contig 41/42 to contig 56/65 and produced amplicons just below 2 kb, consistent with the 
predicted amplicon size of 1,881 bp. Sequence of the amplicon matched IS26*. The other end 
Version 4: 
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∆ 6,702 (4,767)   bp
500bp
∆ 4,497  bp
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of contig 56/65 was joined to contig 23/59 containing the right flank of AbGRI2-1 using the 
published primer combination (mapping PCR indicated above in Fig 5.5A) and the sequence 
of the amplicon was consistent with a standard IS26. A 4,497 bp segment including the aphA1b, 
sul1 and aadA1 genes is missing from the AbGRI2 region of S38 and S39, likely due to the 
IS26* causing an adjacent deletion (Fig 5.5B). The variant of AbGRI2 in S38 and S39 was 
named AbGRI2-13.  
 
5.2.4 No AbGRI2 variant in S27 
The draft genome of S27 contained six contigs ending with fragments of IS26. Contig 131 
(125,012 bp) matched sequence found to the left of AbGRI2-1 and contig 28 (19,716 bp) 
matched the chromosome to the right, but is missing 5,498 bp compared to the region flanking 
AbGRI2-1 (Fig 5.6). Another contig contained aphA1b with fragments of IS26 at each edge. 
However, the aphA1b gene had one SNP compared to that of aphA1b in Tn6020, and the 
segment between the bounding copies of IS26 was of a different size to Tn6020 (described in 
more detail in Chapter 6; Section 6.2.2). Instead, this aphA1b contig and the three remaining 
contigs containing fragments of IS26 were assembled into the third resistance region (see 
Chapter 6). Hence, S27 did not contain any contigs matching the internal sequence of the 
AbGRI2-1 island. Contig 131 was joined directly to contig 28 using the primers RH1315 and 
RH2007 (Fig 5.6). The amplicon produced was just over 1 kb, consistent with the predicted 
size of 1,048 bp and its sequence revealed the presence of IS26. Hence, only a single IS26 is 
left in the vicinity of AbGRI2 in S27. The orientation of the IS26 and the conservation of the 
left boundary of AbGRI2-1 is consistent with it being the IS26 from the left end of AbGRI2 
(Fig 5.6) as the right bounding IS26 is in the opposite orientation (Fig 5.2). 
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Figure 5.6 Assembly of the region around AbGRI2 in S27. The dark green box represents IS26 and the internal 
arrows indicate the transposase orientation. Grey lines above indicate the extent of different contigs in S27. Grey 
arrows indicate the binding sites and orientations of primers. Deletions of surrounding chromosomal sequence 
relative to AbGRI2-1 are indicated by dashed lines. 
 
5.3 PCR mapping of AbGRI2 forms in isolates not sequenced by Illumina 
HiSeq 
The 13 isolates without draft genome sequence available (by Illumina HiSeq) were screened 
using various primer combinations. First, the published primer combinations for AbGRI2-1 
were used (Table 5.4) (188), followed by the primer combinations devised for the 
configurations described above (also summarised in Table 5.5), with the appropriate sequenced 
isolates used as controls.  
 
Table 5.4 AbGRI2-1 screening PCRs 
Isolate LF-a a-b b-c c-d d-RF AbGRI2 matches 
pattern  RH1315-
RH539 
RH605-
RH759 
RH520-
RH880 
RH881-
RH751 
RH668-
RH1316 
1,051 bp 2,650 bp 2,297 bp 2,712 bp 1,219 bp 
S22 + + - - + new 
S23 + + - - + new 
S25 + + - - + new 
S26 + + + + + 1 
S28 + + - - + new 
S30 + + + + + 1 
S31 - - - - + 13 
S32 - + +1 - - 12 
S33 - + +1 - - 12 
S35 - - - - - - 
S36 - - - - - - 
S37 - - - - - - 
S40 - + +1 - - 12 
1100-200 bp smaller than the predicted size.  
∆tnpR blaTEM tnpA1000 tnpR5393c ∆ aphA1b sul1 aadA1orfQ orfPorfP
aacC1 intI1 tnpA1∆
IS26∆ IS6100∆
IS26 IS26 IS26* IS26 IRiIRtIR1000
500bp
IS26
RH1315
131 28
RH2007
A. 
∆ 5,498 bp
LF RF
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The results for S26 and S30 were consistent with the presence of AbGRI2-1 structures (Table 
5.4). In addition to S21, S24 and S29 there are now five isolates with this arrangement, all of 
are a part of group 1 from Chapter 3; Table 3.7, which lack armA and contain aphA6. 
 
Four different patterns from the AbGRI2-1 screening PCRs were detected in the remaining 
armA positive isolates (Table 5.4). Two of these patterns match those of AbGRI2-12 and 
AbGRI2-13, one was novel, and in the fourth no junctions were detected. Where relevant, 
additional linkages were attempted for these isolates using primer combinations utilised in the 
assembly of the AbGRI2 regions in S27, S34 (AbGRI2-12) and S38/S39 (AbGRI2-13) and for 
the detection of deletions in the surrounding chromosome (Table 5.5).  
 
Table 5.5 Results of screening PCRs used to assemble additional AbGRI2 variants 
Isolate LF  
(AbGRI2-12)- a 
AbGRI2-13  
LF-hybrid 
c- 
RF (AbGRI2-12) 
b-∆d  LF- 
RF (S27) 
Predicted 
AbGRI2 
variant RH1563-RH539 
(1,046 bp) 
RH2009-
RH781 
(1,223 bp) 
RH881-RH2008  
(1,581 bp) 
RH520-
RH935 
(1,881 bp) 
RH1315-
RH2007 
(1,048 bp) 
S22 ND ND ND + ND 14 
S23 ND ND ND + ND 14 
S25 ND ND ND + ND 14 
S28 ND ND ND + ND 14 
S31 - + ND + ND 13 
S32 + ND +1 ND ND 12b 
S33 + ND +1 ND ND 12b 
S35 - - - - - ? 
S36 - - - - - ? 
S37 - - - - - ? 
S40 + ND +1 ND ND 12b 
ND denotes that this arrangement was not tested as an arrangement had already been confirmed in this isolate.  
1Product was approximately 200 bp larger than the predicted size.  
 
Three isolates S35, S36 and S37 did not produce any amplicons for the mapping arrangements 
attempted (Table 5.5). This is consistent with earlier gene screening (Chapter 3; Table 3.5) 
which showed that these isolates lacked blaTEM, aphA1b, aacC1, aadA1 and sul1 and suggests 
that like S27, they only contain an IS26 at the chromosomal AbGRI2 position. However, as a 
linkage between the chromosome on the left and on the right of the IS26 in S27 (RH1315-
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RH2007) failed to amplify in S35, S36 and S37 (Table 5.5), it was concluded that they contain 
a different deletion in the region.  
 
5.3.1 AbGRI2-12 with a smaller adjacent deletion 
The isolates S32, S33 and S40 produced amplicons similar to those of AbGRI2-12 (Table 5.4), 
including the smaller amplicon size when RH520 was paired with RH880, indicating that 
IS26∆ of Tn6020 was missing. These three isolates also produced an amplicon of the expected 
size when RH1563 and RH539 were combined (Table 5.5), linking the left flanking 
chromosomal sequence to fragment a, indicating that they also had a 30.6 kb deletion in the 
flanking sequence to the left of the resistance island compared to AbGRI2-1. The aphA1b gene 
was connected directly to the flanking sequence on the right of the island using the primer 
combination RH881 and RH2008. However, the amplicon produced for S32, S33 and S40 was 
approximately 200 bp larger than for S34 (Fig 5.7). The sequence of the larger amplicon 
revealed that these three isolates had a smaller 3,142 bp deletion to the right of the island 
compared to AbGRI2-1, rather than the 3,333 bp deletion in S34. As the actual content of the 
resistance region is the same, the AbGRI2 variant in S34 was designated AbGRI2-12a and in 
S32, S33 and S40 it was named AbGRI2-12b.  
 
 
Figure 5.7 Amplification of the right end of AbGRI2-12 using primers RH881 and RH2008. The isolate 
numbers are shown above their lanes and the sizes of the molecular markers to the right are in kb.  
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5.3.2 Structure of AbGRI2-14, precursor of AbGRI2-13 
The isolate S31 produced amplicons consistent with the predicted size for the two characteristic 
linkages of AbGRI2-13. This included the hybrid left flank containing tnpA1000∆ (RH1563-
RH539) and the connection between tnpR5393c∆ and the partial integron (RH520-RH935) 
(Table 5.5). Hence, S31 likely contains AbGRI2-13 (Fig 5.8A).  
 
 
Figure 5.8 Relationship between AbGRI2-13 and AbGRI2-14. Arrows indicate the extent and orientation of 
genes and open reading frames. The blaTEM gene is blue, the aphA1b gene is red-orange, the sul1 gene is mauve 
and the aadA1 and aacC1 genes are light green and orange, respectively. The dark green box represents IS26 with 
internal arrows indicating the transposase orientation. Vertical bars indicate IRs. Dashed lines represent the extent 
of deletions relative to AbGRI2-1 with the deletion size indicated above.   
 
The isolates S22, S23, S25 and S28, also produced an amplicon of the predicted size for the 
linkage of tnpR5393c∆ to the partial integron (RH520-RH935, Table 5.5) seen in AbGRI2-13. 
Sequence of the amplicon revealed that the island in these isolates includes the same 4,497 bp 
internal deletion as AbGRI2-13, which had removed the aphA1b, sul1 and aadA1 resistance 
genes (Fig 5.8B). However, the left end of AbGRI2 was consistent with the arrangement of 
AbGRI2-1 (Table 5.4) and the variant in S22, S23, S25 and S28 was named AbGRI2-14 (Fig 
5.8B). Hence, it is possible that AbGRI2-13 has arisen from AbGRI2-14 through the deletion 
at the left end of AbGRI2-13 likely caused by recombination between a short segment of 
homologous sequence (Fig 5.5C).  
 
 
 
 
∆tnpA
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tnpR5393c ∆ ∆orfP
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IS26* IS26IRiIR1000 ∆4,497  bp
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aacC1 intI1 tnpA1∆
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5.4 Structures from the Illumina MiSeq draft genomes 
The AbGRI2 regions assembled by PCR mapping in the 10 isolates described above were 
compared to the draft genome sequences of these islands when they became available at the 
end of 2016. Assembly of the draft genome sequences of S22, S23, S25, S26, S28, S30-S33 
and S40 confirmed the they had AbGRI2 structures identical to those predicted using PCR. 
Additional information from the draft genomes of S35, S36 and S37 facilitated the assembly 
of the regions surrounding AbGRI2 in these isolates.  
 
5.4.1 No AbGRI2 variant in S35, S36 and S37 
Examination of the draft genomes of S35, S36 and S37 revealed that, like S27, only a single 
IS26 is present in the region of the chromosome usually occupied by AbGRI2 and that none of 
the internal sequence of AbGRI2-1 has been retained. The two chromosomal contigs that 
contained fragments of this IS26 were contig 26 (47,409 bp) and contig 32 (17,239 bp) in S35 
(Fig 5.9A) and equivalent contigs were present in the draft genomes of S36 and S37. The 
primer RH1563 and the new primer RH2548 were combined to link these two segments and 
produced an amplicon just under 2 kb, consistent with the predicted amplicon size of 1,850 bp. 
The sequence of this amplicon was compared to AbGRI2-1, revealing 30,672 bp of the 
chromosome to the left is missing, an identical deletion as the one found adjacent to AbGRI2-
12a (Fig 5.9B). In addition, 8,115 bp of chromosomal sequence to the right of the island has 
also been lost relative to AbGRI2-1 (Fig 5.9B). The arrangement present in S35, S36 and S37 
could have been derived from AbGRI2-12 by the IS26 at the left of the island, which is in the 
correct orientation, causing a deletion that removed the remainder of the island as well as an 
extra 4.7 kb of chromosome on the right.  
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Figure 5.9 AbGRI2 region of S35, S36 and S37. A. Contigs matching the left and right flanking sequence of 
S35. The dark green box represents IS26 with the internal arrows indicating the transposase orientation. Grey 
lines above indicate the extent of different contigs in S35. Grey arrows show the binding sites and orientations of 
primers. Deletions of surrounding chromosomal sequence are represented by dashed lines and the size is relative 
to AbGRI2-1 is above. B. Relationship between AbGRI2-12 and the AbGRI2 region of S35, S36 and S37. Arrows 
indicate the extent and orientation of genes and open reading frames. The blaTEM gene is blue and the aphA1b 
gene is red-orange. Vertical bars indicate IRs. Deletions are indicated by dashed lines the sizes of deletions of the 
chromosome are relative to AbGRI2-1, but the deletion size of the island is relative to AbGRI2-12.  
 
5.5 Discussion 
The 20 GC2 isolates from Singapore each contained a version of AbGRI2 or had an IS26 in 
the same region of the chromosome, indicating that an AbGRI2 island had been present (Fig 
5.10). AbGRI2-1 was present in the five isolates without the armA gene and with aphA6. 
Within the isolates that contain armA there were three novel AbGRI2 variants (AbGRI2-12, 
AbGRI2-13 and AbGRI2-14) and two different arrangements with only a single IS26 in the 
region. A comparison of these variants is shown in Fig 5.10A. All of the variants can be derived 
from AbGRI2-1 via deletions that, in all but one case, could be caused by IS26. In the outlying 
case of AbGRI2-13, a deletion event likely facilitated by a short region of homology has 
occurred and this is the first case of non-IS26 mediated variation in AbGRI2.  
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IS26 IS26 IS26* IS26IR1000∆30,672 bp
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Figure 5.10 Structures in the AbGRI2 region. A. AbGRI2 variants detected. B. Isolates where only a single 
IS26 is present. Arrows indicate the extent and orientation of genes and open reading frames. The blaTEM gene is 
blue, the aphA1b gene is red-orange, the sul1 gene is mauve and the aadA1 and aacC1 genes are light green and 
orange, respectively. The dark green box represents IS26 and the light blue box is part of IS6100, with the internal 
arrows indicating the transposase orientation. Vertical bars indicate IRs. Dashed lines represent the extent of 
deletions relative to AbGRI2-1, with the deletion size indicated above.  
 
In addition to the missing 47.2 kb segment of chromosome to the left of AbGRI2-1, relative to 
AbGRI2-0 (24), the AbGRI2-13 and AbGRI2-12 variants have lost additional 1.9 kb and 30.7 
kb, respectively. Hence, AbGRI2-12 is missing 77.9 kb of sequence relative to AbGRI2-0. As 
the fitness of these isolates containing this variant does not appear to be affected, it can be 
concluded that this region of the chromosome is non-essential.  
 
The nature of the variation of AbGRI2 provides additional evidence that the collection can be 
separated into two groups, which were initially defined by the presence or absence of aphA6 
and armA (Table 5.6). The five isolates that lack armA, and hence the resistance island that 
contains this gene, possess AbGRI2-1 and are the first report of this variant in isolates from 
hospitals outside of Australia. Furthermore, it was found in an isolate from 1996 (S21), which 
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is three years earlier than the oldest documented isolate with AbGRI2-1 seen in Australia (188, 
193). This indicates a relationship between the common XAR GC2 isolates found across the 
eastern seaboard of Australia and some GC2 isolates from South-East Asia, particularly 
Singapore. Further work is required to examine the nature of the relationship between the GC2 
isolates seen in Australia and South-East Asia.  
 
Table 5.6 Two groups within the collection  
Group armA Isolates AbGRI2  AbGRI1 
1 - S21, S24, S26, S29, S30 1 3, 5, 1 
2 + S32, S33, S34, S40 12 7, 3, 
 + S31, S38, S39 13 6, 1 
 + S22, S23, S25, S28 14 3, 8 
 + S27 IS26 (1) 3 
 + S35, S36, S37 IS26 (2) 7 
 
The 15 isolates with armA in the second group either contain an AbGRI2 variant smaller than 
AbGRI2-1 or have only a single IS26 remaining in the AbGRI2 region (Table 5.6; Fig 5.10A 
and B). All of the AbGRI2 variants in group 2 could be derived from a precursor structure 
corresponding to AbGRI2-14 (Fig 5.10), before Tn6020 was lost. However, MDR-TJ (125), 
which was also isolated in Asia and includes armA (Chapter 6; Section 6.2.1), has AbGRI2-2 
which contains the entire integron fragment and ∆IS6100 (188). Hence, the only AbGRI2 
structure that accounts for all the components found in the AbGRI2 regions of isolates with 
armA is AbGRI2-1. Consequently, the cell that originally acquired the armA containing island 
described in the next chapter must have had AbGRI2-1.  
 
Tracking the AbGRI2 region over time indicates that it entered the GC2 chromosome prior to 
1982 (24). By 1996, the AbGRI2-1 structure, characterised by the inversion and deletion at the 
left end, had arisen. The AbGRI2 structures in more recent isolates in Asia, America and 
Australia appear to have derived from AbGRI2-1 (193, 277), which suggests that either this 
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island variant was successful or the strain containing this variant was successful for other 
reasons, resulting in its subsequent and apparent globalisation. However, there are limited 
sequences of modern and historic GC2 isolates from Europe, so it is currently unclear if the 
GC2 population in Europe is also part of the AbGRI2-1 lineage or if other sub-lineages of this 
clone are present.  
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  6 
 
Characterisation of AbGRI3
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6.1 Introduction 
There are many different antibiotics within the aminoglycoside class but most resistance genes 
confer resistance to only a subset of them. However, often these genes are found in combination 
with one another. In the AbGRI2-1 island, the aacC1 (resistance to gentamicin), aadA1 
(streptomycin and spectinomycin resistance) and aphA1b (kanamycin and neomycin 
resistance) genes are co-located. However, the emergence of acquired 16S rRNA 
methyltransferases that confer resistance to most aminoglycoside antibiotics via one gene is 
most concerning. These genes provide ribosomal protection by hampering the binding of 
aminoglycosides to the 30S subunit (54).  
 
ArmA is a 16S rRNA methyltransferase that was first characterised from a Klebsiella  
pneumoniae isolated from France in 2000 and shown to confer resistance to 4,6-disubstituted 
deoxystreptamines; gentamicin, kanamycin, amikacin, tobramycin, isepamicin, netilmicin and 
sisomicin (72). Subsequently, the context of the armA gene in an IncL/M plasmid, pCTX-M3 
(GenBank accession number AF550415), from a 2002 Citrobacter freundii isolate from Poland 
(82) was characterised. The armA gene was located in a 16.6 kb composite transposon that was 
bounded by two directly-oriented copies of IS26 and called Tn1548 (Fig 6.1) (73). Transposon 
Tn1548 was subsequently reannotated (203) and in addition to armA also contains the 
macrolide resistance genes msrE and mphE, and a class 1 integron containing sul1 
(sulphonamide resistance), aadA2 (resistance to streptomycin and spectinomycin) and dfrA12 
(resistance to trimethoprim) (Fig 6.1). Later, a putative rep gene, annotated as repAciN (55), 
was identified at the left end of the transposon (Fig 6.1). However, this reading frame includes 
73 bp from the end of IS26 and only part of a rep gene. This reading frame is related to the 
repAci2 gene (74% DNA identity), but it is missing the first 174 bp due to the insertion of IS26 
and it had been shown previously that repAciN does not encode a functional replication 
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initiation protein (174). A closely related transposon containing armA but only carrying the 
aadA2 gene cassette was also found in an IncN plasmid, pMUR050 in an E. coli from Spain in 
2002 (83). 
 
 
Figure 6.1 Structure of Tn1548. Arrows indicate the extent and orientation of genes and open reading frames. 
The mphE and msrE genes are orange, the armA gene is maroon, sul1 gene is mauve and the aadA2 and dfrA12 
genes are aqua and lime green, respectively. Boxes represent IS and CR elements and the internal arrows indicate 
the transposase or the rolling circle replicase. IS26 is dark green, ISEc29 and ISEc28 are light and dark blue and 
CR1 is yellow. IS26** is 2 bp different to the standard sequence of IS26. Vertical bars indicate inverted repeats 
and the extent of Tn1548 is shown above. Figure made to scale from pCTX-M3 (GenBank accession number 
AF550415). 
 
The earliest A. baumannii isolates that have been shown to carry the armA gene are from 2003 
and were isolated in South Korea (153). Since then, the armA gene has been reported in strains 
from North America (53, 277 ), Japan (253) China (125, 285, 286), and India (231). This gene 
was also found in isolates from Norway recovered from patients that had previously been 
hospitalised in Asia (136). Where MLST data using the Institut Pasteur (IP) scheme is 
available, most isolates containing the armA gene are ST2 and are consequently members of 
GC2. In the completed genomes of MDR-ZJ06 (285), BJAB0868 and BJAB07104 (286), the 
armA gene was reported to be on a plasmid. However, using isolate UH9907 as their exemplar 
(AY0H00000000), Wright et al. (277) recently described a third chromosomally-located island 
containing the armA gene in GC2 A. baumannii from the USA. This resistance island was 
described as located between ACICU_02398 and ACICU_02399 (using ACICU genome as a 
reference, GenBank accession number CP000863). These authors (277) also identified a 
previously unnoted, related island that was in the same location in the completed genome of 
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TYTH-1 (161), which was isolated in China. In both the chromosome and the sequences 
annotated as plasmids, the armA gene is in an IS26-bounded transposon that is described as 
similar to Tn1548, usually including the aadA1, aacA4, sul1, msrE, mphE and catB8 genes 
(277). This can also be associated with the aphA1b gene.  
 
The work presented in this chapter focuses on characterising the context of the armA gene in 
GC2 A. baumannii. This first involved analysing in detail the regions known to contain the 
armA gene, including those in TYTH-1, UH9907 and pJAB07104, and comparing these 
regions to Tn1548. This analysis then guided the assembly of the regions of the chromosome 
containing the armA gene, which was in 15 of the GC2 Singapore isolates (Chapter 3; Table 
3.5). The extent of variation in this armA containing transposon and the region surrounding it 
in the chromosome was further examined through analysis of the sequences available in 
GenBank.  
 
6.2 Transposons containing armA in GC2 A. baumannii 
6.2.1 AbGRI3 in TYTH-1: AbGRI3-1 
The region containing the armA gene in the completed genome TYTH-1 (GenBank accession 
number CP003856) was analysed and found to be located in a 19 kb IS26 bounded transposon 
(Fig 6.2A). The transposon in TYTH-1 was surrounded by an 8 bp TSD (5` CTCATCCT 3`) 
(Fig 6.2A) and it was found to interrupt the open reading frame ACICU_02399. Thus, it is not 
situated between ACICU_02398 and ACICU_02399 as reported previously (277). The reading 
frame ACICU_02399 codes for a putative GNAT family acetyltransferase, which for simplicity 
will be referred to as atr hereafter. An almost identical transposon (containing 4 SNPs) was 
present in the completed genome of MDR-TJ (GenBank accession number CP003500), also 
interrupting the atr gene, and surrounded by the same 8 bp duplication as in TYTH-1. As the 
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armA transposon represents the third chromosomally-located resistance island in GC2 A. 
baumannii, for simplicity and clarity, I will call it AbGRI3 and the location for AbGRI3 with 
respect to the other two resistance islands is shown in Fig 6.2B. The form of the AbGRI3 island 
present in TYTH-1 and MDR-TJ is called AbGRI3-1. 
 
Figure 6.2 AbGRI3 and its chromosomal location. A. Structure of AbGRI3-1. Arrows indicate the extent and 
orientation of genes and open reading frames. The mphE and msrE genes are orange, the armA gene is maroon, 
sul1 gene is purple and the aadA1, catB8 and aacA4 genes are green, pink and pale blue, respectively. Adjacent 
chromosomal genes are grey. Boxes represent IS and CR elements and the internal arrows indicate the transposase 
or the rolling circle replicase. IS26 is dark green, ISAba24 is purple, ISEc29 and ISEc28 are light and dark blue 
and CR1 is yellow. IS26** is 2 bp different to the standard sequence of IS26, while IS26* is 3 bp different. Black 
and white flags indicate matching TSD. B. Location of AbGRI3 on the GC2 chromosome. Arrows indicate the 
location of resistance island and figure is made to scale from TYTH-1 (GenBank accession number CP003500).  
 
The sequence of the armA containing transposon of AbGRI3-1 was compared to that of Tn1548 
(Fig 6.3). Several differences distinguish these two transposons and hence we have named the 
transposon in TYTH-1 Tn6180. Compared to Tn1548, the integron in Tn6180 carries a 
different set of cassettes aadA1-catB8-aacA4, and a deletion at the right end of the central 
segment has removed 216 bp of the intI1 gene (Fig 6.3). Another difference is the insertion of 
a novel IS, ISAba24, in orf44 in Tn6180 (Fig 6.3). ISAba24 is a member of the IS66 family 
and is 2,421 bp in length with almost perfect inverted repeats of 22 bp with 21 bp identical. 
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This IS is surrounded by an 8 bp TSD. The sequences of the IS26 elements bounding both 
Tn1548 and Tn6180 were also examined. The IS26 on the right of Tn1548 is the standard IS26 
sequence, while the corresponding IS26 in Tn6180 differs at three nucleotide positions 
(G459A, G613A and G614A) and is referred to as IS26*. The IS26 on the left of both 
transposons harbours two of these differences (G613A and G614A) compared to the standard 
IS26 sequence and, here this isoform is called IS26**.  
 
Figure 6.3 Comparison of Tn1548 and Tn6180. Arrows indicate the extent and orientation of genes and open 
reading frames. The mphE and msrE genes are orange, the armA gene is maroon, sul1 gene is mauve, the aadA2 
and dfrA12 genes are aqua and lime green, respectively, while the aadA1, catB8 and aacA4 genes are green, pink 
and pale blue, respectively. Adjacent chromosomal genes are shown in grey. Boxes represent IS and CR elements 
and the internal arrows indicate the transposase or the rolling circle replicase. IS26 is dark green, ISAba24 is 
purple, ISEc29 and ISEc28 are light and dark blue and CR1 is yellow. IS26** is 2 bp different to the standard 
sequence of IS26, while IS26* is 3 bp different. Black and white flags indicate matching TSD. Lines above and 
below indicate the extents of transposons and grey shading indicates matching sequence. Figure made to scale 
from pCTX-M3 (GenBank accession number AF550415) and TYTH-1 (GenBank accession number CP003500).  
 
6.2.2 AbGRI3 in UH9907: AbGRI3-2 
Examination of the armA containing transposon in UH9907 (277), revealed this isolate 
contained AbGRI3 in the same location as TYTH-1 and MDR-TJ, i.e. interrupting the atr gene 
(Fig 6.4A). However, in addition to containing Tn6180, UH9907 also includes an aphA1b 
containing transposon that shares one IS26 with the right IS of Tn6180, and the whole structure 
is surrounded by the same 8 bp TSD as TYTH-1 and MDR-TJ (Fig 6.4A). We named this 2,706 
bp aphA1b containing transposon Tn6179 and Fig 6.4B shows a comparison of Tn6179 to 
Tn6020 (217), the transposon containing aphA1b that is found in AbGRI2 of GC2 A. 
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baumannii isolates (24, 188). The structure of AbGRI3 with both Tn6180 and Tn6179 present 
will be referred to as AbGRI3-2.  
 
Figure 6.4 AbGRI3-2 and Tn6179. A. Structure of AbGRI3-2. B. Tn6179 compared to Tn6020. Arrows indicate 
the extent and orientation of genes and open reading frames. The mphE and msrE genes are orange, the armA 
gene is maroon, the sul1 gene is mauve, the aphA1b gene is red-orange, and the aadA1, catB8 and aacA4 genes 
are green, pink and pale blue, respectively. Chromosomal genes are shown in grey. Boxes represent IS and CR 
elements and the internal arrows indicate the transposase or the rolling circle replicase. IS26 is dark green, 
ISAba24 is purple, ISEc29 and ISEc28 are light and dark blue and CR1 is yellow. IS26** is 2 bp different to the 
standard sequence of IS26, while IS26 is 3 bp different. Black and white flags indicate matching target site 
duplications. Lines above indicate the extents of transposons. Grey shading indicates matching sequence. Figure 
made to scale using UH9907 (GenBank accession number AY0H00000000) and Tn6020 sequence from 3208 
(GenBank accession number FJ172370). 
 
6.2.3 pJAB07104, p2JAB0868 and pMDR_ZJ06 
The putative plasmids pJAB07104 and p2JAB0868 (GenBank accession number CP003887 
and CP003888 respectively) (286) are composed of Tn6180 and Tn6179 in circular form but 
missing one copy of IS26. Hence it corresponds to a circularised TU.  The putative plasmid 
pMDR_ZJ06 (GenBank accession number CP001938) is almost identical to pJAB07104 and 
p2ABB0868, except it contains a different cassette array, aacC1-orfP-orfQ-aadA1. This is the 
standard cassette array of AbGRI2 and in fact, the AbGRI2 region of MDR_ZJ06 contains the 
cassettes that are found in Tn6180. Consequently, it is possible that either the cassettes have 
exchanged places or this switch is a mistake in the assembly. For pJAB07104, p2JAB0868 and 
pMDR_ZJ06 to be plasmids, they need to be able to replicate, however, the only gene 
Tn6180
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resembling a replication initiation gene is the inactive orf repAciN, which does not encode a 
functional replication initiation protein (174). Hence, the assignment of these sequences as 
plasmids is highly questionable and this is examined further in Section 6.4.1.  
 
6.3 AbGRI3 in Singapore isolates 
Previous screening revealed that 15 of the isolates, S22, S23, S25, S27, S28, S31-S40, contain 
the armA gene (Chapter 3; Table 3.5). Primers, RH2001 and RH2004, were designed in the 
chromosomal region surrounding the insertion location of AbGRI3 in the atr gene and were 
used to screen the 20 GC2 Singapore isolates. If the atr gene is intact, the amplicon is predicted 
to be 400 bp in size. The isolates S21, S24, S26, S29 and S30 produced an amplicon of this 
size which is consistent with the absence of armA and AbGRI3 in these isolates (Fig 6.5). The 
atr gene in the other 15 armA positive isolates is interrupted, indicating that they contain a 
version of AbGRI3 or have lost the priming sites (Fig 6.5). 
 
 
Figure 6.5 Is the atr gene intact? Screening the AbGRI3 insertion site using primers RH2001 and RH2004. 
Isolate numbers are shown above the lanes and sizes of the molecular marker to the left and right are in bp. 
 
The assembly of AbGRI3 regions in the 15 armA positive isolates was first performed by 
assembling those of S27, S34, S38 and S39 whose draft genomes were available initially. The 
majority of the AbGRI3 regions in the remaining isolates were deduced by PCR screening 
while for two isolates, additional information was required that was gained once draft genomes 
were available. 
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6.3.1 AbGRI3-2i in S27 
The draft genome of S27 contained five contigs that had a fragment of IS26 on at least one end 
(Table 6.1) but were not assembled as part of the AbGRI2 (Chapter 5; Section 5.2.4).  
 
Table 6.1 S27 contigs with IS26 fragments 
Contig Size (kb) Content Edges 
 Left Right 
3 133.6 LH flank ND ∆atr, IS26-IRr 
30  17.6 Tn6180 IS26-IRl  IS26-IRr 
80  1.1 Tn6179 IS26-IRl IS26-IRr 
37  3.3 RH flank IS26-IRl, atr∆ ∆asr1, IS26-IRl 
5  142 RH chromosome IS26-IRr, asr∆ ND 
1asr stands for aspartate racemase 
 
Through a comparison of these contigs to AbGRI3-2 (Fig 6.6), it was clear that S27 contained 
both Tn6180 and Tn6179. The chromosomal contigs, 3 (133 kb) and 37 (3.27 kb), each 
contained part of the atr gene adjacent to an IS26 fragment and the boundaries between IS26 
and the chromosome-derived sequence were the same as in AbGRI3-1 and -2. However, 
another fragment of IS26 was at the other end of the short contig 37 and the sequence next to 
the IS26 matched a part of an aspartate racemase gene (corresponding to ACICU_02402 in 
ACICU), here called asr for simplicity, which is found 3.1 kb from atr in ACICU. The 
remainder of the asr gene, along with a TSD, was found adjacent to an IS26 outer end on 
chromosomal contig 5 (142 kb). Therefore, an additional copy of IS26 interrupts the asr gene, 
in the chromosome a short distance to the right of the island in S27 (Fig 6.6).   
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Figure 6.6 Draft assembly of AbGRI3 contigs in S27. Arrows indicate the extent and orientation of genes and 
open reading frames. The mphE and msrE genes are orange, the armA gene is maroon, sul1 gene is mauve, the 
aphA1b gene is red-orange, and the aadA1, catB8 and aacA4 genes are green, pink and pale blue, respectively. 
Chromosomal genes are shown in grey. Boxes represent IS and CR elements and the internal arrows indicate the 
transposase or the rolling circle replicase. IS26 is dark green, ISAba24 is purple, ISEc29 and ISEc28 are light and 
dark blue and CR1 is yellow. IS26** is 2 bp different to the standard sequence of IS26, while IS26* is 3 bp 
different. Black and white flags indicate matching TSD. Grey lines above indicate the extent of different contigs 
in S27 and the green bars represent fragments of IS26. Black bars above show the extent of transposons.   
 
The repAciN end of Tn6180 (contig 30) was linked to the atr end of contig 3 (Fig 6.6) using 
the newly designed primers RH2001 and RH2002. These primers were expected to amplify a 
1,323 bp product and the approximately 1.3 kb amplicon produced was sequenced, revealing 
the presence of an IS26**, as in AbGRI3-1 and AbGRI3-2. The other end of Tn6180 was 
joined to Tn6179 (contig 80) using RH2003 and RH880, which produced an amplicon of 2 kb, 
consistent with the expected size of 1,943 bp. The IS26 isoform was IS26*. Linkages could be 
confirmed between Tn6179 and the remainder of atr (RH831-RH2015, 1,576 bp) and over the 
additional IS26, linking the fragments of the asr gene together (RH2005-RH2006, 1,151 bp) 
(Fig 6.7A and 6.7C). However, when the orientation of contig 37 was inverted as in Fig 6.7B, 
which is possible due to the opposite orientation of the two bounding IS26 sequences, 
amplicons of the expected size using RH831 and RH2005 (1,203 bp) and RH2015 and RH2006 
(1,524 bp) were also recovered (Fig 6.7B and C).  
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Figure 6.7 Assembly of AbGRI3 in S27. A. Assembly PCRs performed. B. Potential inversion in the sequence 
surrounding AbGRI3. C. Assembly AbGRI3 in S27. Arrows indicate the extent and orientation of genes and open 
reading frames. The aphA1b gene is red-orange and the aadA1, catB8 and aacA4 genes are green, pink and pale 
blue, respectively. Adjacent chromosomal genes are shown in grey. Boxes represent IS and CR elements and the 
internal arrows indicate the transposase or the rolling circle replicase. IS26 is dark green, ISAba24 is purple, 
ISEc29 and ISEc28 are light and dark blue and CR1 is yellow. IS26** is 2 bp different to the standard sequence 
of IS26, while IS26* is 3 bp different. Black and white flags indicate matching target site duplications. The primers 
used to link sequences are shown above by the black bars, along with PCR amplicon size. The extent of contig 37 
is indicated by the grey line. In C, primer combinations are shown above the gel and the isolates are shown above 
their lanes. The primer combinations of RH831 and RH2015, and RH2005 and RH2006, screen for contig 37 in 
one orientation while RH831 and RH2005, and RH2015 and RH2006, screen for contig 37 in the other orientation. 
Isolate numbers are shown above the lanes and sizes of the molecular marker on the right are in kb. 
 
The amplicons from the reactions of both orientations of contig 37 were sequenced and 
regardless of the orientation of contig 37, the right IS26 of Tn6179 is IS26** as expected, as 
is the additional IS26 downstream of the resistance island.  
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Due to the mechanisms of IS26 transposition, it is very difficult to introduce just a single IS26 
into a sequence. It is likely that through the replicative transposition pathway of IS26, the 
IS26** to the right of Tn6179 has caused an inversion through intramolecular transposition to 
a site in the asr gene, duplicating the 8 bp target site and the IS26 involved (Refer to Chapter 
1; Fig 1.13). The identical sequence of the instigating and duplicated IS26 supports this 
mechanism. Hence, it is most likely that the 3.1 kb of chromosomal sequence of contig 37 was 
originally in inverse orientation as shown in Fig 6.8 and as this is the only difference between 
AbGRI3 in S27 and AbGRI3-2, it is called AbGRI3-2i.  
 
 
Figure 6.8 Comparison of AbGRI3-2 and 2i. Arrows indicate the extent and orientation of genes and open 
reading frames. The repAciN gene is blue, the mphE and msrE genes are orange, the armA gene is maroon, the 
sul1 gene is mauve, the aphA1b gene is red-orange, and the aadA1, catB8 and aacA4 genes are green, pink and 
pale blue, respectively. Adjacent chromosomal genes are shown in grey. Boxes represent IS and CR elements and 
the internal arrows indicate the transposase or the rolling circle replicase. IS26 is dark green, ISAba24 is purple, 
ISEc29 and ISEc28 are light and dark blue and CR1 is yellow. IS26** is 2 bp different to the standard sequence 
of IS26, while IS26* is 3 bp different. Black and white flags indicate matching targe site duplications. Grey boxes 
indicate matching sequence.  
 
As the IS26 elements bounding ∆asr and atr∆ segment are in opposite orientation, the internal 
sequence could be flipping backwards and forwards due to either homologous recombination 
or the action of IS26. To attempt to determine the major direction of this segment, boiled DNA 
preparations for 10 single colonies of S27 were checked for amplification of both orientations. 
Amplicons were detected for both orientations of this sequence in each colony. Though a 
possible explanation for the detection of amplicons in both orientations could be due to PCR 
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artefacts, this is unlikely as other segments that have been inverted did not produce amplicons 
of the re-inverted orientation (for example, see Section 6.3.5.2). Instead, a portion of the 
population could be in the re-orientated state. It is unlikely that that this is homologous 
recombination, as it does not occur at a high enough frequency, and the action of IS26 is 
possible. Cloning of this fragment or long-range sequencing such as Nanopore or PacBio could 
help unambiguously assign the orientation of this segment, if that is possible.  
 
6.3.2 AbGRI3-3i in S38 and S39 
S38 and S39 each had four identical contigs with fragments of IS26 that remained following 
AbGRI2 assembly (Table 6.2). One of these was the 3.3 kb atr-asr fragment found in S27.  
 
Table 6.2 S38 and S39 contigs with IS26 fragments   
Contig (size kb) Content Edges 
S38  S39 Left Right 
10 (133.6) 9 (133.6) LH flank ND ∆atr, IS26-IRr 
17 (13.8) 15 (13.8) ∆Tn6180 IS26-IRl, ∆ISAba24 aacA4, IS26-IRr 
44 (3.3) 50 (3.3) RH flank IS26-IRl atr∆,  ∆asr, IS26-IRl 
16 (175) 19 (175) RH chromosome IS26-IRr, asr∆1 ND 
1126 bp closer to the start of the gene that in contig 5 of S27. 
 
The contig carrying armA was shorter than in S27 and a comparison revealed that there were 
deletions at both ends of Tn6180 in these isolates requiring new primers (RH2010 at the left 
end and at the right end RH2011) to be designed for assembly (Fig 6.9A). In addition, Tn6179 
is not present.  
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Figure 6.9 Assembly of AbGRI3-3i in S38 and S39. A. AbGRI3 contigs in S38 and S39. Arrows indicate the 
extent and orientation of genes and open reading frames. The mphE and msrE genes are orange, the armA gene is 
maroon, the sul1 gene is mauve, the aphA1b gene is red-orange, and the aadA1, catB8 and aacA4 genes are green, 
pink and pale blue, respectively. Adjacent chromosomal genes are shown in grey. Boxes represent IS and CR 
elements and the internal arrows indicate the transposase or the rolling circle replicase. IS26 is dark green, 
ISAba24 is purple, ISEc29 and ISEc28 are light and dark blue and CR1 is yellow. IS26** is 2 bp different to the 
standard sequence of IS26, while IS26* is 3 bp different. Black and white flags indicate matching TSD. Grey 
lines above indicate the extent of different contigs in S38 and S39, green bars indicate fragments of IS26 and grey 
arrows indicate the binding sites and orientations of primers. B. Structure of AbGRI3-3i. Dashed lines represent 
the extent of deletions relative to AbGRI3-2i with the deletion size indicated above. 
 
The chromosome on the left of AbGRI3 (contig 10 in S38 and 9 in S39) was linked to the 
∆ISAba24 end of the truncated Tn6180 (contig 17/15) using RH2001 and RH2010, which 
produced an amplicon slightly larger than 1.5 kb, consistent with the predicted size of 1,605 
bp. The other end of Tn6180, also contained a deletion and was linked to the ∆asr end of contig 
44/50 using RH2011 and RH2005. This combination is predicted to produce a 1,007 bp product 
and the amplicon was approximately 1 kb in size. The ∆atr end of contig 44/50 was linked to 
contig 16/19 using RH2015 and RH2006 which should produce an amplicon of 1,398 bp, and 
the product just under 1.5 kb. This version of AbGRI3 has been called AbGRI3-3i (Fig 6.9B). 
As in the assembly of AbGRI3-2i, the 3.1 kb segment containing ∆asr and ∆atr could be 
detected in both orientations (i.e. amplicons of the expected size for RH2011-RH2015 and 
RH2005-RH2006 were also recovered). Amplicon sequence revealed the presence of IS26 
isoforms indicated in Fig 6.9B. 
 
1 kb
B
Version 4
S34
26 Aba24
orf
∆ 14,300 bp
Version 3i
∆orf44
sul1 aadA1
catB8
aacA4 
26
∆ISAba24
mphE msrE
Inverted
∆ 2,773 bp
∆ 2,846 bp
∆ 126 bp
asr∆
Version 2i
S27
orf
orf
∆asr atr∆repAciN
orf44 ∆ ∆orf44
sul1 aadA1
catB8
aacA4
intI1∆ aphA1b
26
**
orf ∆atr
ISAba24
mphE
ISEc29 ISEc28
rcr1
CR1 IS26*
26
IS26**
msrE
IS26*asr∆ orf
26
**
orf ∆atr
**
orf ∆atr repAciN
orf44 ∆ ∆orf44
mphE msrE
ISEc29 ISEc28
rcr1
CR1
armA
armA
ISEc29 ∆ISEc28
armA
orf
orf
∆asr atr∆
IS26**
IS26**
orf
orf
orf
∆asr atr∆repAciN
orf44 ∆ ∆orf44
sul1 aadA1
catB8
aacA4
intI1∆ aphA1b
26
**
orf ∆atr
ISAba24
mphE
ISEc29 ISEc28
rcr1
CR1 IS26*
26
IS26**
msrE
IS26**asr∆ orfarmA
10/9 17/15 44/50 16/19
RH2001 RH2010 RH2011 RH2005 RH2015 RH2006
1 kb
B.
Version 3i
S38, S39
∆orf44
sul1 aadA1
catB8
aacA4 
26
∆ISAba24
mphE msrE
Inverted
∆ 2,773 bp
∆ 2,846 bp
∆ 126 bp
asr∆
26
**
orf ∆atr
ISEc29 ISEc28
rcr1
CR1
armA orf
orf
∆asr atr∆
IS26**
IS26**
orf
A.
Chapter 6 140	
AbGRI3-3i is easily derived from 2i by the action of IS26. The IS26 on the left of Tn6180 has 
caused a 2,773 bp deletion that extends into ISAba24 (776/2,421 bp remaining). The IS26 on 
the right of Tn6179 has removed aphA1b, the remainder of the intI1 gene, the attI1 site and 7 
bp of the aacA4 gene cassette, leaving the aacA4 reading frame intact. It is likely that without 
the promoter in intI1, the cassettes are no longer expressed but this is unable to be distinguished 
in the phenotype of these isolates due to the presence of armA. The extra IS26** has also 
removed 126 bp of asr∆ (Fig 6.9B).  
 
6.3.3 AbGRI3-4 in S34 
The draft genome of S34 had only two contigs ending with an IS26 fragment unaccounted for, 
contig 17 (122 kb) containing the chromosomal sequence from the left flank of AbGRI3-2i and 
contig 24 (122 kb), which contained the armA gene and chromosomal sequence from the right-
hand side (Fig 6.10A). They were linked using RH2001 and RH2002, as above. Examination 
of contig 24 revealed sequence matching Tn6180 up to 696 bp into ISEc28 (201 bp missing) 
directly adjacent to sequence matching chromosomal sequence located 3,112 bp away from the 
resistance island (Fig 6.10A). The correct assembly of this contig was confirmed by sequencing 
the amplicon (predicted size 1,934 bp) produced by the primer combination of RH2012 and 
RH2014. This version of AbGRI3, called AbGRI3-4, has lost 7,649 bp of Tn6180 as well as 
Tn6179 and 4,765 bp of the right flanking chromosome relative to AbGRI3-2i (Fig 6.10B). An 
alignment of the sequence of ISEc28, the region surrounding the recombination patch of contig 
24 of S34 and the chromosomal sequence downstream of the island revealed that there was a 
4 out of 5 bp identity (boxed in pink in Fig 6.10C) which could have facilitated the event that 
caused the deletion.  
Chapter 6 141	
 
Figure 6.10 Assembly of AbGRI3-4. A. AbGRI3 contigs in S34. Arrows indicate the extent and orientation of 
genes and open reading frames. The mphE and msrE genes are orange, the armA gene is maroon, the sul1 gene is 
mauve, the aphA1b gene is red-orange, and the aadA1, catB8 and aacA4 genes are green, pink and pale blue, 
respectively. Adjacent chromosomal genes are shown in grey. Boxes represent IS and CR elements and the 
internal arrows indicate the transposase or the rolling circle replicase. IS26 is dark green, ISAba24 is purple, 
ISEc29 and ISEc28 are light and dark blue and CR1 is yellow. IS26** is 2 bp different to the standard sequence 
of IS26*, while IS26 is 3 bp different. Black and white flags indicate matching TSD. Grey lines above indicate 
the extent of different contigs in 34, green bars indicate fragments of IS26 and grey arrows indicate the binding 
sites and orientations of primers. B. Structure of AbGRI3-4. Dashed lines represent the extent of deletions relative 
to AbGRI3-2i, with the total size of the deletion indicated above and the missing portion of AbGRI3-2 in brackets. 
C. Putative site of recombination AbGRI3-4. Green nucleotides indicate sequence of ISEc28 and the pink box 
highlights the 4/5 bp that could have facilitated the deletion event. 
 
6.3.4 Prediction of AbGRI3 variant forms in isolates not sequenced by Illumina HiSeq 
Mapping strategies used to assemble AbGRI3 in the isolates sequenced by Illumina HiSeq were 
used to predict the structures of AbGRI3 in eight isolates prior to the availablility of sequence. 
The mapping strategies differed slightly depending on whether the isolates also had an aphA1b 
gene that was not accounted for in their AbGRI2 variant (Table 6.3 or Table 6.4). The isolates 
S22, S23 and S31 have an aphA1b gene that is likely to be located in this island (Table 6.4). 
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Table 6.3 Mapping PCRs for isolates without aphA1b  
Isolate ∆atr (LHC) to 
repAciN 
RH2001-RH2002 
(1,323 bp) 
AbGRI3-4 RJ 
RH2012-RH2014 
(1,934 bp) 
Tn6180 to ∆asr 
RH2003-RH2005 
(1,193 bp) 
∆atr to ∆asr 
RH2015-RH2006 
(1,524 bp) 
AbGRI3 
version  
S25 - - - - ? 
S28 + - +1 +1 1i 
S32 + + ND ND 4 
S33 + + ND ND 4 
S35 + + ND ND 4 
S36 + + ND ND 4 
S37 + + ND ND 4 
S40 + + ND ND 4 
1Amplicons of the expected size were also produced using RH2003-RH2015 (1,566 bp) and RH2005-RH2006 
(1,151 bp). 
 
The isolate S25 did not produce an amplicon for any of the mapping PCRs and the assembly 
of its AbGRI3 variant in described is Section 6.3.5.2. However, six of the eight isolates without 
the aphA1b gene contained AbGRI3 variant 4 (Table 6.3). The isolate S28 harboured an 
AbGRI3 variant containing only Tn6180, like AbGRI3-1 found in TYTH-1 and MDR-TJ. 
However, this isolate also contains the additional IS26 interrupting the asr gene that has caused 
an inversion of 3.1 kb of chromosomal sequence. Therefore, the variant in S28 was called 
AbGRI3-1i (Fig 6.11). As the additional IS26 is IS26**, it is likely that previously Tn6179 
was present in this isolate to provide the IS26** for the intramolecular inversion reaction. The 
shared IS26* of Tn6180 and Tn6179 could then have caused a deletion, removing the Tn6179 
TU (aphA1b and one IS26).  
 
Figure 6.11 Structure of AbGRI3-1i. Arrows indicate the extent and orientation of genes and open reading 
frames. The mphE and msrE genes are orange, the armA gene is maroon, the sul1 gene is mauve, the aphA1b gene 
is red-orange, and the aadA1, catB8 and aacA4 genes are green, pink and pale blue, respectively. Adjacent 
chromosomal genes are shown in grey. Boxes represent IS and CR elements and the internal arrows indicate the 
transposase or the rolling circle replicase. IS26 is dark green, ISAba24 is purple, ISEc29 and ISEc28 are light and 
dark blue and CR1 is yellow. IS26** is 2 bp different to the standard sequence of IS26, while IS26* is 3 bp 
different. Black and white flags indicate matching TSD. Dashed lines represent the extent of deletions relative to 
AbGRI3-2i, with the size of the deletion indicated above. The bar above shows the sequence that is inverted.  
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Table 6.4 PCR screening of AbGRI3 in isolates containing armA and aphA1b 
Isolate ∆atr (LHC) to 
repAciN 
∆atr (LHC) to 
∆ISAba24 
Tn6180 to 
Tn6179 
Tn6179 to 
∆asr 
RH831-
RH2005 
(1,203 bp) 
∆atr to asr∆ 
RH2015-
RH2006 
(1,524 bp) 
AbGRI3 
version 
 RH2001-
RH2002 
(1,323 bp) 
RH2001-
RH2010 
(1,650 bp) 
RH2003-
RH880 
(1,934 bp) 
 
S22 + ND + +1 +1 2i 
S23 + ND + +1 +1 2i 
S31 - +2 + +3 - ? 
1Amplicons of the expected size were also produced using RH831-RH2015 (1,576 bp) and RH2005-RH2006 
(1,151 bp). 
2Amplicon was just larger than 2 kb. 
3Amplicon on the expected size for the S38/S39 deletion in asr∆ was also produced using RH2005-RH2006. 
 
AbGRI3-2i, with the adjacent inversion, was also detected in S22 and S23 (Table 6.4). The 
AbGRI3 of S31 was able to be partially assembled using mapping PCRs (Table 6.4) and 
contained a ∆Tn6180 and Tn6179. The boundary between the chromosome on the left and 
Tn6180 was amplified using the same primers as for AbGRI3-3i (RH2001-RH2010, see Fig 
6.9), which has a deletion at the left end of Tn6180. However, the product for S31 was larger 
than for AbGRI3-3i. Sequencing of the amplicon revealed that S31 also had a deletion at the 
end of Tn6180 but had retained 541 bp more of ISAba24 (1,316 of the full 2,421 bp ISAba24) 
than AbGRI3-3i (Fig 6.12).  
 
 
Figure 6.12 Assembly of AbGRI3-5i. Arrows indicate the extent and orientation of genes and open reading 
frames. The mphE and msrE genes are orange, the armA gene is maroon, the sul1 gene is mauve, the aphA1b gene 
is red-orange, and the aadA1, catB8 and aacA4 genes are green, pink and pale blue, respectively. Adjacent 
chromosomal genes are shown in grey. Boxes represent IS and CR elements and the internal arrows indicate the 
transposase or the rolling circle replicase. IS26 is dark green, ISAba24 is purple, ISEc29 and ISEc28 are light and 
dark blue and CR1 is yellow. IS26** is 2 bp different to the standard sequence of IS26, while IS26* is 3 bp 
different. Black and white flags indicate matching TSD. Dashed lines represent the extent of deletions relative to 
AbGRI3-2i, with the total size of the deletion indicated above. The bar above shows the sequence that is inverted. 
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The other end of Tn6179 could be joined to ∆asr (RH831-RH2005) but asr∆ could also be 
linked to ∆asr (RH2005-RH2006) and the amplicon produced was the same size as the deletion 
AbGRI3-3i. However, no amplicon was produced when RH2015 and RH831 or RH2015 and 
RH2006 were paired, indicating that a deletion may be present in S31 which has removed the 
binding site of RH2015. 
 
6.3.5 Final assembly using the draft genomes.  
The AbGRI3 regions mapped by PCR were compared to the draft genomes of these isolates 
when the Illumina MiSeq data became available. The draft genomes were consistent with the 
AbGRI3 regions assembled in S22, S23, S28, S32, S33, S35, S36, S37 and S40. Additional 
information from the draft genomes of S31 and S25 facilitated assembly of AbGRI3 in these 
isolates.  
 
6.3.5.1 AbGRI3-5i in S31 
Examination of the draft genome of S31 revealed that there was a 785 bp deletion, likely caused 
by IS26, that had removed atr∆ and the binding site for RH2015. Amplification, using a new 
primer RH2016 in combination with RH2006 (Fig 6.13A), completed the assembly of a novel 
variant named AbGRI3-5i (Fig 6.13B), and revealed that 126 bp of asr∆ was also missing, 
likely caused by a deletion by the adjacent IS26**. The segment between the right of the island 
and the extra IS26** could also be detected in both orientations, despite containing a 785 bp 
deletion at one end (Fig 6.13B).  
 
Chapter 6 145	
 
Figure 6.13 AbGRI3-5i in S31.  A. Final link to assemble AbGRI3 in S31. B. Structure of AbGRI3-5i. Arrows 
indicate the extent and orientation of genes and open reading frames. The mphE and msrE genes are orange, the 
armA gene is maroon, the sul1 gene is mauve, the aphA1b gene is red-orange, and the aadA1, catB8 and aacA4 
genes are green, pink and pale blue, respectively. Adjacent chromosomal genes are shown in grey. Boxes represent 
IS and CR elements and the internal arrows indicate the transposase or the rolling circle replicase. IS26 is dark 
green, ISAba24 is purple, ISEc29 and ISEc28 are light and dark blue and CR1 is yellow. IS26** is 2 bp different 
to the standard sequence of IS26, while IS26* is 3 bp different. Black and white flags indicate matching TSD. 
Dashed lines represent the extent of deletions relative to AbGRI3-2i, with the total size of the deletion indicated 
above. In A. the bar above indicated the primers along with amplicon size while in B the bar above shows the 
sequence that is inverted.  
 
6.3.5.2 AbGRI3-6 in S25 
A search in the draft genome of S25 retrieved 4 contigs containing fragments of IS26 (Table 
6.5) which were tiled to AbGRI3-2i and surrounds (Fig 6.14A). Tn6180 was separated into two 
contigs, 56 and 31, which had IS26 on both edges, indicating the presence of an additional IS26 
within the transposon. However, no sequence matching Tn6179 or sequence containing ∆atr-
asr were present.  
 
Table 6.5 AbGRI3 contigs of S25 
Contig Length Features Edges 
Left Right 
14 133826 LH flank NA IS26-IRr 
56 559 ∆repAciN IS26-IRl IS26-IRl 
31 16187 ∆Tn6180 IS26-IRr IS26-IRl 
9 175053 RH chromosome IS26-IRr NA 
 
Results of previous screening indicated that contig 56 and 14 with sequence of chromosome to 
the left of the island could not be linked using RH2001 and RH2002 (Table 6.3, Fig 6.14B).  
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Figure 6.14 AbGRI3-6 in S25. A. AbGRI3 contigs in S25. B. Assembly of the left end of AbGRI3-6. C. Structure 
of AbGRI3-6. For A. and C. arrows indicate the extent and orientation of genes and open reading frames. The 
repAciN gene is blue, the mphE and msrE genes are orange, the armA gene is maroon, the sul1 gene is mauve, the 
aphA1b gene is red-orange, and the aadA1, catB8 and aacA4 genes are green, pink and pale blue, respectively. 
Adjacent chromosomal genes are shown in grey. Boxes represent IS and CR elements and the internal arrows 
indicate the transposase or the rolling circle replicase. IS26 is dark green, ISAba24 is purple, ISEc29 and ISEc28 
are light and dark blue and CR1 is yellow. IS26** is 2 bp different to the standard sequence of IS26. Black and 
white flags indicate matching TSD. In A., grey lines above indicate the extent of different contigs in S25, green 
bars indicate fragments of IS26 and grey arrows indicate the binding sites and orientations of primers. B. depicts 
the screening PCRs to orient contig 56 in S25. The primer combinations are shown above the gel and the isolates 
are shown above the lane. The primer combination RH2001-RH2002 and RH2547-RH2048 will amplify contig 
56 in one direction, while RH2001-RH2547 and RH2002-RH2048 will amplify it in the other. Sizes of the 
molecular marker to the left and right are in kb. In C. dashed lines represent the extent of deletions relative to 
AbGRI3-2i, with the total size of the deletion indicated above and the missing portion of AbGRI3-2 in brackets. 
 
Instead, contig 14 was linked to contig 56 using RH2001 and RH2547, which detect the 
opposite orientation. This produced an amplicon approximately 1,200 bp in size.  (Fig 6.14B). 
Hence, it is likely that through intramolecular transposition the IS26** at the left end of Tn6180 
has targeted a site in repAciN, duplicating itself and an 8 bp target site and inverting the 
intervening sequence (Fig 6.14C).  
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The other end of 56 was then linked with the remainder of Tn6180 (contig 31) using RH2002 
and RH2048, producing an amplicon of a size consistent with the expected 2,638 bp (Fig 
6.14B). The intI1∆ and all but 8 bp of the attI site is missing at the integron end of Tn6180. 
RH2011 was used to link this end of contig 31 directly to contig 9 which had the right boundary 
of the additional IS26 in asr∆. Hence, a deletion of 9.7 kb is present in this isolate removing 
the 3.1 kb of chromosomal sequence, Tn6179 and intI1∆ (Fig 6.14C). The AbGRI3-6 variant 
in S25 can be derived from AbGRI3-2i by the action of IS26.  
 
6.3.6 Assembled AbGRI3 variants 
Overall, 6 variants of AbGRI3 were detected in the 15 isolates that were armA positive (Fig 
6.15). Some of these variants were only found in one isolate (AbGRI3-1i, AbGRI5i and 
AbGRI3-6) while the other variants were found in two or more isolates. The flanking 
chromosomal sequence on the left of each variant was always the same but differences have 
arisen both within the island and in the chromosomal sequence to the right of the resistance 
island. Most of this variation can be accounted for by the action of IS26 either causing deletions 
or inversions in adjacent sequences. However, the deletion in AbGRI3-4, which was present in 
6 isolates, is due to a different type of event. All variants, except AbGRI3-4 have clearly arisen 
from AbGRI3-2i as they all contain the IS26** interrupting the asr gene.  
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Figure 6.15 Six AbGRI3 variants. Arrows indicate the extent and orientation of genes and open reading frames. 
The mphE and msrE genes are orange, the armA gene is maroon, the sul1 gene is mauve, the aphA1b gene is red-
orange, and the aadA1, catB8 and aacA4 genes are green, pink and pale blue, respectively. Adjacent chromosomal 
genes are shown in grey. Boxes represent IS and CR elements and the internal arrows indicate the transposase or 
the rolling circle replicase. IS26 is dark green, ISAba24 is purple, ISEc29 and ISEc28 are light and dark blue and 
CR1 is yellow. IS26** is 2 bp different to the standard sequence of IS26*, while IS26 is 3 bp different. Black and 
white flags indicate matching TSD. Dashed lines represent the extent of deletions relative to AbGRI3-2i, with the 
total size of the deletion indicated above and the missing portion of AbGRI3-2 in brackets. The black bar above 
indicates the extent of inverted sequence.  
 
6.4 AbGRI3 in completed GC2 genomes in GenBank 
A search of the non-redundant database of GenBank using the sequence of AbGRI3-2, revealed 
that in addition to TYTH-1 and MDR-TJ described in Section 6.2.1, a version of AbGRI3 could 
be discerned in 31 other completed GC2 genomes (Table 6.6). Only two of these have been 
described previously. The region of AbGRI3 in NCGM_237 containing Tn6180 with deletions  
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Table 6.6 Completed GC2 genomes containing AbGRI3 variants as of July 2017 
Isolate Year of 
Isolation 
Location AbGRI3 Accession Reference 
Chromosome left Content Chromosome 
right 
MDR-ZJ06 2006 Zheijiang, China + IS261 ∆25,935 bp CP001937 (285) 
BJAB07104 2007 Beijing, China + IS261 + CP003846 (286) 
BJAB0868 2008 Beijing, China + IS261 + CP003849 (286) 
MDR-TJ <2011 Tianjin, China + Tn6180 + CP003500 (125) 
TYTH-1 2008 Taiwan + Tn6180 + CP003856 (160) 
NCGM_237 2012 Japan ∆2,814 bp Tn6180 ∆36,971 bp AP013357 (253) 
XH586 2010 Guangdong, China + Tn6180, Tn6179 + CP014541  
ORAB01 2012 Oregon, USA + Tn6180, Tn6179 + CP015483  
KPN10P02143 2012 Daegu, South Korea +2 Tn6180, Tn6179 + CP013924 (157) 
XH386 2014 Guangzhou, China + Tn6180, Tn6179 + CP010779 (62) 
DU202 <2014 Korea + Tn6180, Tn6179 + CP017152 (155) 
CMC-CR-
MDR-Ab4 
<2016 USA + Tn6180, Tn6179 + CP016295  
XDR-BJ83 2007 Beijing, China + Tn6180, Tn6179 + CP018421  
AF-673 2008 Arizona, USA + Tn6180, Tn6179 + CP018256  
CMC-CR-
MDR-Ab66 
<2016 USA + Tn6180, Tn6179 ∆243 bp CP016300  
XDR-BJ83 2007 Beijing, China + Tn6180, Tn6179 + CP018421  
SSA6 2013 Seoul, South Korea + Tn61803, Tn6179 ∆35,691 bp CP020591  
CMC-MDR-
Ab59 
<2016 USA + Tn6180, Tn6179x2 + CP016298  
XH8574 2010 Guangdong, China + Tn6180, Tn6179 ∆18,304 bp CP014540  
HRAB-85 2014 Beijing, China + ∆Tn61805, Tn6179 + CP018143  
YU-R612 2014 Seoul, Korea ∆2,850 bp 2 copies of ∆Tn61806 + CP014215 (156) 
USA2 2013 Seoul, South Korea + ∆Tn61807 ∆1,155 bp CP020592  
JBA13 2013 Jeonbuk, South Korea ∆1,004 bp8 ∆Tn61807 + CP020584  
SSA12 2013 Seoul, South Korea ∆1,004 bp8 ∆Tn61807 + CP020578  
KAB07 2015 Jeonbuk, South Korea ∆1,004 bp8 ∆Tn61807 + CP017654  
15A34 2014 South Korea + Tn61803, 9 ∆35,691 bp10 CP020590  
SAA14 2013 Seoul, South Korea + 11 ∆Tn61807,12 + CP020579  
KAB04 2015 Busan, South Korea + 11 ∆Tn618013 + CP017648  
KAB02 2015 Daegon, South Korea ∆2,850 bp14 ∆Tn61807, 15 ∆1,1391 bp CP017644  
15A5 2013 South Korea +16 ∆Tn61807 + CP020574  
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SSMA17 2013 Seoul, South Korea ∆3,286 bp17 ∆Tn61807 + CP020581  
KAB06 2015 Daegu, South Korea ∆4,203 bp ∆Tn61807, 18 ∆312 bp CP017652  
KAB05 2015 Daegu, South Korea ∆4,203 bp ∆Tn61807, 18 ∆312 bp CP017650  
KAB08 2015 Gyeonggi, South Korea + ∆Tn618019 + CP017656  
KAB03 2015 Daejeon, South Korea ∆785 bp version 420 ∆3,937 bp CP017646  
KAB01 2015 Daejeon, South Korea ∆785 bp version 421 ∆3,937 bp CP017642  
1These genomes include a Tn6180-Tn6179 TU form said to be a plasmid. 
22,858 bp has been inverted by intramolecular transposition of IS26.  
3Missing the 19 duplication in attI1. 
4Is a triple locus variant of ST2 (Institute Pasteur scheme). 
5Missing 2,013 bp at the left end. 
6First copy of ∆Tn6180 is missing 4,729 bp from the left end and is missing 772 bp from the right end, and the second copy of ∆Tn6180 is also missing 4,729 bp from the left 
but instead is only missing 434 bp from the right end.  
7Missing 434 bp at the right end. 
8Inversion of 1,854 bp caused by intramolecular transposition of IS26. 
91,035 bp inverted at the left end due to intramolecular transposition of IS26.  
10Located approximately 2.5 Mb away, due to an IS26 mediated inversion. 
11An IS26 surrounded by TSD is located 2,858 bp away.  
12Missing 1,929 bp at the left end. 
13Missing 2,013 bp at left end, followed by a 2,165 bp inversion and another 156 bp deletion. 
14IS26 is in the opposite orientation. 
154,250 bp missing at the left. 
162,505 bp has been inverted caused by intramolecular transposition of IS26. 
17Located approximately 1 Mb away, due to an IS26 mediated inversion.  
18Missing 7,693 bp from left end. 
19Missing 678 bp left end, 356 bp from the right and 37 bp of IS26 adjacent to the right IS26. 
20Missing 10 bp at the left end. 
21Missing 6,436 bp at the left end. 
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in both flanking sequences (253) and YU-R612 (156) includes two partial copies of a ∆Tn6180 
with a deletion in the flanking sequence to the left. The remainder of AbGRI3 variants in Table 
6.6 were analysed in this study. Overall, 14 isolates contained a variant related to AbGRI3-2, 
i.e. had all or part of both Tn6180 and Tn6179, 16 isolates had an island related to AbGRI3-1, 
i.e. with only Tn6180, and KAB03 and KAB01 from South Korea carried AbGRI3-4. 
However, deletions and/or inversions caused by IS26, have contributed to the large variation 
both within Tn6180 and Tn6179, as well as in the surrounding chromosome (Table 6.6). 
However, none of the genomes listed in Table 6.6 contain an IS26 interrupting the asr gene. 
The location of this IS26 and the resulting difficulty in assigning the direction of the intervening 
sequence appears to be specific to the isolates from SGH.  
 
6.4.1 Examination of the chromosome in MDR_ZJ06, BJAB0868 and BJAB07104 at 
the AbGRI3 insertion site 
The region of the chromosome where AbGRI3 is located was examined in MDR_ZJ06, 
BJAB0868 and BJAB07104, which were claimed to contain plasmids composed of Tn6180 
and Tn6179 (Section 6.2.3).  In the genomes of BJAB0868 and BJAB07104, an IS26 is present 
in the location of AbGRI3 interrupting the atr gene and surrounded by the same 8 bp TSD. 
MDR-ZJ06 also has a suitably located IS26 but 25.9 kb of adjacent chromosomal sequence is 
missing. Thus, it is likely that the proposed plasmid forms actually belong in the chromosome, 
as AbGRI3, and this should be investigated.  
 
6.4.2 An independent acquisition of a Tn6180 variant in a GC2 isolate 
 
A transposon related to Tn6180 was also identified in the GC2 isolate XH859 from China 
(GenBank accession number CP014539). The transposon in XH859 had ISAba24 in the same 
position as in Tn6180, interrupting orf44. However, the intI1 gene has been lost and there is an 
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additional segment containing the blaPER resistance gene (resistance to extended spectrum 
cephalosporins) downstream of the sul1 gene in XH859, followed by a second copy of CR1 
and sul1, then up to 8 bp into the aadA1 gene cassette before the right IS26** (bottom line, Fig 
6.16A).  
  
Figure 6.16 Variant of Tn6180 found in XH859. A. Comparison of Tn6180 and the armA containing transposon 
in XH859. Arrows indicate the extent and orientation of genes and open reading frames. The mphE and msrE 
genes are orange, the armA gene is maroon, the sul1 gene is mauve, the aphA1b gene is red-orange, the blaPER 
gene in dark purple and the aadA1, catB8 and aacA4 genes are green, pink and pale blue, respectively. Adjacent 
chromosomal genes are shown in grey. Boxes represent IS and CR elements and the internal arrows indicate the 
transposase or the rolling circle replicase. IS26 is dark green, ISAba24 is purple, ISEc29 and ISEc28 are light and 
dark blue and CR1 is yellow. IS26** is 2 bp different to the standard sequence of IS26. Black and white flags 
indicate matching TSD. Grey boxes indicate regions of identical sequence. B. Schematic of XH859 chromosome. 
The inverted section of the chromosome is in red and insertions are indicated by arrows. Figure made from XH859 
(GenBank accession number CP014539).  
 
The atr gene of XH859 is intact so this transposon is not in the same location as AbGRI3. 
Instead, the chromosomal sequence flanking the right end of the Tn6180 relative in XH859 is 
located 280 kb from the AbGRI2 insertion location (Fig 6.16B). The sequence that would be 
expected at the left of the island was adjacent to an IS26, 600 kb away. The IS26 at the left of 
the transposon in XH589 has likely caused an inversion of chromosomal sequence through 
intramolecular transposition. Unfortunately, the TSD that would have arisen from this event is 
not present due to more than one deletion events. Following the in-silico reversal of this 
inversion, the location for the original insertion of the Tn6180-relative in the GC2 chromosome 
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can be narrowed down to a 13 kb region. Nonetheless, it represents a second acquisition of 
transposon related to Tn6180 in GC2 isolates.  
 
6.5 Discussion 
AbGRI3 is the third and most recently acquired resistance island in GC2 A. baumannii. 
Evidence suggests that the AbGRI3 island, bringing with it the armA resistance gene, entered 
the GC2 chromosome in the early 2000s, likely in Asia. The isolates examined in this study, 
S22 and S23 from 2004, containing AbGRI3-2i that include both Tn6180 and Tn6179, are now 
the earliest sequenced examples of GC2 A. baumannii containing this third resistance island. 
The origin of these isolates in Singapore is consistent with the original acquisition of this island 
by a GC2 isolate in Asia. The armA gene has been detected by PCR in earlier isolates from 
2003 in Korea. (153). However, as the location of the gene was not determined, it is not known 
if armA was located in AbGRI3 or within the related transposon in XH859 that is found in the 
second location in the GC2 chromosome. In addition, the armA gene in another transposon 
related to Tn1548, has been found in a set of large conjugative plasmids that have no known 
rep gene (135, 240, 272). This Tn1548-like transposon carries the cmlA5-arr2 gene cassettes 
(chloramphenicol and rifampicin resistance) as well as the blaPER gene (resistance to extended 
spectrum cephalosporins) (135, 240, 272) and is located within another transposon in these 
plasmids. Current whole genome sequence data indicates that the AbGRI3 island entered the 
GC2 chromosome prior to 2004 but additional information about isolates from the early 2000s 
should enable this date to be refined.  
 
The presence of an 8 bp target site duplication in the surrounding sequence of the resistance 
island indicates that, like AbGRI2, AbGRI3 also entered the chromosome by the action of IS26. 
What is less clear, is if Tn6180 and Tn6179 entered together or individually. Both routes are 
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plausible using either the replicative or the conservative mechanism of transposition of IS26. 
A translocatable unit (TU) made up of a circular piece of DNA containing both Tn6180 and 
Tn6179 with only two IS26s could have inserted into the atr gene, duplicating the target site 
and one copy of IS26**. The plasmid pMUR050, an IncN plasmid isolated in Spain in 2002 
(83), contains a transposon related to Tn1548 along with Tn6179. The transposons also overlap 
in pMUR050, but share the IS26 at the repAciN end of the Tn1548-like transposon rather than 
the intI1 end (top line Fig 6.17). The armA containing transposon of pMUR050 is also missing 
216 bp of intI1, the same truncation as found in Tn6180, but it only contains a single gene 
cassette aadA2 in its integron. Because of this, it was investigated as a potential source for both 
transposons of AbGRI3-2. 
 
Hypothetically, homologous recombination between the IS26s at the bounding ends of these 
transposons in pMUR050 could form a circular TU that was composed of the Tn1548-related 
transposon and Tn6179 but only two IS26s (Fig 6.17). If the central IS26 instigated the 
insertion of the TU into the asr gene (IS26-2 in Fig 6.17), the order of the transposons would 
be reversed and the configuration seen in AbGRI3 created. However, the addition of ISAba24 
and the switching of the cassettes in the integron to be those in AbGRI3 would still be required, 
as would the change of IS26 to IS26*. 
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Figure 6.17 pMUR050, a potential source for the transposons in AbGRI3. Arrows indicate the extent and 
orientation of genes. The armA gene is maroon and the aadA2 and the aphA1b genes are aqua and red-orange, 
respectively. The green boxes represent IS26 and the internal arrow indicates the orientation of the transposase. 
IS26** is 2 bp different to the standard sequence of IS26. Figure not to scale.  
 
Most of the island variants assembled from the 15 armA positive Singapore isolates, also 
contain an additional copy of IS26**, that is located 3.1 kb away in from the resistance island 
in the chromosome and the intervening sequence has been inverted. This has likely occurred 
by intramolecular transposition of the IS26** at the right of Tn6179, which in one step, has 
duplicated itself and the target site and caused the inversion. A surprising finding was the 
chromosomal segment that has been inverted could be detected in both orientations using PCR, 
and further experiments such as cloning the fragment or sequencing using long-range platforms 
such as PacBio or Oxford Nanopore could be used to determine if this segment is actually 
inverting frequently. This additional IS26** was not present in any of the genomes examined 
in GenBank as of July 2017 and appears to be unique to SGH isolates. Hence, its presence and 
the chromosomal inversion associated with it, can be used to define a sub-lineage of AbGRI3-
containing GC2 isolates. As this marker is present in the current earliest known isolates with 
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AbGRI3 (S22 and S23 from 2004) we can conclude it was acquired soon after the acquisition 
of AbGRI3. It would be interesting to determine if more recent isolates from SGH are members 
of this lineage or instead are a part of the original AbGRI3 lineage.  
 
After most of the work in this chapter had been completed, a manuscript that had also analysed 
the AbGRI3 region of A. baumannii from Sweden was published (135). The authors identified 
a structure identical to AbGRI3-2 structure (including both Tn6180 and Tn6179) in the isolate 
A071 (GenBank accession number KT317075) and named the complete structure Tn6279 
(135). Interestingly, the same study also reported that circular forms of the TU of AbGRI3-2 
(Tn6180 and Tn6179 with only two copies of IS26) as well as just AbGRI3-1 (Tn6180 with 
one copy of IS26) could be detected by PCR in this isolate. These circular TUs are consistent 
with the “plasmids” described in Section 6.4.1 and could account for the annotation of these 
sequences as plasmids.  
 
Since its acquisition, the AbGRI3 region has continued to evolve in situ. As for AbGRI2, this 
variation has mainly occurred through deletions occurring adjacent to copies of IS26. Other 
versions of AbGRI3 found in armA positive Singapore isolates are smaller than AbGRI3-2i. 
They have clearly evolved from AbGRI3-2i, by various deletions of sequence adjacent to 
copies of IS26, as versions 1i, 3i, 5i all contain the adjacent chromosomal inversion. AbGRI3-
6 has also likely evolved from AbGRI3-2i, as the right boundary of this island is in the same 
position as the additional IS26**. Whether AbGRI3-4 is also derived from AbGRI3-2i cannot 
be discerned, as the characteristic deletion in AbGRI3-4 extends past the inverted chromosomal 
segment. This deletion has now been detected in isolates from Singapore, South Korea, India 
(231) and Sweden (135), suggesting that the sub-lineage containing AbGRI3-4 has dispersed 
quite successfully.   
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The 15 isolates that have AbGRI3 do not contain AbGRI2-1. Instead, they have different 
variants that can be derived AbGRI2-1 (Chapter 5; Fig 5.10) and contain different segments of 
AbGRI2-1. Hence, it is likely that the cell which first acquired AbGRI3 contained AbGRI2-1, 
or something very closely related to it, as the sul1 and aadA1 genes may already have been 
missing. Since the acquisition of AbGRI3, deletions in the AbGRI2 region have occurred and 
in four isolates, no resistance genes have been retained in this region (Table 6.7).  
 
Table 6.7 Features isolates containing AbGRI3  
Isolate Year ST(Ox) AbGRI1 AbGRI2 AbGRI3 Additional oxa23 locations in the 
chromosome 
S22 2004 218 3 14 2i AbaR4 (1) 
S23 2004 218 3 14 2i AbaR4 (1) 
S25 2006 218 3 14 6  
S27 2007 218 4 IS26a3 2i  
S28 2007 11281 8 14 1i  
S31 2008 208 6 13 5i AbaR4 (2) 
S32 2009 1951 7 12b 4  
S33 2009 1951 7 12b 4  
S34 2009 11662 4 12a 4 Tn2006 
S35 2010 1951 7 IS26b4 4  
S36 2010 1951 7 IS26b4 4  
S37 2010 1951 7 IS26b4 4  
S38 2011 208 1 13 3i AbaR4 (2) 
S39 2011 208 1 13 3i AbaR4 (2) 
S40 2011 1951 7 12b 4  
1SLV of ST208 in the gpi allele.  
2TLV of ST208 in the cpn60, gpi and rpoD alleles.  
3A single IS26 is present in the AbGRI2 region and 5,498 bp of the right flank of AbGRI2-1 is missing.  
4A single IS26 is present in the AbGRI2 region and 30.6 kb of sequence of the left flank and 8.1 kb of the right 
flank of AbGRI2-1 is missing.  
 
The range of antibiotic resistance phenotypes conferred by genes in the AbGRI3 region replace 
and extend those conferred by the genes in AbGRI2-1, so deletions in the AbGRI2 region do 
not contribute to a reduction in phenotypic resistance. Due to extensive variation in AbGRI1 
in isolates containing AbGRI3 (Table 6.7), it is less clear what AbGRI1 structure was present 
in the cell that first acquired AbGRI3, though I postulate that this island likely resembled 
AbGRI1-3, containing both a copy of Tn6022 and Tn6022∆, but not Tn2006. 
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CHAPTER  
  7 
 
ISAba1 mapping
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7.1 Introduction 
ISAba1 is an IS often found associated with A. baumannii. ISAba1 is 1,180 bp in size and 
creates a 9 bp TSD. Examination of the distribution of copies of ISAba1 in genomes has been 
shown to be a useful method to discriminate A. baumannii isolates (2, 111). Original methods 
involved digestion of genomic DNA followed by hybridisation with an ISAba1 probe and the 
different profile patterns were indicative of different ISAba1 insertion sites (111). However, 
more recently ISAba1 positions have been manually identified in whole genome sequences (2, 
277). Two different bioinformatic programs have been developed to automatically identify the 
insertion positions in genome sequences, ISMapper which uses unassembled reads (108) and 
ISseeker which uses assembled contigs (1). These programs identify reads or contigs that 
contain sequence derived from the selected IS. Attempts are then made to pair these sequences 
to make a complete IS, i.e. with a left and right end, by looking for proximity of the position 
of the flanking sequences in the reference sequence (1, 108). IS positions present in the 
reference genome as well as novel positions are able to be identified by these programs and the 
output provides the IS locations in relation to the reference genome. Unless a copy of Tn2006 
is present in the reference genome these programs miss Tn2006 due to the inverse orientation 
of the bounding copies of ISAba1 and manual finishing is needed.  
 
The ISAba1 profiles of the 20 SGH isolates was determined using ISMapper for those 
sequenced by Illumina HiSeq and ISseeker for those sequenced by Illumina MiSeq. Profiles 
were then compared to elucidate relationships among these 20 isolates and to determine if they 
were consistent with the groupings from earlier chapters. In addition, these profiles were 
compared to representatives of XAR GC2 isolates from Australia to examine additional 
connections.   
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7.2 ISAba1 mapping of the Singapore genomes 
The genome of XH386 (GenBank accession number CP010779) was selected as the reference 
genome for both ISmapper and ISseeker as it was sequenced by PacBio and is ST208, and the 
majority of the Singapore isolates are ST208 or an SLV of this ST (Chapter 3, Section 3.5.2). 
ISAba1 insertion locations were detected using the ISMapper program on the reads generated 
by Illumina HiSeq sequencing for S21, S24, S27, S29, S34, S38 and S39. The positions of 
ISAba1 in the 13 isolates sequenced by Illumina MiSeq were located using ISseeker on the 
assembled contigs. Each position of ISAba1 detected by the programs was manually checked 
to confirm the TSD, orientation and location in the reference genome XH386. The copies of 
ISAba1 flanking Tn2006 (which are inversely oriented and not easily identifiable by the 
programs) and ISAba1 locations in plasmids are examined in more detail in Chapter 4 and 
Chapter 8, and were not included in the analysis presented in this chapter.  
 
Overall, 74 different ISAba1 insertion locations in the chromosome were detected in the 20 
isolates and 31 of these positions were unique to one isolate (Table 7.1). All isolates contained 
at least 10 ISAba1 insertions and the most found in one isolate was 19 (Table 7.1).  
 
Isolates with the same coloured shading in Table 7.1 have ISAba1 insertions in identical 
positions or share a high proportion of their ISAba1 insertion positions. This indicates that 
these isolates are closely related and supports the groupings found in earlier chapters. For 
example, S22 and S23 contain the same AbGRI1, AbGRI2 and AbGRI3 structures as one 
another, as well as an AbaR4 in a specific position in the chromosome. S31, S38 and S39 share 
10 ISAba1 insertion positions (S31 contains a unique ISAba1 insertion as well) and contain 
AbaR4 in another identical chromosomal location.  
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Table 7.1 ISAba1 positions in the chromosome of 20 isolates 
Isolate Total positions Unique positions 
S21 13 4 
S22 10 - 
S23 10 - 
S24 19 7 
S25 10 - 
S26 19 1 
S27 13 4 
S28 11 1 
S29 18 - 
S30 13 7 
S31 10 1 
S32 18 1 
S33 17 -1 
S34 16 2 
S35 18 2 
S36 16 - 
S37 16 - 
S38 10 - 
S39 10 - 
S40 15 1 
Isolates with the same shading have identical ISAba1 positions.  
1Has one side of position 305 (present in S30) and the other of position 308 (found in S32). S33 likely had both 
positions but has lost an ISAba1 and the 722 bp between the sites.  
 
The positions of ISAba1 insertions unique to each isolate are shown in Appendix I; Fig A1.1 
and Appendix I; Table A1.3 details the location of the each ISAba1 insertion in the genome of 
XH386, the TSD and the locus tags of the surrounding open reading frames. The positions of 
ISAba1 shared between two or more of the 20 isolates from SGH isolates are shown in Fig 7.1. 
Certain ISAba1 positions have been colour coded to aid in the descriptions of the groups within 
this collection. A filled box indicates that the isolate contains a copy of ISAba1 in that position, 
except in the case of the grey boxes of S33 (Fig 7.1). The two grey boxes indicate that an 
ISAba1 in S33 is flanked by one side of position 305 and the other side of position 308. Hence, 
the most likely explanation for this arrangement is that S33 previously had an ISAba1 at 
position 305 and 308 but they have recombined and the intervening sequence (approximately 
200 bp) and one ISAba1 has been lost. 
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Figure 7.1 Shared ISAba1 positions. The coloured boxes indicate ISAba1 positions. The grey boxes indicate a recombination event between position 305 and position 308 in 
S33. Position 5 denotes ISAba1 adjacent to sul2 in AbGRI1 and ISAba1 upstream of ampC is position 1. The Singapore isolates highlighted in pink lack armA and contain 
aphA6, while those highlighted in green have armA and lack aphA6. 
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WM99c 1999 208pD72-1+ + + + + + + + + + + + + +
S21 1996 208 + + + + + + + + + + + + +
G2 2003 208 + + + + + + + + + + + + + +
S24 2006 208 + + + + + + + + + + + + + +
K16 2004 208 + + + + + + + + + + + + +
S26 2006 1165 + + + + + + + + + + + + + + + + + + +
S29 2007 1165 + + + + + + + + + + + + + + + + + + +
S30 2008 369 - + + + + + +
XH386 2014 208 + + + + + + + +
S22 2004 218 + + + + + + + + + + +
S23 2004 218 + + + + + + + + + + +
S25 2006 218 + + + + + + + + + + +
S28 2007 1128 + + + + + + + + + + +
S27 2007 218 + + + + + + + + + +
S31 2008 208 - + + + + + + + + +
S38 2011 208 - + + + + + + + + + +
S39 2011 208 - + + + + + + + + + +
S34 2009 1166 + + + + + + + + + + + + + + +
S32 2009 195 + + + + + + + + + + + + + + + + + +
S33 2009 195 + + + + + + + + + + + + + + + +
S35 2010 195 + + + + + + + + + + + + + + + + +
S36 2010 195 + + + + + + + + + + + + + + + + +
S37 2010 195 + + + + + + + + + + + + + + + + +
S40 2011 195 + + + + + + + + + + + + + + +
D86 2010 195 + + + + + + + + + + + + + +
Isolates Year MLST	
(Oxford)	
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All of the Singapore isolates have an ISAba1 in position 1, which corresponds to the ISAba1 
upstream of ampC, as well as in positions 2, 3, 4 and 12 (Fig 7.1). XH386 and additional 
Australian isolates included for comparison (see below) also have ISAba1 in these positions. 
The location of these five positions as well as position 5, which corresponds to the ISAba1 
adjacent to the sul2 gene in AbGRI1 and is present in most isolates, are depicted on the 
schematic of the GC2 chromosome in Fig 7.2. The isolates lacking the ISAba1 insertion at 
position 5 (S30, S31, S38 and S39) have either AbGRI1-1 or AbGRI1-6 that have lost the 
region containing sul2 and this ISAba1. Therefore, the presence of ISAba1 in position 5 is not 
as useful for epidemiology as it is located in a resistance island that is subject to variation. 
Unlike position 1, the impact of these other four common ISAba1 insertions is unclear. 
Positions 2 and 3 do not interrupt any reading frames and are not appropriately positioned to 
increase the expression of any neighbouring genes. The ISAba1 in position 4 truncates an open 
reading frame annotated as a transcriptional regulator and provides it with an in-frame stop 
codon that translates a protein 14 aa shorter than for the native stop codon. An open reading 
frame annotated as a translation elongation factor is interrupted by ISAba1 in position 12.  
 
 
Figure 7.2 Location of ISAba1 positions 1-5 and 12. Block arrows show the orientation and approximate 
insertion location of copies of ISAba1 on a schematic of the GC2 chromosome. The location of AbGRI1 is 
indicated by the black arrow.  
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The positions of some of the additional ISAba1 copies present in these isolates help distinguish 
groups in the Singapore collection. Overall, the general trend remained consistent with that in 
earlier chapters as four of the five aphA6 containing isolates (shaded in pink in Fig 7.1) shared 
four additional ISAba1 insertions with one another (indicated by the orange boxes in Fig 7.1). 
The presence of ISAba1 in two other positions (green boxes in Fig 7.1) were common to the 
armA containing isolates (shaded in green in Fig 7.1). However, the one exception to this was 
S30. The ISAba1 pattern of this isolate did not match the other aphA6 containing isolates and 
only contained the ISAba1 positions shared by both the aphA6 and armA containing isolates. 
This suggests that S30 is from an earlier lineage that predates movement of ISAba1 to the 
orange or green ISAba1 positions.  
 
Additional ISAba1 positions shared between the isolates (shown in black to the right of Fig 
7.1) indicate a closer relationship between them. For example, the 6 ISAba1 positions shared 
between S26 and S29 (Fig 7.1) may indicate that these isolates are siblings.  
 
The ISAba1 profiles of a selected group of Australian isolates (kindly provided by Dr Steven 
Nigro) were included to compare to the ISAba1 profiles of the 20 SGH isolates. This included 
WM99c, isolated in 1999 from Westmead Hospital in Sydney, in which AbGRI2-1 was 
characterised (188). The ISAba1 profile of WM99c represents the profile of larger group of 
GC2 A. baumannii isolated from the east coast of Australia. The ISAba1 profile of G2 from 
Alfred Hospital in Melbourne (2002) and K16 (2004) from the Royal Adelaide Hospital were 
also included as representatives of the GC2 populations in these hospitals. G2 and K16 have 
AbGRI1-5 (personal communication, Dr Steven Nigro) which is same AbGRI1 structure seen 
in S24, S26 and S29 indicating that they may be related to the Singapore isolates. D86, isolated 
from Royal North Shore Hospital in Sydney in 2010 was also included for comparison as the 
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armA gene was identified in the draft genome of this isolate using ResFinder. Assembly of the 
AbGRI3 region in D86 (described in Appendix II; Section A2.1), named AbGRI3-7, revealed 
that armA was located in an island related to and likely derived from AbGRI3-4. The right end 
of AbGRI3-7 had the same deletion as AbGRI3-4 but left end of the island was different.  
 
7.3 ISAba1 positions in the AbGRI3 lineage 
7.3.1 ISAba1 positions 58 and 62 are indicative of AbGRI3 lineage 
The 15 Singapore isolates highlighted in green in Fig 7.1 contain the armA gene in an AbGRI3 
resistance island and ISAba1 in positions 58 and 62 (green boxes in Fig 7.1 and the insertion 
location is indicated in the chromosome in Fig 7.3) that were not in the aphA6-containing 
Singapore isolates. In addition, ISAba1 was in these two positions in XH386 from China which 
carries AbGRI3-2 (Chapter 6, Table 6.6) (23). There were also present in the sporadic isolate 
from Sydney, D86, which was found to contain AbGRI3-7 (Appendix II; Section A2.1). It was 
concluded that ISAba1 present in these two positons may be in all AbGRI3-containing isolates.  
 
 
Figure 7.3 Location of ISAba1 position 58 and 62. Coloured block arrows show the orientation and approximate 
insertion location of copies of ISAba1 on a schematic of the GC2 chromosome. Black arrows indicate the location 
of AbGRI1, AbGRI2 and AbGRI3.  
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To test this hypothesis, the completed GC2 genomes that contain AbGRI3 (listed in Chapter 6; 
Table 6.6) were examined for ISAba1 in positions 58 and 62. All genomes contained ISAba1 
at these two chromosomal locations.  
 
In the course of this analysis, three additional completed genomes, CBA7 (CP020586), 
AB345299 (CP014291) and XH860 (CP014538), that did not carry armA but had ISAba1 in 
these two positions were identified. Closer examination of the region of the chromosome where 
AbGRI3 is located revealed that these isolates contain a suitably located IS26, indicating that 
AbGRI3 had been present but its content was subsequently lost. Hence, as these two ISAba1 
positions are found only in isolates with AbGRI3 or a remnant of this island, they are a marker 
for the lineage of GC2 that contains AbGRI3. Hence, either the cell that first acquired AbGRI3 
already had ISAba1 in these positions or gained these ISAba1 insertions soon after the 
acquisition of AbGRI3. 
  
The GC2 isolate XH859 (GenBank accession number CP01459), which contains a relative of 
Tn6180 in a location in the chromosome different to that of AbGRI3 (Chapter 6; Section 6.4.2), 
was also examined to determine if it carried ISAba1 in the two positions characteristic of 
AbGRI3 containing isolates. XH859 did not have ISAba1 at these positions, providing 
additional evidence that the acquisition of the Tn6180 relative in this isolate was a separate 
event to that of AbGRI3.  
 
7.3.2 Six additional ISAba1 insertions are associated with AbGRI3-4 
In addition to containing ISAba1 at position 58 and 62 (green boxes in Fig 7.1), 8 of the 15 
AbGRI3 containing SGH isolates share an ISAba1 at position 206 (brown box in Fig 7.1). The 
other 7 isolates, S32-S37 and S40, share six other ISAba1 insertions (yellow boxes in Fig 7.1). 
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All of the latter group contain AbGRI3-4 that is characterised by a specific deletion at the right 
end of the island. D86 also includes ISAba1 at these six positions and has an AbGRI3 variant 
containing an identical deletion at the right end of the island (Appendix II; Section A2.1). 
Hence, these six insertions of ISAba1 are markers for the sub-lineage of AbGRI3-4 containing 
isolates.  
 
7.4 Relationship between GC2 isolates from Singapore and Australia  
7.4.1 S21 contains 11 of the 12 ISAba1 positions core to the east coast Australian isolates 
In addition to ISAba1 upstream of ampC (position 1) and next to sul2 in AbGRI1 (position 5), 
the majority of Australian isolates have ISAba1 in 12 other shared positions that are indicated 
by the white, orange, light and dark blue arrows in Fig 7.4. These include positions 2-4 and 7-
14. The isolate S21 contains ISAba1 in all of these positions, except position 11 (indicated in 
dark blue in Fig 7.4). In addition, S21 contains AbGRI2-1, which to date had only been seen 
in Australia and the ISAba1 data further connects this isolate from 1996 to a precursor of the 
majority of isolates from the Australian eastern seaboard. 
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Figure 7.4 Location of ISAba1 positions 1-14. Coloured block arrows show the orientation and approximate 
insertion location of copies of ISAba1 on a schematic of the GC2 chromosome. The colour scheme is consistent 
with that used in Fig 7.1. Black arrows indicate the location of AbGRI1 and AbGRI2.  
 
7.4.2 S24, S26 and S29 share positions with isolates from Melbourne and Adelaide 
S24, S26 and S29 contain ISAba1 in only 8 of the 12 positions core to the east coast Australian 
isolates (Fig 7.1). Instead, these 5 isolates have an ISAba1 at positions 207, 208 and 209 
(indicated by the purple boxes in Fig 7.1). The isolates from Adelaide (Hospital K) and 
Melbourne (Hospital G), represented by K16 and G2, respectively, also share these three 
ISAba1 positions. The three isolates from SGH and K16 and G2 all contain AbGRI1-5, which 
arose from AbGRI1-3 by a recombination between tniC and tniCb, and ISAba1 in these three 
positions may have been present in the cell in which this recombination event occurred. 
However, the reverse order could also be possible and without additional information there is 
no way to determine which was first.  
 
7.5 Discussion 
The mapping of the positions of insertions of ISAba1 in the chromosome of the 20 isolates in 
the Singapore collection confirmed and strengthened the relationships between these isolates. 
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Combining the ISAba1 profile with the structures of AbGRI1, AbGRI2 and, if present, 
AbGRI3, allowed key lineage specific insertions to be identified, such as the two ISAba1 
insertions characteristically present with AbGRI3. A further example of this is the six 
additional ISAba1 insertions for the isolates with AbGRI3-4.  
 
All of the isolates examined in this chapter, except A320, shared five (or six, if the copy of 
ISAba1 adjacent to sul2 in AbGRI1 was present) ISAba1 positions. Hence, all of these isolates, 
which includes isolates originating from Singapore, China and Australia, have a common 
ancestor. Apart from the ISAba1 upstream of ampC, the impact of these other shared ISAba1 
positions is unclear and needs to be investigated further. As A320, isolated in 1980 (190), 
contains the ancestral AbGRI2 structure, perhaps this isolate predates the acquisition of ISAba1 
at these positions.  
 
The structure of the chromosomal resistance islands and ISAba1 profiles of the 20 SGH 
isolates, as well as those of the selected GC2 isolates from Australia, was amalgamated with a 
genome wide phylogenetic tree and is depicted in Fig 7.5. The core genome phylogeny of these 
isolates (kindly provided by Dr Steven Nigro) was generated from the draft genome reads by 
SNP (single nucleotide polymorphism) calling against reference genome XH386 (GenBank 
accession number CP010779), followed by a maximum likelihood phylogenetic inference on 
the SNP alignments using RAxML to build a genome-wide phylogenetic tree. 
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Figure 7.5 ML tree, island structure and ISAba1 positions for 27 GC2 A. baumannii. Origin of isolates is indicated by the coloured circles adjacent to isolate names. 
ISAba1 insertions are shown by coloured rectangles and ovals of matching colours on the tree indicate branching events characteristic of these positions. ML tree generated by 
Dr S. Nigro using Gubbins and RAxML.
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The isolates from Singapore, Australia and XH386 from China cluster into two main clades. 
The first clade includes the isolates S21, S24, S26 and S29 (all have aphA6 and lack armA) as 
well as the representative Australian isolates WM99c, G2 and K16 (Fig 7.5). These isolates all 
contained an ISAba1 in the four positions indicated in orange in Fig 7.5 and these IS were 
likely present in their progenitor (branch point indicated by the orange oval in the tree in Fig 
7.5). However, these isolates then break into two sub-clades, identifiable by the insertions of 
either three ISAba1 indicated by the light blue boxes or by the three insertions indicated by the 
purple boxes (Fig 7.5). 
 
The sub-clade characterised by the four ISAba1 positions shown in blue in Fig 7.5, includes 
S21 and WM99c, the latter of which is a representative of the homogenous east coast Australian 
GC2 population. This provides additional evidence of the relationship between the common 
XAR GC2 isolates found in the eastern seaboard of Australia and S21 from Singapore, 
indicating that these isolates have a common source. 
 
The second sub-clade, based on the presence of the insertions of ISAba1 in purple (Fig 7.4), 
includes S24, S26 and S29 with G2 (2002) from Melbourne and K16 (2004) from Adelaide. 
These isolates also share the same AbGRI1 structure, AbGRI1-5, that contains a deletion that 
is unlikely to arise in precisely the same location twice. This suggests a strong connection 
between this three GC2 isolates from Singapore and those recovered at hospitals in Adelaide 
and Melbourne.  
 
Using only the ISAba1 data, S30 could be representative of the ancestral lineage of both clades. 
However, based on the core phylogeny, S30 lies within the second clade (Fig 7.5), but all 
isolates in the second clade, except S30, contain AbGRI3 and hence armA. This suggests that 
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S30 may be related to the cell that first acquired AbGRI3. This isolate also contains AbGRI2-
1, which is the AbGRI2 structure that was predicted to be present in the ancestral AbGRI3 
containing isolates. The AbGRI3-containing isolates separate away from S30 by the addition 
of the two ISAba1 insertions indicated in green (Fig 7.5).  
 
The Singapore isolates containing AbGRI3 split into two sub-clades based on the insertion of 
the ISAba1 indicated by either the maroon box or the six copies of ISAba1 at the positions 
indicated by the yellow boxes in Fig 7.5. The progenitor of the yellow clade likely contained 
AbGRI3-4, which is another island structure that arose via a unique deletion that is unlikely to 
occur twice. XH386, isolated in China, sits on its own branch (Fig 7.5), but if additional 
sequences from related isolates were include, such as those in Chapter 6; Table 6.6, they may 
form another sub-clade with their own characteristic positions of ISAba1.  
 
Examination of the ISAba1 profiles isolates from the Wright et al. (277) study also revealed 
clade specific ISAba1 insertions. Unfortunately, as the authors used a different reference 
genome, TYTH-1 and as the specific coordinates of each positon were not provided, it is 
difficult to determine if any of these isolates from America shared positions with the isolates 
examined in this chapter and this should be looked at in the future. 
 
The congruence of the SNP tree, chromosomal resistance island structure and ISAba1 profiles 
demonstrates that the recording of ISAba1 positions is a potentially powerful epidemiological 
tool that can be used to define and track the evolution of GC2 lineages.  
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8.1 Introduction 
The plasmid originally used to represent the RepAci6 family of conjugative plasmids is 
pACICU2 (GenBank accession number CP000865) (21). However, the pACICU2 sequence is 
incomplete (90). Members of this plasmid family have been detected in Acinetobacter isolated 
from all over the world (21, 90, 129, 192, 277) and the first complete plasmid pAb-G7-2 
(GenBank accession number KF669606) provides the backbone sequence (97). The RepAci6 
plasmid backbone carries the repAci6 gene, which encodes RepAci6 replication initiation 
protein matching Pfam0309 (Fig 8.1, blue arrow), and two separate regions with genes 
involved in conjugal transfer (red arrows in Fig 8.1) (97). The first region encodes the 
mobilisation genes trwC and trwB which most closely resemble those of IncW and nick the 
plasmid at the origin of transfer, while the second region includes the tra genes which are 
responsible for mating pair formation (MPFF) of the type IV secretion system (97). The 
backbone is comprised of three segments separated by a repeated sequence (green boxes R1, 
R2 and R3 in Fig 8.1). Repeat 1 is only partial and 225 bp, while repeats 2 and 3 are two full 
copies of 422 or 423 bp (99). Primers have previously been designed (99, 192) to amplify these 
repeat regions as this facilitates assembly from short-read sequencing technologies.  
 
 
Figure 8.1 RepAci6 plasmid backbone and repeat sequences.  A. Structure of the RepAci6 backbone and B. 
Repeat 1, 2 and 3. Arrows indicate the extent and orientation of genes and open reading frames. The repAci6 gene 
is blue, genes involved in conjugal transfer are red and the res and umuC gene are orange. Green boxes indicate 
the three repeat sequences. Figure made to scale using pAb-G7-2 (GenBank accession number KF669606). 
 
1 kb
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Although RepAci6 plasmids have a conserved structure, two related backbone types, type 1 
represented by pAb-G7-2 (97) and type 2 exemplified by pA85-3 (99) have been found. These 
two types are distinguished based on SNPs throughout the backbone as well as short insertions 
(Fig 8.2). Differences in the sequence surrounding the third repeat (Fig 8.2) can produce 
amplicons of different sizes that easily distinguish between the type 1 and 2 backbones (99). 
 
 
 
Figure 8.2 Comparison of the two RepAci6 plasmid backbone types. Arrows indicate the extent and 
orientation of genes. The repAci6 gene is blue, genes involved in conjugal transfer are red and the res and umuC 
gene are orange. Green boxes indicate the three repeat sequences. Regions of homology are shown by grey boxes 
and the numbers display DNA identity. Vertical pink arrows show the insertion location TnaphA6 and AbaR4. 
Figure is made to scale using pAb-G7-2 (GenBank accession number KF669606) for type 1 and from pA85-3 
(GenBank accession number KJ493819) for type 2. 
 
RepAci6 plasmids are important as some have been associated with the carriage of antibiotic 
resistance genes, including the aphA6 gene (confers resistance to amikacin, kanamycin and 
neomycin) and the oxa23 gene (confers resistance to carbapenem antibiotics).   
 
The aphA6 gene is located in TnaphA6 (197), and so far, this transposon has been found in two 
different positions in the Type 1 backbone in RepAci6 plasmids. The first position (TnaphA6 
(A) in top line of Fig 8.2), was detected in a plasmid from an Australian isolate, pAb-G7-2 (99) 
and later in pABUH1 from the US (196, 277). pACICU2 was originally reported to be cryptic 
(129). However, it was later shown to carry Tnaph6 in the same position as pAb-G7-2 (90) and 
the two plasmids are likely identical. The second position of TnaphA6 (TnaphA6 (B) in top 
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line of Fig 8.2) was found in pD72-2 (192) and pD46-3 (196), which are both type 1 plasmids 
from isolates recovered at different hospitals within in Australia.  
 
The oxa23 gene has been detected in various transposon contexts in RepAci6 plasmids. These 
include oxa23 within Tn2008 (277), Tn2009 (125) and Tn2006 (196) or AbaR4 (Tn2006 
inserted in Tn6022) (99). In some RepAci6 plasmids both the oxa23 and the aphA6 gene are 
both present (196, 277).  
 
The aim of the work presented in this chapter was to examine if RepAci6 plasmids are found 
in the 20 GC2 isolates from SGH and, if they are present, to determine what backbone they 
have and whether any of them harbour TnaphA6 or oxa23 containing transposons.  
 
8.2 Screening for RepAci6 plasmids 
The primers RH2045 and RH2046 were designed to amplify a 482 bp region of the repAci6 
gene and were used to screen the 20 isolates (Fig 8.3A and B).  S20-S30, S32, S34, S36 and 
S40 produced an amplicon around 500 bp indicating that they contain a repAci6 plasmid. S31, 
S33, S35, S37-S39 did not generate any amplicon indicating that these isolates do not have a 
repAci6 plasmid and this was later confirmed when the draft genomes of these isolates were 
examined. Repeat 1, 2 and 3 in the isolates that were positive for repAci6 were then screened 
for (shown in Fig 8.3A and summarised in Table 8.1). 
 
The primers spanning R3, RH1397 and RH1503, will produce a 1,575 bp amplicon if the 
plasmid is type 1, while if it is type 2 a 1,774 bp amplicon will be generated (Fig 8.3A). S24, 
S26, S29 and S30 produced an amplicon close to 1.5 kb in size indicating that they contained 
type 1 plasmids (Fig 8.3B). However, S21, S22, S25, S27, S28, S32, S34 and S40 produced an 
Chapter 8 177	
amplicon approximately 1.8 kb in size matching the type 2 control (Fig 8.3B). For repeat 2, the 
primers RH1320 and RH1394 were used to amplify a region of 1,534 bp in type 2 and 1,525 
bp in type 1 plasmids (Fig 8.3A). All isolates screened, except S30, produced an amplicon 
around 1.5 kb in size. The RepAci6 plasmid in S30 may contain additional sequence in this 
region or the primer binding sites may be absent from the backbone of S30.  
 
 
Figure 8.3 Screening PCRs over repeat 1, 2 and 3. A. Location of the primers on the plasmid backbone. Arrows 
indicate the extent and orientations of genes and open reading frames. The repAci6 gene is blue, genes involved 
in conjugal transfer are red and the res and umuC gene are orange. Green boxes indicate the three repeat sequences. 
Primers used to span the repeat sequences as well as detect the repAci6 gene are shown by the bars above along 
with the PCR amplicon size. B. Screening repeat 3 using primers RH1397 and RH1503. The amplicon is 1,576 
bp for type 1 and 1,774 bp for type 2. C. RH1398 and RH1399 were paired to detect an amplicon of 987 or 991 
bp depending if the type 1 or 2 backbone is present, respectively. The sizes of molecular markers on the left and 
right in B. are in kb, as are the sizes on the left of C. Those on the right in C. are in bp. Isolate numbers are shown 
above their lanes with T1 and T2 representing type 1 and type 2, respectively.  
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When the primers RH1398 and RH1399 were used to amplify repeat 1, which should yield a 
predicted product size of 978 bp or 991 bp depending if the plasmid is type 1 or type 2 
respectively (Fig 8.3A), the results were variable (Fig 8.3C). The isolates S22-S25, S27, S28, 
S34, S36 and S40 amplified a product around 1 kb, matching the expected amplicon for either 
backbone type (Fig 8.3B). However, S21 and S30 generated a product approximately 3-4 kb, 
while S26 and S29 failed to produce an amplicon (Fig 8.3B). It appears that S21 and S30 have 
an additional 2-3 kb of sequence in the region of repeat 1 (Table 8.1). S26 and S29 may also 
contain additional sequence in this region that may be too large to be amplified under the 
conditions used here, or there may be variability in the region of the plasmid backbone where 
the primers should bind in the plasmids of these two isolates therefore preventing proper 
annealing.  
 
Table 8.1 Properties of the isolates containing repAci6 plasmids 
Isolate ST 
(ox) 
AbGRI3 Repeat 1 Repeat 2 Repeat 31 TnaphA6 
pAb-G7-2 position 
S24 208 - + + + (1) + 
S26 1165 - - + + (1) + 
S29 1165 - - + + (1) + 
S30 369 - +2  - + (1) + 
S21 208 - +2  + + (2) - 
S22 218 + + + + (2) - 
S23 218 + + + + (2) - 
S25 218 + + + + (2) - 
S27 218 + + + + (2) - 
S28 1128 + + + + (2) - 
S32 195 + + + + (2) - 
S34 1166 + + + + (2) - 
S36 195 + + + + (2) - 
S40 195 + + + + (2) - 
1The backbone type is in the parenthesis.  
2Amplicon is 2-3 kb larger than expected.  
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PCR screening results separated the RepAci6 plasmid of the 14 isolates into backbone types 
based on the size of amplicon over repeat 3 (Table 8.1). However, amplification of repeat 1 
and 2 revealed additional differences (summarised in Table 8.1).  
 
The type 1 plasmid pAb-G7-2 contains TnaphA6 (location (A) indicated by the vertical arrow 
in the top line of Fig 8.2). From previous screening S21, S24, S26, S29 and S30 also contain 
the aphA6 gene located in TnaphA6 (Chapter 3; Section 3.3.4). These five isolates (four 
containing a type 1 plasmid and one containing a type 2 plasmid) were screened using 
published primers (RH1501 and aphA6R, and aphA6F and RH1502, which should amplify a 
1,930 bp region and a 2,540 bp region (97), respectively), to determine if TnaphA6 is located 
in the same place in the backbone of the repAci6 plasmids (Fig 8.4). The four isolates 
containing a type 1 plasmid produced amplicons of the predicted sizes for both junctions of 
this transposon (Fig 8.4B) and hence harboured TnaphA6 in the same position as pAb-G7-2 
(Table 8.1). TnaphA6 in the S21 may be located in a different position of the backbone of its 
type 2 RepAci6 plasmid or elsewhere in the genome of this isolate.  
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Figure 8.4 Screening pAb-G7-2 location of TnaphA6. A. Location of TnaphA6 in pAb-G7-2. Arrows indicate 
extent and orientation of genes and open reading frames. Genes involved in conjugal transfer are red, the res gene 
is orange and the aphA6 gene is in purple. ISAba125 is represented by a green box and the internal arrow indicates 
the transposase orientation. Primers used to detect TnaphA6 are shown above by the bars along with the PCR 
amplicon size. B. Amplicons produced using RH1501 and aphA6R and aphA6F and RH1502 if TnaphA6 is in 
the same location as in G7. The sizes of the molecular marker are shown to the left and right in kb and isolate 
numbers are shown above their lanes.  
 
8.3 Type 1 plasmids 
Based on screening over repeat 3, the isolates S24, S26, S29 and S30 contained a type 1 
RepAci6 plasmid carrying TnaphA6. The number of contigs matching repAci6 plasmids in 
each isolate depended on what technology was used to sequence the isolates, either HiSeq or 
MiSeq sequencing platforms, and if additional insertions were present. If the draft genome of 
the isolate was sequenced by HiSeq, the RepAci6 plasmid was in at least three fragments (F1, 
F2 and F3 in Fig 8.5). Due to the longer read length of Illumina MiSeq, there were generally 
fewer contigs as the assembly did not always break at the repeat sequences or over some 
insertions.  
 
21 2124 2426 2629 2930 30G7 G7M M
3
2
1.5
3
2
1.5
RH1501-aphA6R
1,930 bp
aphA6F-RH1502
2,540 bp
trwCtrwB res A LaphA6
1 kb
RH1501-aphA6R
1,930 bp
aphA6F-RH1502
2,540 bp
A. 
B. 
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Figure 8.5 Three fragments of the RepAci6 backbone produced by assembly of Illumina HiSeq reads. 
Arrows indicate the extent and orientation of genes and open reading frames. The repAci6 gene is blue, genes 
involved in conjugal transfer are red and the res and umuC genes are orange. Green boxes indicate the three repeat 
sequences. The lines above of different colours indicate fragment 1 (purple), fragment 2 (blue) and fragment 3 
(pink).  
 
8.3.1 Assembly 
The type 1 backbone was used as a query against the draft genomes of S24, S26, S29 and S30.  
The contigs were tiled to the type 1 backbone and the features at the edges of each contig were 
examined (Table 8.2). The draft assembly of the RepAci6 plasmids in S24 and S29, which 
were produced by Illumina HiSeq, were each in five contigs. Due to the longer read length of 
Illumina MiSeq the draft RepAci6 plasmid of S26 was in fewer contigs and in S30, it was only 
in one. The plasmid in S30 had a number of differences to the type 1 backbone and this plasmid 
is described in more detail in Section 8.6.  
 
Table 8.2 Contigs matching RepAci6 plasmid backbone in S24, S26, S29 and S30 
Isolate Contig 
number 
Contig 
length 
(bp) 
Description Contig edges3 
 
Left Right 
S241 14 9,864 F2 R1 IRl of Tn6022 
 15 38,664 F1, tra region, repAci6 ISAba125 R1 
 36 4,476 F3 R2 R3 
 43 12,056 F1, trw genes R3 ISAba125 
 65 1,752 F2  IRr of Tn6022 R2 
 55 978 aphA6 ISAba125 ISAba125 
S291 12 4,464 F3 R2 R3  
 23 11,441 F2 R1 R2  
 25 11,970 F1, trw genes R3 ISAba125  
 29 45,852 F1 (extra 10 kb), tra region, repAci6 IRr of Tn6022 R1  
 39 2,235 F1, res ISAba125  IRl of Tn6022  
 63 972 aphA6 ISAba125 ISAba125  
S262 20 62,163 F1 (tra region, repAci6), F2, F3 IRr of Tn6022 repeat 3 
 38 17,312 F1 (trw genes, TnaphA6) Repeat 3  IRl of Tn6022 
 87 424 R2 and R3 sequence   
S302 18 73,043 F1 (TnaphA6), F2 and F3 ISAba1 (IRl) ISAba1 (IRr) 
1Sequenced by Illumina HiSeq. 
2Sequenced by Illumina MiSeq. 
3R1, R2 and R3 stand for repeat 1, 2 and 3, respectively. 
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The five RepAci6 contigs of S24 (Fig 8.6A) were almost completely assembled by sequencing 
the amplicons of the screening PCRs over the three repeats and TnaphA6.  However, there was 
an additional break just upstream of the second repeat (Fig 8.6A). Contig 14 and 65 had the IR 
sequence of Tn6022 at one end, and adjacent to this sequence was a 4 bp target site duplication 
(5`-GTCG-3`), indicating that AbaR4 was present in this location.  
 
 
Figure 8.6 Assembly of pS24-1. A. pS24-1 contigs tiled against the type 1 backbone. Arrows indicate the extent 
and orientation of genes and open reading frames. The repAci6 gene is blue, genes involved in conjugal transfer 
are red and the res and umuC genes are orange. Green boxes indicate the three repeat sequences. Grey lines above 
indicate the extent of different pS24-1 contigs. The black bars underneath show the primers used for assembly 
along with PCR amplicon size. Vertical arrows indicate the insertion location of AbaR4 and TnaphA6 B. 
Assembly of AbaR4 in pS24-1. The oxa23 gene is magenta and the IR sequences of Tn6022 are shown in olive 
green. The blue box indicates ISAba1 and the internal arrows indicate the transposase orientation. The primers 
used to span AbaR4 are shown above by the black bars, along with PCR amplicon size. The lines below indicate 
the transposons.  
 
To map this AbaR4 location a new primer, RH2024, was designed at the end of contig 14 and 
combined with RH584 to produce an amplicon 5,034 bp in size (Fig 8.6B). Oxa23R and 
another new primer RH2025 designed at the end of contig 65 should produce a 4,683 bp 
amplicon if AbaR4 is present (Fig 8.6B). In both cases, products were of the expected size and 
were sequenced. The internal AbaR4 PCR, RH910 and RH743, which should produce an 
amplicon 9,363 bp in size was performed and an amplicon of the expected size was generated. 
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Therefore, the RepAci6 plasmid in S24, named pS24-1, is 86,916 bp in size and contains 
TnaphA6 as well as AbaR4 (Fig 8.7, top line).  
 
 
 
Figure 8.7 Linear comparison of pS24-1, pS26-1 and pS29-1. Arrows indicate the extent and orientation of 
genes and open reading frames. The repAci6 gene is blue, genes involved in conjugal transfer are red, res and 
umuC genes are orange and the oxa23 gene is magenta. Green boxes indicate the three repeat sequences. Vertical 
arrows indicate the insertion of a transposon and the identity of the transposon is shown above. ISAba125 and 
ISAba1 are represented by the green and light blue box respectively, and the internal arrows indicate the 
transposase orientation.  
 
The RepAci6 plasmids in S26 and S29, called pS26-1 and pS29-1, were assembled using a 
similar process and details of each assembly can be found in Appendix III; A2.2.1. The 
plasmids pS26-1 (96,203 bp) and pS29-1 (96,201 bp) also contained AbaR4 in the same 
position and surrounded by a 5 bp target site duplication (5`-AATTG-3`) but this was a 
different location to that in pS24-1 (Fig 8.7). AbaR4, in both positions in the type 1 plasmids, 
had interrupted an open reading frame, however the products of both have no known functions 
(Table 8.3). An additional 9.3 kb of sequence was located just upstream of repeat 1 in pS26-1 
and pS29-1 (Fig 8.7), accounting for the lack of amplification of this repeat in these isolates 
(Table 8.1).  
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Table 8.3 AbaR4 location in the type 1 plasmids 
Plasmid Duplication 
(5`-3`) 
Location of AbaR4 Description of 
interrupted 
protein 
Novel 
position?  
pS24-1 GTCG  Interrupts a gene encoding a 209 
aa protein. 
No conserved 
domains – ORF  
Y 
pS26-1/ 
pS29-1 
AATTG  Interrupts a gene encoding a 144 
aa protein. 
No conserved 
domains - ORF 
Y 
 
8.3.2 9.3 kb transposon in pS26-1 and pS29-1 
The boundaries of the additional sequence prior to repeat 1 in pS26-1 and pS29-1 was defined 
by comparison to the type 1 backbone. The insert was found to be 9,279 bp in size and 
surrounded by a 7 bp duplication (5`-ATTCTAG-3`). An examination of the end of the insert 
revealed a 75 bp inverted repeat with 64 bp identical (bases highlighted in green in Fig 8.8A). 
Six open reading frames were identified in this 9.3 kb region (Fig 8.8B) and pBLAST was used 
to predict their putative function where possible (Table 8.4).  
 
 
Figure 8.8 Features of the 9.3 kb novel transposon. A. Identification of the 75 bp inverted repeat with 64 bp 
identical. The bases highlighted in green are the IR. B. Schematic of the 9.3 kb transposon. Arrows indicate the 
extent and orientation of genes and open reading frames, those in blue are likely involved in transposition. Vertical 
lines indicate the IR sequences.  
 
 
 
 
 
 
 
TGCAAAATACTGGATAAAACAACCACCCATTCCTGCTCCTACCATACCAGTCATTCTTGTTCGTGCTATACCACTATAATTAAAATAAAAGGGAGA 
|||| | ||||| |||||   |||||||||||||  |||||| ||||||| ||||| ||||||||||||||||||  | ||||| | | |  |   
TGCATATTCCTGCATAAACATACCACCCATTCCTATTCCTACTATACCAGCCATTCCTGTTCGTGCTATACCACTTGAGTTAAACTGATAAAGGCT 
 
64/75 bp !
IRl
IRr
1 kb
1 2 3 4 5 6
A. 
B. 
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Table 8.4 Open reading frames and predicted products encoded by the 9.3 kb 
transposon 
orf AA Superfamily Multi-domains Description 
1 246 IstB_IS21_ATP  DnaA  
2 522 COG4584 COG4584 transposase 
3 315 Arc 
superfamily 
  
4 382 Cupin_like    
5 422 Type_I_hlyD  EmrA Efflux/secretion proteins 
6 709 SunT  NHLM_micro_ABC1 Bacteriocin/antibiotic exporter 
 
Orf 1 hit the IstB protein of IS21, which is the second protein encoded by IS21 family IS, while 
Orf 2 matched a transposase. IS21 family IS encode two proteins necessary for transposition, 
IstA, the transposase and IstB, a helper protein, and both are necessary for efficient and 
accurate transposition (18). The two reading frames encoding IstB and IstA are just overlapped, 
as are orf 1 and 2 in the 9.3 kb insert. The first two proteins from the insert were queried against 
the ISFinder database to examine if they showed any homology to those of the IS21 family. 
Orf 2 matched with 34% aa identity to IstA of ISPpu23 (Fig 8.9A) while Orf 1 matched with 
37% aa identity to IstB of ISPpu23 (Fig 8.9B). ISPpu23 is a member of the IS21 family and 
these matches extend over most of the IstA and IstB proteins (Fig 8.9A and B). IS21 family 
members produce target site duplications ranging from 2-9 bp in size.  
 
As Orf 1 and 2 show similarity to the transposase and helper protein of IS21 family IS, it is 
likely that they are responsible for the transposition functions of this 9.3 kb insert. However, 
as they are moving a much larger region including additional genes, this 9.3 kb insert is a novel 
transposon. The proteins encoded by orf 3 and 4 do not have any strong matches. The products 
of orf 5 and 6 contain domains matching efflux/secretion proteins and bacteriocin/antibiotic 
exporter, respectively, and could potentially be involved in the virulence of these isolates 
(Table 8.4).  
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Figure 8.9 Homology of Orf1 and 2 to the transposases of the IS21 family. A. Similarity of Orf 1 to IstB of 
ISPpu23 and B. Similarity of Orf 2 to IstA of ISPpu23.   
 
A search of the nucleotide database of GenBank revealed that four other A. baumannii isolates 
from South Korea and China contain a copy of this 9.3 kb Tn (Table 8.5). This transposon was 
found in the same location in pUSA15-1, another RepAci6 plasmid that was isolated in Seoul 
in South Korea in 2013. The RepAci6 plasmids present in KAB04 and KAB08 also contain a 
http://www.ebi.ac.uk/Tools/services/rest/clustalo/result/clustalo-I20170704-064622-0245-21186620-pg/aln-clustal 1/1
orf_1 MLKQSVKDKLERLKLKGFLRTAEASLDQMLAQGKSFEDFLDFCLDAELNDRTNRRIERLF 
ISPpu23_IstB      MLPHPTLDKLQTLRLTGMLKALAEQLKTPDIDSLSFVERLGLLVDRELTERDDKRLSSRL 
** : . ***: *:*.*:*::   .*.    :. ** : *.: :* **.:* ::*:.  : 
orf_1 SIAKFRYPTARLEHIDYAPERKIKKADISRYANCEWISDCRGLIISGATGVGKSWLACAL 
ISPpu23_IstB      RQARLK-HNACLEDIDYRSPRGLDKALILQLSSGQWLRDGLNLIINGPTGVGKTWLACAL 
*:::  .* **.***   * :.** * : :. :*: *  .***.* *****:****** 
orf_1 GAEACHLSYSAMYFNAISLFDEISSAITLGEIKDFKKKVCSTKLLIIDDFGLGGFNQSLA 
ISPpu23_IstB      AHQACREGYSVRYLRLPRLLEELGLAHGDGRFAKLMSGYAKTDLLILDDWGLAPFNAEQR 
. :**: .**. *:.   *::*:. *   *.: .: .  ..*.***:**:**. ** .   
orf_1 PSFLEIIDKQSQSGGLLITSQVPKRLWFEQFQDPTLADAVMDRILHRSYELEISGRSYRE 
ISPpu23_IstB      RDMLELLDDRYGQRSTIVTSQMPVDNWHELIGDPTLADAILDRLVHNAYRINLKGESMRK 
.:**::*.:  . . ::***:*   *.* : *******::**::*.:*.:::.*.* *: 
orf_1 KIYAQ------- 
ISPpu23_IstB      QTKKLTTPGTSD 
                  :           
orf_2 
ISPpu23_IstA      
MRIETDKIRQIVRL-LNLGHSQRSTAIQARANRSSVKTIFDKLT----LFPIDNSELNLF 
----MRKIREVLRLKFEVGLSARQIAVSVQIGRVTVGDYLNRFAASGLAWPCSLSDS--- 
***:::** :::* * *. *:..: .* :*   :::::     :* . *:    
orf_2 
ISPpu23_IstA      
TNLELLDYFEISRTPTY-PTRKIYPDFEYINQELKKRDMTLELLWQEYIAQYKEGLSYSR 
---ELEQ-QLFPPPPAVPSEQRPLPDWSWVHAELRRPGVTLALLWQEYRLSQPKGFQYSW 
** :   :   *:    ::  **:.::: **:: .:** ******  .  :*:.** 
orf_2 
ISPpu23_IstA      
FCHVFNHFRNKKHASMRQTFKSGEVLLVDFCGRTMEITSPVDGSKSYAQVFVGVLGASAY 
FCEHYRAWQGKLDVVMRQEHRVGEKLFVDYAGQTVPVIDRHSGEIRQAQVFVAVLGASSY 
**. :. ::.* .. *** .: ** *:**:.*:*: : .  .*.   *****.*****:* 
orf_2 
ISPpu23_IstA      
TFAYAVPSQRVEHWLECFIKTFDHIGGVPATVITDNLKSAVLKNNKTGLIFQKDFEDFAA 
TFAEATWSQQLPDWLGSHVRCFAFLGGVPEIVVPDNLRSAVSKSHRYEPDINPSYRDLAE 
*** *. **:: .** ..:: * .:****  *: ***:*** *.::    :: .:.*:*  
orf_2 
ISPpu23_IstA      
YYDFAIIPTRPRHPKDKGLAEVSVQIVQRAVLASLRNQKFFSIEELNQAIQEKMDVINRK 
HYGVAVVPARARKPRDKAKAEVGVQVVERWILAALRNRQFFSLDELNSAIALLLERLNRR 
:*..*::*:* *:*:**. ***.**:*:* :**:***::***::***.**   :: :**: 
orf_2 
ISPpu23_IstA      
TTRRFTISRYEQFLVLDSKDISPLPLYPYELCSWKRHVRVSEFYRVEYEGNQYSVPYTYI 
PFRKLPGSRHSAFEALDRPALSPLPEQPYVYAEWKKA-RVHIDYHVEVDGHYYSVPYQLV 
*::  **:. * .**   :****  **  ..**:  **   *:** :*: *****  : 
orf_2 
ISPpu23_IstA     
HLHVDLKVTQSAIHIFYEREKIAEHAISHGICLDICLDEHMSPAHRAQKGLSKDEIIHWA 
KKQLEVRLTARTVECFHANQRVASHLRSPHKGRHSTQTEHMPKSHREHAEWTPQRLIRWA 
: ::::::*  ::. *: .:::*.*  *     .    ***  :** :   : :.:*:** 
orf_2 
ISPpu23_IstA      
NRAGPNTSHYVCHILNQKRDLARNIKSLNKLRKWVVDNQKSHCLEEACDFASQRQIYALD 
EQTGPHTAGVISHILERRIHPTQGYRACLGILRLG-KTHGEVRLELACRRALSLGACSYK 
:::**:*:  :.***::: . ::. ::   : :   ..: .  ** **  * .    : . 
orf_2 
ISPpu23_IstA      
RLQRIIANSAYQIQQQPL-SDALSHIPTSHHNIRGADYYLQNSGVAHA 
SLESILRQG---LENLPLAQQHLPLLPDDHANLRGPGYYH-------- 
*: *: :.   ::: ** .: *  :* .* *:** .**
A.
B.
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version of this transposon. However, in these two plasmids it is located 102 bp downstream of 
repeat 3, surrounded by an 8 bp TSD (Table 8.5). In addition, orf 4 of the 9.3 kb transposon in 
these plasmids is interrupted by ISAba10. KAB04 and KAB08 were isolated from Busan and 
Gyenoggi respectively, in South Korea in 2015. A copy of the 9.3 kb transposon was found in 
a third location in the genome of XH857 (GenBank accession number CP014540) which was 
isolated in Guangdong in China in 2010. In this isolate the transposon was surrounded by a 7 
bp direct repeat of 5` AAACTAG 3` (Table 8.5).  
 
Table 8.5 Sequences containing the 9.3 kb transposon 
Sequence  Tn 
size 
(kb) 
Location of Tn TSD 
(5`-3`) 
Geographical 
origin 
GenBank 
accession 
number 
pS26-1, 
pS29-1 
9.3 43 bp prior to R1 ATTCTAG Singapore  
pUSA15-1 9.3 43 bp prior to R1 ATTCTAG Seoul,  
South Korea 
CP020594 
pKAB04 10.31  RepAci6 plasmid, 
102 bp after R3 
GGATAGGC Busan,  
South Korea 
CP017649 
pKAB08 10.31 RepAci6 plasmid, 
102 bp after R3 
GGATAGGC Gyenoggi, 
South Korea 
CP017657 
XH857 9.3 Chromosome AAACTAG Guangdong, 
China 
CP014540 
1An ISAba10 interrupts orf 4.  
 
8.3.3 Plasmid comparison and conjugation  
The backbone of pAb-G7-2 is 67,025 bp and when the inserts of pS24-1, pS26-1 and pS29-1 
were removed the backbones of these three plasmids were the same size. These backbones 
were then compared to that of pAb-G7-2, but only minor differences were detected (Table 8.6).  
All three plasmids had a SNP in traH causing an amino acid substitution in the translated 
protein, while pS24-1 and pS29-1 had additional SNPs.  
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Table 8.6 Type 1 plasmid backbone comparisons 
Plasmid Backbone 
size (bp) 
Identity to 
backbone of 
pAb-G7-2 
Location of SNPs relative to 
pAb-G7-2 
(base change; aa change) 
pS24-1 67,025 67,022/67,025 - trwC (T to A; NàK) 
- traB (T to C; SàL) 
- traH (A to T; NàY) 
pS26-1 67,025 67,024/67,025 - traH (A to T; NàY) 
pS29-1 67,025 67,017/67,025 - 5 SNPs and 2 gaps in a 909 bp 
region over repeat 2 
- traH (A to T; NàY) 
 
As pS24-1, pS26-1 and pS29-1 confer resistance to ticarcillin (oxa23 in AbaR4) and kanamycin 
(aphA6 in TnaphA6) their conjugation proficiency was able to be examined. Each isolate was 
mated with ATCC 19606Rif (rifampicin resistant) and transconjugants were selected for using 
plates supplemented with ticarcillin and rifampicin.  
 
Ticarcillin and rifampicin resistant transconjugants were recovered from the S24 mating (Table 
8.7). These colonies were additionally found resistant to kanamycin, indicating that the aphA6 
gene is also present. PCR screening confirmed the presence of the oxa23 (oxa23R-oxa23F) and 
the aphA6 (aphA6F-aphA6R) genes. Hence, pS24-1 is transfer proficient indicating that the 
SNP in traH is not detrimental for conjugation (Table 8.6). A conjugation frequency of pS24-
1 of 2.09x10-5 transconjugants/donor was determined by selecting the ticarcillin and nalidixic 
acid transconjugants of three independent matings of ATCC 19606Rif (pS24-1) with 
AB307_0294Nx (nalidixic acid resistant) (Table 8.7).  
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Table 8.7 Type 1 plasmid conjugations 
Plasmid Resistance Mating of each strain with 
ATCC 19606Rif 
Mating of ATCC 19606Rif (RepAci6 
plasmid) with AB307_0294 
  Transconjugants 
(TICRif) 
Conjugation 
frequency1 
Conjugation 
frequency1 
Mean 
Conjugation 
frequency2 
pS24-1 TIC, Km + 
 
4.55x10-6 1.18x10-5 
3.86x10-5 
6.00x10-6 
2.09x10-5 
pS26-1 TIC, Km - 
 
<1.84x10-10   
pS29-1 TIC, Km -  
 
<1.25x10-10   
TIC, ticarcillin; Km, kanamycin.  
1Conjugation frequency expressed as transconjugants per donor. Each frequency is from an independent 
determination.  
2Mean frequency expressed as transconjugants per donor calculated from three independent determinations.  
 
However, when either S26 or S29 was used as a donor and mated with ATCC 19606Rif, 
following the removal of rifampicin-resistant mutants of the donor, no transconjugants were 
recovered. Hence, both pS26-1 and pS29-1 were unable to transfer at a detectable frequency 
(Table 8.7). The only SNP causing an amino acid substitution in pS26-1 and pS29-1 is in traH 
(Table 8.6) but the presence of this SNP does not abolish conjugation in pS24-1. An obvious 
difference between S24-1 and pS26-1/pS29-1 is the location of AbaR4. The reading frame 
AbaR4 interrupts in S26-1/pS29-1 plasmids is located downstream of the res gene and within 
the transfer region (Table 8.3). Although, it encodes a protein of unknown function this protein 
may be required for the self-transmission of the plasmid.  
 
8.4 Type 2 plasmids 
8.4.1 Assembly 
The contigs matching RepAci6 plasmid in S21, S22, S23, S25, S27, S28, S32, S34, S36 and 
S40 were retrieved, tiled to the type 2 backbone. Edges of the contigs were analysed and 
assembled using a similar process to pS24-1. The specifics of the assembly of each plasmid 
can be found in Appendix II, A2.2. Linearized versions of 9 type 2 plasmids (pS22-2, pS23-2, 
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pS25-2, pS27-2, pS28-2, pS32-2, pS24-2, pS36-2 and pS40-2) are shown in Fig 8.10. The 
plasmid pS21-2 was quite different to the other type 2 plasmids and is described in Section 8.5.  
 
 
Figure 8.10 Linear comparison of Type 2 plasmids. Arrows indicate the extent and orientation of genes and 
open reading frames. The repAci6 gene is blue, genes involved in conjugal transfer are red, res and umuC genes 
are orange and the oxa23 gene is magenta. Green boxes indicate the three repeat sequences. Vertical arrows 
indicate the insertion of a transposon or IS and its identity is shown above. ISAba19 and ISAba1 are represented 
by the purple and light blue box respectively, and the internal arrows indicate the transposase orientation. The 
asterisk indicates the orf with a SNP in S28-2 and the cross signifies the orf with the early stop codon in pS34-2. 
 
Among the type 2 RepAci6 plasmids present in the Singapore isolates, four groups were 
distinguished based on the location of their insertions (Fig 8.10, Table 8.8). The plasmids pS32-
2 and pS26-2 did not harbour any resistance genes but carried ISAba19. The same AbaR4 
location as in pA85-3 was found in 6 plasmids (referred to as AbaR4(1) in Table 8.8) but three 
of them additionally contained a copy of ISAba1 (Fig 8.10). The plasmid pS34-2 also 
harboured AbaR4, but it was in a different and novel location (Fig 8.10, Table 8.8).  
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Table 8.8 Type 2 RepAci6 plasmids 
Plasmid Plasmid size (bp) Inserts1 
AbaR4  Other 
pS32-2 70,833  ISAba19 
pS36-2 70,833  ISAba19 
pS22-2 86,340 AbaR4 (1)  
pS23-2 86,340 AbaR4 (1)  
pS40-2 86,340 AbaR4 (1)  
pS25-2 87,529 AbaR4 (1)  ISAba1 
pS27-2 87,530 AbaR4 (1)  ISAba1 
pS28-2 87,529 AbaR4 (1)  ISAba1 
pS34-2 86,336 AbaR4 (2)  
1The number inside the bracket indicates the position of AbaR4 insertion.  
 
The two locations of AbaR4 in type 2 plasmids both interrupt genes encoding proteins of 
unknown function (Table 8.9).  
 
Table 8.9 Type 2 AbaR4 locations 
Plasmid Duplication 
(5`-3`) 
Location of AbaR4 Description of 
interrupted protein 
Novel position? 
 
pS27-2, pS22-2, 
pS23-2, pS25-2, 
pS28-2, pS40-2 
CCATT  Interrupts a gene 
encoding 108 aa protein  
No conserved domain - 
ORF 
N (Same as 
pA85-3) 
 
pS34-2 TCCAC  Interrupts a gene 
encoding a 372 aa 
protein. 
No conserved domains 
- ORF 
Y 
 
 
8.4.2 Backbone comparisons and conjugation 
The backbone of pA85-3, once AbaR4 and the 5 bp direct repeat is removed, is 69,524 bp in 
size. By removing the inserts present in each of the nine type 2 plasmids, along with a copy of 
the direct repeat, the backbone of each plasmid was revealed (Table 8.10). These backbones 
were then queried against the pA85-3 backbone to detect any differences (Table 8.10).  All of 
the plasmids were above 99.9% nucleotide identity to pA85-3.  
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Table 8.10 Type 2 backbone identity 
Plasmid Backbone 
size (bp) 
Identity to backbone 
of pA85-3  
Location of SNPs or gaps 
(base change, aa change) 
pS22-2/ 
pS23-2/ 
pS25-2/ 
pS40-2 
69,523 69,523/69,524 
(1 gap) 
- Missing T in repeat 2 
 
pS27-2 69,524 69,523/69,525 
 (2 gaps) 
- Missing T in repeat 2 
- Extra A in an intergenic region 
pS28-2 69,523 69,522/69,524 
(1 gap) 
- orf (A to T, MàL) 
- Missing T in repeat 2 
pS32-2/ 
pS36-21 
69,521 69,510/69,525   
(10 gaps) 
 -Spread over backbone (intergenic regions, repeats or 
cause single aa substitutions in ORFs) 
pS34-2 69,519 69484/69532  
(21 gaps) 
-truncates an ORF (392aa instead of 426aa) 
-Spread over backbone (intergenic regions, repeats or 
cause single aa substitutions in ORFs) 
1Are one SNP different from one another. 
 
The nine plasmids in Table 8.10 are missing a base in repeat 2 compared to pA85-3. This 
missing base is the only difference between the backbone of pA85-3 and that of pS22-2, pS23-
2, pS25-2 and pS40-2. The plasmid pS27-2 has gained an extra A in an intergenic region, while 
a SNP in an orf which causes a single aa substitution in a hypothetical located in the region 
between repeat 1 and repeat 2 (marked by an asterisk in Fig 8.10) is present in pS28-2 (Table 
8.10).  
 
The backbone of pS32-2 and pS36-2 are 69,521 bp in size and only have one difference 
between them. This SNP is located in an orf and is a silent mutation. Compared to the backbone 
of pA85-3 there are a greater number of differences in pS32-2 and pS36-2. The nucleotide 
identity to pA85-3 of pS32-2 and pS36-2 is 69,510/69,525 bp and 69,511/69,525 bp 
respectively, and both contain 5 single nucleotide gaps (Table 8.10). These 14 or 15 SNPs are 
spread over the backbone of these two plasmids and are located either in intergenic regions, 
repeats or cause single aa substitutions in orfs of unknown function.  
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The backbone of pS34-2 is 69,519 bp in size and its identity to pA85-3 is 69,484/69,524 bp, 
with 21 gaps (Table 8.10). A large portion of these SNPs, 36, were concentrated in a 50 bp 
region resulting in the truncation of an orf from 426 aa in pA85-3 to 392 aa in pS34-2 (indicated 
by the cross in Fig 8.10). Again, the protein it encodes has no known function. The other SNPs 
are spread throughout the backbone and, like those in pS32-2 and pS36-2, are located in either 
intergenic regions, repeats or cause single aa substitutions in orfs of unknown function.  
 
The ability of these plasmids to conjugate was determined for the seven of these plasmids that 
contained a selectable marker, the oxa23 gene in AbaR4, conferring resistance to ticarcillin. 
Each isolate was mated with ATCC 19606Rif (rifampicin resistant) and transconjugants were 
selected on media supplemented with rifampicin and ticarcillin. Plasmids pS22-2, pS23-2, 
pS40-2, pS27-2, pS25-2 and pS40-2 transferred to the recipient (Table 8.11).  
 
As a number of these plasmids are closely related to one another and have the same insertions 
in the same positions in the plasmid backbone, a representative of each group (bold in Table 
8.11) was selected and conjugation frequencies utilising the same backgrounds were 
determined. ATCC 19606Rif containing pS22-2, pS27-2 or pS34-2 was mated with 
AB307_0294Nx (nalidixic acid resistant) and transconjugants were selected using L-agar 
supplemented with nalidixic acid and ticarcillin. The representative of type 2 plasmids 
conjugated at a higher frequency than the type 1 plasmids pS24-1 (Table 8.7 and Table 8.11). 
The plasmid pS40-2 transferred at the highest frequency of 2.02x10-3 transconjugants/donor 
while pS22-2 and pS27-2 transferred at a frequency of 8.05x10-4 and 2.02x10-4 
transconjugants/donor, respectively (Table 8.11).  
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Table 8.11 Conjugation of type 2 plasmids 
Plasmid Inserts Resistance Mating of each strain with  
ATCC 19606Rif 
 
Mating of ATCC 19606Rif 
(RepAci6 plasmid) with 
AB307_0294  
Transconjugants 
(TICRif) 
Conjugation 
frequency2 
Conjugation 
frequency2 
Mean 
Conjugation 
frequency3 
pS32-2 ISAba19 - +1 ND   
pS36-2 ISAba19 - ND    
pS22-2 AbaR4(1) TIC + 1.49x10-4 2.22x10-4 
8.04x10-4 
1.39x10-3 
8.05x10-4 
pS23-2 AbaR4(1) TIC + 
 
3.20x10-5 ND  
pS40-2 AbaR4(1) TIC + 6.13x10-5 ND  
pS27-2 AbaR4(1) 
ISAba1 
TIC + 2.43x10-7 1.31x10-4 
7.26x10-4 
3.33x10-4 
3.96x10-4 
pS25-2 AbaR4(1) 
ISAba1 
TIC + 1.04x10-5 ND  
pS28-2 AbaR4(1) 
ISAba1 
TIC - 
 
<1.80x10-10   
pS34-2 AbaR4(2) TIC + 2.95x10-5 4.38x10-3 
1.28x10-3 
3.87x10-4 
2.02x10-3 
TIC; ticarcillin. 
1pS32-2 was able to mobilise a small antibiotic resistant plasmid. Details in Chapter 9; Section 9.5.3.  
2Conjugation frequency expressed as transconjugants per donor. Each frequency is from a single determination.  
3Mean frequency expressed as transconjugants per donor calculated from three independent determinations.  
 
However, the plasmid pS28-2 did not transfer above the limit of detection (Table 8.11). The 
inability of pS28-2 to transfer is not accounted for by the location of its inserts, as they are in 
the same position as pS27-2 and pS25-2 and both of these plasmids can conjugate. In addition, 
pS28-2 is only one SNP away from pS25-2 (Table 8.10) and this difference causes an amino 
acid substitution in a protein of unknown function (marked by an asterisk in Fig 8.10). 
However, whether this orf performs a vital role in conjugation needs closer examination. It is 
possible that additional effects such as fertility inhibition are playing a role.  
 
Despite the absence of any antibiotic resistance genes, pS32-2 was determined to be self-
transmissible through mobilisation of another co-residing plasmid, pS32-1, which contains the 
oxa23 carbapenem resistance gene as a selectable marker. This is described in more detail in 
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Chapter 9; Section 9.5.3.  As pS32-2 and pS36-2 are only one SNP different (Table 8.10), it is 
likely that pS36-2 is also conjugative.  
 
8.5 The plasmid pS21-2 
Despite producing the amplicon size expected for type 2 plasmids over repeat 3 (Section 8.2), 
the RepAci6 backbone contigs of S21 (Table 8.12) were a better match to the type 1 backbone, 
although regions of difference were still present (Fig 8.11A).  
 
Table 8.12 S21 contigs matching RepAci6 plasmid  
Contig 
numbe
r 
Contig 
length 
(bp) 
Kmer 
coverage  
Description Contig edges (L, R)1,2 
10 63,879 31.8 F1 (extra 35.6 kb), tra region ISAba12-like, IRl of Tn6022 
20 11,091 31.9 F3 R3, ISAba12-like 
38 12,233 31.8 F1, repAci6 IRr of Tn6022 
41 365 59.6 Repeat sequence  
50 11,828 31.8 F2 R1, R3 
55 4,672 30.9 F1, trw genes R2, R3 
120 2,272 29.8 Novel R sequence at both ends 
1Contig edges from Left to Right.  
2R1, R2 and R3 stand for repeat 1, 2 and 3 respectively  
 
Sequencing the >3 kb product of the reaction between RH1398-RH1399 over Repeat 1 in S21 
(Section 8.2), revealed that an additional contig (120), with repeat sequence on its edges, was 
present between contig 38 and contig 50. The RepAci6 plasmid in S21 contains 2.2 kb of 
sequence adjacent to repeat 1, followed by another partial repeat sequence which has been 
called repeat 4.   
 
In addition to the breaks in the assembly at repeat 2 and 3 which had been screened previously, 
there were two additional breaks in pS21-2. Assembly of contig 20 and 10, using RH1391 and 
RH2021, revealed an ISAba12-like element, surrounded by a 9 bp target site duplication (5` 
Chapter 8 196	
GTTCATAGA 3`) (Fig 8.11A) (Table 8.13). The sequence of this IS is 97.3% (1011/1039) 
identical to the sequence of ISAba12.  
 
Figure 8.11 Assembly of pS21-2 contigs. A. pS21-2 contigs tiled to pAb-G7-2. Arrows indicate the extent and 
orientation of genes and open reading frames. The repAci6 gene is blue, genes involved in conjugal transfer are 
red and the res and umuC genes are orange. Green boxes indicate the three repeat sequences. Grey lines above 
indicate the extent of different pS21-2 contigs. The black bars underneath show the primers used for assembly 
along with PCR amplicon size. Vertical arrows indicate the insertion location of AbaR4 and ISAba12-like 
element. B. Assembly of AbaR4 in pS21-2. The oxa23 gene is magenta and the IR sequences of Tn6022 are 
shown in olive green. The blue box indicates ISAba1 and the internal arrows show the transposase orientation. 
The primers used to span AbaR4 are shown above by the black bars, along with PCR amplicon size. The lines 
below indicate the transposons.  
 
The break between contig 10 and 38 revealed another location for AbaR4 (Table 8.13). The IR 
of Tn6022 was found on the left and right edges of contig 38 and 10, respectively, as was a 5 
bp TSD (5`-TCTAC-3`) (Table 8.13).  This region was then screened for the presence of AbaR4 
(Fig 8.11B) using a new primer on the end of contig 10, RH2022, with RH583 to generate a 
5,171 bp amplicon. The right end of AbaR4 was detected using oxa23R with a new primer on 
the end of contig 38 to amplify a 4,757 bp region (Fig 8.11B). In both cases, an amplicon of 
the expected size was produced and sequenced, confirming the presence of AbaR4 in this 
location in pS21-2. The internal AbaR4 PCR of RH910 and RH743, linking Tn2006 to tniA, 
was also performed and produced an amplicon at the approximate size of 10 kb and the 
AbaR4 TnaphA6
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predicted size was 9,363 bp. Again, AbaR4 in pS21-2 interrupts an orf, but the function of the 
product of this orf is unknown (Table 8.13).  
 
Table 8.13 pS21-2 insertions 
Insertion Location  Target site 
duplication (5`-3`) 
Description of 
interrupted 
protein 
Novel position? 
 
ISAba12-like Intergenic region 
(between 2 orfs 
located 3 or 4 
downstream of trwC) 
GTTCATAGA N/A Y 
35.6 kb Tn umuC GCTTA Error-prone DNA 
polV subunit 
Y 
AbaR4 Interrupts a gene 
encoding a 372 aa 
protein.1 
TCTAC No conserved 
domains- ORF 
Y 
1AbaR4 in pS34-2 also interrupts this gene but in a different position.  
  
An additional 35.6 kb of sequence (Fig 8.11A) was also identified in contig 10 and this 
transposon is described in detail in Section 8.5.3. The plasmid pS21-2 is 123,432 bp in size 
(Fig 8.12) and contains an insertion adjacent to repeat 1, followed by repeat 4, an ISAba12-
like IS, 35.6 kb of additional sequence and a new insertion location for AbaR4 (Table 8.13). 
  
 
Figure 8.12 Linear schematic of pS21-2. Arrows indicate the extent and orientation of genes and open reading 
frames. The repAci6 gene is blue, genes involved in conjugal transfer are red and the res and umuC genes are 
orange. Light green boxes indicate the three repeat sequences, while the dark green box represents ISAba12-like 
and the internal arrow indicates the transposase orientation. Vertical arrows show the location of insertions with 
the identity of the insertion is shown above.  
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8.5.1 pS21-2 conjugation 
The ability of ticarcillin resistance to be transferred by the conjugation of pS21-2 was tested 
by mating S21 with rifampicin resistant ATCC 19606Rif. From three independent experiments, 
no ticarcillin and rifampicin resistant transconjugants were recovered, averaging a conjugation 
frequency for pS21-2 of less than 6.55x10-9 transconjugants/donor. Although the backbone of 
pS21-2 is different to type 1 and 2 plasmids, and this is addressed in more detail in the following 
section, all of the genes involved in transfer appear to be intact, with no premature stop codons. 
Hence, it may be the location of the insertions, particularly that of the 35.6 kb of extra sequence, 
that has diminished the self-transmissibility of pS21-2 (Fig 8.12).  
 
8.5.2 pS21-2 is a new backbone type 
The backbone of pS21-1 is 69,951 and is significantly different to both type 1 and type 2 
plasmids (Fig 8.13). The region between repeat 3 and 1, encoding genes involved in transfer 
and the replication initiation protein in pS21-2 is within 1% difference to type 1 plasmids. The 
greatest region of variation appears to be between repeat 1 and 3 with approximately a 2-3.3% 
difference to type 1, and a 3-4% difference to type 2 (Fig 8.13), and the additional segment is 
within this region. Hence, pS21-2 represents a new backbone type, type 3.  
 
Repeat 1 and 4 are partial compared to repeat 2 and 3. Repeat 4 is even smaller than repeat 1, 
but they are both fragments of the right end of the complete repeat sequence (Fig 8.14A). The 
additional 2.2 kb sequence between repeat 1 and repeat 4 in pS21-2 has two reading frames 
(Fig 8.14B). The first produces a 363 aa hypothetic protein which hits the CysH superfamily 
(COG0175) and is most commonly annotated as a phosphohydrolase. The second open reading 
frame is commonly annotated as hypothetical protein and translates to a 263 aa protein.   
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Figure 8.13 pS21-2 represents a new and third RepAci6 backbone type. Arrows indicate the extent and orientation of genes and open reading frames. The repAci6 gene is 
blue, genes involved in conjugal transfer are red and the res and umuC genes are orange. Green boxes indicate the three repeat sequences. Pink vertical arrows show the location 
of insertions with the identity of the insertion shown above. Regions of homology are shown by grey boxes and the numbers display DNA identity. Figure is made to scale 
from GenBank accession number KF669606 (pAb-G7-2 for type 1) and KJ493819 (pA85-3 for type 2).
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Figure 8.14 A fourth repeat and novel sequence. A. Comparison of repeat lengths. Green boxes indicate repeat 
sequences. B. Additional 2.2 kb between repeat 1 and repeat 4. Arrows indicate open reading frames.  
 
This segment along with repeat 4 is also found in 11 plasmids from A. baumannii isolated in 
South Korea (Table 8.14).  
 
Table 8.14 Plasmids with repeat 4 and the 2.2kb of sequence  
Plasmid Location GenBank Accession 
Number 
Reference 
pUSA2_1 Seoul, South Korea CP020593  
p15A5_1 South Korea CP020573  
pYU-R612-1 Seoul, South Korea CP014216 (156) 
p15A34_1 South Korea CP020589  
pSSA12_1 Seoul, South Korea CP020577  
pKAB07 Jeonju, South Korea CP017655  
pKAB02 Daejeon, South Korea CP017645  
pABKp1 South Korea CP001922 (202) 
pKAB05 Daegu, South Korea CP017651  
pKAB01 Daegu, South Korea CP017643  
pKAB06 Daegu, South Korea CP017653  
 
8.5.3 Tn6177 
35.6 kb of additional sequence was present downstream of the tra genes in the backbone of 
pS21-1. Comparison to the type 1 backbone enabled the boundaries of this extra sequence to 
be defined as well as its precise location. The extra sequence interrupts the umuC gene and is 
2 and 3
 1
4
225
422/423 
179 
100 bp
R1 R4
250 bp
Repeat Size (bp)
A. 
B. 
2.2 kb
orf1 orf2
Chapter 8 201	
surrounded by a 5 bp target site duplication (5`-GCTTA-3`) (Table 8.13). The outer ends of 
the 35.6 kb (Fig 8.15) were then examined to determine if inverted repeats (IRs) were present. 
An imperfect 26 bp IR (blue in Fig 8.15), with 24 bp identical, was identified starting with 5` 
TGT 3`. This IR is about the same size and starts with the same bases as Tn6019, the backbone 
transposon of AbaR4. Partial duplications of the IR sequence were also detected in the 
sequence internal to the IRs (Fig 8.15).  
Figure 8.15 Identification of the inverted repeat of the 35.6 kb transposon. The bases highlighted in blue 
show the terminal IR sequences. The top line shows IRl while the bottom line is IRr sequence. Arrows indicate 
internal partial copies of the IR sequence and the bases in bold are identical to the sequence of the IR.  
 
Due to the presence of an IR, target site duplication and the size of the insert, it is likely a 
transposon and has been named Tn6177. Tn6177 harbours 26 open reading frames and 
pBLAST was used to attempt to determine their putative function (Figure 8.16, Table 8.15).  
 
Figure 8.16 Structure of the Tn6177 copper resistance transposon. Arrows indicate the extent and orientation 
of genes and open reading frames. Transposition genes are in blue while known genes involved in copper 
resistance are in brown. Vertical lines indicate the IR sequences.  
 
 
 
 
 
 
 
 
 
 
 
 
 
S21s IR 
 
TGTCATTTACAAAGAACTATGCGACAATTTAAGCGTGAGTCAATAACTTAGAACGCT 
||| ||||||||| |||||||||||| |  ||       |     | 
TGTGATTTACAAACAACTATGCGACATTACAAACAACTATGCGACAAGTTATTCCGT 
 
24/26 bp 
 
J9s IR 
TGTCATTTACAAAGAACTATGCGACAATTTAAGCTTGAGTCAATAACTTAGAACGCT 
||| ||||||||| |||||||||||  |  ||       |     |       |  
TGTGATTTACAAACAACTATGCGACGTTACAAACAACTATGCGACAAAGTACTCTGT 
 
Duplication for S21s 
TAGAAGGC TATGTCATTTACAAAGAACT 
   |  |||||  
ATCACAGCTTAGAAAAGCTAATTTG 
 
Duplication for J9s 
GGTTTAGGGTGTGAACCGCTGTCATTTACA 
         |   ||||||
GTTTGTAAATCACAACCGCCCCCAACC 
 
 
TGTCATTTACAAAGAACTATGCGACAATTTAAGCGTGAGTCAATAACTTAGAACGCTTTTTACAAAGAACTGTGCGACAAATCTTA 
||| ||||||||| |||||||||||| |  || |     |     |  |    |  |  |                   ||    | 
TGTGATTTACAAACAACTATGCGACATTACAAACAACTATGCGACAAGTTATTCCGTAATACTGTATCCAGAGCTTTAGAACTCAA 
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Table 8.15 Open reading frames and predicted products encoded by Tn6177 
orf AA Superfamily Description Product  
1 237 Tn7_Tnp_TnsA (pfam08722)  TniC  
2 629 Rve (pfam00665)  TniA  
3 283 TniB (pfam05621  TniB  
4 361 TniQ (pfam06527  TniD  
5 480 -  TniE  
6 328 CopD (pfam05425)  CopD  
7 126 CopC (pfam04234)  CopC  
8 785 ATPase-1B1_Cu (TIGR01511) copper-translocating P-type ATPase Orf  
9 475 cztS_silS_copS (TICR01386)  CopS  
10 227 cstR_silR_copR (TICGR01387)  CopR  
11 127 PcoB (COG3667)  uncharacterized protein involved in 
copper resistance 
Orf  
12 627 copper_res_A (TIGR01480)  CopA  
13 306 CopB (pfam05275)  CopB  
14 153 -  Orf  
15 434 TolC (COG1538) TolC family protein Orf  
16 499 HlyD_D23 (pfam16576) 
barrel-sandwich domain of CusB 
HylD membrane-fusion Orf 
 
17 1048 CusA (COG3696)  CusA  
18 120 CusF_Ec (pfam11604)  CusF  
19 609 FeoB (COG0370)  FeoB  
20 438 Cation_efflux (pfam01545) Co/Zn/Cd efflux Orf  
21 130 HTH_CadR-PbrR (TIGR02047) 
Cd(II)/Pb(II)-responsive 
transcriptional regulator  Orf 
 
22 601 -  Orf  
23 533 HNH_2 (pfam13391 HNH endonuclease Orf  
24 163 Prok-JAB (pfam14464)  Orf  
25 576 ThiF (pfam00899)  ThiF  
26 346 
NT_2-5OAS_ClassI-CCAase 
(cd05400) nucleotidlyltransferase Orf 
 
27 368 HTH_XRE (cd0093)  Orf  
 
The first 5 open reading frames show homology to the transposition proteins produced by the 
backbone transposon of AbaR4, Tn6019 (Table 8.16), and two of them show shorter regions 
of similarity to the transposition proteins of Tn7. Similar to their role in Tn6019, these proteins 
likely form the transposition module of this transposon and facilitate its movement.  
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Table 8.16 Relationship of the predicted transposition proteins of Tn6177, Tn6019 and 
Tn7 
35.6 kb Tni proteins 
 
Similarity to 
respective proteins 
in Tn6019 
Similarity to 
respective proteins 
in Tn71 
TniC (2358aa) 37% 
81/218 
NS 
TniA (630aa) 45% 
245/548 
23% 
129/571 
TniB (384aa) 40% 
114/283 
22% 
56/252 
TniD (362aa) 31% 
112/360 
NS 
TniE (481aa) 65% 
226/466 
NS 
1E. coli strain 3.5-R3 transposon Tn7, GenBank accession number KX117211. TniA, TniB, TniD and TniE 
were matched to TnsA, TnsB, TnsC, TnsD and TnsE, respectively. Non-significant matches are noted by NS.  
 
 
A number of the later open reading frames have homology to either Cop or Cus proteins which 
are known to be involved in copper resistance (241) (Table 8.15, Fig 8.16). However, copper 
resistance was not examined. This transposon also includes feoB gene involved in iron transport 
and a thiF gene which is involved in thiamine synthesis.  
 
8.6 pS30-2  
Only one contig matching the RepAci6 plasmid backbone was retrieved from the draft genome 
of S30 sequenced by Illumina MiSeq (Table 8.17). This contig fragments of ISAba1 on both 
ends. Adjacent to the IRr end of the ISAba1 was sequence of F1 just prior to repeat 2 while on 
next to the IRl end of ISAba1 was the oxa23 gene located in Tn2008 and then repeat 2.  
 
Table 8.17 RepAci6 plasmid contig of S30 
Isolate Contig Length (bp) Description Edges 
S30 18 73,043 F1 (TnaphA6), F2 and F3 ISAba1 (IRl), ISAba1 (IRr) 
 
To circularise the sequence, the oxa23R primer was combined with RH1320 and produced an 
approximately 2 kb amplicon that matched the predicted size and was sequenced. The oxa23 
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gene in pS30-2 was in Tn2008A, instead of AbaR4. Tn2008A in pS30-2 was surrounded by a 
9 bp target site duplication (5`-AGATAATTA-3`) and this is a novel insertion site for this 
transposon (194) that is located just prior to repeat 2 (Fig 8.17). The different context of the 
oxa23 gene in pS30-2 is consistent with the findings from the earlier oxa23 screening Chapter 
3; Section 3.3.3. pS30-2 also includes the same 2.2 kb adjacent to repeat 1, followed by repeat 
4, as in pS21-2 (Fig 8.17).  
 
 
Figure 8.17 Linear schematic of pS30-2. Arrows indicate the extent and orientation of genes and open reading 
frames. The repAci6 gene is blue, genes involved in conjugal transfer are red and the res and umuC genes are 
orange. The oxa23 and aphA6 gene are magenta and purple, respectively. Green boxes indicate the three repeat 
sequences. The light blue and green boxes represent ISAba1 and ISAba125, respectively, and the internal arrow 
indicates the transposase orientation. Vertical arrows show the location of insertions with the identity of the 
insertion shown above.  
 
8.6.1 New backbone type 4  
The plasmid pS30-2 amplified the type 1 amplicon size over R3 in Section 8.2, but its 71,056 
bp backbone appears to have key features of the three different backbone types (Fig 8.18).  A 
large section of the backbone, including the tra region (boxed in yellow in Fig 8.18), is within 
.3% to that of type 1 plasmids, and pS30-2 contains TnaphA6 in the same location as pAb-G7-
2 (indicated by the pink arrow in Fig 8.18). However, there are sections of greater difference 
and pS30-2 contains extra sequence compared to type 1 plasmids. Overall, pS30-2 is more 
distantly related to type 2 plasmids but contains an additional segment upstream of repeat 2 
(boxed in blue in Fig 8.18) that is present in this plasmid type. Thirdly, the extra sequence 
following repeat 1, as well as the partial duplication of this repeat is closely related to that of 
pS21-2 (green in Fig 8.18). The backbone of pS30-2 appears to be a fourth and hybrid backbone 
type, with a large segment closely related to the type 1 backbone but also contains segments 
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Figure 8.18 pS30-2 represents a new and fourth RepAci6 backbone type. Arrows indicate the extent and orientation of genes. The repAci6 gene is blue, genes involved in 
conjugal transfer are red and the res and umuC gene are orange. Green boxes indicate the three repeat sequences. Pink vertical arrows show the location of insertions with the 
identity of the insertion shown above or below. Regions of homology are shown by grey boxes and the numbers display DNA identity. Figure is made to scale from GenBank 
accession number KF669606 (pAb-G7-2 for type 1) and KJ493819 (pA85-3 for type 2). Boxes shaded in yellow, blue and red show regions specific to the type 1, 2 and 3 
backbone types.
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from the type 2 and 3 backbones, demonstrating the recombination that can occur in these 
closely related plasmids. 
 
8.6.2 Conjugation 
Transconjugants that were rifampicin and ticarcillin resistant were recovered from the mating 
of S30 with rifampicin resistant ATCC 19606Rif. The mean conjugation frequency of pS30-2 
was 8.38x10-2 transconjugants per donor was averaged from three independent matings of 
ATCC 19606Rif (pS30-2) with AB307_0294 (Table 8.18). This frequency is much higher than 
that determined for the other plasmids, indicating that conjugation may have somehow been 
de-repressed in pS30-2.  
 
Table 8.18 pS30-2 conjugation 
Plasmid Inserts Resistance Mating of S30 with 
ATCC 19606Rif 
Mating of ATCC 19606-RfR 
(pS30-2) with AB307_0294 
Transconjugants 
(TICRif) 
Conjugation 
frequency1 
Conjugation 
frequency1 
Mean 
Conjugation 
frequency2 
pS30-2 Tn2008, 
TnaphA6 
TIC 
Km 
+ 
 
2.34x10-5 1.18x10-1 
7.5x10-2 
5.75x10-2 
8.38x10-2 
TIC, ticarcillin; Km, kanamycin. 
1Conjugation frequency is expressed as transconjugants per donor. Each frequency is from a single 
determination.  
2Mean frequency expressed as transconjugants per donor calculated from three independent determinations. 
  
8.7 Discussion 
Fourteen RepAci6 plasmids from the isolates examined in this project were assembled and 
characterised. The backbones of most resembled the two known backbone types, including 
three type 1 plasmids and 9 type 2 plasmids. However, single examples of two novel backbone 
types, pS21-2 (type 3) and pS30-2 (type 4), were also identified. Plasmids in this family clearly 
contribute to the spread of oxa23 and aphA6. Twelve of the plasmids carry the oxa23 gene, 
either in Tn2008 or AbaR4 and hence, can contribute to carbapenem resistance. The AbaR4 
transposon has been repeatedly acquired by RepAci6 plasmids as it was found in two positions 
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in the type 1 backbone, two positions in the backbone of type 2 plasmids, as well as in another 
different location in pS21-2. In addition to carrying carbapenem resistance, the three type 1 
plasmids and the type 4 plasmid pS30-2, also contain the amikacin resistance transposon 
TnaphA6. Two novel transposons, one containing copper resistance genes, were also detected 
in the RepAci6 plasmids examined. The majority of these plasmids were shown to be 
conjugative and hence RepAci6 plasmids are playing a significant role in the spread of genes 
conferring resistance to carbapenems and amikacin, and both of these antibiotics are important 
for the treatment of A. baumannii infections. The reasons for failure of pS26-1, pS29-1, pS28-
2 and pS21-2 to conjugate will require further investigation. 
 
8.7.1 Type 1 plasmids 
Three of the TnaphA6 containing plasmids, pS24-1, pS26-1 and pS29-1, have a type 1 
backbone and are the first plasmids of this type to contain AbaR4. Twelve other RepAci6 
plasmids in the non-redundant database of GenBank were found to also be members of this 
backbone type (Table 8.19). These plasmids were isolated from isolates of different STs 
indicating spread (Table 8.19). A number of different transposons and IS have inserted into 
type 1 plasmids (Table 8.19) and the location of these transposons are indicated in Fig 8.19. 
Two of the type 1 RepAci6 plasmids in GenBank did not contain TnaphA6, but when this 
transposon was present, it was commonly found in position A (originally identified in pAb-
G7-2) (Table 8.19, Fig 8.19) (97). However, there were also two examples of TnaphA6 in 
position B (the pD72-1 TnaphA6 location) (192) and a single example of the position C 
insertion location in pA105-1(135), indicating that this transposon has been picked up by type 
1 RepAci6 plasmids on at least three occasions (Table 8.19, Fig 8.19). A 3.3 kb transposon 
containing aphA6 in pAba3207b (35) is bounded by directly-orientated copies of ISAba125, 
but the internal segment shares only 98% nucleotide identity to that of TnaphA6 and is 310 bp 
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longer (Table 8.19). Hence, this aphA6-containing transposon in pAba3207b is the second time 
that ISAba125 has mobilised the aphA6 gene from A. guillouiae (279).  
 
 
Figure 8.19 Location of insertions in the type 1 backbone. Arrows indicate the extent and orientation of genes. 
The repAci6 gene is blue, genes involved in conjugal transfer are red and the res and umuC genes are orange. 
Green boxes indicate the three repeat sequences. Vertical pink arrows show the locations of insertions in Type 1 
plasmids listed in Table 8.19. Figure is made to scale using pAb-G7-2 (GenBank accession number KF669606).  
 
The plasmids pS24-1, pS26-1 and pS29-1, also contain the oxa23 containing transposon 
AbaR4, in two novel locations. AbaR4 in the position found in pS26-1 and pS29-1 was also 
present in a plasmid from a South Korean isolate, pUSA15_1 (Table 8.19). In fact, pUSA15_1 
also contains the 9.3 kb transposon and the only difference between pUSA15_1 and pS26-
1/pS29-1 is the presence of 2 copies of ISAba13 in pUSA15 (Table 8.19).   
 
However, AbaR4 is not the only vehicle carrying the oxa23 gene found in Type 1 RepAci6 
plasmids. The plasmid pD46-3 was previously reported to contain Tn2006 (196). Tn2008 has 
been reported in the plasmid pABUH1-74 (GenBank accession number 
NZ_AYOH01000010.1) (277) and this Tn2008 location was also found in pCMCVTAb2-Ab4 
and pCMCVTAb2-Ab66 (Table 8.19). Other resistance genes have been acquired by 
p1AB5075 and pAB8098 in a 13.5 kb region flanked by mite sequences, which contains the 
sul1, dfrA7- aacA4- blaGES-11, aadA2-cmlA1-aadB as well as the strA, strB resistance genes 
(74). The plasmid pC13-2 contains Tn6166, a transposon carrying copper resistance genes, 
which is quite different to Tn6167 identified in pS21-2.  
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Table 8.19 Type 1 plasmids in GenBank as of July 2017 
Plasmid ST of 
isolate 
(IP)1 
Size 
(bp) 
TnaphA6 
location2 
Additional insertions Location Year GenBank 
Accession 
number 
Reference 
pAb-G7-2 1 70,100 A  Melbourne, Australia 2002 KF669606 (97) 
pS24-1 2 86,916 A AbaR4 (1) Singapore 2006  This study 
pS26-1/pS29-1 2 96,203 A AbaR4 (2), 9.3 kb Tn Singapore 2006/7   This study 
         
pCMCVTAb2-Ab4 2 74,090 A Tn20083, ISAba1 Virginia, USA <2017 CP016297  
pC13-2 2 103,871 A Tn61764  Sydney, Australia  2006 KU549175 (194) 
p1AB5075 1 83,610 A 13.5 kb region bounded by mites5 USA 2008 CP008707 (74) 
pAB8098 499 82,6676 A 13.5 kb region bounded by mites5 Tunisia 2010 KY022424  
pUSA15_1 1 98,301 A AbaR4 (2)7, 9.3 kb Tn, 2xISAba13 Seoul, South Korea 2013 CP020594  
pAB34299 2 84,9678 A ISAba1 - 2015 CP014292  
pD72-2 2 70,102 B  Sydney, Australia 2010 KM051846 (192) 
pD46-3 25 74,916 B Tn20069 Sydney, Australia 2013 KM977710 (196) 
pA105-1 636 70,098 C  Sweden 2008 KR535992 (135) 
pAba3207b 422 80,546 D10 10.1 kb additional sequence11 Monterrey, Mexico 2010 CP015366 (35) 
pCMCVTAb2-Ab66 2 73,188 -12 Tn20083, 2xISAba125 Virginia, USA <2017 CP016302  
pMAL-2 492    Serbia <2016 KX230794 (57) 
1Using the Institut Pasteur MLST scheme, of the isolate containing the plasmid. ST492 is a single locus variant of ST2, while ST636 is a triple locus variant. ST25, ST499 
and ST422 are not related to ST1 or ST2.  
2pAb-G7-2 location is position A, position B is the location found in pD72-2 while position C and D are unique to pA105-1 and pAba3207b, respectively.  
3Interrupts an orf 3,055 bp prior to R1.  
433.8 kb transposon that contains copper resistance genes, but is different to Tn6177. 
5Inserted 770 bp prior to repeat 2 and the region contains the sul1, dfrA7- aacA4- blaGES-11, strA, strB, aadA2-cmlA1-aadB resistance genes. 
6Is missing the centre 942 bp of the ISAba125 on the right in TnaphA6. 
7AbaR4 is located in the same position as in pS26-2 and pS29-2 as is the 9.3 kb Tn. 
8Duplication of 13.7 kb of plasmid backbone. 
9Located 728 bp upstream of repeat 2 and interrupts an orf. 
10The ISAba125 bounded transposon is 3,382 bp in size and has 310 bp extra prior to the right ISAba125 compared to TnaphA6.  
11Located 2,395 bp prior to the TnaphA6(A) insertion site and is surrounded by a 9 bp duplication.  
12Has two copies of ISAba125 in opposite orientation and the 4.7 kb of backbone sequence between them is inverted. If the sequence is re-inverted then the one of the copies 
of ISAba125 is in the same position as TnaphA6 in pAb-G7-2. 
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8.7.2 Type 2 plasmids 
Nine of the RepAci6 plasmids characterised in this work had a type 2 plasmid and this 
backbone type was only present in the isolates that contain a version of AbGRI3. Six of these 
plasmids harboured AbaR4 in the same location as pA85-3 (location 1) (99), while a novel 
insertion site of AbaR4 was detected in pS34-2 (location 2). In addition to pA85-3, only three 
other type 2 plasmid sequences were found in GenBank (Table 8.20). Like pS32-2 and pS36-
2, none of these plasmids contained resistance genes but other insertions were present (Table 
8.20).  
 
Table 8.20 Type 2 plasmids in GenBank as of July 2017 
Plasmid Size (bp) Additional 
insertions 
Location Year GenBank 
accession 
number 
Reference 
pA85-3 86,334 AbaR4 (1) Sydney, 
Australia 
2003 KJ493819 
 
(99) 
pS22-2, pS23-2, 
pS40-2 
86,340 AbaR4 (1) Singapore 2004-2011  This study 
pS25-2, pS27-2, 
pS28-2 
87,529 AbaR4 (1), 
ISAba1 
Singapore 2006-2007  This study 
pS34-2 86,336 AbaR4 (2) Singapore 2009  This study 
pS32-2, pS36-2 70,833 ISAba19 Singapore 2009   
pJBA13_1 90,972 20.4 kb Tn1 
ISAba10 
Jeonbuk,  
South Korea 
2013 CP020582  
pSSMA17_1 90,973 20.4 kb Tn1 
ISAba10 
Seoul,  
South Korea 
2013 CP020580  
pKAB04 121,4852 
 
9.3 kb Tn3, 
20.4 kb Tn1, 
2xISAba10 
Busan,  
South Korea 
2015 CP017649  
1Class 3 family transposon that also includes a copy of ISAba10. 
219,166 bp of the backbone is duplicated. 
3Located downstream of repeat 3 and orf 4 of the transposon is interrupted by ISAba10.  
 
8.7.3 Further backbone types 
Two novel backbone types, pS21-2 and pS30-2, were also discovered in the isolates examined 
in this chapter. The backbone of pS21-2 has large regions of sequence that are different (up to 
4-6% nucleotide different) to both type 1 and type 2 plasmids, as well as 2.2 kb of extra 
sequence adjacent to repeat 1 and a copy of repeat 4. The backbone of pS30-2 appears to be
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Table 8.21 Other RepAci6 plasmids in GenBank as of July 2017 
Plasmid Size 
(bp) 
Backbone features Backbone 
type 
Additional 
insertions 
Location Year GenBank 
accession 
number 
Reference 
2.2 
kb 
and 
R4 
1.2 kb 
prior to 
R2 
1 kb 
downstream 
of R3 
parB 
downstream 
of umuC 
pS21-2 123,432 +    3 Tn61671, 
AbaR42 
Singapore 1996  This study 
pS30-2 76,933 + +   4 TnaphA6(A)3, 
Tn20084 
Singapore 2008  This study 
pKAB08 101,406  + + 
 
+ 
 
5 9.3 kb Tn5,  
20.4 kb Tn6, 
ISAba10 
Gyeonggi,  
South Korea  
2015 CP017657  
pUSA2_1 74,241 + +  + 6  Seoul,  
South Korea 
2013 CP020593  
p15A5_1 74,241 + +  + 6  South Korea 2013 CP020573  
pYU-R612-1 74,241 + +  + 6  Seoul,  
South Korea 
2014 CP014216 (156) 
pKAB05 70,884 +   + 7  Daegu,  
South Korea 
2015 CP017651  
pKAB01 70,875 +   + 7  Daejeon,  
South Korea 
2015 CP017643  
pKAB06 70,884 +   + 7  Daegu,  
South Korea  
2015 CP017653  
pABKp1 74,451 +  + +7 8 ISAba1  South Korea <2010 CP001922  
pKAB07 72,073 +  + + 8  Jeonju,  
South Korea  
2015 CP017655  
p15A34_1 72,076 +  + + 8  South Korea 2014 CP020589  
pSSA12_1 73,264 +  + +7 8  Seoul,  
South Korea 
2013 CP020577  
pKAB03 73,891    + 
 
9 3xISAba10 Daejeon,  
South Korea 
2015 CP017647  
pAB_CC 65,8908    + 
 
9  China 2013 KF889012 (161) 
pAb04-2 87,569 
 
   + 10 AbaR4(1), 
ISAba1259  
Edmonton, 
Canada 
2012 CP012008 
 
(272) 
1Interrupts the umuC gene. 
2Interrupts the orf downstream of umuC. 
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3Located in the same position as in pAb-G7-2. 
4Interrupts the orf prior to repeat 2. 
5Located 6,355 bp away from repeat 3 and orf 4 of the transposon is interrupted by ISAba10. 
6Class 3 family transposon that include a copy of ISAba10.  
7Adjacent to parB is ISAba1.  
8Missing 5,977 bp of backbone including repeat 2. 
9ISAba125 is in the same position as TnaphA6(B) in pD72-2.
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 a hybrid of the three backbone types, indicating the recombination that can occur between 
these closely-related plasmids.  
 
Examination of 14 additional RepAci6 plasmids in GenBank, revealed a number of further 
backbone types, based on combinations of specific backbone features and the high sequence 
similarity between them (Table 8.21). A subset of RepAci6 plasmids also contain a parB 
partitioning gene that is located downstream of umuC (Table 8.21). The plasmid pAb04-2 (type 
10 in Table 8.21), appears to be another hybrid as it contains AbaR4 in the pA85-3 position 
(position 1), has parB but also contains an ISAba125 in the same location as TnaphA6 in the 
type 1 plasmid pD72-1 (position B). The backbones of RepAci6 plasmids are diverse and 
further work will be required to characterise them fully. 
 
8.7.4 Conserved orientation of AbaR4 transposon 
Overall, AbaR4 has been found in a total of five positions in the different RepAci6 plasmid 
backbones. In each location, the AbaR4 transposon is always in the same orientation with 
respect to the repAci6 gene, with IRl of Tn6022 on the left and IRr on the right. This orientation 
specific insertion into plasmid sequence has also been observed in Tn7 transposons (210).  
Interestingly, Tn6167, the class III transposon containing a tni transposition module in pS21-
2, is also in the same orientation. This suggests that the Acinetobacter class III transposons 
may also target the lagging strand. 
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9.1 Introduction 
A number of small plasmids that are cryptic or contain resistance genes have been identified 
in Acinetobacter and have been classified using the sequence of their replication initiation 
proteins (Rep proteins) and assigned RepAci numbers (21). Plasmids with a Rep protein 
matching RepAci1 such as pACICU1 (129) and pAB0057 (3) or a RepAci2 type such as 
pABVA01 (21), are fairly common in sequenced isolates (Table 9.1). The RepAci1 and 
RepAci2 proteins are 85% aa identical. The plasmid pABVA01 contains the carbapenem 
resistance gene oxa24 located between two inversely-oriented XerC-XerD binding sites (46). 
XerC-XerD binding sites have also been detected in plasmids with RepAci1 (46, 220). In 
genomes of A. baumannii from Australia a cryptic RepAci1 plasmid pAb-G7-1, is prevalent in 
GC1 isolates (Dr M. Hamidian, personal communication) (Fig 9.1). The plasmid pAb-G7-1 is 
almost identical to pAB0057, except pAB0057 is missing two bases and contains a SNP. 
However, the missing bases were determined to be a sequencing error (Dr M. Hamidian, 
personal communication) and during the writing of this chapter a corrected sequence was 
released under GenBank accession umber CP001183. In GC2 isolates from Australia a cryptic 
RepAci2 plasmid, named pD72-1, is most common (193) (Fig 9.1).  
 
Table 9.1 RepAci1 and RepAci2 plasmids 
Rep 
type 
Plasmid  Size (bp) Resistance 
genes 
Mobilisation 
genes 
GenBank 
Accession 
number 
RepAci1 pACICU11 28,279 oxa58 - CP000864 
 pAB0057 8,729 - - CP001183 
 pAB-G7-1 8,731 - - KJ586856 
RepAci2 pABVA01 8,963 oxa24 - FM210331 
 pD72-1 10,967 - mobA, mobC KM051986 
1Contains two replication initiation genes and is likely a fusion of two plasmids. 
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Figure 9.1 pAb-G7-1 and pD72-1 comparison. Arrows indicate the extent and orientation of genes and open 
reading frames. Genes encoding putative toxin/antitoxin modules are pink patterned and rep genes are shown in 
blue. The tonB gene is grey and genes showing homology to mobilisation proteins are yellow. The green box 
represents ISAba125 and the internal arrow shows the transposase orientation. The orange box indicates the iteron 
sequence. Vertical lines indicate XerC-XerD binding sites and the orientation of these sites are shown above. The 
extents of regions with significant DNA identities are shown in grey. 
 
Genes involved in plasmids mobilisation (mob genes) have been detected on several 
Acinetobacter plasmids, including pD72-1 (192) (Fig 9.1), the repAci9 plasmid pMAC (56) 
and pRAY* (100) which does not contain a recognisable rep gene. Most of these have not been 
experimentally characterised, but the mobilisation region of pMAC has been shown to be 
functional (56). The plasmid pMAC encodes a mobA/L gene that produces a protein related to 
the MobA protein of RSF1010 and pSC101 (56). The region encoding this gene and an 
additional region thought to contain the oriT (origin of transfer) sequence was cloned into 
pUC18 and shown to be mobilised by pRK2073 (a derivative of RK2, an IncP plasmid) in a 
tri-parental mating at very low frequency (56). However, IncP plasmids are not normally found 
in Acinetobacter isolates.  
 
The aim of the work presented in this chapter was to determine if any small RepAci1 and 
RepAci2 plasmids are present in the 20 GC2 isolates from Singapore General Hospital and if 
so to characterise their structure. Plasmid incompatibility and mobility were examined using 
RepAci1 and RepAci2 plasmids containing resistance genes.  
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9.2 Detection of RepAci1 and RepAci2 plasmids 
To detect and distinguish between the RepAci1 and RepAci2 cryptic plasmids represented by 
pAb-G7-1 and pD72-1 respectively, primers were designed in a unique region of each plasmid 
backbone (Fig 9.2A). For detection of pAb-G7-1, the primers RH2035 and RH2036 were 
paired to amplify a region 328 bp in size and an amplicon slightly larger than 300 bp was 
amplified in S22, S23, S25, S27, S28 and S31-S40 (Fig 9.2B), indicating that they contained a 
plasmid of the pAbG7-1 type.  
 
 
Figure 9.2 Detection of pAb-G7-1 and pD72-1. A. Comparison of pAb-G7-2 and pD72-1. Arrows indicate the 
extent and orientation of genes and open reading frames. Genes encoding putative toxin/antitoxin modules are 
pink patterned and rep genes are shown in blue. The tonB gene is grey and genes showing homology to 
mobilisation proteins are yellow. The green box represents ISAba125 and the internal arrow is the transposase 
gene. The orange box indicates the iteron sequence. Vertical lines indicate XerC-XerD binding sites and the 
orientation of these sites are shown above. Primers used to differentiate the backbone types are shown by the bars 
above, along with PCR amplicon size. The extent of regions with significant DNA identities are shown in grey B. 
Screening for a 328 bp region of the backbone of pAb-G7-2 using primers RH2035 and RH2036. C. Screening 
for backbone of pD72-1. RH2037 and RH2038 were paired to detect an amplicon 263 bp in size. In B. and C. the 
sizes of the molecular markers on the left and right are in bp and isolates are shown above their lanes. 
 
 
The primers RH2037 and RH2038 were designed to amplify a 263 bp region of pD72-1, 
including part of the mobC gene. When these primers were used in combination, S21was the 
only isolate to produce a strong amplicon that was around 250 bp in size, consistent with that 
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of pD72-1 (Fig 9.2C). From these screening results, S24, S26, S29 and S30 did not contain a 
plasmid containing a similar backbone to that of pAb-G7-2 or pD72-1. The absence of a 
RepAci1 or RepAci2 plasmid in these four isolates was later confirmed when the draft genome 
sequence became available.  
 
9.3 Plasmid assembly and analysis 
9.3.1 pAbG7-1 type (RepAci1) 
The entire backbone of pAb-G7-1 was retrieved in a single contig from the assemblies of S27, 
S34, S38 and S39 (Table 9.2). As the assembly program is unable to complete a circular 
sequence, the assembly of each plasmid broke randomly and at a different point in the backbone 
for each plasmid. The ends of the contigs overlapped by approximately 80 bp in each isolate. 
The overlapping sequence was removed and the contigs were circularised in silico and 
reopened at the same point to facilitate comparisons. These four plasmids, named pS27-1, 
pS34-1, pS38-1 and pS39-1, were identical to each other and were 8,731 bp in size. They all 
had one SNP relative to pAb-G7-1 sequence (position 1,399, C® A, silent mutation) in the orf 
adjacent to repAci1 (Fig 9.2A). This is the same SNP that is present in pAB0057.  
 
Once the MiSeq sequences became available, contigs containing pAb-G7-1 sequence were also 
retrieved (Table 9.2) and all but the plasmid in S32 were assembled using the same method as 
above. The plasmids present in S22, S23, S25, S28, S31 and S33-S40 (named pS22-1 to pS40-
1) were identical to those in the initial four isolates, each containing the pAB0057 SNP. The 
edges of contig 40 in S32 (highlighted in orange in Table 9.2) did not overlap with each other, 
instead ending with fragments of the same end of ISAba1.  
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Table 9.2 Contigs matching pAb-G7-1 
Isolate1 Contig Length Kmer coverage  Final length (bp) 
S22 32 8,858 1297.3200 8,731 
S23 32 8,858 818.4330 8,731 
S25 34 8,858 1057.7100 8,731 
S27 1 8,811 139.4231 8,731 
S28 37 8,858 418.8120 8,731 
S31 33 8,858 510.0670 8,731 
S32 40 9,080 541.0410 >8,731 
S33 36 8,858 845.5050 8,731 
S34 13 8,811 80.4217 8,731 
S35 37 8,858 921.4150 8,731 
S36 38 8,858 1180.2400 8,731 
S37 37 8,858 1008.0900 8,731 
S38 3 8,813 77.8566 8,731 
S39 4 8,811 80.8631 8,731 
S40 39 8,858 946.5960 8,731 
1Isolates in bold were sequenced by Illumina HiSeq and were assembled using Velvet. The others were sequenced 
using Illumina MiSeq and were assembled using SPAdes.  
 
9.3.1.1  pS32-1 includes Tn2006 
The fragments of ISAba1 at the ends of contig 40 of the S32 genome were in inverse orientation 
to each other, but a 9 bp direct repeat (5` AATTTCTAG 3`) was adjacent to each fragment of 
ISAba1. This is consistent with the presence of the oxa23 containing transposon Tn2006, which 
from earlier screening is present in S32 (Chapter 3; Section 3.3.3). If Tn2006 was located here, 
from the sequence of its direct repeat, it would be a novel insertion position for this transposon 
(194). Furthermore, the kmer coverage of the oxa23 containing contig is 618.6430, which is 
approximately equivalent to that of the backbone of pS32-1 (Table 9.2).  The insertion in the 
backbone of pS32-1 directly follows the stop codon of the tonB gene, leaving the reading frame 
intact. Two primers were designed facing outwards at each end of the contig (RH2505 and 
RH2506) and paired with internal Tn2006 primers (Figure 9.3A), to determine the orientation 
of this transposon in pS32-1.  
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Figure 9.3 pS32-1 contains Tn2006. A. Structure of pS32-1. Arrows indicate the extent and orientation of genes 
and open reading frames. Genes encoding putative toxin/antitoxin modules are pink patterned and the rep gene 
blue. The tonB and oxa23 gene are coloured grey and orange, respectively. The box represents ISAba1 and the 
internal arrows show the transposase orientation. The orange box indicates the iteron sequence and flags indicate 
matching TSD. Primers used to span Tn2006 are shown by the bars above, along with amplicon size. Vertical 
lines indicate XerC-XerD binding sites and the orientation of these sites are indicated above. B. Confirming the 
location of Tn2006 using primer pairs RH2505 and RH743 were predicted to amplify a 2,728 bp product, while 
RH2506 and oxa23R were used in combination to produce an amplicon of 2,317 bp. The sizes in kb of the 
molecular marker are shown to the right. 
 
The primer pair combinations shown in Fig 9.3A were the only ones that amplified products. 
The amplicons were approximately 3 kb and 2.5 kb (Fig 9.3B), matching the predicted 
amplicon sizes of 2,728 bp (for RH2505 and RH743) and 2,317 bp (for oxa23R and RH2506) 
respectively, and were sequenced to complete the assembly of the 13,545 bp plasmid carrying 
Tn2006.  
 
9.3.2 pD72-1 type (RepAci2) 
Sequence matching the backbone of the pD72-1 type of RepAci2 plasmids was only found in 
the genome of S21, consistent with the previous PCR screening (Fig 9.2C).  
 
9.3.2.1 pS21-1 contains TnaphA6 
The genome of S21 only contained a single contig that matched pD72-1 (contig 12, 10,042 bp 
in size, kmer coverage of 86.2788). This contig had fragments of ISAba125 at its ends and the 
ISAba125 appeared to be in the same location as in pD72-1 (top line in Fig 9.4C). Hence, a 
previously designed primer pair (RH1348 and RH1322) was used to complete the plasmid 
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(location of primers indicated in the top line in Fig 9.4C). When the two primers amplify over 
the single ISAba125 in pD72-1 the product is 1,251 bp, however, the amplicon of pS21-1 was 
approximately 2 kb larger than this (Fig 9.4A), indicating that additional sequence was present.  
 
 
Figure 9.4 pS21-1 contains TnaphA6. A. pS21-1 has sequence additional to ISAba125. The primer combination 
of RH1348 and RH1322 produce an amplicon size of 1,251 bp when only a single ISAba125 is present. If 
TnaphA6 is present the amplicon is 3,236 bp. B. Confirmation of TnaphA6 in pS21-1. RH1348 and aphA6F and 
RH1322 and aphA6R were paired producing predicted amplicons of 1,847 bp and 1,624 bp respectively. In A. 
and B. the sizes in kb of the molecular marker are shown to the left and right. The isolates are shown above their 
lane. C. Comparison of pD72-1 and pS21-1. Arrows indicate the extent and orientation of genes and open reading 
frames. Genes encoding putative toxin/antitoxin modules are pink patterned and rep genes are shown in blue. The 
tonB and aphA6 genes are coloured grey and magenta. The green boxes represent ISAba125 and the internal arrow 
indicates the transposase orientation. An orange box indicates the iteron sequence and matching flags indicate 
TSD. Primers used to span ISAba125 or TnaphA6 are shown by the bars above along with predicted amplicon 
size. Vertical lines indicate XerC-XerD binding sites and the orientation of these sites are indicated above.   
 
Earlier screening (Chapter 3; Section 3.3.4) showed that S21 contains the transposon TnaphA6, 
which is 3,072 bp in length and is bounded by directly orientated copies of ISAba125. The 
kmer coverage of the contig containing aphA6 in S21 is 90.3650, which is equivalent to that of 
the contig of the plasmid backbone, indicating it is likely to be present here. Each of the 
backbone primers was paired with one in TnaphA6 (Fig 9.4B and C), yielding products around 
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2 and 1.5 kb, consistent with the predicted amplicon sizes of 1,824 bp and 1,624 bp 
respectively, indicating that TnaphA6 was present. Hence, pS21-1 is 12,643 bp in size and the 
only difference between pS21-1 and pD72-1 is the presence of TnaphA6 in the same location 
as ISAba125 in pD72-1 (Fig 9.4C). Like pD72-1, pS21-2 also contains the potential 
mobilisation genes mobA and mobC. The MobA protein of pS21-1 shares 32% aa identity to 
that of the MobA of RSF1010 and its MobC protein is 40% identical to MobC of RSF1010.  
 
9.4 Plasmid compatibility 
The repAci1 and repAci2 genes are 80% identical (772/961) and the proteins they encode are 
85% (270/316 aa) identical to one another. Approximately 50 bp upstream of the repAci1 and 
repAci2 genes are iteron sequences. Iteron sequences are the binding sites for the plasmid-
encoded Rep proteins and have control properties (49). There are four identical repeats of 22 
bp in RepAci1 plasmids (top line in Fig 9.5A), while RepAci2 plasmids have three identical 
repeats of the 22 bp iteron sequence and one of 21 bp, where the final A is missing (bottom 
line in Fig 9.5A). The almost identical iteron sequence (19 out of 22 bp) shared by the RepAci1 
and RepAci2 plasmids (comparison shown in Fig 9.5B), and the high identity of their 
replication initiation proteins may result in the incompatibility of these two plasmids and to 
date these two Rep types have not been observed in the same isolate. The availability of 
antibiotic resistant plasmids pS21-1 and pS32-1 allowed the compatibility of RepAci1 and 
RepAci2 plasmids to be examined for the first time.  
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Figure 9.5 RepAci1 and RepAci2 iteron sequences. A. Structure and sequence of the iteron region in RepAci1 
and RepAci2 plasmids. The bars above indicate the iteron sequences and the arrows below represent the start of 
the repAci1 or repAci2 gene. B. Comparison of iteron sequence.  
 
 
 
 
9.4.1 pS21-1 (RepAci1) and pS32-1 (RepAci2) are compatible 
pS32-1 was transformed into AB307_0294 and its presence was confirmed by PCR screening 
(Table 9.3). Then AB307_0294 containing pS32-1 was transformed with pS21-1. 
Transformants recovered were both ticarcillin and kanamycin resistant, and the boundaries of 
Tn2006 in pS32-1 and TnaphA6 in pS21-1 were detected (Table 9.3).  
 
Table 9.3 Transformation of AB307_0294Rif with pS32-1 and pS21-1 
Plasmid/s 
transformed  
Phenotype pS32-1 Tn2006 
location 
pS21-1 TnaphA6 
location 
 RH2505-
RH743 
oxa23R-
RH2506 
RH1348-
aphA6F 
RH1322-
aphA6R 
N/A Rif, Nx - - - - 
pS32-1 TIC, Rif, Nx + + - - 
pS32-1, 
pS21-1 
TIC, Km, 
Rif, Nx 
+ + + + 
Kanamycin, Km; Nalidixic acid, Nx; Rifampicin, Rif; Ticarcillin, TIC.  
 
Plasmid DNA of an AB307_0294 (pS21-1 and pS32-1) transformant was extracted and 
visualised on a TAE gel (Fig 9.6A). There was only one band present in the lane of the 
transformant (Fig 9.6A), but as there is less than 1 kb difference between the size of pS21-1 
(12,643 bp) and pS32-1 (13,545 bp) it is possible that they would not separate on a standard 
CCTATATGTCCACGTTTACCTTGCAATATGTCCACGTTTACCTTGCAATATGTCCACGTTTACCTTGCAATATGTCCACGTTTACCTTGCA-53bp-ATGAGAG 
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TAE gel. The differences in the brightness of the plasmid bands indicates that pS32-1 may 
have a higher copy number than pS21-1 (Fig 9.6A).  
 
 
 
Figure 9.6 AB307_0294 containing pS21-1 and pS32-1. A. Plasmid DNA of a pS21-1 containing AB307_0294 
21), a pS32-1 containing AB307_0294 (32), a pS21-1 and pS32-1 containing AB307_0294 transformant (TF 21 
& 32) and empty recipient AB307_0294 (AB). These were run alongside plasmid DNA from 39R861+ (S) in a 
0.7% agarose tris-acetate-EDTA gel. Sizes of plasmids in 39R861+ and the position of chromosomal DNA (chr) 
are indicated to the left.  B. Plasmid DNA of a pS21-1 containing AB307_0294 (21), a pS32-1 containing 
AB307_0294 (32) and a pS21-1 and pS32-1 containing AB307_0294 transformant (TF 21 & 32) digested with 
SwaI. The sizes in kb of the molecular marker are shown to the right. The red and white dots indicate bands visible 
in the original gel, white for pS21-1 fragments and red for pS32-1 fragments, respectively.  
 
To confirm the presence of both plasmids, plasmid DNA of the AB307_0294 (pS21-1, pS32-
1) transformant as well as plasmid DNA of each individual plasmid was digested with SwaI. 
The digests of the pS21-1 and pS32-1 matched the in silico digests of each plasmid (Table 9.4, 
Fig 9.6B). The digest pattern of the transformant matched a combination of the individual 
plasmids confirming that both pS21-1 and pS32-1 are present in the transformant (Fig 9.6B).  
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Table 9.4 In silico SwaI digest 
pS32-1 pS21-1 
4,663 6,830 
4,483 2,703 
3,298 1,961 
1,101 1,101 
 24 
 24 
 
AB307_0294 (pS21-1, pS32-1) conferring resistance to ticarcillin and kanamycin, was grown 
without antibiotic selection over five cycles of serial subculture. Following each cycle of 
overnight culture (approximately 22 generations) the total number of cells, as well as the 
number of cells growing in kanamycin, ticarcillin, and both ticarcillin and kanamycin were 
determined. The results from a single experiment showed that over the 5 passages, 
approximately 110 generations, the proportion of antibiotic resistant cells did not decrease 
(Table 9.5). Fifty of the colonies selected on the L-agar at Day 5 were then patched onto L-
agar supplemented with kanamycin or ticarcillin. All were still resistant to both antibiotics and 
the junctions of TnaphA6 in pS21-1 and Tn2006 in pS32-1 were screened and confirmed in 
five of these (screening PCRs shown in Table 9.4). Hence, confirming that pS21-1 and pS32-
1 are compatible with one another over 110 generations.  
 
Table 9.5 Cell counts over 5 serial passages (110 generations) 
Overnight 
culture 
L-agar  
(cfu/mL) 
Km 
(cfu/mL) 
TIC 
(cfu/mL) 
KmTIC 
(cfu/mL) 
1 4.7x108 7.9x108 5.5x108 6.3x108 
2 6.1x108 4.3x108 6.6x108 5.8x108 
3 7.3x108 8.0x108 8.0x108 7.2x108 
4 10.2x108 10.3x108 11.2x108 11.1x108 
5 11.8x108 14.0x108 12.7x108 14.7x108 
Kanamycin, Km; Ticarcillin, TIC.  
 
9.5 Plasmid mobilisation  
9.5.1 Comparison of mobilisation genes 
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The sizes of the mob genes and hence the Mob proteins of RSF1010, pS21-1, pMAC and pRAY 
are quite varied (Table 9.6). Despite both having some similarity to RSF1010, the mob genes 
of pS21-1 and pMAC showed no sequence identity to one another. When the MobA protein of 
each plasmid was compared, they matched with 29% identity over 46% of the protein. This 
match was concentrated in the N-terminus region. Hence, the MobA proteins encoded by each 
of these plasmids are quite different and may be mobilised by different conjugative plasmids. 
The MobA protein of pS21-1 matched with 30% identity over only 5% of the MobA protein 
of pRAY. The MobC proteins of pS21-1 and pRAY are also quite different with a match of 
83% identity over only 5% of the protein.  
 
Table 9.6 Mobilisation gene and protein lengths 
 mobA gene (bp) MobA (aa) mobC gene (bp) MobC (aa) 
RSF1010 2130 710 285 95 
pS21-1 1437 479 306 102 
pMAC 1170 390 765 255 
pRAY 1815 605 408 136 
 
A number of plasmids containing mobA and mobC genes closely related to those in pS21-1 
were identified following a search of the nucleotide database (Table 9.7). However, no 
experimental work has been performed on plasmids containing mob genes of this type to 
determine if they are functional and which conjugative plasmids are capable of mobilising 
them. 
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Table 9.7 Mob proteins related to those of pS21-1   
Plasmid Acinetobacter 
species 
Size (bp) Rep Identity to pS21-1 GenBank 
Acc. No. 
Ref 
MobA  MobC 
pD72-1, pC21 baumannii 10,967 RepAci2 100% 
[478/478] 
100% 
[101/101] 
KU549174 (193) 
p6AsACE schindleri 7,943 RepAci33 91.42% 
[437/478] 
94.06% 
[95/101] 
CP015621  
pM131-5 sp. 7,641 RepAci33 89.92% 
[437/486] 
95.05% 
[96/101] 
JX101644  
CIP70.10 
plasmid II 
baumannii 7,742 RepAci5 91.21% 
[436/478] 
95.05% 
[96/101] 
LN865144  
pALWVS1.1 lwoffii 134,7672 New Rep4 91.42% 
[437/478] 
98.02% 
[99/101] 
KX426232 (175) 
        
p5AsACE schindleri 10,085 New Rep5 81.59% 
[390/478] 
95.05% 
[96/101] 
CP015620  
1Is a 2.5 kb deletion variant of pD72-1. 
2Is a combination of two plasmids. 
3The rep genes of these two plasmids are 99.9% identical. 
475.1% DNA identity to repAci1. 
582% identical to the rep of pABa3207a (GenBank accession number CP015365).  
 
9.5.2 pS21-1 is not mobilised by a RepAci6 plasmid  
The co-residing RepAci6 plasmid in pS21 was found to be non-conjugative (Chapter 8; Section 
8.5.1). A different donor strain was constructed by first transforming A25, which carries no 
other plasmids (Chapter 2; Table 2.5), with pS21-1 (RepAci1, containing the aphA6 gene and 
conferring kanamycin resistance), then conjugating in the self-transmissible RepAci6 plasmid 
pS27-2 (containing oxa23, conferring ticarcillin and clavulanic acid resistance) (Chapter 8; 
Section 8.4.1). The presence of both plasmids in A25 was confirmed by screening for the 
junctions of TnaphA6 in pS21-1 and the presence of the oxa23 gene and a region of the 
RepAci6 backbone for pS27-2, as summarised in Table 9.8.  
 
Table 9.8 Construction of A25 (pS21-1 and pS27-2) 
Plasmid/s  Phenotype pS21-1 specific PCRs pS27-2 specific PCRs 
 RH1348-
aphA6F 
RH1322-
aphA6R 
RH1348-
aphA6F 
RH1322-
aphA6R 
pS21-1 Km + + NA NA 
pS21-1,  
pS27-2 
Km, 
TIC/CLAV 
+ + + + 
Kanamycin, Km; Ticarcillin/clavulanic acid, TIC/CLAV.  
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A24 (pS27-2, pS21-1) was mated with AB307_0294Nx (nalidixic acid resistant) and all possible 
outcomes were tested (Table 9.9). This included selection for just pS27-2 (ticarcillin/clavulanic 
acid and nalidixic acid resistance), just pS21-1 (kanamycin and nalidixic acid resistance) or 
both pS27-2 and pS21-1 (kanamycin, ticarcillin/clavulanic acid and nalidixic acid resistance) 
moving.  
 
Table 9.9 A25 (pS21-1, pS27-2) and AB307_2094Nx mating 
Plasmid/s Selection  Observed 
transconjugants 
(transconjugants/ 
donor)1 
pS27-2 TIC/CLAVNx 6.37x10-4   
pS21-1 KmNx <3.7x10-8 
pS21-1, pS27-2 KmTIC/CLAVNx <3.7x10-8 
Kanamycin, Km; Nalidixic acid, Nx; Ticarcillin/clavulanic acid, TIC/CLAV. 
1Transfer frequency is only calculated from one experiment. 
 
Transconjugants were only present on the ticarcillin/clavulanic acid and nalidixic acid selection 
plates (Table 9.9) and 50 of these were screened for resistance to kanamycin but none 
harboured this additional resistance phenotype. Therefore, only the conjugative pS27-2 
plasmid was moving and if pS21-1 was mobilised it was below the limit of detection (Table 
9.9). Hence, it is likely that pS21-1 cannot be mobilised by pS27-2, and probably cannot be 
transferred by other RepAci6 plasmids.   
 
9.5.3 Mobilisation of pS32-2 by RepAci6 plasmids 
S32 contains two plasmids, firstly a RepAci1 plasmid pS32-1 carrying the oxa23 gene and no 
mobilisation genes, and second, pS32-2, a potentially conjugative RepAci6 plasmid (Chapter 
8; Section 8.4.2). However, pS32-2 does not contain a selectable marker preventing tracking 
of its movement. S32 was mated with AB307_0294Rif (rifampicin resistant) and potential 
transconjugants were detected using selection for movement of pS32-1 (ticarcillin and 
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rifampicin resistance). From one experiment, pS32-1 transferred at a frequency of 4.62x10-6 
transconjugants/donor. A selection of transconjugants (numbering five) were screened by PCR 
for pS32-1 and pS32-2 (detail shown in Table 9.10) and both plasmids were detected.  
 
Table 9.10 Transconjugant screening 
Phenotype pS32-1 specific 
PCRs 
pS32-2 
specific PCR 
Plasmid/s 
present 
oxa23F-
oxa23R 
RH2506-
oxa23R 
RH1397-
RH1503 
TICRif + + + pS32-1, pS32-2 
Rifampicin, Rif; Ticarcillin, TIC. 
 
As the donor S32 is resistant to kanamycin, 100 potential transconjugants were additionally 
screened for resistance to this antibiotic to confirm that they were not rifampicin resistant 
mutants of the donor. All but one was susceptible to kanamycin indicating that they were 
transconjugants. To confirm that both of the plasmids were intact and no recombination had 
occurred to assist in the transfer of pS32-1, plasmid DNA was isolated from the donor, an 
empty recipient and a transconjugant. In both the donor and the transconjugant, bands at 
approximately the right size for pS32-1 (13,545 bp) and pS32-2 (70,833 bp) were detected 
(Figure 9.7). Hence, the plasmids had not fused. Plasmid DNA was digested with SwaI and 
compared to fragment sizes predicted by the in silico digest of the plasmid sequences (Figure 
9.8A and B). The digest of the donor and the transconjugant matched each other and the 
predicted product sizes. However, the 3 bands between 8-9 kb and the 3 bands between 4-5 kb 
did not separate, and the bands below 4 kb from pS32-2 are too faint to be detected (Figure 
9.8A and B). Therefore, pS32-1 is able to be mobilised by pS32-2 and likely by other RepAci6 
plasmids. 
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Figure 9.7 Plasmid visualisation in transconjugant. Plasmid DNA from S32 and from a pS32-1 containing 
AB307_0294 transconjugant (TC) and the empty recipient (AB) AB307_0294. These were run alongside plasmid 
DNA from 39R861+ (S) in a 0.7% agarose tris-acetate-EDTA gel. Sizes of plasmids in 39R861+ and the position 
of chromosomal DNA (chr) are indicated to the left.  
 
 
Figure 9.8 Restriction digest of transconjugant. A. Plasmid DNA of S32 and of the AB307_0294 
transconjugant (TC) containing pS32-1 digested with SwaI. HindIII l ladder (M1) and 1 kb DNA Ladder (M2) 
was used as markers and band sizes in kb are shown to the left and right. B. Predicted SwaI digestion pattern of 
pS32-1 and pS32-2.  
 
Mobilisation frequencies could not be calculated using S32 as a donor as the frequency of 
transfer of the cryptic pS32-2 could not be determined due to the absence of a selectable 
7 kb
chr
38 kb
66 kb
95 kb
S32 TC ABS
23.1 
9.4 
6.5 
4.3 
2.3 
2.0 
10 
8 
6 
5 
4 
3 
2
1.5 
1.0
0.5 
S32 TC M2
A. B.SwaI 
M1
in silico SwaI digest 
predictions (bp) 
pS32-1 pS32-2 
 25,278 
 13,514 
 8,536 
 8,270 
 8,159 
4,663  
4,483  
 4,399 
3,298  
 2,613 
1,101  
  64 
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marker. A different donor of ATCC 17978rif-A (sulphonamide susceptible and rifampicin 
resistant) containing pS32-1 (conferring resistance to ticarcillin) and the conjugative repAci6 
plasmid pAbG7-2 (containing TnaphA6 and conferring resistance to kanamycin) was 
constructed.  First, G7 was mated with ATCC 17978Rif-A and kanamycin resistant ATCC 
17978Rif-A were recovered and the of boundaries of TnaphA6 in pAb-G7-2 were detected 
(Table 9.11). pS32-1 was then transformed into ATCC 17978Rif-A (pAb-G7-2), and the 
presence of the transposon boundaries of Tn2006 and TnaphA6 in each plasmid was confirmed 
by PCR screening (Table 9.11).  
 
Table 9.11 Construction of ATCC 17978Rif-A (pS32-1, pAb-G7-2) 
Plasmid/s Phenotype pS32-1 Tn2006 location pAb-G7-2 TnaphA6 location 
RH2505-
RH743 
oxa23R-
RH2506 
RH1501-
aphA6R 
RH1502-
aphA6F 
N/A RfNx - - - - 
pAb-G7-2 RfNxKm - - + + 
pS32-1,  
pAb-G7-2 
RfNxKmTIC + + + + 
Kanamycin, Km; Nalidixic acid, Nx; Rifampicin, Rif; Ticarcillin, TIC.  
 
ATCC 17978Rif-A containing pS32-1 and pAb-G7-2 was mated with AB307_0294Nx (nalidixic 
acid resistant) and all outcomes of the mating were selected for (Table 9.12). The conjugative 
plasmid pAb-G7-2 transferred at frequencies ranging from 2.34x10-3 to 
4.06x10-4 transconjugants per donor, though the movement of pS32-1 was much less frequent 
(Table 9.12). In fact, following the removal of nalidixic-acid resistant mutants of the donor, 
over the three independent experiments, 82 ticarcillin and nalidixic acid resistant colonies were 
recovered. Two nalidixic acid and ticarcillin resistant transconjugants from each experiment 
were screened using PCRs shown in Table 9.11 and the junctions of both transposons were 
present. A small number of the nalidixic acid and ticarcillin resistant transconjugants (3/82) 
were kanamycin susceptible and while the junctions of Tn2006 in pS32-1 were present, neither 
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the junctions of TnaphA6 in pAb-G7-2 or the repAci6 gene was present in these 
transconjugants.  
 
Table 9.12 Frequency of pS32-1 mobilisation  
Plasmid/s 
selected  
Phenotype Observed transconjugants (transconjugants/donor) 
Round 1 Round 2 Round 3 Average 
pAb-G7-2 KmNx 2.34x10-3 4.06x10-4 6.16x10-4 1.12x10-3 
pS32-1 TICNx 2.90x10-8 4.51x10-8 1.45x10-8 2.95x10-8 
pS32-1, 
pAb-G7-2 
TICKmNx 3.18x10-8 1.31x10-8 9.68x10-9 1.12x10-8 
% mobilisation of pS32-11 0.0012 0.0111 0.0025 0.0049 
Kanamycin, Km; Nalidixic acid, Nx; Ticarcillin, TIC.  
1Frequency of pS32-1 (TICNx) divided by frequency of pAb-G7-2 (KmNx). 
 
Each independent experiment provided a low, but consistent, transfer frequency of pS32-1 
averaging at 2.95x10-8 transconjugants per donor (Table 9.12). The plasmid pS32-1 is able to 
be mobilised by repAci6 plasmids, at a proportion averaging 0.0049% of the transfer of pAb-
G7-2 (Table 9.12). 
 
9.6  Putative oriT region of pS32-1 
As pS32-1 does not contain genes matching any known relaxases (mob genes) (see Figure 9.1) 
it could be moving by “relaxase in trans” mobilisation. If this is the case both pS32-1 and 
pS32-2, and hence other RepAci6 plasmids, must have a closely-related oriT (origin of 
transfer) sequence. The oriT of RepAci6 plasmids has not been located nor has one been 
experimentally identified for any other Acinetobacter plasmid. The mobilisation genes of 
RepAci6 plasmids have previously been called trwB (an accessory protein) and trwC (the 
putative relaxase) the products of these genes are 27% and 30% aa identical to those of R388, 
an exemplar of the IncW plasmids. The nick region of the oriT of R388 is an F type (149).  
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The nucleotide sequence of pS32-1 was compared to the sequence of pS32-2 using pairwise 
BLAST to find any regions of identity. There was a strong match of 29/32 bp, that in pS32-2 
was located upstream of the trwB gene (Figure 9.9A). Just downstream of the trwB gene in 
pS32-2 is the trwC gene which encodes the predicted relaxase of the RepAci6 plasmid. In 
pS32-1, this match was located in the intergenic region between the last two open reading 
frames (Figure 9.9B). The 32 bp matching nucleotides of pS32-1 and pS32-2 as well as some 
additional surrounding sequence were compared to the oriT sequence of R388 (GenBank 
accession number X51505) (Figure 9.9C) and 7 of the 8 conserved bases of the F-type nick site 
(149) were present in pS32-1 and pS32-2 (green in Figure 9.9C).  
 
 
Figure 9.9 Putative oriT region of pS32-1 and pS32-2. A. trwB and trwC region of pS32-2. A pink circle 
indicates the location of the putative oriT region. Red arrows indicate direction and extent of the mobilisation 
genes. B. Linear structure of pS32-1. Genes encoding putative toxin/antitoxin modules are pink patterned and the 
rep genes is shown in blue. The tonB and oxa23 genes are coloured grey and orange.  The light blue boxes 
represent ISAba1 and the internal arrow indicates the transposase orientation. The orange box indicates the iteron 
sequence and flags indicate matching TSD. Vertical lines indicate XerC-XerD binding sites and the orientation 
of these sites are indicated above. C. Comparison of the putative oriT region of pS32-1 and pS32-2, compared to 
the oriT region of R388. Bases highlighted in green are conserved in F type nick sites and a vertical arrow indicates 
the nic-site. Coloured horizontal arrows indicate matching inverted repeats. The oriT sequence of R388 is taken 
from GenBank accession number X51505. 
 
A common feature of oriT sequences is the presence of direct and/or inverted repeats which 
produce a secondary structure that function as recognition sites for DNA-binding proteins 
A.
repAci1 500 bp
pS32-1
tonBabkA 
abkB
ISAba1 ISAba1oxa23 
trwB trwC
B.
pS32-2
C.
C/D D/C D/C
 
ATTTTTTTG-TCACACACCACGCATCTAACGATGACACCC-CTCAAAGCCTTACAGGA-TAAGGATTTCAGCGATT 
||||||||  |||||||||||||| |||||| ||       ||||| |||||   ||   |||| ||| || |  | 
ATTTTTTTTCTCACACACCACGCACCTAACGGTGCTTTTAGCTCAA-GCCTTTATGGTGCAAGGTTTTGAGTGGAT 
|| |        | |||   ||||||||  ||||||   ||  |||  |  ||||   ||             ||| 
ATCTGG-GCTATAGACAATACGCACCTTTCGGTGCGCGTAAGTCATTG-ATTTACAATGACTTCCACGCCAAGGAC  
 
 
pS32-1
pS32-2
R388 oriT
oriT
oriT
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(149). In the three plasmids compared above there are two sets of inverted repeats located in 
approximately the same region of DNA (indicated by horizontal coloured arrows in Figure 
9.9C). There is a short-inverted repeat (4-6 bp) located seven nucleotides away from the nic 
site (vertical arrow in Figure 9.9C). Further away from the nic site is the second set of inverted 
repeats (Blue arrows in Figure 9.9C) and in R388 this is a perfect 9 bp inverted repeat, while 
in pS32-1 and pS32-2 they are imperfect and are 12 and 11 nucleotides, respectively.  
 
The regions of pS32-1 and pS32-2 identified above, appear to be good candidates for the nick 
site and surrounding oriT region for of these plasmids. It is likely that the variation of the oriT 
site in each of these plasmids accounts for the low co-transfer frequency. Further work such as 
cloning the putative oriT region is still required to experimentally prove this assignment and to 
further characterise these regions.  
 
9.9 Discussion 
The small RepAci1 and RepAci2 plasmids analysed here are closely related to plasmids 
detected in isolates from Australia, and in the case of RepAci1 plasmids, from around the 
world. Unlike GC2 isolates in Australia, the most common small plasmid type was the RepAci1 
pAb-G7-1 type (also known as the pAB0057 type). Only S21 contained a RepAci2 plasmid 
that was closely related to the RepAci2 plasmid pD72-1 found in Australian isolates (193). The 
distribution of these small plasmids also correlated with the features of the resistance islands 
of the isolates. A RepAci1 plasmid was found in each of the 15 isolates that also contained 
AbGRI3.  The isolates that do not have AbGRI3 and contained AbGRI2-1, either had a 
RepAci2 plasmid in the case of S21, or do not include a version of either of these small 
plasmids.  
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The carriage of Tn2006 and TnaphA6 on pS32-1 and pS21-1 respectively, is the first time these 
transposons have been identified in RepAci1 or RepAci2 plasmids. Previously, Tn2006 had 
been seen either in the chromosome or in RepAci6 plasmids (194) and TnaphA6 has also been 
detected in RepAci6 plasmids (97, 192, 277). Resistant versions of the RepAci1 and RepAci2 
plasmids enabled incompatibility studies to be performed and showed for the first time that 
these plasmids were compatible.  
 
The plasmid pS21-1, a selectable RepAci2 plasmid containing mobilisation genes, was not 
mobilised by the conjugative RepAci6 plasmid, pS27-2. Perhaps other conjugative plasmids 
found in Acinetobacter, such as those of the pA297-3 type (87) or the conjugative plasmid 
types containing the NDM-1 gene (123, 284) would be able to mobilise pS21-1 and this should 
be tested. The only difference between pS21-1 and pD72-1 is the presence of TnaphA6 
(ISAba125-aphA6-ISAba125) where only a single copy of ISAba125 is present in pD72-1 and 
these insertions are in exactly the same location. Hence, either the pS21-1 version came first 
and recombination removed a copy of ISAba125 and the region containing aphA6 to form 
pD72-1, or pD72-1 came first and the region containing aphA6 and ISAba125 inserted adjacent 
to the copy of ISAba125 already present in pD72-1 to form pS21-1. The first scenario is 
plausible but unusual as this involves the loss of a useful resistance gene. The second scenario 
is interesting as it suggests that ISAba125 may function like IS26 and hence, be able to target 
itself (107).  
 
The plasmid pS32-1, the resistant version of the pAb-G7-1 RepAci1 plasmid, was shown to be 
mobilised at low frequency by two RepAci6 plasmids, firstly by the co-residing plasmid pS32-
2 and secondly by pAb-G7-2. Hence, it is likely that other plasmids resembling pAb-G7-1 are 
also able to be mobilised by RepAci6 plasmids. A putative oriT sequence of the F-type was 
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identified in pS32-1 and pS32-2, and it appears to be a good candidate due to conservation of 
bases at the nic site and the presence of inverted repeats in the adjacent sequence. However, 
further work will be required to confirm this. As pS32-1 does not contain any mobilisation 
genes, this is the first case of mobilisation in trans in Acinetobacter. This mode of mobilisation 
where the oriT of the small non-conjugative plasmid mimics the oriT of the conjugative 
plasmids was first detected in plasmids from Staphylococcus (200). Mobilisation in trans has 
also been detected in Gram-negatives with plasmids from E.coli (personal communication, 
Robert Moran). The detection of in trans mobilisation across Gram-negative and Gram-
positive species suggests that this form of mobilisation may be quite common and that small 
plasmids without mobilisation genes are likely to be playing a greater role in horizontal gene 
transfer than initially thought.  
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10.1 Introduction 
The XerC and XerD recombination system is used by most genera of bacteria to resolve dimers 
of circular chromosomal DNA into monomers (173). This system involves two tyrosine 
recombinases XerC and XerD which bind to a specific target site called a dif site located in the 
replication termination region of the chromosome (173). A dif site is 28 bp long and contains 
the 11 bp binding sites for the XerC and XerD recombinases, separated by a 6 bp spacer (173). 
Some mobile elements exploit the XerC-XerD recombination system of their host. Certain 
plasmids hijack this system to resolve plasmid dimers such as those containing a cer (39, 251) 
or psi (41) site. These sites contain a core dif-like site with the XerC and XerD binding site as 
well as additional sequence for the binding of necessary accessory proteins (173). Some 
integrative mobile elements do not encode their own recombinase but utilise the Xer 
recombination system of their host to integrate at dif (173). These are known as integrative 
mobile elements exploiting Xer (IMEXs) and a well-studied example is the CTXf phage which 
recombines into one of the dif sites of its host Vibrio cholerae (264).   
 
The oxa24 carbapenemase gene and its single base pair variant encoding OXA-72, have been 
found in plasmids from various Acinetobacter species. However, unlike other resistance genes 
such as the aminoglycoside resistance gene aphA6 or the different carbapenemase resistance 
gene oxa23, the oxa24 gene is not located in any known transposon. In the plasmid pABVA01, 
the authors identified conserved inverted repeats of 28 bp homologous to XerC-XerD binding 
sites (46) (Fig 10.1A, top line) surrounding the oxa24 gene. These sites contained the 11 bp 
binding sites for the XerC and XerD recombinase separated by a 6 bp spacer (46). In sequences 
of related plasmids available at the time, the authors also identified XerC-XerD binding sites 
in the same position of the backbone relative to rep, but they flanked different segments of 
DNA (46), suggesting that these modules are mobile. Since then, the oxa24 module has been 
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located in plasmids of different rep types, with different sequence on either side and in one 
case it is found twice in the same plasmid (46, 85, 172, 220), increasing the likelihood that this 
module is mobile (Fig 10.1A).  
 
 
Figure 10.1 Sequences containing the oxa24 and oxa58 carbapenemase genes. Arrows indicate the extent and 
orientation of genes and open reading frames. A. Plasmids containing the oxa24 dif module. The rep genes are 
dark blue and oxa24 is purple. Genes encoding putative toxin/antitoxin modules are pink patterned. Yellow arrows 
indicate genes encoding proteins showing homology to mobilisation proteins and the tonB dependent transporter 
is in grey. Vertical black bars indicate pdif sites and the orientation of the site is indicated above. B. Re27-1 
elements surrounding the oxa58 gene in A. baumannii MAD. The light green box represents ISAba2, the dark 
green box is ISAba3 and the arrows inside indicates the transposase orientation. Re27 elements are indicated as 
red bars. Figures made to scale from GenBank accession numbers FM210331 (pABVA01), GQ342610 
(pMMCU1), JX069966 (pAB120) and AY665723 (MAD).  
 
As the XerC and XerD binding sites do not appear to have any additional accessory sequence, 
similar to dif sites in the chromosome, we will refer to them as plasmid borne dif sites or pdif 
from now on. Several further modules surrounded by inversely-oriented pdif sites (46), 
hereafter referred to as dif modules, have been identified. A putative toxin/antitoxin system in 
pAB120 (indicated by the pink striped arrows in Fig 10.1A) is located between two inversely-
oriented pdif sites and also found in unrelated plasmids may also be mobile (220). Examination 
ara1ISAba2∆ISAba3 
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est oxa58 ara2lysE rt3ISAba3∆
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tonBoxa24
C/D D/C
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of the sequence surrounding the oxa58 carbapenemase-encoding resistance gene revealed 
direct repeats of 27 bp, also called Re-27 elements (red lines in Fig 10.1B) (216). Later these 
repeat elements were also recognised to be pdif sites (46).  
 
Recently, the small plasmid pRCH52-1 recovered from a non GC1 or GC2 clinical isolate from 
Brisbane was found to contain the tet39 tetracycline resistance determinant (98). However, 
identification of clear boundaries for a module containing these genes using the two additional 
sequences available in GenBank at the time was unsuccessful (98).  
 
The work in this chapter focuses on a small plasmid from the Singapore GC2 collection 
carrying the tet39 determinant and the msrE and mphE macrolide resistance genes. Analysis 
revealed that both of these resistance determinants are located in dif modules. Several further 
dif modules were also identified.  
 
10.2 pS30-1 
During the Stand-alone BLAST search of the S30 genome using the pAb-G7-1 backbone as 
query, two contigs were retrieved (Table 10.1).  A small segment of 237 bp of contig 39 (7.5 
kb) matched with 85% identity to a region prior to the rep gene in pAb-G7-1. Contig 38 (7.7 
kb) matched pAb-G7-1 with a 100% identity over a short region of 34 nucleotides. Both contig 
38 and 39 ended with fragments of the same IS, which is related to ISAjo2 (Fig 10.2A). Another 
search of the draft genome of S30 recovered the internal ISAjo2-like IS sequence (Table 10.1). 
 
Table 10.1 Contigs of pS30-1  
Contig Length Coverage Features 
38 7,498 285.2070 tet39 determinant, msrE, mphE 
39 7,770 306.8410 - 
44 1,482 526.6480 ISAjo2-like IS 
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ISAjo2 is 1,482 bp in length and is reported to produce a 5-6 bp target site duplication upon 
insertion into a DNA sequence (64) (https://www-is.biotoul.fr). Primers were designed to link 
the ends of contig 38 and 39 that had matching 5 bp duplications to assemble pS30-1 (Fig 
10.2A). RH2502 and tet39R were paired, predicted to amplify a product 1,918 bp in size, while 
RH2503 and RH2504 should produce an amplicon of 2,058 bp. In both cases, the amplicon 
appeared to be of the predicted size and was then sequenced to complete the plasmid, which 
was named pS30-1. This plasmid was 18,234 bp in size and the copy number relative to the 
chromosome calculated from sequence coverage is approximately 10 to 11.  
 
 
Figure 10.2 Assembly and structure of pS30-1. A. Schematic of contig 38 and 39.  Boxes indicate fragments of 
an ISAjo2-like IS and the arrows inside indicate the direction of the transposase gene. Matching TSD are shown 
above the line. The bars below the line show primers used for assembly along with the size of the amplicons. B. 
Annotation of pS30-1. Arrows indicate extent and orientation of genes and open reading frames. Genes encoding 
putative toxin/antitoxin modules are pink patterned and rep genes are shown in blue. The tet39 determinant is red 
while the msrE and mphE genes are orange.  Mobilisation genes are highlighted yellow and ser is purple. The box 
represents ISAjo2-1 and the internal arrow indicates the transposase orientation. The orange box indicates the 
iteron sequence and matching flags indicate target site duplication.   
 
The two IS copies inserted in pS30-1 are identical to one another and share 94% DNA identity 
with ISAjo2. They are referred to as ISAjo2-1 from here on. ISAjo2-1 contains a single open 
reading frame that produces a 458 aa putative transposase that shares 97% aa identity with that 
of ISAjo2.  
 
rep(new2) orf tetA39 tetR39 msrE mphE mobAISAjo2-1 ISAjo2-1ser orf orf orf orfmobC
orf orf
pS30-1
higB
higA
500 bp
S30_39 S30_39S30_38
AACGC AACGC ACACT ACACT
500 bp
A. 
B. 
RH2502-tet39R
1,918 bp
RH2503-RH2504
2,508 bp
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Several open reading frames were identified in pS30-1 and pBLAST was used to determine 
their putative functions where possible (Table 10.2 and annotated on Fig 10.2B).  
 
Table 10.2 Open reading frames and predicted products encoded by pS30-1 
orf orf length 
(bp) 
Protein 
size (aa) 
Product Pfam 
1 924 307 RepA (new-2)1 Rep_3, pfam01051 
2 537 178 OrfQ YlxM, COG2739 
3 1,326 441 TnpA, ISAjo2-1 Rve, pfam00665 
4 1,122 374 TetA39 MFS_1, pfam07690 
5 720 240 TetR39 TetR_C, pfam02909 
6 321 106 HigB, toxin RelE, pfam062960 
7 273 90 HigA, anti-toxin HTH_3, pfam01381 
8 1,476 492 MsrE Uup, COG0488 
9 885 295 MphE MPH2`, cd05152 
10 609 203 Ser2 Resolvase, pfam00239 
11 333 111 Orf  
12 171 56 Orf  
13 222 73 Orf  
14 1,326 441 TnpA, ISAjo2-1 Rve, pfam00665 
15 1,026 341 Orf  
16 1,248 415 Orf  
17 309 102 Orf  
18 306 101 MobC Fam199X, pfam15814 
19 1,437 479 MobA MobA/mobL, 
pfam03387 
1new-1 is in pMMCU1 in Fig XA.   
2Short for Serine Recombinase. 
 
pS30-1 encodes a replication initiation protein Rep that belongs to the Rep_3 superfamily 
(pfam01051). The Rep of pS30-1 is 99.7% (306/307 aa) identical to the Rep protein of pM131-
5, (GenBank accession number JX101644) (126) from an A. soli. To date only Rep types from 
Acinetobacter baumannii plasmids have been characterised and allocated Aci numbers (21), 
hence we have called the Rep of pM131-5 and pS30-1 Rep (new 2).  Thereafter, the closest 
numbered Rep is RepAci3 (GenBank accession number GU978997), with 91% aa identity 
(278/307 aa). A putative iteron sequence of four identical repeats of 22 bp is located 
approximately 50 bp upstream of the rep gene (5` AACGAGGTTTACCTTGCATTAA 3`) in 
pS30-1 and pM131-5. 
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The orf directly following the rep gene in pS30-1 contains a domain matching YlxM, which is 
a predicted DNA binding protein (Table 10.2). Most small plasmids in Acinetobacter contain 
a second reading frame directly downstream of the rep gene. This reading frame is most often 
also annotated as rep, implying it has some role in replication, though the reasoning for this is 
not explained (46). Furthermore, during analysis of pMAC (56), it was determined that the 
sequence containing the iterons and the region encoding the Rep protein, RepAci9 (178/308 
aa, 58% identical to Rep of pS30-1), was all that was required for replication. Henceforth, we 
will refer to the gene following the rep of pS30-1 as orfQ.  
 
Table 10.3 Comparison of OrfQ of pS30-1 to the product of the orf following the rep gene 
in selected plasmids 
Plasmid Rep type Length of Orf 
following Rep (aa) 
Pfam of Orf % identity to OrfQ 
of pS30-1 (aa) 
pAb-G7-1 RepAci1 1911 HTH_17, 
pfam12728 
28% (56/200 aa) 
pD72-1 RepAci2 1911 HTH_17, 
pfam12728 
28% (57/199 aa) 
pBAL_204-1 RepAci3 181 - 79% (144/182 aa) 
pMAC RepAci9 172 - 51% (94/185 aa) 
pM131-5 Rep (new 2) 178 YlxM, COG2739 99% (176/178 aa) 
1These two protein as 190/191 aa identical to each other.  
 
The sequence of the orf following the rep gene is variable in Acinetobacter plasmids as not all 
of the proteins match the same Pfam or even have a recognisable conserved domain (Table 
10.3). Furthermore, the RepAci1 and RepAci2 plasmids pAb-G7-1 and pD72-1 both produce 
proteins of 99.5% identity (190/191 aa) (Table 10.3) and this homology is clear in the DNA 
comparison in Chapter 9; Fig 9.1. OrfQ in pS30-1 is most closely related to that produced 
pM131-5, followed by the Orf translated from the RepAci3 plasmid pBAL_204-1, while only 
distantly related to the Orf encoded by pAb-G7-1 and pD72-1 (Table 10.3).  
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Plasmid pS30-1 (Fig 10.2B) contains the tet39 tetracycline determinant composed of the tetA39 
and tetR39 genes (6) and the macrolide resistance genes msrE and mphE (132). In addition, 
there is also a putative toxin/antitoxin system (indicated by the pink arrows in Fig 10.2B), the 
first orf of which produces a 107 aa protein of the HigB toxin family (256), while the second 
translates to a 91 aa protein with a helix-turn-helix DNA binding domain (274), likely 
performing the function of the counterpart antitoxin HigA. A small serine recombinase, here 
named ser (serine recombinase), is also present (purple arrow in Fig 10.2B). The last orf 
encodes a 479 aa protein that shares 31% aa identity over 49% of the 709 aa MobA protein of 
RSF1010 (GenBank accession number NC_001740), the prototype for the MOBQ family of 
mob genes (68). The reading frame upstream of mobA in pS30-1 translates to an 88 aa protein 
that shares 42% identity with the 94 aa MobC protein of RSF1010. A number of other open 
reading frames are also present; however, they produce hypothetical proteins of unknown 
function (Table 10.2).  
 
10.3 pS30-1 transformation 
pS30-1 was transformed into ATCC 17978-A and tetracycline resistant transformants were 
screened to detect specific genes and junctions of the plasmid (Table 10.4). The CDS profile 
of one transformant was determined and was consistent with the presence of pS30-1 and 
showed the absence of the second plasmid, pS30-2 (described in detail in Chapter 8; Section 
8.6), which would confer resistance to kanamycin (Table 10.4). The tet39 determinant 
conferred resistance to tetracycline, reduced susceptibility to doxycycline but did not affect 
minocycline (Table 10.4), which is consistent with the findings in the original report of this 
resistance determinant (6).   
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Table 10.4. Transformation of pS30-1 
Strain Plasmid pS30-1 specific PCRs Annular radius (mm) 
 tetA39F-
tetA39R 
tetA39R- 
RH2502 
Tc Mc Do Km Su  
S30 pS30-1 + + 0 5 1 0 0  
ATCC17978-A - - - 7 10 10.5 8.5 12  
ATCC 17978-A TF-1 pS30-1 + + 0 9 6 9 13  
Tetracycline, Tc; Minocycline, Mc; Doxycycline, Dc; Kanamycin, Km; Sulphamethoxazole, Su.  
 
 
The msrE and mphE genes confer resistance to macrolide antibiotics (132), a class of antibiotic 
not commonly used clinically for treatment of Gram-negative bacteria due to a high level of 
intrinsic resistance (151). However, initial characterisation of these genes involved 
transforming a region containing both genes into an E. coli, which resulted in an increase in 
erythromycin resistance from 0.5 µg/L to 64 µg/L (132). The ability of pS30-1 to confer 
resistance to erythromycin was tested by patching ATCC 17978-A and two pS30-1 containing 
transformants on agar containing increasing concentrations of erythromycin; 2, 8, 16, 32, 64, 
128 mg/L (Fig 10.3).  
 
ATCC 17978-A had faint growth on 16 mg/L of erythromycin and could not grow on 
concentrations above this (Fig 10.3). However, even the highest concentration tested (128 
mg/L) was unable to inhibit growth of transformants when pS30-1 was present (Fig 10.3). 
Although these concentrations of erythromycin are much higher than what would be used 
clinically it still enables the resistance genes to be detected in the laboratory.  
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Figure 10.3 Erythromycin resistance. The concentration of erythromycin tested in each frame is shown above. 
TF1 is ATCC 17978-A(pS30-1) TF-1, TF2 is ATCC 17978-A(pS30-1) TF-2 and  R is the empty recipient ATCC 
17978-A. 
 
10.4  RepAci6 plasmids does not mobilise pS30-1 
As pS30-1 harbours mobilisation genes the ability for it to be mobilised by a RepAci6 plasmid 
was tested. S30 contains two plasmids, pS30-1 and pS30-2, the second of which is a 
conjugative RepAci6 plasmid containing the oxa23 gene in Tn2008 (conferring resistance to 
ticarcillin) as well as the aphA6 gene in TnaphA6 (conferring resistance to kanamycin) 
(Chapter 8; Section 8.2). Transfer experiments were performed using S30 as a donor and ATCC 
19606Rif (rifampicin resistant) or AB307_0294Rif (rifampicin resistant) as the recipient and 
testing all possible outcomes (Table 10.5). With both recipients, only ticarcillin resistance was 
transferred, attributed to the transferral of only pS30-2, as confirmed via PCR screening (Table 
10.5). Hence, pS30-1 is not mobilised by pS30-2 and likely not by other RepAci6 plasmids.  
 
 
 
 
128 mg/L32 mg/L
16 mg/L2 mg/L
RTF2TF1
R
R
TF2
TF2
TF1
TF1
TF1 RTF2
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Table 10.5 pS30-1 mobilisation experiments 
Strain Plasmids Phenotype Observed 
transconjugants1 
pS30-1 specific 
PCRs 
pS30-2 specific 
PCRs 
 tet39F-
tet39R 
tet39R-
RH1502 
oxa23F-
oxa23R 
RH1503-
RH1397 
S30-1 (donor) pS30-1, 
pS30-2 
TcTIC N/A + + + + 
ATCC19606Rif 
(recipient) 
N/A Rif N/A - - - - 
ATCC19606Rif  pS30-1 TcRif <8.7x10-9 N/A N/A N/A N/A 
ATCC19606Rif  pS30-2 TICRif Y 
2.34x10-5 
- - + + 
ATCC19606Rif  pS30-1, 
pS30-2 
TcTICRif <8.7x10-9 N/A N/A N/A N/A 
AB307_0294Rif 
(recipient) 
N/A Rif N/A - - - - 
AB307_0294Rif  pS30-1 TcRif <3.9x10-9 N/A N/A N/A N/A 
AB307_0294Rif  pS30-2 TICRif Y 
3.90x10-5 
- - + + 
AB307_0294Rif pS30-1, 
pS30-2 
TcTICRif <3.90x10-9 N/A N/A N/A N/A 
Rifampicin, Rif; Tetracycline, Tc; Ticarcillin, TIC.  
1 Frequency is expressed as transconjugants per donor and is calculated from one experiment. 
 
10.5  XerC-XerD binding sites in pS30-1 
Plasmid pS30-1 did not have any clear relatives in GenBank. Rather, small fragments of this 
plasmid matched fragments of other Acinetobacter plasmids. Some of these matching regions 
included the sequence encoding the tet39 tetracycline resistance determinant and the msrE and 
mphE macrolide resistance genes. The boundaries of the tet39 determinant have not been 
previously defined (98) and the macrolide resistance genes in pS30-1 do not appear to be in 
any known transposon. As XerC-XerD binding sites had been found surrounding the oxa24 
and the oxa58 resistance genes in Acinetobacter plasmids, a manual search for these sites in 
pS30-1 was performed, resulting in the identification of 8 pdif sites, numbered from left to right 
(Fig 10.4). The location and orientation of the pdif sites are indicated on Fig 10.4A, with 
sequences of the identified pdif sites compared in Fig 10.4B. For these identified pdif sites, 
there is greater variability in the sequence of the XerC binding sites than XerD binding sites. 
Apart from the sequence of the spacer in the first and third pdif site, the rest of the spacers are 
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unique. A number of these sites surround segments of DNA containing 1 or 2 genes, including 
the region containing the tet39 determinant and the msrE-mphE genes and the following sub-
sections of Section 10.5 detail these.  
 
 
Figure 10.4 pS30-1 pdif sites. A. The location of dif sites in pS30-1. Arrows indicate the extent and orientation 
of genes and open reading frames. The tetA gene and the tetR genes of tet39 are shown in red and rep genes are 
dark blue. Genes encoding putative toxin/antitoxin modules are pink or pink patterned. The msrE and mphE 
resistance genes are orange and ser, encoding a serine recombinase is purple. Genes encoding proteins showing 
homology to mobilisation proteins are coloured yellow. The light green box represents ISAjo2-1 and the internal 
arrow indicates the transposase orientation. Vertical bars indicate pdif sites and the orientation of the site is shown 
above. B. Comparison of the sequence of the 8 pdif sites from left to right. The bases highlighted in red in the 
XerC and XerD sites vary.  
 
10.5.1 pdif sites bound tet39 
The first two pdif sites (pdif1 and pdif2) identified in pS30-1 surround the tetA39 and tetR39 
genes. Like the oxa24 module, these two sites are inversely-oriented with XerC-XerD on the 
left and XerD-XerC on the right. These sites surround a 2,001 bp DNA segment containing the 
tet39 determinant that together likely form a dif module. Using this putative dif module as a 
query in GenBank, five sequences were retrieved (Table 10.6). A manual search for pdif sites 
was performed in each of these five sequences as no pdif sites had been annotated previously 
(Table 10.6).  
 
rep(new2) orf tetA39 tetR39 msrE mphE mobA
C/D1 C/D3D/C2 D/C4 D/C8
ISAjo2-1 ISAjo2-1ser orf orf orf orf
mobC
C/D5 C/D6
D/C7
orf orfhigB
higA
   XerC         XerD
ATTTCGTATAA GGTGTA TTATGTTAATT
GTTTCGCATAA CAGCCA TTATGTTAAAT
ATTTCGTATAA GGTGTA TTATGTTAATT
ACTTCACATAA GAAATT TTATGTTAAAT
AGTTCGTATAA TACGTA TCATATTAATT
ATTTCGTATAA CGTGTA TTATGTTAATT
ACTTCGTATAA CCGCCA TTATGTTAAAT
ATTGCGTATAA GAGATT TTATGTTAAAT
500 bp
A. 
B. 
pdif1
pdif2
pdif3
pdif4
pdif5
pdif6
pdif7
pdif8
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Table 10.6 Sequences containing the tet39 dif module 
Sequence Sequence 
Length 
(bp) 
pdif 
sites 
Source Accession no. Reference 
pS30-1 18,234 8 A. baumannii KY617771 This study 
pRCH52-1 11,164 3 A. baumannii KT346360 (98) 
pAB1H8 10,246 3 A. baumannii ANNC01000048 (118) 
pLU56051 3,727 1 Acinetobacter AY743590    (6) 
TE_01Z_000_contig 111 2,446 2 Uncultured 
bacterium 
KU545777 (206) 
TE_IN_B_contig_81 3,953 3 Uncultured 
bacterium  
KU544458 (206) 
1Partial sequences 
 
The same 2,001 bp segment was also found surrounded by inversely-oriented pdif sites in 
pRCH52-1, pAB1H8, TE_01_00_contig 11 and TE_IN_B_contig8 (Fig 10.5). The original 
sequence for the tet39 determinant in pLUH5605 (GenBank accession number AY743590) (6) 
has a pdif site on the left but does not extend far enough to include the pdif site to the right. 
Beyond the bounding pdif sites there is little similarity between each of the sequences (Fig 
10.5), allowing the boundaries of this dif module to be defined. Hence, the tet39 determinant 
is located in a dif module that has been found in 6 different contexts, which demonstrates that 
it is mobile.  
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Figure 10.5 The tet39 dif module. Comparison of regions containing the tet39 resistance determinant. Partial 
sequences are marked with an asterisk. Arrows indicate the extent and orientation of genes and open reading 
frames. The tetA gene and the tetR genes of tet39 are shown in red and rep genes are dark blue. Genes encoding 
putative toxin/antitoxin modules are pink or pink patterned. The msrE and mphE resistance genes are orange and 
ser, encoding a serine recombinase is purple. Genes encoding proteins showing homology to mobilisation proteins 
are coloured yellow. The tonB gene encodes a TonB-dependent transporter homologue. The light green box 
represents ISAjo2-1 and the internal arrow represents the transposase orientation. The extents of regions with 
significant DNA identities are shown in grey. Vertical bars indicate pdif sites and the orientation of the site is 
shown above, and flags indicate target site duplications. The picture is drawn to scale from the GenBank entries 
listed in Table 10.6.  
 
The sequences of the pdif sites flanking the tet39 module were compared (Table 10.7) and both 
the left and the right pdif sites showed variation. Consequently, neither the left or right pdif site 
could be clearly be assigned to the module. If variation in the XerC-XerD sequence was 
present, it was located in the outermost sites (in this case XerC) and the 6 bp spacer region 
(Table 10.7), while the innermost XerD sites were always conserved.  
 
 
 
 
 
 
 
rep(new2) orf tetA39 tetR39 msrE mphE mobA
C/D1 C/D3D/C2 D/C4 D/C8
ISAjo2-1 ISAjo2-1
C/D D/C
rep(new3) orf
ser
tetA39 tetR39
orf orf orf orf
mobC
orf orf orf orfabkA 
abkB
tetA39 tetR39
C/D C/DD* D/C
rep(new4)orf orf orf orfabi abiEi orfmobA
C/D 500 bp
tetA39 tetR39rep(new5) orf
mobS∆
C/D D/C
tetA39 tetR39
tetA39 tetR39∆mphE
C/DD/C D/C
TE_IN_B_contig_8*
TE_01Z_000_contig11*
pLUH5605*
pAB1H8
pRCH52-1
tonB
C/D5 C/D6
D/C7
orf orf
pS30-1
83% 74% 86%
78%65%
90%
100%
100%
100%
100%
100%
ser
higB
higA
D/C
Sequence tet39 fragment 
size (bp) 
Left dif site: XerC-XerD Right dif site: XerD-XerC 
pS30-1 2,001 ATTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAATGGCTGTTATGCGAAAC 
pRCH52-1 2,001 ATTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAATGGATATTATACGAAGT 
pAB1H8 2,001 ATTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAATAGAGCTTATGCGAAAT 
pLUH5605 1,986 ATTTCGTATAAGGTGTATTATGTTAATT - 
TE_01Z_000_contig11 2,001 ATTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAATAGAGCTTATACGAAAT 
TE_IN_B_contig_8 2,001 AATTCGTATAACGCGTATTATGTTAATT ATTTAACATAATAGAGCTTATACGAAAT 
!
A.
B.
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Table 10.7 Comparison of pdif sites surrounding the tet39 determinant  
Sequence tet39 
fragment 
size (bp) 
Left pdif site: XerC-XerD Right pdif site: XerD-XerC 
pS30-1 2,001 ATTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAATGGCTGTTATGCGAAAC 
pRCH52-1 2,001 ATTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAATGGATATTATACGAAGT 
pAB1H8 2,001 ATTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAATAGAGCTTATGCGAAAT 
pLUH5605 1,986 ATTTCGTATAAGGTGTATTATGTTAATT - 
TE_01Z_000_
contig11 
2,001 ATTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAATAGAGCTTATACGAAAT 
TE_IN_B_ 
contig_8 
2,001 AATTCGTATAACGCGTATTATGTTAATT ATTTAACATAATAGAGCTTATACGAAAT 
Red bases vary.  
 
10.5.2 pdif sites bound the msrE-mphE gene pair 
The pdif sites 3 and 4 are in inverse orientation with XerD sites internal (XerC-XerD and XerD-
XerC) and flank a 2,950 bp segment containing the msrE and mphE macrolide resistance genes 
(Fig 10.4A). A search of GenBank with this segment revealed that five other plasmids and 
partial sequences contain the same segment (Table 10.8). However, none these five plasmids 
also included the tet39 determinant (Table 10.8).  
 
Table 10.8 Plasmids containing the msrE and mphE dif module 
Sequence Sequence 
Length (bp) 
pdif 
sites1 
Source Accession no. Reference 
EF1022402 13,122 5 A. baumannii EF102240 (213) 
pABIR 29,823 13 (2) A. baumannii EU294228 (281) 
pOXA58_882 36,862 16 (2) A. pittii CP014479 (7) 
pXBB1-9 398,857 12 (9) A. johnsonii CP010351 (64) 
p255n-1 92,939 9 A. baumannii KT852971 (235) 
1Number of pdif sites identified in this study. If any pdif or Re27 sites were identified previously, the number 
found is in brackets.  
2This sequence is of a cloned insert of a larger plasmid from A. baumannii A1.   
 
No XerC-XerD sites in the sequence of EF102240 and p255n-1 had been annotated. pABIR 
(281) and pOXA58_882 (7) had previously been reported to contain two Re27 sites while 
pXBB1-9 had been annotated with both Re27 and XerC-XerD sites (totalling 9 sites) (64). All 
sequences were manually searched for pdif sites and in all cases additional sites were identified 
(Table 10.8). The region containing the msrE-mphE genes were compared (Fig 10.6) to attempt 
to define the module containing these genes.   
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Figure 10.6 msrE-mphE dif module. Comparison of sequences containing the msrE and mphE resistance genes. 
Partial sequences are marked with an asterisk. Arrows indicate the extent and orientation of genes and open 
reading frames. The tetA gene and the tetR genes of tet39 are shown in red. Genes encoding putative 
toxin/antitoxin modules are pink or pink patterned. The msrE and mphE resistance genes are orange and ser, 
encoding a serine recombinase is purple. Genes encoding proteins showing homology to mobilisation proteins are 
coloured yellow. The light green box indicates ISAjo2-1, while and the dark green box indicates IS18, and the 
internal arrows indicates the transposase orientation. Vertical bars indicate pdif sites and the direction of the site 
is shown above, and flags indicate TSD. The extents of regions with significant DNA identities are shown in grey 
and the numbers are the DNA identities. The picture is drawn to scale from the following GenBank accession 
numbers listed in Table 10.8.  
 
Unlike the tet39 modules, all sequences had the same putative toxin/antitoxin sequence to the 
left of the msrE-mphE genes and all apart from p255n-1 had the ser gene on the right (Fig 
10.6). As a consequence, when the sequences of the pdif sites surrounding the msrE-mphE 
genes were compared there were only two variants (Table 10.9) and the second was present in 
p255n-1, which is consistent with the different set of genes adjacent to the right pdif site. Again, 
variation was present in the outermost binding site. In the case of the msrE-mphE genes, the 
msrE mphE serISAba8 ∆ISAjo2orftox2
atox2
500 bp
D/C D/C D/CC/D C/D
EF102240*
4517/4521 bp
tetA39 tetR39 msrE mphE
C/D3 D/C4
higB orf
C/D5
 KU544458
higA
4502/4502 bp
hicA toxin
hicB antitoxin
tox3
atox3
D/C C/D C/DD/C D/C
pABIR
msrE mphE
msrE mphE IS18tox3
D/C D/C D/CC/D C/D
pOXA58_882
5730/5734 bp
orf
atox3
orf
msrE mphE IS18 orf∆ISAjo2
pXBB1-9
orf
C/D D/C
pS30-1
33/33 bp
ISAjo2∆
6706/6720 bp
33/33 bp
ser
ser
ser
ser
C/D
D/C2
orf
C/D1
msrE mphEorf orforf
C/D D/CD/C
p255n-1
3699/3700 bp
higB
higA
higB
higA
higB
higA
higB
higA
higB
higA
Sequence msr(E)/mph(E) 
fragment size 
(bp) 
Left dif site: XerD-XerC Right dif site: XerC-XerD 
pS30-1 2,950 ATTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAAAATTTCTTATGTGAAGT 
p255n-1 2,950 ATTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAAAATTTCATATACGAAAT 
!
msrE mphE
D/C
ISEc29 ∆orf44armA
tetA39 tetR39 msrE mphE
C/D D/C
higB orf
C/D
higA
pS30-1
ser
D/CC/D
Tn1548/Tn6180
2916/2919 bp
A.
B.
C.
500 bp
E-mphE C-XerD D erC
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dif module was defined as the central 2,950 bp containing these resistance genes surrounded 
by inversely-oriented pdif sites, which was present in the 6 sequences examined here (Fig 10.6).  
 
Table 10.9 pdif sites surrounding the msrE-mphE determinant 
Sequence msrE-mphE 
fragment size 
(bp) 
Left pdif site: XerC-XerD Right pdif site: XerD-XerC 
pS30-11 2,950 ATTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAAAATTTCTTATGTGAAGT 
p255n-1 2,950 ATTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAAAATTTCATATACGAAAT 
Tn1548 2,891 - ATTTAACATAAAATTTCTTATACGAAAT 
1EF102240, pABIR, pOXA58_882 and pXBB1-9 have the same sequence pdif sequence.  
 
The msrE and mphE resistance genes are also found in Tn6180, located in AbGRI3 in some 
GC2 isolates (Chapter 6) (23), and in the closely related transposon Tn1548 (83). These two 
transposons were examined for pdif sites and were found contained the right pdif site of the 
msrE-mphE dif module, but an ISEc29 has replaced the left pdif site and 120 bp of the internal 
sequence (Fig 10.7). The sequence of the right pdif site is a third variation (Table 10.9).  
 
 
Fig 10.7 Comparison of the region containing msrE-mphE in pS30-1 and Tn1548/Tn6180. Arrows indicate 
the extent and orientation of genes and open reading frames. The armA, tet39 determinants, msrE-mphE are 
coloured maroon, red and orange, respectively. Putative toxin-antitoxin genes are pink and the ser gene is purple. 
The light blue box is ISEc29 and the internal arrow indicate the direction transposase orientation. Vertical bars 
indicate pdif sites and the direction of the site is shown above. The extents of regions with significant DNA 
identities are shown in grey.  
 
 
 
msrE mphE serISAba8 ∆ISAjo2orftox2
atox2
500 bp
D/C D/C D/CC/D C/D
EF102240*
4517/4521 bp
tetA39 tetR39 msrE mphE
C/D3 D/C4
higB orf
C/D5
 KU544458
higA
4502/4502 bp
hicA toxin
hicB antitoxin
tox3
atox3
D/C C/D C/DD/C D/C
pABIR
msrE mphE
msrE mphE IS18tox3
D/C D/C D/CC/D C/D
pOXA58_882
5730/5734 bp
orf
atox3
orf
msrE mphE IS18 orf∆ISAjo2
pXBB1-9
orf
C/D D/C
pS30-1
33/33 bp
ISAjo2∆
6706/6720 bp
33/33 bp
ser
ser
ser
ser
C/D
D/C2
orf
C/D1
msrE mphEorf orforf
C/D D/CD/C
p255n-1
3699/3700 bp
higB
higA
higB
higA
higB
higA
higB
higA
higB
higA
Sequence msr(E)/mph(E) 
fragment size 
(bp) 
Left dif site: XerD-XerC Right dif site: XerC-XerD 
pS30-1 2,950 ATTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAAAATTTCTTATGTGAAGT 
p255n-1 2,950 ATTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAAAATTTCATATACGAAAT 
!
msrE mphE
D/C
ISEc29 ∆orf44armA
tetA39 tetR39 msrE mphE
C/D D/C
higB orf
C/D
higA
pS30-1
ser
D/CC/D
Tn1548/Tn6180
2916/2919 bp
A.
B.
C.
500 bp
E-mphE C-XerD D erC
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10.5.3 Additional dif modules in pS30-1 
In addition to the two modules described above, four other potential dif modules bounded by 
inversely-oriented pdif sites were identified in pS30-1. One, located between the tet39 and the 
msrE-mphE modules, contains two overlapping open reading frames that encode a putative 
HigB toxin and HigA antitoxin system (Fig 10.4A), and are flanked by inversely-oriented pdif 
sites (XerD-XerC and XerC-XerD).  As mentioned in Section 10.5.2, this module was located 
to the left of the msrE-mphE module in the six plasmids examined (Fig 10.6). However, in 
most cases the plasmids differed in the sequence to the left of the higB/higA module (Fig 10.6 
and Table 10.10). Where the left and right pdif sites were detected, the sequences were 
identical, including the sequence of the 6 bp spacer (Table 10.10).   
 
Table 10.10 The higB and higA toxin/antitoxin dif module 
Sequence higB/higA 
fragment 
size (bp)1 
Sequence left of 
module 
Left dif site: XerD-XerC Right dif site: XerC-XerD Sequence 
right of 
module 
pS30-1 701 tet39 ATTTAACATAATGGCTGTTATGCGAAAC ATTTCGTATAAGGTGTATTATGTTAATT msrE-mphE 
p255n-1 701 orf  
(META domain) 
ATTTAACATAATGGCTGTTATGCGAAAC ATTTCGTATAAGGTGTATTATGTTAATT msrE-mphE 
pOXA58_
882 
703 orf  
(SMI1_KNR4 
domain) 
ATTTAACATAATGGCTGTTATGCGAAAC ATTTCGTATAAGGTGTATTATGTTAATT msrE-mphE 
pABIR 701 orf  
(SMI1_KNR4 
domain) 
ATTTAACATAATGGCTGTTATGCGAAAC ATTTCGTATAAGGTGTATTATGTTAATT msrE-mphE 
EF102240 4,1472 orf  
(no known 
domains) 
ATTTAACATAATGGCTGTTATGCGAAAC ATTTCGTATAAGGTGTATTATGTTAATT msrE-mphE 
pXBB1-9 >7013 orf  
(HTH domain) 
- ATTTCGTATAAGGTGTATTATGTTAATT msrE-mphE 
1Sequence between the left and right dif site.  
2ISAjo2 has inserted adjacent to the left dif site and an ISAba8 has interrupted the ISAjo2.  
3Has a fragment of ISAjo2 in the same location as EF102240 but then goes into different sequence and there is 
no discernible dif site in this sequence.  
 
Downstream of the msrE-mphE module in pS30-1 is a region encoding a small serine 
recombinase (ser) surrounded by pdif4 and pdif5 which are inversely-oriented (XerD-XerC and 
XerC-XerD). With the exception of p255n-1, the ser gene is also found following the msrE-
mphE module (Fig 10.6), however, there are two variants of the ser module based on the 
presence of a pdif site on the right (Table 10.11).  
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Table 10.11 The ser dif module  
Sequence ser 
fragment 
size (bp)1 
Sequence 
left of 
module 
Left dif site: XerD-XerC Right dif site: XerC-XerD Sequence 
right of 
module 
pS30-1 809 msrE-mphE ATTTAACATAAAATTTCTTATGTGAAGT AGTTCGTATAATACGTATCATATTAATT orf (no known domains) 
pABIR 809 msrE-mphE ATTTAACATAAAATTTCTTATGTGAAGT AATTCGTATAACGTGCATTATGTTAATT hicA/hicB 
TE_IN_B_ 
contig_8 
809 msrE-mphE ATTTAACATAAAATTTCTTATGTGAAGT AATTCGTATAACGCGTATTATGTTAATT tet39 
EF102240 809 msrE-mphE ATTTAACATAAAATTTCTTATGTGAAGT AATTC- - 
pOXA58_882 7802 msrE-mphE ATTTAACATAAAATTTCTTATGTGAAGT  IS18, orf 
pXBB1-9 7802 msrE-mphE ATTTAACATAAAATTTCTTATGTGAAGT  IS18, orf 
1Sequence between the left and right dif site.  
2After 780 bp the sequence diverges from the sequence in pS30-1 and the other plasmids.  
 
The variant with the pdif site on the right includes pS30-1, TE_IN_B_contig_8 (KU54458) and 
pABIR. EF102240 is also a member of this group though the available sequence only extends 
4 bp into the XerC binding site of the right dif. The right pdif sequence and 29 bp of the ser 
module directly prior to it have been replaced 33 bp of unrelated sequence including an IS18 
in pOXA58_882 and pXBB1-9 (Fig 10.6), with the absence of any site resembling a XerC-
XerD binding site found in the sequence directly following the IS18. Serine recombinases bind 
to three subsites within an approximately 114 bp res site, resI, II and III (243). They then cut 
the DNA at the centre of the active site, located within resI, with a 2 bp ‘stagger’ (248). It is 
reasonable to suggest that a res site for ser is located in the sequence between the start codon 
of ser and the dif site on the right (these sites are underlined and boxed Fig 10.8, respectively). 
The divergence in sequences between groups could be explained by the ser gene facilitating a 
recombination event within resI in pOXA58_882 and pXBB1-9, accounting for the divergence 
in sequence between the two groups. The putative 2 bp stagger is in bold in Fig 10.8.  
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Figure 10.8 Comparison of the sequence at the right end of the ser module. The nucleotides of the ser gene 
are purple and the start codon is underlined. Sequence of IS18 is green. The XerC and XerD binding sites are 
boxed in red and orange, respectively. The putative two base pair stagger is in bold. Asterisks indicate conserved 
base pairs.   
 
The pdif sites 6 and 7 in pS30-1 are also in inverse orientation to one another, bounding 368 
bp of DNA with a single open reading frame that encodes a protein of no known function (Fig 
10.4A). This same 368 bp fragment of DNA is also found in pALWVS1.1 (GenBank accession 
number KX426232) (175) and a search of the surrounding sequence revealed two pdif sites, 
the sequence of which are compared to those of pS30-1 in Table 10.12. As this module was in 
different contexts in pS30-1 and pALWVS1.1 (Table 10.12) there is evidence that it too is a 
mobile dif module.  
EF102240        AACTAACAATGTGTCACCTTGATTTGCTTCTGACAGTAGCTTATTCAATTCAGGTCGGTC 
pABIR           AACTAACAATGTGTCACCTTGATTTGCTTCTGACAGTAGCTTATTCAATTCAGGTCGGTC 
pOXA58_882      AACTAACAATGTGTCACCTTGATTTGCTTCTGACAGTAGCTTATTCAATTCAGGTCGGTC 
pXBB1-9         AACCAACAAGGTGTCACCTTGATTTGCTTCTGACAGTAGCTTATTCAATTCAGGTCGGTC 
                *** ***** ************************************************** 
pS30-1          TAACTTCGTACCACTATAGTTTTCCACGTACACAATGGTTTCACCCAAATTCAAGTTTTG 
KU544458        TAACTTCGTACCACTATAGTTTTCCACGTACACAATGGTTTCACCCAAATTCAAGTTTTG 
EF102240        TAACTTCGTACCACTATAGTTTTCCACGTACACAATGGTTTCACCCAAATTCAAGTTTTG 
pABIR           TAACTTCGTACCACTATAGTTTTCCACGTACACAATGGTTTCACCCAAATTCAAGTTTTG 
pOXA58_882      TAACTTCGTACCACTATAGTTTTCCACGTACACAATGGTTTCACCCAAATTCAAGTTTTG 
pXBB1-9         TAACTTCGTACCACTATAGTTTTCCACGTACACAATGGTTTCGCCCAAATTCAAGTTTTG 
                ****************************************** ***************** 
pS30-1          GTTTAGATCCTGAAGAATCTGCAAAGCCCTTTCTGCATCTTGATCTTTAGTTGAAGCTCG 
KU544458        GTTTAGATCCTGAAGAATCTGCAAAGCCCTTTCTGCATCTTGATCTTTAGTTGAAGCTCG 
EF102240        GTTTAGATCCTGAAGAATCTGCAAAGCCCTTTCTGCATCTTGATCTTTAGTTGAAGCTCG 
pABIR           GTTTAGATCCTGAAGAATCTGCAAAGCCCTTTCTGCATCTTGATCTTTAGTTGAAGCTCG 
pOXA58_882      GTTTAGATCCTGAAGAATCTGCAAAGCCCTTTCTGCATCTTGATCTTTAGTTGAAGCTCG 
pXBB1-9         GTTTAGATCCTGAAGAGTCTGCAAAGCCCTTTCTGCATCTTGATCTTTAGTTGAAGCTCG 
                **************** ******************************************* 
pS30-1          TAGATAAATACGTGTATTCATTTCTATCATTTAATCTTAATTCTATTAGATTAATGATAA 
KU544458        TAGATAAATACGTGTATTCATTTCTATCATTTAATCTTAATTCTATTAGATTAATGATAA 
EF102240        TAGATAAATACGTGTATTCATTTCTATCATTTAATCTTAATTCTATTAGATTAATGATAA 
pABIR           TAGATAAATACGTGTATTCATTTCTATCATTTAATCTTAATTCTATTAGATTAATGATAA 
pOXA58_882      TAGATAAATACGTGTATTCATTTCTATCATTTAATCTTAATTCTATTAGATTAATGATAA 
pXBB1-9         TAGATAAATACGTGTATTCATTTTTATCATTTAATCTTAATTCTATTAGATTAATGATAA 
                *********************** ************************************ 
pS30-1          TACTATCATTTAATTATTGCATTAAGTCTAATGATAGATATTGTATGCGATTTGGCTCGC 
KU544458        TACTATCATTTAATTATTGCATTAAGTCTAATGATAGATATTGTATGCGATTTGGCTCGC 
EF102240        TACTATCATTTAATTATTGCATTAAGTCTAATGATAGATATTGTATGCGATTTGGCTCGC 
pABIR           TACTATCATTTAATTATTGCATTAAGTCTAATGATAGATATTGTATGCGATTTGGCTCGC 
pOXA58_882      TACTATCATTTAATTATTGCATTAAGTCTAATGATAGATATTGTATGCGATTTGGCTCGC 
pXBB1-9         CACTATCATTTAATTATTGCATTAAGTCTAATGATAGATATTGTATGCGATTTGGCTCGC 
                 *********************************************************** 
pS30-1          TATCATTCAGGTATACTCTTTTGATAGAAAAAGCATGACTGAAAGCCATGCTTTGGGAGT 
KU544458        TATCATTCAGGTATAGTCTTTTGATAAAAAAAGCATGACTAAAAGCCATGCCTTGGGAAT 
EF102240        TATCATTCAGGTATACTCTTTTGATAAAAAAAGCATGACTAAAAGCCATGCCTTGGGAAT 
pABIR           TATCATTCAGGTATAGTCTTTTGATAAAAAAAGCATGACTAAAAGCCATGCCTTGGGAAT 
pOXA58_882      TATCATTCAGGTATAGTCTTTTGATAGACTGCTTGTTTGCGGAATGTTCCGATTTGAACC 
pXBB1-9         TATCATTCAGGTATAGTCTTTTGATAGACTGCTTGTTTGCGGAATGTTCCGATTTGAACC 
                *************** ********** *       *      **        ** * *   
pS30-1          TCGTATAATACGTATCATATTAATTTTGGAAAAATTAGATATTGATTGGGAGTGA  
KU544458        TCGTATAACGCGTATTATGTTAATTTTAGATAAACTATAGAATCCATTAGTTTTT  
EF102240        TC-----------------------------------------------------  
pABIR           TCGTATAACGTGCATTATGTTAATTTTAGAAAAGCTTAAGAAATATCATTAAAAA  
pOXA58_882      ACGCAGATTCAAATCCCAAGTGCAACACATTTGTAGTCAGTTGAAAAAGTTAGGT  
pXBB1-9         ACGCAGATTCAAATCCCAAGTGCAACACATTTGTAGTCAGTTGAAAAAGTTAGGT  
                 *                                                           
pS30-1          CTAAAGCTGTAGAGTTTCTTTTTAAGTGAGTCCCCAAAATGAAAT- 
KU544458        AAACCAATAAATTAAATATTTTAT-GGAACTCCAGAATATTTATTC 
EF102240       ---------------------------------------------- 
pABIR         TCAGGTTTACAATTTCCGAAAATC-ATACCTCTAGGGTTATTGACA 
pOXA58_882      CATAGAATCATTAGA-CTTTTTCAACTCGCAATTG-----GAAAGC 
pXBB1-9         CATAGAATCATTAGA-CTTTTTCAACTCGCAATTG-----GAAAGC 
                                                               
XerC XerD
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Table 10.12 pdif sites 6 and 7 bound a dif module 
Sequence orf 
fragment 
size (bp) 
Sequence 
left of 
module1 
Left dif site: XerC-XerD Right dif site: XerD-XerC Sequence 
right of 
module1 
pS30-1 368 orf, orf ATTTCGTATAACGTGTATTATGTTAATT ATTTAACATAATGGCGGTTATACGAAGT ISAjo2-1, orf 
pALWVS1.1 368 antitoxin2/ 
toxin3 
ACTTCGTATAAGGTGTATTATGTTAATT ATTTAACATAATGGCGCTTATACGAAGT orf 
1All genes called orf are different.  
2 RelE/DinJ family. 
3 RelE/StbE family. 
 
The pdif8 site upstream of the mobC gene and pdif1 are also in inverse-orientation and could 
potentially move as a module (Fig 10.4A). However, when comparing this region to available 
sequences in GenBank this does not appear to be the case. A comparison of pS30-1 to pM131-
5, which contains a rep almost identical to pS30-1, is shown in Fig 10.9. The region of high 
similarity (98.9 % DNA identical) over the rep gene ends approximately 100 bp prior to the 
first pdif site of pM131-5.  In addition, the match over the region containing the mob genes 
starts just prior to these genes and does not encompass dif8 (Fig 10.9).  
 
 
Figure 10.9 Comparison of pM131-5 and pS30-1. Arrows indicate the extent and orientation of genes and open 
reading frames. The tetA gene and the tetR genes of tet39 are shown in red and rep genes are dark blue. Genes 
encoding putative toxin/antitoxin modules are pink or pink patterned. The msrE and mphE resistance genes are 
orange and ser, encoding a serine recombinase is purple. Genes encoding proteins showing homology to 
mobilisation proteins are coloured yellow. The tonB gene encodes a TonB-dependent transporter homologue. The 
light green box represents ISAjo2-1 and the internal arrow indicates the transposase orientation. Vertical bars 
indicate pdif sites and the direction of the site is shown above. The extents of regions with significant DNA 
identities are shown in grey and the numbers are the DNA identities. 
 
The pdif sites 5 and 6, and 7 and 8, are in direct orientation with one another (Fig 10.4A). These 
two pairs of sites flank open reading frames that produce proteins of unknown functions (Table 
10.2). When these segments of DNA were used as queries against GenBank, no matches were 
rep (new 2)
orf tetA39 tetR39 msrE mphE mobA
C/D1 C/D3D/C2
D/C4 D/C8
ISAjo2-1 ISAjo2-1ser orf orf orf orf mobC
C/D5 C/D6D/C7
orf orfhigB higA
500 bp
C/D D/C D/C
98.90% 100% 97.44% 96.62% 90.69%
rep (new 2) vapC toxinorf orf mobAmobC
pM131-5
pS30-1
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detected. Hence, it is unclear at this point if these two segments are potentially mobile dif 
modules.  
 
10.7 Two types of dif modules 
An emerging feature from the analysis of the pdif sites in pS30-1 and in several other plasmids 
is that, in most cases, the pdif sites surrounding a module are inversely-oriented. This was 
noticed earlier using only a few sequences (46) and is largely true in the cases described above.  
This inevitably leads to two types of dif modules. One variation of the dif module is flanked by 
pdif sites which are oriented as XerC-XerD and a XerD-XerC site respectively, such that the 
XerD binding sites are internal to the segment. I will henceforth refer to such dif modules as D 
modules, which include the tet39 and msrE-mphE module (Fig 10.4A) as well as the oxa24 
module (Fig 10.1) (46). The second variation of dif modules are instead bounded with pdif in 
the XerD-XerC/XerC-XerD arrangement (XerC sites are internal) are referred to as C modules. 
Examples of these include the higA/higB, ser and orf module in pS30-1 (Fig 10.4A).  
 
10.6.1 C and D modules alternate 
When a region contains multiple dif modules, the D and C modules should alternate due to the 
nature of inversely-oriented pdif sites. The first four modules in pS30-1 alternate (Fig 10.10).  
 
 
Figure 10.10 Alternating C and D modules in pS30-1. Arrows indicate the extent and orientation of genes and 
open reading frames. The tetA gene and the tetR genes of tet39 are shown in red and rep genes are dark blue. 
Genes encoding putative toxin/antitoxin modules are pink or pink patterned. The msrE and mphE resistance genes 
are orange and ser, encoding a serine recombinase is purple. Genes encoding proteins showing homology to 
mobilisation proteins are coloured yellow. The light green box represents ISAjo2-1 and the internal indicates the 
transposase orientation. Vertical bars indicate pdif sites and the orientation of these sites are shown above. D and 
C modules are indicated above by pink and blue dashed lines bounded by arrows, respectively.  
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As the Re-27 sites surrounding the oxa58 gene were identified as direct repeats (64, 216, 281), 
the regions surrounding this gene in A. baumannii MAD were examined. The partial 7.8 kb of 
sequence supplied in GenBank accession number AY665723) (214, 216), which is a part of an 
approximately a 30 kb plasmid, was examined for additional pdif sites. As shown in Fig 10.11, 
two additional pdif sites were found, and both are in the opposite orientation to the Re-27 sites. 
One creates a smaller C type dif module containing oxa58 and an adjacent D module containing 
genes usually annotated araC and lysE. The second additional pdif site discloses an additional 
adjacent C dif module (Fig 10.11). and with the additional pdif sites in A. baumannii MAD the 
identified modules in this sequence follow the trend of C and D alternation (Fig 10.11).   
 
Figure 10.11 The oxa58 gene is located in a dif module in pMAD. Arrows indicate the extent and orientation 
of genes and open reading frames. The oxa58 gene is dark orange. The light green box represents ISAba2, the 
dark green box is ISAba3 and the internal arrows indicate the transposase orientation. Vertical red and black bars 
represent Re27 and pdif sites, respectively, and the orientation of the pdif sites are shown above. D and C modules 
are indicated above by pink and blue dashed lines bounded by arrows.  
 
To further test whether alternation of the C and D dif modules is a general feature of dif module 
regions, pABIR (29.8 kb) and pOXA58_882 (36.8 kb) were examined. These two plasmids 
were identified in the msrE-mphE module comparison and when more of the adjacent sequence 
was examined, a total of 13 and 16 pdif sites, respectively (Table 10.8) were identified. The 12 
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modules in pABIR all alternate, as do the 15 modules in pOXA58_882 (Fig 10.12A and B). 
Both of these plasmids include the oxa58 resistance gene, and although this gene is located 
between two inversely-oriented dif sites in both plasmids the internal sequence of this module 
appears to vary.  
 
The overall trend when there are multiple dif modules in the same sequence appears to be that 
the two types of dif module should alternate. However, as seen in pS30-1 (Fig 10.10), this is 
not always the case.  Two regions of this plasmid are surrounded by directly-oriented pdif sites 
and careful examination did not reveal an additional site within them. Another region bounded 
by directly-orientated dif sites containing the abkA-abkB toxin/antitoxin system and the tonB 
gene, is found in pD72-1 and pAb-G7-2 (Chapter 9; Fig 9.1) and the same region is also present 
in pRCH51-1 (Fig 10.13A). Whether these regions are actually fusions of two dif units may 
become apparent as further sequences become available but a clear fusion can be seen in the 
case of the ser module (Fig 10.6) and the incomplete mphE-msrE gene module in Tn1548 (Fig 
10.7), suggesting that these events do occur.  
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Figure 10.12 Runs of C and D modules. Alternating C and D modules in A. pABIR and B. pOX58_882. Arrows indicate the extent and orientation of genes and open reading 
frames. The oxa58 and msrE-mphE genes are in dark orange and orange. The purple arrow is ser, and genes encoding proteins showing homology to mobilisation proteins are 
coloured yellow. Putative toxin/antitoxin genes are pink or pink patterned. Boxes indicate various IS and the identity of each is shown below, and the internal arrows indicates 
the transposase orientation. pdif sites are shown as vertical bars and their orientation is shown above. D and C modules are indicated above by pink and blue dashed lines 
bounded by arrows. Figure made to scale from GenBank accession numbers EU29428 (pABIR) and CP014479 (pOXA58_882).
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10.7  XerC-XerD experiments 
In order to begin to understand how these dif modules are moving, an experiment was designed 
to attempt to detect recombination. Two plasmids that have different selectable marker located 
within dif modules were required. The sequence of the 6 bp spacer may be a factor in 
recombination, so the plasmids were also chosen to share an identical spacer region in at least 
one of the pdif sites present. To make the possible recombination events easier to discern the 
plasmids used were also selected to contain as few pdif sites as possible.    
 
10.7.1 pRCH51-1 and pBAL_204-1 
Within the collection of sequenced isolates available in the Hall laboratory, two plasmids fit 
the above requirements. These were pRCH51-1 (102) (GenBank accession number KT34360) 
and pBAL_204-1 (235) (GenBank accession number KT946773), and the structures of these 
two plasmids are shown in Fig 10.13. pRCH51-1 is resistant to tetracycline as it contains the 
tet39 determinant in a dif module while pBAL_204-1 has the oxa24 gene in a dif module and 
is resistant to ticarcillin. pRCH51-1 is identical to pRCH52-1 (mentioned in section 10.6.1). 
The repA genes of pRCH51-1 and pBAL_204-1 are 86% identical, with the RepA proteins 
sharing 90% aa identity.  However, the iteron sequences of the two plasmids are identical (5` 
TAAAACGAGGTTTACCTTGCAT 3`). This indicates that the two plasmids may be 
incompatible with one another. Utilising the regions of variability, primers were designed to 
independently detect the rep region of each plasmid (Fig 10.13). The combination of RH2530 
and RH2531 will amplify an 860 bp region of pRCH51-1 while RH2528 and RH2529 will 
amplify an 833 bp region of pBAL_204-1. The sequence of the pdif sites in both plasmids are 
shown in Fig 10.13 with identical 6 bp spacer sequences in matching colours. Additionally, 
plasmids can be distinguished by a unique restriction enzyme site, PstI in pRCH51-1 and DraIII 
in pBAL_204-1 (indicated by the vertical arrows in Fig 10.13A and B).   
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Figure 10.13 Structure of pRCH51-1 and pBAL_204-1. Arrows indicate the extent and orientation of genes 
and open reading frames. The rep genes are blue and the tetA39 and tetR39 genes are shown in red. Genes 
encoding putative toxin/antitoxin modules are shades of pink. The oxa72 gene is purple. Vertical bars indicate dif 
sites and the sequence and the direction of the sites are shown above. Vertical arrows show enzyme restriction 
sites. Bars indicate different PCRs and the primers and product sizes are provided. The asterisk associated with a 
XerD site indicates that it is 10 bp long rather than 11 bp.  
 
10.7.2 pRCH51-1 and pBAL_204-1 in AB307_0294 
Electrocompetent AB307_0294 was transformed with RCH51 genomic DNA (2 µL of 1,585.8 
ng/µL). Transformants were selected for using tetracycline and 100 potential transformants 
were present on the 10-1 dilution.  Five were screened for the presence of the tetA39 gene (using 
primers tet39F and tet39R, amplicon size of 219 bp) (Fig 10.13A) to confirm the presence of 
pRCH51-1.  Additionally, AB307_0294 was also transformed with BAL_204 genomic DNA 
(2 µL of 1,431 ng/µL). Only 30 potential transformants were recovered on plates supplemented 
with ticarcillin and 5 were screened for the presence of the oxa24 gene (utilising the primers 
oxa24-F and oxa24-R to amplify a 249 bp product) (Fig 10.13B) to confirm the presence of 
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C/D D/C
C/D
D/C
pBAL_204-1
KT946773
7,155 bp
ATTTCGTATAA GGTGTA TTATGTTAATT
ATTTAACATAA TGGGCG TTATATGAAAT
ATTTCGGATAA CGCCCA TTATGTTAAAT
AATTAACATAA TACACC TTATACGAAGC
500 bp
RH2530-RH2531
860 bp
tet39F-tet39R
219 bp
RH2528-RH2529
833 bp
RH2534-oxa24-R
1,221 bp
oxa24-F-oxa24-R
249 bp
D*/C
ATTTAAATAA AATCTC TTATGCGAAAT
orf
A.
B.
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pBAL_204-1. The lower transformation frequency reveals pBAL_204-1 is either less readily 
transformed into AB307_0294 or is less stable than pRCH51-1.  
 
AB307_0294 containing pBAL_204-1 was then transformed with pRCH51-1 and tetracycline 
resistant transformants containing pRCH51-1 were selected. 419 tetracycline resistant colonies 
were detected on the 10-1 dilution and 50 of these were screened for additional resistance to 
ticarcillin. All were susceptible to ticarcillin indicating that they had lost pBAL_204-1, 
supporting the predicted incompatibility of pBAL_204-1 with pRCH51-1. The reciprocal 
experiment was performed where AB307_0294 containing pRCH51-1 was transformed with 
pBAL_204-1, selecting for ticarcillin resistant transformants containing pBAL_204-1. Only 
three colonies were recovered from the undiluted transformation mix. Upon screening, all 
colonies were susceptible to tetracycline, indicating that they had not retained pRCH51-1. The 
lowered yield of transformants recovered from the second experiment could be due to 
replication incompatibility, but it may not be the only constraint. Indeed, competition between 
different toxin/anti-toxin systems identified on each of these plasmids (pink arrows in Fig. 
10.13A and B) may also be a factor. 
 
The transformation mix of AB307_0294 containing pRCH51-1 (TcR) transformed with 
pBAL_204-1 (TICR) was then tested using plates supplemented with tetracycline and ticarcillin 
to select transformants resistant to both antibiotics. However, no transformants were recovered 
and the experiment was not repeated due to time limitations. 
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10.8 ISAjo2 and ISAba32 target dif sites 
10.8.1 ISAjo2 and relatives 
Both copies of ISAjo2-1 (97% aa identity to ISAjo2) in pS30-1 are inserted 5 bp away from a 
XerC binding site of a pdif site (Fig 10.14). The IS also faces in the same direction with respect 
to the orientation of the pdif site in both cases. When the copy of ISAjo2 found in EF102240 
(Fig 10.6) was examined here, it was also found to be adjacent to a XerC binding site (Fig 
10.14).  
 
Figure 10.14 Alignment of ISAjo2 insertion sites in pS30-1 and EF102240. The bases in green are part of the 
left IR of ISAjo2 and the arrows indicate the direction of the transposase. pdif sites are highlighted in orange and 
the XerC and XerD binding sites are underlined. Bases in bold represent the target site which is duplicated.  
 
A search of the nucleotide database using ISAjo2 as a query was performed to determine if 
other relatives of ISAjo2 were also located adjacent to putative pdif sites. A number of IS were 
identified (Table 10.13) with DNA identity to ISAjo2 ranging from 90% to 100%. Most of 
these IS would be considered to be isoforms of ISAjo2 by ISFinder as the amino acid similarity 
of their transposase to that of ISAjo2 is 98% or higher. Therefore, they were numbered as 
variants of ISAjo2 (Table 10.13). The context of these IS were examined and they were always 
found to be facing the same orientation, 5 or 6 bp away from a putative XerC binding site of a 
dif site (Table 10.13).  This indicates that ISAjo2 and its relatives target a specific location in 
an orientation specific manner and generate a 5 or occasionally 6 bp TSD.  
 
pS30-1                  XerC            XerD 
CTATTTTGGAGTTACAAACGCATTTCGTATAAGGTGTATTATGTTAATTTTAGATAAACTATAGAATC 
 
CTATTTTGGAGTTACAAGTGTACTTCGTATAACCGCCATTATGTTAAATGGGGAATAAAATACGATCA 
EF102240  
CTATTTTGGAGTTACAATCTCGTTTCGCATAACAGCCATTATGTTAAATGCAGGGTATCTAATTTCTA 
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ISAjo2 is currently in the IS1202 group of the ISNCY (not characterised yet) category in 
ISFinder. The gene internal to this IS encodes a 441 aa protein (Fig 10.15A) that matches 
Pfam00665, which is a member of the retroviral integrase superfamily of transposases i.e. a 
DDE transposase. The IR of this transposon is 24 nucleotides long as shown in Fig 10.15B 
with 21 bp identical and the bounding ends are 5` TGT 3`. The size of this IR and the sequence 
of its terminal bases, as well as causing a 5 bp duplication, is similar to those of Tn7 (210), 
Tn5053 and Tn402 (138) and Tn6019, Tn6021 and Tn6022 (88). A feature of these transposons 
is the repetition of the IR sequence just within each end of the transposon which delineate the 
right and left end of the transposon. Almost complete direct duplication and a smaller inverse 
duplication of the IR sequence can also be found at each end of ISAjo2-1 (black triangles and 
arrows in Fig 10.15A and B) and their different spacing could differentiate each end.  
 
 
Figure 10.15 IR of ISAjo2-1. A. Schematic of ISAjo2-1. The green box is ISAjo2 and the internal arrow indicates 
the transposase orientation. The black triangles above indicate the location and the orientation of IR or partial IR 
repeats. B. The IR of ISAjo2-1 is repeated within each end. The bases highlighted in green are the IR sequences. 
The arrows above and below indicate the location and extent of repeated sequence matching the IRs. The numbers 
indicate the identity of the repeat sequence to the IR and the bases in bold are the same as the IR.  
 
The closest relative to ISAjo2 in the IS1202 group is ISAba32, was also discovered in A. 
baumannii (96), and the location of these IS were examined to determine if they are also found 
adjacent to dif sites.  
tnpA 100 bp
ISAjo2 IR (20/24 bp) 
TGTAAGCCCCAAGTAGAAATGTCCGGTTTCTCCA 
||| |  || ||||||||||||||    |    | 
TGTTATTCCTAAGTAGAAATGTCCTACCTAATAA 
A. 
B. 
1,482 bp
 
 
TGTAACTCCAAAATAGAAATGTCCGGTTTCTCCAAAGTAAAAATGTCCGCTTTTAGAATATGCACTTTTGCAATTTCGTTAGCGGACGGTTTGATATGTTGGTG 
||| | |||||| |||||||||||    |    |    | | |  |   || |  | | |        |  |     |      ||     |  | || | |   
TGTTATTCCCAAGTAGAAATGTCCTACCTAATAACCAAATAGAAATGTCCTATATGGACAATTCCAAGTCAAGCACAGGATTTAGATTTCGTTCTTTGATTGCT 
17/19 bp
16/17 bp 9/11 bp
9/14 bpIRl
IRr
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Table 10.13 Relatives of ISAjo2 in GenBank 
Sequence Number 
of IS 
copies 
Identity to ISAjo2 ISAjo2 variant Distance from 
XerC binding 
site (bp) 
Source GenBank 
accession 
number 
Reference 
pXBB1-9 11 100% [1482/1482] ISAjo2 52 A. johnsonii CP010351 (64) 
pM131-2 1 100% [1482/1482] ISAjo2 5 Acinetobacter sp. JX101647  
EF102240 1 96.6% [1432/1482] ISAjo2-2 5 A. baumannii EF102240 (213) 
pNDM-32 23 94.4% [1399/1482] ISAjo2-1 5 A. baumannii LN833432  
pAF-401 33 94.1% [1395/1482] ISAjo2-1 5 A. baumannii CP018255  
AF-401 1 94.1% [1395/1482] ISAjo2-1 5 A. baumannii CP018254  
pS30-1 23 94.1% [1394/1482] ISAjo2-1 5 A. baumannii KY617771 This study 
pMMCU2 1 94.1% [1394/1482] ISAjo2-1 6 A. baumannii NC_013506 (172) 
pNCu2D-2 14 92.6% [1373/1483] ISAjo2-3 6 Acinetobacter sp. CP015595  
p1AsACE 11  91.6% [1357/1482] ISAjo2-4 6 A. schindleri CP015616  
pAV2 23 90.9% [1349/1484] ISAjo2-5 5 A. venetianus DQ278486  
pAHTJS2 1 90.2% [1337/1484] ISAjo2-6 5 A. haemolyticus CP018873  
1Partial copy also present. 
2Reported as 6 in ISFinder. 
3Copies are within the same sequence and are identical to each other. 
4SNPs truncate the tnpA gene. 
 
Table 10.14 Relatives of ISAba32 in GenBank. 
Sequence Number 
of IS 
copies 
Identity to 
ISAba32 
ISAba32 
variant 
Distance 
from XerC 
binding site 
(bp) 
Source GenBank 
accession 
number 
Reference 
pD36-4 1 100% [1482/1482] ISAba32 5 A. baumannii CP012956 (96) 
pALWED2.1 1 94.0% [1393/1482) ISAba32-1 5 A. Iwoffii KX426229 (175) 
pALWED3.1 1 92.8% [1375/1482] ISAba32-2 5 A. Iwoffii KX528687 (175) 
TTH0-4 2 91.8% [1360/1482] ISAba32-3 5 Acinetobacter sp.  CP012608  
  91.5% [1356/1482] ISAba32-4 5    
pXBB1-8 1 91.2% [1351/1482] ISAba32-5 5 A. johnsonii CP010358 (64) 
pHH1107 11 89.6% [1327/1482] ISAba32-6 5 Uncultured bacterium FJ012881 (112) 
pHHV216 11 896% [1327/1482] ISAba32-6 5 Uncultured bacterium FJ012880 (112) 
pM131-2 11 89.3% [1323/1482] ISAba32-7 5 Acinetobacter sp.  JX101647  
a1,481 bp in length.
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10.8.2 ISAba32 and close relatives 
The sequence of ISAba32 is 73.3% identical to ISAjo2 and the encoded 445 aa transposase is 
72% identical to that of ISAjo2. Interestingly, examination of the sequence surrounding the 
copy of ISAba32 in pD36-4 (GenBank accession number CP012956) (96), revealed that it was 
also inserted 5 bp to the XerC binding site of a pdif site that was not noted previously. ISAba32 
is also 1,482 bp in size and created a 5 bp direct duplication upon insertion. The 26 bp inverted 
repeats with 20 bp identical of ISAba32 are longer than those of ISAjo2 but share homology 
with those of ISAjo2 at the inner and outermost ends (Fig 10.16). 
 
  
Figure 10.16 IR sequence of ISAba32 and its relationship to that of ISAjo2-1. The blue highlighted 
nucleotides are IR sequence of ISAba32 while the green bases are the IR of ISAjo2-1.  
 
Several entries in GenBank contained unnamed IS with sequence identity of 89% or higher to 
ISAba32 (Table 10.14). In each of these sequences, careful inspection of the surrounding 
regions revealed that the IS was again located 5 bp away from a previously unidentified XerC 
binding site.  
 
It appears that the variants of ISAjo2 and ISAba32 both target the same sequence, a XerC 
binding site, though how this targeting is achieved is unclear. Transposons Tn7 (210), Tn402 
(176) and the related transposons Tn6019, Tn6021 and Tn6022 in A. baumannii have also been 
shown to target a specific sequence (88, 217). Target specificity in Tn7 (210) and Tn402 (176) 
 
IS in pS30-1 
TGTTATTCCCAAGTAGAAATGTCCTACCTAATAACCAAATAGAAATGTCC 
||| | ||| || |||||||||||    |   |    | | |     | 
TGTAACTCCAAAATAGAAATGTCCGGTTTCTCCAAAGTAAAAATGTCCGC 
 
 
 
17/23 
TGTTATTCCTAAGTAGAAATGTCCTACCTAATAA 
||||||||   | |  |||||||    | || || 
TGTTATTCACCAATTAAAATGTCTATGCGAAAAA 
 
 
ISAjo2 IR (20/24 bp) 
TGTAAGCCCCAAGTAGAAATGTCCGGTTTCTCCA 
||| |  || ||||||||||||||    |    | 
TGTTATTCCTAAGTAGAAATGTCCTACCTAATAA 
 
 
ISAba32 (20/26 bp) 
TGTTAGAACCCATTTAAAGTGTCTATATTCTCAC 
|||||    ||| ||||| |||||||      |      
TGTTATTCACCAATTAAAATGTCTATGCGAAAAA 
 
ISAjo2-1 vs ISAba32 
17/22 bp 
TGTTATTCCCAAGTAGAAATGTCCTACCTAATAA 
|||||||| | | |  |||||||    | || ||   
TGTTATTCACCAATTAAAATGTCTATGCGAAAAA 
 
 
ISAjo vs ISAba32 (14/23 bp) 
TGTAAGCCCCAAGTAGAAATGTCCGGTTTCTCCA 
||| |  | | |    |||||||          | 
TGTTATTCACCAATTAAAATGTCTATGCGAAAAA 
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is provided by an additional protein encoded in the transposon. As the only open reading frame 
in ISAjo2 and ISAba32 is the transposase, this protein is likely to be performing this role as 
well.  
 
10.9 Discussion  
The finding that the tet39 determinant and the msrE-mphE gene pair are each part of mobile 
dif modules adds to those carrying the oxa24 and oxa58 genes (46, 64, 85, 172, 216, 220, 281) 
bringing the number of antibiotic resistance determinants found in dif modules in Acinetobacter 
plasmids to four (bold in Table 10.15). However, the oxa58 module in pMAD was redefined 
here (Top line in Fig 10.17).  
 
Table 10.15 dif modules in Acinetobacter plasmids 
dif module Module size (bp)1 Module type 
tet39A, tet39R 2,001 XerD 
msrE-mphE 2,950 XerD 
higB, higA 701 XerC 
ser 8092 XerC 
orf 368 XerD 
oxa58 3,5683 XerC 
oxa24 911 XerD 
Toxin/antitoxin4 1,369 XerC 
dif modules containing antibiotic resistance determinants.  
1Nucleotides between the flanking pdif sites.  
2When the full module is present. 
3This is the distance present in pMAD and this distance varies in other plasmids.  
4Present in pAB120.  
 
During the analysis of pMAD, pOXA58_882 and pABIR it was noted that the content of the 
oxa58 module was quite variable (Fig 10.17 and Table 10.15). In fact, the oxa58 module was 
a different size in each of these three plasmids (Table 10.15). Most of this variation can be 
accounted for by the addition of various IS (location of insertion indicated by the dotted lines 
in Fig 10.17). However, the left end of the module is missing in pABIR. The pdif site on the 
left and the 27 bp next to it in pMAD and pOXA58_882 have been replaced by IS26 and a 
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fragment of Tn5393 (Fig 10.17). It is possible that an IS26 located within another module, 
caused an adjacent deletion, leading to a fusion of two modules. The sequence of pdif site on 
the left in pABIR is consistent with this as it is the first time that there has been variability in 
the sequence of the internal dif site (Table 10.15). Further work is required to analyse all the 
variants of the oxa58 module available in GenBank.  
 
Figure 10.17 Variation in the oxa58 module. Arrows indicate the extent and orientation of genes and open 
reading frames. The oxa58 gene is dark orange. Coloured boxes represent IS, the identity of each is shown below 
and the internal arrows indicate the transposase orientation. Vertical red and black bars represent Re27 and pdif 
sites, respectively and the orientation of the pdif sites are shown above. 
 
Interestingly, S30 is one of the isolates that does not contain a version of AbGRI3 and hence, 
does not contain the macrolide resistance gene pair msrE-mphE in this island. Despite this, 
S30, like many other Acinetobacter isolates, has acquired these genes on plasmids. As the class 
of antibiotics, macrolides, that the msrE-mphE genes confer resistance to are not commonly 
used to treat infections caused by Gram-negative microorganisms, the presence of these genes, 
in many different locations and contexts in the Acinetobacter genome is curious. There may be 
selective pressure to maintain these genes in the hospital environment or they may be moving 
with other, more relevant antibiotic resistance genes.  
 
In addition to the antibiotic resistance genes, a toxin-antitoxin system (higB, higA) was found 
in a dif module, as was a serine recombinase (Table 10.2). A number of other toxin-antitoxin 
ISAba2
∆ISAba3 
ISAba3 est ISAba3∆
D/C D/CC/D
500 bp
C/DD/C
oxa58 ∆ISAba3 ISAba11 ISAba3 lysEara1
lysEara1oxa58 
D/C
D/C D/CC/D
ISAba3 
ISAba18 IS26 oxa58 ara1 lysE∆tnpA5393 ∆ISAba3 
∆ISAba3 
27 bp and pdif site missing
pABIR
pMAD
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gene combinations were identified throughout this investigation (Fig 10.6), as were new 
modules containing hypothetical proteins, and more work is required to catalogue all of these 
modules. In most publications and GenBank entries to date, only a limited number of pdif sites 
(or Re27 repeats) have been recorded and presence of further sites in the broader vicinity has 
not been investigated, likely due to the difficulty in finding them. The thorough analysis of the 
of all of the plasmids used in this study enabled some features of this dif module mobilisation 
system to be defined. It was concluded that there are two types of dif modules, C and D type 
modules, which in the general case alternate along the plasmid (Fig 10.12A and B).  
 
Attempts to detect the occurrence of dif module recombination was not successful. Due to our 
increasing understanding of this system and the preference for D and C type modules to 
alternate, the two plasmids chosen to perform this experiment were not ideal candidates. There 
is no specific location for the oxa24 D module to move to in pRCH51-1 that would maintain 
C and D alternation (Fig 10.13), though perhaps, if two modules moved together, this pattern 
would be maintained. Ideally, these experiments would be repeated using a host plasmid that 
only contains a single pdif site along with a selectable marker. Experimental investigation of 
module movement will be needed to understand the mechanism of mobilisation and to 
demonstrate that the XerC and XerD recombinases are involved.  
 
A pair of dif modules were recently found in Proteus mirabilis (81) and this represents the first 
time that dif modules have been found outside the Acinetobacter genus. One of the modules is 
related to the smaller oxa58 module described above and the second is a novel module that 
includes an ampC gene that confers resistance to amoxicillin. In this case, the pair of dif 
modules, oxa58 with XerD sites internal and ampC with XerC sites internal, were reported to 
be present three times in a single array (81). However, only sequence for one array was 
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provided for in the GenBank accession KX668205. This configuration clearly should preserve 
the alternation of a XerC-XerD and a XerD-XerC sites seen in Acinetobacter plasmids and 
again raises the possibility that dif modules may usually move in pairs. 
 
It appears that the variants of ISAjo2 and ISAba32 both target the same sequence, a XerC 
binding site, though how this targeting is achieved is unclear and further investigation of the 
ISAjo2 group of insertion sequences is warranted. Nonetheless, these IS can serve to pinpoint 
pdif sites that may otherwise be difficult to find. 
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General discussion
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11.1 Overview 
In order to explore the diversity of GC2 A. baumannii from Singapore a set of 20 XAR GC2 
isolates from Singapore General Hospital, isolated over a period of 15 years, were examined. 
One of these isolates (S35) was also resistant to the last line antibiotic colistin as well as 
rifampicin, however, as resistance to polymyxin B was not tested, it was unable to be classified 
as pan resistant. The relationships between the isolates were determined by analysing and 
assembling all regions containing antibiotic resistance genes in the chromosome or in plasmids, 
as well as determining ST and KL and the ISAba1 profiles of the isolates. The variety of Oxford 
MLST profiles (Table 11.1) gives an indication of the diversity in these isolates. Seven 
different STs were detected, two of which were novel. Most of the variation in the ST was due 
to changes in the gpi allele, which was caused by capsule locus replacement (Chapter 3; Table 
3.11, Table 11.1). Isolates containing the most recently acquired island AbGRI3 belong to five 
different STs (Table 11.1), indicating that replacement of the capsule locus has occurred 
relatively recently. However, the AbGRI3-4 variant was strongly associated with ST195, both 
in this collection (Table 11.1) and in other sequences isolates (Chapter 7; Fig 7.1).  
 
The majority of the acquired antibiotic resistance genes in this set of GC2 A. baumannii were 
concentrated in one or more of the three known GC2-associated chromosomal resistance 
islands, AbGRI1, AbGRI2 and AbGRI3. One group of five isolates contained only a version 
of AbGRI1 and AbGRI2 (Table 11.1). These isolates contain the aphA6 gene (resistance to 
amikacin, kanamycin, neomycin) but TnaphA6 is located on plasmids. The second group of 15 
isolates contain a version, or remnant of AbGRI1 and AbGRI2 but also contain AbGRI3, which 
contains the armA gene (resistance to all clinically relevant aminoglycosides) and the presence 
of this genomic island distinguished this group (Table 11.1). Numerous different structures for 
variant forms of AbGRI1, AbGRI2 and AbGRI3 were characterised. 
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Table 11.1 Features of the 20 GC2 isolates from Singapore General Hospital 
Isolate Year  ST 
(Ox) 
KL1 OCL1 Chromosomal 
resistance 
Plasmids 
  AbGRI Other 
oxa23 
locations 
RepAci6     Small plasmids4 
  12 2 3  Backbone 
type 
TnaphA6  
(G7 
position) 
AbaR4 
position3 
Extras  
S21 1996 208 2 1 3 1 -  3 - 3-1 Tn6177, ISAba12-like RepAci2 (TnaphA6) 
S24 2006 208 2 1 5a 1 -  1 + 1-1 - - 
S26 2006 1165 73 1 5b 1 -  1 + 1-2 9.3 kb Tn - 
S29 2007 1165 73 1 5b 1 -  1 + 1-2 9.3 kb Tn - 
S30 2008 369 49 1 1 1 -  4 + - Tn2008 pS30-1  
(tet39, msrE-mphE) 
S31 2008 208 2 1 6  5 5i AbaR4 (2) -    RepAci1 
S38 2011 208 2 1 1 5 3i AbaR4 (2) -    RepAci1 
S39 2011 208 2 1 1 5 3i AbaR4 (2) -    RepAci1 
S27 2007 218 7 1 4  6 2i  2 - 2-1 ISAba1 RepAci1 
S22 2004 218 7 1 3 4 2i AbaR4 (1) 2 - 2-1 - RepAci1 
S23 2004 218 7 1 3 4 2i AbaR4 (1) 2 - 2-1 - RepAci1 
S25 2006 218 7 1 3 4 6  2 - 2-1 ISAba1 RepAci1 
S28 2007 1128 32 1 8  4 1i  2 - 2-1 ISAba1 RepAci1 
S34 2009 1166 49 1 4  3 4 Tn2006 2 - 2-2 - RepAci1 
S32 2009 195 3 1 7  2 4  2 - - ISAba19 RepAci1 (Tn2006) 
S33 2009 195 3 1 7 2 4  -    RepAci1 
S40 2011 195 3 1 7 2 4  2 - 2-1 - RepAci1 
S36 2010 195 3 1 7 7 4  2 - - ISAba19 RepAci1 
S37 2010 195 3 1 7 7 4  -    RepAci1 
S35 2010 195 3 1 7 7 4  -    RepAci1 
Coloured boxes indicate isolates that share multiple features.  
1KL and OCL provided by Dr J. Kenyon. 
2AbGRI1-4, -6, -7 and -8 contain AbaR4, AbaR4∆, AbaR4 and AbaR4∆, and Tn2006, respectively.  
3The AbaR4 position number is given in respect to the RepAci6 backbone type e.g. 3-1 is backbone 3 and position 1.  
4The RepAci1 and RepAci2 plasmids are closely related to pAb-G7-1 and pD72-1, respectively.
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These variants were often shared by multiple isolates, further subdividing the groups (coloured 
boxes in Table 11.1). For example, the yellow box around S32, S33 and S40 in Table 11.1 
highlights that these isolates contain the same island variants and are likely more closely related 
to one another than to the other isolates that contain AbGRI3. This relationship is also evident 
in the phylogeny shown in Chapter 7, Fig 7.5. Most of the variation within AbGRI1 was due 
to recombination between closely related transposons (Tn6022, Tn6022∆1 and AbaR4), while 
in AbGRI2 and AbGRI3 the majority was caused by IS26.  
 
The oxa23 gene was present in all isolates, but found in multiple locations in the chromosome 
including in AbGRI1, or in plasmids in the isolates in the collection. As oxa23 does not have 
a fixed location, it is likely that the acquisition of this gene is a more recent adaption by 
antibiotic resistant GC2 A. baumannii. This is consistent with the more recent introduction of 
carbapenems for therapy. In all but one isolate, S30, which had Tn2008A, the oxa23 gene was 
located in Tn2006. However, Tn2006 was only found by itself in three isolates (Table 11.2). 
Most often, Tn2006 was located within AbaR4 or AbaR4∆ (Table 11.2). These two transposons 
were present in many of the AbGRI1 variants characterised in the isolates that contain AbGRI3 
(Table 11.2). However, a subset these AbGRI3-containing isolates also contained an oxa23-
containing transposon in other chromosomal locations (Table 11.2). New chromosomal 
positions for AbaR4 and Tn2006 were also detected and positions shared between different 
isolates indicated their relatedness (orange and green boxes in Table 11.1), in a way that is 
consistent with the phylogeny, shared IS and other indicators. Assays for these locations may 
help in tracking related isolates that may carry them.  
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Table 11.2 Location of oxa23 containing transposons 
Isolate Context of oxa23 in 
AbGRI1 
Other chromosomal 
locations 
AbaR4 or Tn2008 on 
RepAci6 plasmid1 
Small plasmid 
S21   AbaR4, 3-1  
S24   AbaR4, 1-1  
S26, S29   AbaR4, 1-2  
S30   Tn2008  
S25   AbaR4, 2-1  
S22, S23  AbaR4 (1) AbaR4, 2-1  
S27 AbaR4  AbaR4, 2-1  
S34 AbaR4 Tn2006 AbaR4, 2-2  
S28 Tn2006  AbaR4, 2-1  
S31 AbaR4∆1 AbaR4 (2)   
S38, S39  AbaR4 (2)   
S32 AbaR4, AbaR4∆1   Tn2006 
S33, S35, S36, 
S37 
AbaR4, AbaR4∆1    
S40 AbaR4, AbaR4∆1  AbaR4, 2-1  
1 The AbaR4 position number is given in respect to the RepAci6 backbone type e.g. 3-1 is backbone 3 and 
position 1.  
 
Plasmids also played an important role in the carriage of antibiotic resistance genes in this 
collection. The oxa23 and aphA6 genes were both found on large conjugative RepAci6 
plasmids. Fourteen of the 20 isolates examined had a RepAci6 plasmid. Twelve of these carried 
AbaR4 or Tn2008A transposons containing oxa23 and, of these, four also included TnaphA6 
(Table 11.1). Surprisingly, the AbaR4 transposon was in five different positions in the RepAci6 
plasmid backbone indicating it had been acquired repeatedly rather than once generating a 
single plasmid that spread through the population (Table 11.1 and Table 11.2). In one isolate, 
Tn2006 was found in a small RepAci1 plasmid, and TnaphA6 was located in a small RepAci2 
plasmid in another isolate.  
 
A novel small plasmid pS30-1 containing additional antibiotic resistance genes was found in a 
single isolate. However, these genes were not located in transposons or known mobile 
elements. Instead, the tet39 resistance determinant along with the msrE and mphE macrolide 
resistance genes were found to be located within dif modules that were defined as part of this 
work and discussed below. Isolate S30 lies between the two main groups in the phylogeny, 
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appearing intermediate between them. It also includes a unique RepAci6 plasmid carrying 
Tn2008. 
 
11.2 Acquisition and evolution of antibiotic resistance islands in GC2 A. baumannii 
Over the last 30-40 years, the GC2 global clone has accrued sets of genes involved in antibiotic 
resistance in three blocks. The oldest GC2 isolate for which data is available, A320 from 1982, 
already contained AbGRI1 (190) and AbGRI2 (24). These two resistance islands conferred 
resistance to most older antibiotics (to the left of the bold line in Fig 11.1). Additional work 
has shown that these regions were brought into the GC2 chromosome from plasmids. The 
source of AbGRI1 has been shown recently to be an A. baumannii plasmid (94), while the 
ancestral version of AbGRI2 was identified on an M1 plasmid from S. marcescens (22).  
 
 
Figure 11.1 Timeline of when antibiotics suitable for Gram-negative pathogens were first used clinically. 
The black bar separates the new and old antibiotics.  
 
The AbGRI3 island was acquired much later. The first report of this island (277) was published 
at the commencement of this project but a complete analysis of this region was performed here. 
Analysis of the set of isolates from Singapore General Hospital revealed that AbGRI3 had been 
acquired by 2004 (Table 11.1). However, further examination of A. baumannii from the early 
2000’s may allow this date to be further refined. Like AbGRI2, the surrounding TSD suggests 
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that the AbGRI3 region was acquired in a single-step. There are a number of related armA-
carrying transposons in Enterobacterial plasmids, again indicating a potential source of the 
genes in this transposon from outside Acinetobacter.  
 
The AbGRI1 and AbGRI2 islands have not remained unchanged over the last three decades. 
Although versions or remnants of these islands are always present in antibiotic resistant GC2 
isolates, many different variants have been detected. In particular, AbGRI2 has been subject to 
a large amount of change due the presence of multiple copies of IS26. The structure of AbGRI2 
in A320 is much larger than variants detected in most recent isolates. In fact, modern variants 
of AbGRI2, particularly those in isolates from Asia and Australia, have evolved from an 
important variant, AbGRI2-1(188), a structure unlikely to arise on two independent occasions. 
Hence, there appears to have been a constriction of the GC2 population but then a clade has 
expanded from the cell containing the AbGRI2-1 island structure and thereafter AbGRI2-1 has 
diverged. AbGRI2-1 is smaller than AbGRI2-0 (A320) as the chloramphenicol resistance gene 
catA1 and mercury resistance region are missing (24). As Acinetobacter are intrinsically 
resistant to chloramphenicol, this loss is without consequence. AbGRI2-1 was first detected in 
isolates from the east coast of Australia in 1999 and, in this project, AbGRI2-1 was found in a 
1996 isolate from Singapore General Hospital, indicating that it arose even earlier.   
 
The AbGRI2 region of the isolates containing AbGRI3 studied here, was always smaller than 
AbGRI2-1 but based on the deviations in all the variants, the cell that gained AbGRI3 must 
have originally contained AbGRI2-1. Deletions in AbGRI2 have removed antibiotic resistance 
genes and in some cases, a single IS26 in the AbGRI2 region of the chromosome is all that 
remains. The loss of resistance genes from AbGRI2, particularly loss of the aminoglycoside 
resistance gene aacC1, has had no impact on the overall phenotype of an AbGRI3 containing, 
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and hence armA containing isolate. In addition, due to the resistance spectrum of armA, there 
is no need for isolates containing this gene to acquire aphA6, and this is reflected in the gene 
distribution in the Singapore isolates (Table 11.1).  
 
The AbGRI1 island had acquired the oxa23 carbapenem resistance gene in Tn2006 at a number 
of different positions. Tn2006 located within Tn6022 as AbaR4 as well as in Tn6022∆1 as 
AbaR4∆1 was seen (Table 11.2). It is likely that recombination between a copy of AbaR4 and 
the pre-existing Tn6022 or Tn6022∆1 has facilitated the acquisition of the oxa23 transposon 
by AbGRI1. Tn2006 was also detected by itself in one isolate (Table 11.2) and in addition to 
the Tn2006 position in AbGRI1-2 seen in Australian isolates (191), is the second site of this 
transposon in AbGRI1. Thus, the AbGRI1 island appears to be playing an important role in 
carbapenem resistance as well as conferring resistance to tetracycline, sulphonamides and 
streptomycin.  
 
11.3 Plasmids with resistance genes 
The plasmids in clinical A. baumannii isolates are contributing significantly to antibiotic 
resistance and its spread. The larger conjugative RepAci6 plasmids are playing a key role in 
resistance to carbapenems and amikacin which became available for clinical use later (Fig 11.1) 
as many carry oxa23 and/or aphA6. These antibiotics are important in the treatment of 
antibiotic resistant A. baumannii. Both the TnaphA6 and the transposons harbouring oxa23, 
Tn2006, Tn2008 and AbaR4, have been acquired multiple times by RepAci6 plasmids.  
 
Large conjugative plasmids were not the only ones to contribute to antibiotic resistance in these 
isolates. Within the collection, a small RepAci1 plasmid resembling pAb-G7-1 (97) had 
acquired Tn2006, while a RepAci2 plasmid related to pD72-1 (192) had gained TnaphA6 
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(Table 11.1). A small plasmid from isolate S30 contained two sets of antibiotic resistance 
genes, the tet39 tetracycline resistance determinant and msrE-mphE macrolide resistance genes 
(Table 11.1). These genes were located in dif modules, a novel type of mobile element.  
 
11.4 Plasmid evolution and movement  
The backbones of the RepAci6 plasmids analysed in this project were quite closely related but 
harboured some differences. Among the 13 RepAci6 plasmids assembled in this project, four 
different backbone types were detected, doubling the known number of backbone types (Table 
11.1). Examination of plasmids in the public database increased this to 10 backbone types. The 
backbones of the variants have large regions that share high levels of homology, particularly 
over the transfer and replication region, but contain short segments of diverged sequence (as 
little as 80% DNA identity) or have gained additional short regions of DNA including a fourth 
repeat or a parB gene. As more and more isolates are sequenced this number is likely to 
continue to increase. In addition to antibiotic resistance genes, some of the RepAci6 plasmids 
detected contain genes predicted to be involved in copper resistance (Tn6177, Table 11.1).  
 
The RepAci6 plasmid backbone has all the required genes for self-transmission. However, 
when tested, three plasmids that appeared to have all transfer genes intact failed to conjugate. 
Further work is required to understand the transfer deficiency of these plasmids.  
 
Some RepAci6 plasmids are cryptic, and two of the plasmids characterised from the isolates 
from Singapore contained no antibiotic resistance genes. However, these conjugative plasmids 
can still contribute to the spread of antibiotic resistance via their role in mobilising small 
plasmids that contain antibiotic resistance genes and lack any conjugation or mobilisation 
genes. The small plasmid characterised here, pS32-1 containing Tn2006, was mobilised by a 
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co-resident conjugative RepAci6 plasmid and this is the first example of in trans mobilisation 
in Acinetobacter. This enabled the identification of a putative oriT in both plasmids though 
these will need to be experimentally confirmed. A number of small non-conjugative plasmids 
have been found to harbour antibiotic resistance genes in Acinetobacter, including two others 
characterised in this project and the importance of these small plasmids in the spread of 
antibiotic resistance is likely much greater than first-thought.  
 
11.5 dif modules 
One small plasmid from a Singapore isolate contains the tet39 determinant and the msrE-mphE 
genes in novel mobile dif modules. The oxa24 gene had already been detected in a dif module 
but in this work another carbapenem resistance gene, oxa58, was also shown to be in a dif 
module. Analysis here expanded the number of different of toxin/antitoxin systems located 
within dif modules and many hypothetical proteins were also found. The mechanism of 
movement of these modules and how they are exploiting the chromosomal recombinases XerC 
and XerD has yet to be elucidated, but features of this system have now been highlighted. In 
particular, there are two types of dif modules, C and D, and, where multiple modules are present 
in a sequence, these two module types usually alternate. So far, this system appears to be 
specific to Acinetobacter species.  
 
11.6 Globalisation 
As each resistance island, AbGRI1, AbGRI2 and AbGRI3, is defined by its specific location 
in the chromosome, they were each initially acquired by a single cell. The progeny of these 
ancestor have been successful in spreading throughout the globe, though the islands have also 
evolved in situ. With the current lack of strains available from prior to 1982, currently there is 
no way of knowing if AbGRI1 or AbGRI2 entered the chromosome first. 
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The third island was acquired by a cell that already contained both AbGRI1 and AbGRI2. 
Evidence so far suggests that it was acquired in the early 2000’s, likely in Asia. AbGRI3 
containing isolates have since been detected throughout Asia, America and sporadically in 
Sweden and Australia. In addition, the AbGRI3-4 variant is unlikely have to occurred in more 
than one cell as it is an unusual deletion event. Here, this particular variant of AbGRI3 
wasobserved in isolates from Singapore, South Korea, India and Sweden, indicating the 
globalisation of this new lineage of the GC2 clone.  
 
11.7 Links to Australian isolates 
Specific features linked some the isolates from Singapore General Hospital to isolates from the 
east coast of Australia as well as to those from Adelaide and Melbourne. The isolate S21 had 
AbGRI2-1, as seen in isolates from the east coast of Australia, and shared 11 of the 12 common 
ISAba1 positions present in all the east coast isolates. This indicated that S21 and isolates from 
this area of Australia have a common origin. Another set of isolates from Singapore General 
Hospital had the same deletion in AbGRI1 as isolates from Melbourne and Adelaide. This link 
was further supported by their additional shared set of ISAba1 positions. In future, it should be 
possible to compare a larger group, such as including the positions of ISAba1 from Wright et 
al. (277), and this will assist in tracking specific GC2 lineages as they spread.  
 
11.8 Future directions 
This in-depth analysis of antibiotic resistance regions and plasmids will underpin larger studies 
of GC2 A. baumannii from Singapore and across South-east Asia. The knowledge gained 
through this project about the contents, location and forms of the three chromosomal resistance 
islands as well as plasmid variants can now be fed into bioinformatic pipelines that should 
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quicken future analysis. The GC2 populations in Australia, Asia and America appear to be 
mainly of the AbGRI2-1 lineage. It would be interesting to examine A. baumannii isolates from 
Europe and Africa in detail to determine if they are also part of this lineage or if other lineages 
been successful in these regions. However, at present genomes from these regions are scarce, 
a situation that should be rectified.  
 
As the number of A. baumannii isolates sequenced has increased, so has the number and 
diversity of plasmid sequences. There is a real need for the typing system for Acinetobacter 
plasmids to be extended to include all of these new sequence types. As the biology of plasmids 
from Acinetobacter is so different from that of plasmids from Enterobacteriaceae, experimental 
studies determining what genes and regions are absolutely required for plasmid maintenance 
and/or transfer are needed. In addition, mobilisation of small plasmids needs to be further 
studied. Further research into understanding dif modules, particularly into their mechanism of 
movement, would also be important.  
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Table A1.1 Completed A. baumannii genomes as of July 2017 
Isolate Accession 
No. 
GC ST 
(IP) 
Country Submission  
year 
Size  
(Mb) 
G+C 
(%) 
Genes Plasmids Sequencing technology Isolation 
Date 
ATCC 17978 CP000521 - 437 France 2007 4.00 38.9 3,469 2  454 1995 
AB0057 CP001182 1 1 USA 2008 4.06 39.2 3,892 1 454/Sanger 2004 
AB307-0294 CP001172 1 1 USA 2008 3.76 39 3,510 - 454 1994 
ACICU CP000863 2 2 Italy 2008 4.00 38.9 3,802 2 454 2005 
AYE CU459141 1 1 France 2008 4.05 39.3 3,879 4 Sanger 2001 
SDF CU468230 - 17 France 2008 3.48 39.1 3,664 3 Sanger <2004 
1656-2 CP001921 2 2 South Korea 2011 4.02 39.1 3,887 2 454 <2010 
TCDC-AB0715 CP002522 2 2 Taiwan 2011 4.22 38.9 4,010 2 Illumina 2007-9 
MDR-ZJ06 CP001937 2 2 China 2011 4.01 39 3,847 1  454 2006 
MDR-TJ CP003500 2 2 China 2012 4.15 39.1 4,014 2  454 <2011 
TYTH-1 CP003856 2 2 Taiwan 2012 3.96 39 3,758 -  Illumina 2008 
D1279779 CP003967 - 267 Australia 2013 3.71 39 3,523 1 454 2009 
BJAB07104 CP003846 2 2 China 2013 4.04 39 3,882 2  Illumina HiSeq 2007 
BJAB0715 CP003847 - 23 China 2013 4.05 38.9 3,899 1  Illumina HiSeq 2007 
BJAB0868 CP003849 2 2 China 2013 4.01 38.9 3,822 3  Illumina HiSeq 2008 
ZW85-1 CP006768 - 639 China 2013 3.93 39.2 3684 2 454 ? 
NCGM 237 AP013357 2 2 Japan 2013 4.02 39.1 3894 -  PacBio 2012 
AC29 CP007535 2 2 Malaysia 2014 3.85 39.0 3659 -  Illumina 2011 
AC30 CP007577 2 2 Malaysia 2014 3.92 38.8 3729 3  Illumina 2011 
AB031 CP009256 - 638 Canada 2014 3.80 39.2 3599 - PacBio 2010 
AB030 CP009257 - 79 Canada 2014 4.34 39.00 4339 - PacBio 2010 
LAC-4 CP007712 - 10 USA 2014 3.97 38.9 3821 2 454/Illumina MiSeq/HiSeq 1997 
IOMTU 433 AP014649 - 622 Nepal 2014 4.19 39.10 3999 1  PacBio 2013 
A1 CP010781 1 1 UK 2015 3.91 39.30 3735 1 Illumina HiSeq/PacBio 1982 
6411 CP010368 - 322 USA 2015 4.0 38.80 3773 2 PacBio <2014 
6200 CP010397 - 464 Colombia 2015 4.07 39.20 3876 3 PacBio 2012 
AB5075-UW CP008706 1 1 USA 2015 4.07 39.10 3929 3 PacBio 2008 
XH386 CP010779 2 2 China 2014 4.08 39.16 4062 - Illumina/PacBio 2015 
B8300 CP021347 - -1 India 2015 3.82 39.30 3711 1 PacBio 2014 
Ab04-mff CP012006 - 10 Canada 2015 4.19 38.92 4067 2 Illumina/PacBio 2012 
ATCC17978-mff CP012004 - 437 - 2015 4.06 38.94 3796 1 Illumina/PacBio - 
AbH12O-A2 CP009534 - 79 Spain 2014 3.88 39.10 3673 - Illumina HiSeq <2014 
D36 CP012952 1 81 Australia 2015 4.13 39.02 3974 4 PacBio 2008 
KPN10P02143 CP013924 2 2 South Korea 2016 4.13 39.07 4006 1 PacBio 2012 
YU-R612 CP014215 2 2 South Korea 2016 4.16 38.99 4035 2 PacBio 2014 
Appendix I 306	
XH860 CP014538 2 2 China  2016 3.85 39.00 3673 - PacBio 2009 
XH859 CP014539 2 2 China  2016 3.98 39.10 3786 - PacBio 2009 
XH857 CP014540 - 215 China  2016 3.88 39.00 3702  PacBio 2010 
XH856 CP014541 2 2 China  2016 3.91 39.10 3716 - PacBio 2010 
XH858 CP014528 - 23 China  2016 4.17 38.90 4020 - PacBio 2010 
3207 CP015364  422 Mexico 2016 4.09 38.99 3788 2 Illumina/PacBio 2008 
KAB01 CP017642 2 2 South Korea 2016 4.03 38.90 3894 1 PacBio 2015 
KAB02 CP017644 2 2 South Korea 2016 4.09 38.99 3980 1 PacBio 2015 
KAB03 CP017646   2 2 South Korea 2016 4.06 38.90 3920 1 PacBio 2015 
KAB04 CP017648 2 2 South Korea 2016 4.13 38.96 4018 1 PacBio 2015 
KAB05 CP017650 2 2 South Korea 2016 4.04 39.00 3925 1 PacBio 2015 
KAB06 CP017652 2 2 South Korea 2016 4.04 39.00 3925 1 PacBio 2015 
KAB07 CP017654 2 2 South Korea 2016 4.05 39.00 3944 1 PacBio 2015 
KAB08 CP017656 2 2 South Korea 2016 4.07 38.89 3963 1 PacBio 2015 
HRAB-85 CP018143 2 2 China 2016 4.10 39.01 3977 1 PacBio 2014 
AF-637 CP018256 2 2 USA 2016 4.09 39.07 3930 1 PacBio 2008 
AF-401 CP018254 - 79 Mexico 2016 4.27 39.09 4153 1 PacBio 2009 
XDR-BJ83 CP018421 2 2 China 2016 4.08 38.91 3942 1 PacBio 2007 
CMC-CR-MDR-Ab4 CP016295 2 2 USA 2017 4.16 38.97 4021 2 PacBio <2016 
CMC-MDR-Ab59 CP016298 2 2 USA 2017 4.08 39.07 3910 1 PacBio <2016 
CMC-CR-MDR-
Ab66 
CP016300 2 2 USA 2017 4.17 38.98 4045 2 PacBio <2016 
AB0422 CP019034 - 437 - 2017 4.00 39.00 3838 - PacBio - 
JBA13 CP020584 2 2 South Korea 2017 4.07 39.00 3943 2 PacBio 2013 
CBA7 CP020586 2 2 South Korea 2017 4.11 39.17 4030 1 PacBio 2013 
15A34 CP020590 2 2 South Korea 2017 3.94 39.00 3799 1 PacBio 2014 
15A5 CP020574 2 2 South Korea 2017 4.05 38.89 3916 2 PacBio 2013 
USA2 CP020592 2 2 South Korea 2017 3.99 38.90 3825 1 PacBio 2013 
SSA6 CP020591 2 2 South Korea 2017 3.88 39.00 3703 - PacBio 2013 
HWBA8 CP020597 - 25 South Korea 2017 4.27 39.06 4115 1 PacBio 2013 
WKA02 CP020598 - 10 South Korea 2017 3.87 38.90 3734 - PacBio 2013 
USA15 CP020595 1 1 South Korea 2017 4.03 39.08 3896 1 PacBio 2013 
SAA14 CP020579 1 1 South Korea 2017 3.97 39.10 3823 - PacBio 2013 
SSA12 CP020578 2 2 South Korea 2017 4.06 38.99 3957 2 PacBio 2013 
SSMA17 CP020581 2 2 South Korea 2017 4.02 38.99 3906 1 PacBio 2013 
Ab736 CP015121 - 52 USA 2017 3.99 39.19 3820 1 PacBio 2015 
A85 CP021782 1 1 Australia 2017 4.14 39.18 4068 3 PacBio/Illumia HiSeq 2003 
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1 fusA-3, gltA-5, pyrG-26, recA-6, rplB-2, rpoB-3 
2Lab mutant of ATCC 17978 that overexpresses the AdeIJK efflux pump 
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Table A1.2 Results of CDS disk diffusion for GC2 isolates from Singapore General Hospital   
Strain Year 
Annular radius of zone of inhibition                                              
IPM MER Dor Ap SAM TIM TZP CTX CAZ CRO FEP Sm Sp Su Tc Mc Dc Tp Cl Fl Km Nm Gm Ne Ak Tm Nx CIP LVX Rif 
S21 1996 
4 0  0 3 0  0 1   0 0 0 0   0 0 0 0 1 3 7 1 8 0 0  7.0 
  
4 3 0  2 0 2   0 0     5 1            2.5 5.0 
  
3 0  0 2.5 0  0 1   0 0 0 0   0 0 0 0 0 2 6 0 7 0 0  7.0 
    
3.5 0.5 0   3 0 2     0 0         4 1                       2 6.0 
S22 2004 
1 1  0 2.5 0  0 0   0 0 0 0   0 0 0 0 2 0 0 0 0 0 0  6.0 
  
2 1 0  2 0 1   0 0     4.5 1            0 6.5 
  
1 1  0 2.5 0  0 0   0 0 0 0   0 1 0 0 2 0 0 0 0 0 0  6.5 
    
2 1 0   2.5 0 1     0 0         5 1                       0 7.0 
S23 2004 
3 3  0 3 0  0 5   0 0 0 0   0 0 0 0 3 0 0 0 0 0 0  8.0 
  
2 1.5 0  3 0 2   0 0     4.5 0.5            0 8.0 
  
3 3  0 3.5 0  0 5   0 0 0 0   0 0 0 0 3 0 0 0 0 0 0  8.0 
    
1.5 1.5 0   2 0 2     0 0         5 0.5                       0 8.5 
S24 2006 
2 1  0 2.5 0  0 1   0 0 0 0   0 1 0 0 2 3 7 3 7 0 0  7.0 
  
1 1 0  2 0 1   0 0     4.5 1            0 6.5 
  
1 1  0 2.5 0  0 2   0 0 0 0   0 0 0 0 2 2 6 2 7 0 0  7.0 
    
2 1.5 0   2 0 1     0 0         4.5 1                       0 6.0 
S25 2006 
1 2  0 2.5 0  0 1   0 0 0 0   0 0 0 0 7 0 0 0 0 0 0  6.0 
  
2.5 2 0  1.5 0 2   0 0     4 1            0.5 5.0 
  
2 2  0 2.5 0  0 1   0 0 0 0   0 0 0 0 7 0 0 0 0 0 0  6.0 
    
2.5 2 0   2 0 2     0 0         4.5 1                       0.5 6.0 
S26 2006 
3 3  0 2.5 0  0 1   0 0 0 0   0 1 0 0 2 2 6 2 7 0 0  7.0 
  
3.5 2 0  2 0 2   0 2     5.5 1            2.5 6.0 
  
2 2  0 2.5 0  0 1   0 0 0 0   0 1 0 0 2 2 6 2 7 0 0  8.5 
    
3.5 2 1   2 0 2     0 0         4.5 1                       3 6.5 
Black performed by M. Wynn and Red performed in this project 
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Strain Year 
Annular radius of zone of inhibition                                              
    IPM MER Dor Ap SAM TIM TZP CTX CAZ CRO FEP Sm Sp Su Tc Mc Dc Tp Cl Fl Km Nm Gm Ne Ak Tm Nx CIP LVX Rif 
S27 2007 
1 1  0 3 0  0 0   0 0 0 0   0 0 0 0 1 0 0 0 0 0 0  6.0 
  
1 1 1.5  3 0 1   0 1.5     5 1            0.5 6.5 
  
1 1  0 4 0  0 0   0 0 0 0   0 0 0 0 2 0 0 0 0 0 0  8.0 
    
1 0.5 1   3 0 1.5     0 0         4 1                       0.5 6.0 
S28 2007 
1 1  0 0 0  0 1   0 0 0 0   0 0 0 0 6 0 0 0 0 0 0  6.0 
  
1.5 1 1  2 0 2   0 1.5     5.5 2            0 6.0 
  
1 1  0 2 0  0 2   0 0 0 0   0 0 0 0 6 0 0 0 0 0 0  6.0 
    
1 0 0   2.5 0 1.5     0 0         4 1                       0.5 6.5 
S29 2007 
3 2  0 2.5 0  0 2   0 0 0 0   0 0 0 0 2 2 6 2 7 0 0  7.0 
  
3 2 0  2 0 2   0 0     4 1            2.5 6.0 
  
3 2  0 2.5 0  0 1   0 0 0 0   0 0 0 0 2 2 6 2 7 0 0  7.0 
    
3 2 0   2.5 0 2     0 2         5 1                       2.5 6.0 
S30 2008 
2 2  0 2.5 0  0 2   0 0 0 0   0 0 0 0 3 3 6 3 8 0 0  6.5 
  
1 1 1.5  2 0 2   0 1.5     5 1            1 5.5 
  
1 1  0 2 0  0 2   0 0 0 0   0 0 0 0 3 3 6 2 8 0 0  6.0 
    
1.5 1 0   2 0 2     0 2.5         5 1                       1.5 6.0 
S31 2008 
1 1  0 3.5 0  0 2   0 0 0 0   0 0 0 0 1 0 0 0 0 0 0  6.0 
  
0.5 0.5 1  2.5 0 1.5   0 1.5     3.5 1            2 6.0 
  
1 1  0 3.5 0  0 3   0 0 0 0   0 0 0 1 0 1 0 0 0 0 0  6.0 
    
1 0.5 0   3 0 1     0 1.5         4 1                       2.5 6.0 
S32 2009 
0 0  0 0 0  0 0   0 0 0 0   0 0 1 0 2 0 0 0 0 0 0  6.0 
  
0 0 0  1 0 0   0 0     5 1            2 7.0 
  
0 0  0 0 0  0 0   0 0 0 0   0 0 0 0 2 0 0 0 0 0 0  6.0 
    
0 0 0   1 0 0     0 0         4 1                       2 6.0 
Black performed by M. Wynn and Red performed in this project 
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Strain Year 
Annular radius of zone of inhibition                                              
    IPM MER Dor Ap SAM TIM TZP CTX CAZ CRO FEP Sm Sp Su Tc Mc Dc Tp Cl Fl Km Nm Gm Ne Ak Tm Nx CIP LVX Rif 
S33 2009 1 0  0 0 0  0 0   0 0 0 0   0 1 1 0 1 0 0 0 0 0 0  6.0 
  0.5 1 0.5  1 0 1   0 0.5     4.5 1.5            3 6.0 
  1 1  0 0 0  0 0   0 0 0 0   0 1 0 0 1 0 0 0 0 0 0  6.0 
    0.5 0.5 1   1.5 0 1     0 1.5         5 1.5                       2.5 6.0 
S34 2009 1 1  0 0 0  0 1   1 6 0 0   0 1 0 0 3 0 0 0 0 0 1  7.0 
  0.5 0 0.5  1 0 1   0 2     6 2.5            4 6.0 
  1 1  0 0 0  0 1   2 7 0 0   0 1 1 0 4 0 0 0 0 0 1  7.0 
    1 1 1   1 0 1     0 1.5         5.5 1.5                       4 6.5 
S35 2010 2 2  0 0 0  0 0   0 0 0 0   0 1 1 0 8 0 0 0 0 0 0  0.0 
  1 1 1  2 0 2   0 1     5 0.5            1.5 0.0 
  2 2  0 4 0  0 0   0 0 0 0   0 1 1 0 9 0 0 0 0 0 0  0.0 
    1 1 1   3.5 0 2     0 2         4 1                       2 0.0 
S36 2010 1 1  0 0 0  0 0   0 0 0 0   0 1 0 0 9 0 0 0 0 0 0  6.0 
  0.5 0.5 1  3 0 2   0 1.5     4 1            2 6.0 
  2 2  0 3.5 0  0 0   0 0 0 0   0 0 0 0 8 0 0 0 0 0 0  7.0 
    1 0.5 2   4 0 2     0 1         5 1                       1.5 7.0 
S37 2010 4 3  0 3.5 0  0 0   0 0 0 0   0 1 0 0 12 0 0 0 0 0 0  7.0 
  2 1 1  4.5 0 3   0 4     5.5 1            3 8.0 
  4 4  0 4.5 0  0 1   0 0 0 0   0 1 0 0 12 0 0 0 0 0 0  7.5 
    2 1.5 1   4 0 2.5     0 5         4.5 1                       3 6.5 
S38 2011 2 2  0 4.5 0  0 2   0 0 0 0   0 1 0 0 8 0 0 0 0 0 0  6.0 
  2 2 2  4 0 2   0 1.5     5 2            2 5.0 
  2 2  0 4..5 0  0 2   0 0 0 0   0 0 0 0 8 0 0 0 0 0 0  6.0 
    1.5 1 2   3.5 0 2     0 1.5         4 1                       2 5.5 
Black performed by M. Wynn and Red performed in this project 
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Strain Year 
Annular radius of zone of inhibition                                              
    IPM MER Dor Ap SAM TIM TZP CTX CAZ CRO FEP Sm Sp Su Tc Mc Dc Tp Cl Fl Km Nm Gm Ne Ak Tm Nx CIP LVX Rif 
S39 2011 2 2  0 5 0  0 2   0 0 0 0   0 0 0 0 8 0 0 0 0 0 0  7.0 
  2 1.5 1  4 0 2   0 2     5 1            2 5.5 
  2 2  0 4 0  0 2   0 0 0 0   0 0 0 0 8 0 0 0 0 0 0  6.0 
    2 1.5 1.5   4 0 2     0 2         4 1                       2.5 6.0 
S40 2011 1 0  0 0 0  0 0   0 0 0 0   0 0 0 0 2 0 0 0 0 0 0  5.5 
  1 0.5 1  2 0 2   0 0.5     5 1.5            0.5 5.5 
  1 0  0 0 0  0 0   0 0 0 0   0 0 0 0 2 0 0 0 0 0 0  5.5 
  0.5 0 1  1.5 0 1.5   0 0.5     3 1.5            0.5 5.0 
Black performed by M. Wynn and Red performed in this project 
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Table A1.3. Isolates sequenced for this study by HiSeq 
Isolate 
name 
Source Year Mean  No. 
contigs 
Assembly size  N50  Accession 
No.  
read depth (bp) (bp) (reads) 
S21 Unknown 1996 93.5 110 4,170,306 173,010 ERR246920 
S24 Trach 2006 85.9 113 4,092,060 184,961 ERR246931 
S27 Blood 2007 80.7 64 4,061,936 220,457 ERR246908 
S29 Blood 2007 69.7 108 4,079,807 173,031 ERR246924 
S34 Blood 2009 88.2 90 3,969,270 122,571 ERR246957 
S38 Sputum 2011 87.1 66 4,001,907 220,529 ERR246919 
S39 Sputum 2011 89 66 4,001,565 291,078 ERR246911 
  
Table A 1.4. Isolates sequenced for this study by MiSeq 
Isolate name Source Year Mean read 
depth 
No. contigs Assembly size       
(bp) 
N50      
(bp) 
Accession No. 
(assemblies) 
S22 ETTA 2004 72.850 71 4,006,455 220,589 PYEO00000000 
S23 ETTA 2004 62.895 68 4,003,659 220,582 PYEN00000000 
S25 ETTA 2006 64.600 66 4,077,806 205,040 PYEM00000000 
S26 ETTA 2006 71.885 79 4,090,882 162,244 PYEL00000000 
S28 Blood 2007 65.094 76 4,125,741 205,040 PYEK00000000 
S30 ETTA 2008 67.568 62 4,055,552 262,554 PYEJ00000000 
S31 Trach 2008 50.688 56 4,008,413 220,565 PYEI00000000 
S32 Blood 2009 71.146 75 3,959,824 162,580 PYEH00000000 
S33 Blood 2009 65.782 62 3,923,847 168,007 PYEG00000000 
S35 Sputum 2010 72.473 55 3,830,627 177,675 PYEF00000000 
S36 Blood 2010 81.878 58 3,949,724 168,007 PYEE00000000 
S37 ETTA 2010 93.141 73 3,895,702 172,149 PYED00000000 
S38 Blood 2011 67.435 76 4,014,692 162,581 PYEC00000000 
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Figure A1.1. Unique positions of ISAba1. The coloured boxes indicate ISAba1 positions. The Singapore isolates highlighted in pink lack armA and contain aphA6, while those highlighted in 
green have armA and lack aphA6. 
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4
WM99c 1999 208pD72-1+ + + + 17
S21 1996 208 + 13
G2 2003 208 + + + 16
S24 2006 208 + + + + + + 19
K16 2004 208 + + + + + 17
S26 2006 1165 + 19
S29 2007 1165 18
S30 2008 369 + + + + + + + 13
XH386 2014 208 + + + + + + + + 15
S22 2004 218 10
S23 2004 218 10
S25 2006 218 10
S28 2007 1128 + 11
S27 2007 218 + + + + 13
S31 2008 208 + 10
S38 2011 208 10
S39 2011 208 10
S34 2009 1166 + + 16
S32 2009 195 + 18
S33 2009 195 15
S35 2010 195 + + 18
S36 2010 195 16
S37 2010 195 16
S40 2011 195 + 15
D86 2010 195 13
Isolates Year TotalMLST	
(Oxford)	
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Table A1.5 Positions of ISAba1 in XH386  
Position DR Location1 Left ID Right ID 
1 gattagctc 1152001-1152009 
and 1153190-
1153198 
TE32_05280 TE32_05295 
2 aattttttg 1968340-1968348 
and 1969529-
1969537 
TE32_09325 TE32_09340 
3 aaaacaatt 2012130-2012138 
and 2013319-
2013327 
TE32_09525 TE32_09540 
4 ctaattttt 2679800-2679808 
and 2680989-
2680997 
TE32_12810 TE32_12825 
5 aataataat 3827583-3827591 TE32_18435 TE32_18450 
6 ataattatt 1725127-1725135 TE32_08240 TE32_08245 
7 tatttacta 2209351-2209359 TE32_10555 TE32_10555 
8 ttaattcta 2888103-2888111 TE32_13960 TE32_13965 
9 caaaattga 3496575-3496583 TE32_16880 TE32_16880 
10 attgtttgg 3733796-3733804 TE32_17980 TE32_17980 
11 aaaaatgtc 2352487-2352495 TE32_11285 TE32_11285 
12 aaaaggatg 2516673-2516681 
and 2517862-
2517870 
TE32_12045 TE32_12060 
13 aaaaaataa 3145756-3145764 TE32_15250 TE32_15255 
14 ttaaaaata 1342037-1342045 TE32_06310 TE32_06315 
15 gaataattt 1431965-1431973 TE32_06745 TE32_06750 
16 caactcaat 1798506-1798514 TE32_08585 TE32_08585 
17 ttagaattt 2464309-2464317 TE32_11790 TE32_11795 
30 tcttttaaa 1662070-1662078 
and 1663259-
1663267 
TE32_07900 TE32_07925 
58 aaataatgc 639171-639179 and 
640360-640368 
TE32_03070 TE32_03095 
62 catcttaag 1527476-1527484 
and 1528665-
1528673 
TE32_07175 TE32_07190 
82 aaaataaac 173320-173328 and 
174509-174517 
TE32_00770 TE32_00790 
97 tattttttt 688354-688362 TE32_03320 TE32_03320 
103 atttcattt 921116-921124 and 
922305-922313 
TE32_04240 TE32_04265 
124 ctcaaattt 1515941-1515949 TE32_07115 TE32_07115 
133 ataagcttc 1921632-1921640 TE32_09115 TE32_09115 
135 ataattttc  TE32_09245 TE32_09265 
148 ttctttttt 2242741-2242749 TE32_10745 TE32_10750 
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149 ttaatcttt 2266415-2266423 
and 2267604-
2267612 
TE32_10855 TE32_10870 
165 aaaaaccat 2917716-2917724 TE32_14110 TE32_14115 
168 aaaatattt 3022078-3022086 TE32_14575 TE32_14590 
169 aaaatattt 3030511-3030519 TE32_14625 TE32_14640 
178 ctattcata 3394522-3394530 TE32_16405 TE32_16405 
182 aaaaaattt 3524825-3524833 TE32_17015 TE32_17020 
195 acctttaaa 3998431-3998439 
and 3999620-
3999628 
TE32_19235 TE32_19250 
206 atttaatga 1148871-1148879 TE32_05270 TE32_05275 
207 aaataaaat 763919-763927 TE32_03680 TE32_03685 
208 caaagattt 1908965-1908973 TE32_09040 TE32_09040 
209 attactttt 2060729-2060737 TE32_09750 TE32_09755 
210 tttttttc 2516016-2516023 TE32_12040 TE32_12040 
211 tactttttt 2752368-2752376 TE32_13150 TE32_13155 
212 ttaaaactc 83132-83140 TE32_00380 TE32_00380 
213 gctataaat 353989-353997 TE32_01640 TE32_01645 
214 acaaaagac 572546-572554 TE32_02765 TE32_02770 
215 attgatttt 57796-577934 TE32_02795 TE32_02800 
216 atatttttt 970487-970495 TE32_04520 TE32_04525 
217 aaaaattat 1017606-1017614 TE32_04735 TE32_04735 
218 attgaaaat 1156758-1156766 TE32_05305 TE32_05305 
219 gtggttttt 1157455-1157463 TE32_05305 TE32_05305 
220 attttggca 1186155-1186163 TE32_05425 TE32_05425 
221 cataatttt 1680070-1680078 TE32_07995 TE32_08000 
222 tacccgcaa 2094052-2094060 TE32_09935 TE32_09935 
223 aactgcttt 2098502-2098510 TE32_09960 TE32_09960 
224 aacgttttt 2161845-2161853 TE32_10235 TE32_10235 
225 aagtcttat 2268556-2268564 TE32_10870 TE32_10875 
226 gaaaattag 2889722-2889730 TE32_13970 TE32_13975 
227 ttaatattt 3154882-3154890 TE32_15290 TE32_15295 
228 aaaaaatta 3994561-3994569 TE32_19225 TE32_19225 
229 taccgattg 2947339-2947347 TE32_14240 TE32_14240 
230 aaaactttc 3535574-3535582 TE32_17055 TE32_17060 
231 aattaatat 3807230-3807238 TE32_18340 TE32_18345 
232 atatctttt 3897581-3897589 TE32_18775 TE32_18780 
2332 aaaatttat    
234 ttaatttta 595524-595532 TE32_02875 TE32_02875 
235 aagaattac 1148296-1148304 TE32_05265 TE32_05270 
236 atttggttt 2730078-2730086 TE32_13065 TE32_13065 
244 atttttttt 374168-374176 TE32_01740 TE32_01745 
257 aacaatttt 250397-250405 TE32_01130 TE32_01130 
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263 tgatactag 1739594-1739602 TE32_08300 TE32_08300 
265 tacatattt 1919375-1919383 TE32_09090 TE32_09095 
294 aaaatttat 299616-299624 TE32_01395 TE32_01400 
295 aaaaattaa 1334849-1334857 TE32_06265 TE32_06265 
296 attcttaac 1984284-1984292 TE32_0935 TE32_09400 
297 aacttactt 552833-552841 TE32_02685 TE32_02685 
298 ttcgggatg 1165893-1165901 TE32_05335 TE32_05335 
299 agcttttta 1201188-1201196 TE32_05480 TE32_05485 
300 aaaatactg 2373350-2373358 TE32_11385 TE32_11385 
301 aaagaattt 2507052-2507060 TE32_11995 TE32_11995 
302 ctaatttaa 2870306-2870314 TE32_13890 TE32_13890 
303 aaacgtcca 2930084-2930092 TE32_14170 TE32_14170 
304 taaaaattt 3051823-3051831 TE32_14725 TE32_14725 
305 ataatttca 3359535-3359543 TE32_16245 TE32_16245 
306 ctatttctt 209269-209277 TE32_00930 TE32_00935 
307 tttaattat 552617-552625 TE32_02685 TE32_02685 
308 aaatttga 1018337-1018344 TE32_04735 TE32_04740 
309 aattttaag 1342703-1342711 TE32_06315 TE32_06315 
310 aataaattt 3798732-3798740 TE32_18295 TE32_18300 
311 ctaaatttc 118374-118382 TE32_00535 TE32_00535 
312 gtagtcact 721842-721850 TE32_03480 TE32_03485 
313 aataatcta 876395-876403 TE32_04055 TE32_04060 
314 aattttttt 3119804-3119812 TE32_15115 TE32_15115 
315 taataaaa 3364074-3364081 TE32_16265 TE32_16265 
316 tgtaaaaat 2358980-2358988 TE32_11305 TE32_11310 
317 aattgtttt 2542732-2542740 TE32_12160 TE32_12160 
1In XH386 (GenBank accession number CP010779) 
2Region not in XH386 
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A2.1 AbGRI3-7 in D86 
The armA region of D86 was assembled using a similar strategy to that used in Chapter 6, by 
first retrieving IS26 bounded contigs and using combinations of primers to order the contigs. 
D86 contains the same characteristic deletion caused by recombination as AbGRI3-4. 
However, the left end of AbGRI3 in D86 is different (Fig A2.1A) and this variant has been 
named AbGRI3-7. Firstly, the fragment of the atr gene usually bounding the left junction of 
AbGRI3 was found to be located approximately 1 Mb away, adjacent to an IS26** that has a 
fragment of an orf corresponding to ACICU_01435 in the genome of ACICU2 on the other 
side (Fig A2.1A). The remainder of ACICU_01435 was found to be adjacent to the left end of 
AbGRI3 in D86 (Fig A2.1). It is likely that the IS26** at the left of the island targeted 
ACICU_01435 and through intramolecular transposition inverted 1 Mb of the chromosome 
(red segment in Fig A2.1B), duplicating itself and causing an 8 bp TSD (grey flags in Fig 
A2.1A and B). A small inversion is also present in the left end of AbGRI3 in D86, where again 
the IS26 on the left has targeted ISAba24, inverting the 1.9 kb of intervening sequence, 
duplicating IS26 and producing a TSD (green flags in Fig A2.1B).  
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Figure A2.1 AbGRI3 in D86 and chromosomal inversion. A. Structure of AbGRI3 in D86.  B. Schematic of 
the chromosome of D86 showing the location of the inversion. For A. arrows indicate the extent and orientation 
of genes and open reading frames. The mphE and msrE genes are orange, the armA gene is maroon chromosomal 
genes are shown in grey. Boxes represent insertion sequences and the internal arrow indicates the orientation of 
the transposase or the rolling circle replicase. IS26 is dark green, ISAba24 is purple, ISEc29 and ISEc28 are light 
and dark blue and CR1 is yellow. IS26** is 2 bp different to the standard sequence of IS26. Green and grey flags 
indicate matching TSD. In B., the red segment indicates the 1 Mb inversion and black arrows indicate the 
approximate locations of the resistance islands and the extra IS26.  
 
A2.2 RepAci6 plasmid assembly 
A2.2.1 Type 1 plasmid assembly of pS29-1 and pS26-1.  
The contigs matching RepAci6 plasmids in the draft genomes of S26 and S29 were retrieved, 
analysed (Table A2.1) and tiled to the type 1 backbone. 
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Table A2.1 Contigs matching RepAci6 plasmids in S26 and S29  
Isolate Contig number Contig length (bp) Description Contig edges2 
 
Left Right 
S291 12 4,464 F3 R2 R3 
 23 11,441 F2 R1 R2 
 25 11,970 F1, trw genes R3 ISAba125 
 29 45,852 F1 (extra 10 kb), tra 
region, repAci6 
IRr of 
Tn6022 
R1 
 39 2,235 F1, res ISAba125  IRl of 
Tn6022 
S262 20 62,163 F1 (tra region, 
repAci6), F2, F3 
IRr of 
Tn6022 
repeat 3 
 38 17,312 F1 (trw genes, 
TnaphA6) 
Repeat 3  IRl of 
Tn6022 
 87 424 R2 and R3 sequence   
1Sequenced by Illumina HiSeq. 
2R1, R2 and R3 stand for repeat 1, 2 and 3, respectively. 
 
 
The pS29-1 contigs broke at repeat 2, 3 and the insertion site of TnaphA6 which have already 
been mapped (Chapter 8; Section 8.2). The reason for the lack of amplicon of repeat 1 is due 
to an additional 9.3 kb of sequence inserted between the location of annealing of RH1398 and 
the first repeat. The primer RH2030 was designed closer to the end of contig 29 and used with 
RH1399 to amplify a 1,069 bp region. This new combination of primers produced an amplicon 
of the expected size (Fig A2.2).  
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Figure A2.2 Assembly of pS29-1 contigs. A. pS29-1 contigs tiled to the type 1 backbone. Arrows indicate the 
extent and orientation of genes and open reading frames. The repAci6 gene is blue, genes involved in conjugal 
transfer are red and the res and umuC genes are orange. Green boxes indicate the three repeat sequences. Grey 
lines above indicate the extent of pS26-1 contigs. The black bars underneath show the primers used for assembly 
along with PCR amplicon size. Vertical arrows indicate the insertion location of AbaR4 and TnaphA6 B. 
Assembly of AbaR4 in pS29-1. The oxa23 gene is magenta and the IR sequences of Tn6022 are shown in olive 
green. The blue box is ISAba1 and the internal arrows indicate the transposase orientation. The primers used to 
span AbaR4 are shown above by the black bars, along with PCR amplicon size. The lines below indicate the 
transposons.  
 
An additional break in the assembly was located just downstream to TnaphA6. Contig 39 and 
29 had the left and right IR of Tn6022 on one edge and a 5 bp target site duplication (5` AATTG 
3`) was adjacent to the IR sequence on each contig. Again, this may be a new insertion site of 
AbaR4. New primers RH2019 and RH2020 were used in combination with RH583 or oxa23R 
to amplify a 4,983 or 4,307 bp product respectively (Fig A2.2B). The amplicons produced were 
of the expected sizes and were sequenced. The internal AbaR4 PCR, RH910 and RH743, which 
should produce an amplicon 9,363 bp in size was performed and a product of the expected size 
was generated. pS29-1 is 96,201 bp in size and contains TnaphA6, AbaR4 in a new location as 
well as an extra 9.3 kb of unknown sequence (Fig A2.2, bottom line).  
 
The assembly of pS26-1 fragmented at repeat 3 which has been previously screened (Chapter 
8, Section 8.2), and at the IR sequences of Tn6022. The backbone sequences flanking these IR 
sequences are identical to that of the AbaR4 location in pS29-1. Hence, the same primer 
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combination of RH2019-RH584 and oxa23R and RH2020 were used to confirm that AbaR4 
was present in this location (Fig A2.2). Contig 38 also included TnaphA6 in the pAb-G7-2 
location. A brief look at the sequence prior to repeat 1 revealed that pS26-1, like S29-1, also 
contained 9.3 kb of extra sequence, accounting for the lack of amplification of PCR screening 
over repeat 1 (Chapter 8, Section 8.1).  
 
A2.2.2 Assembly of Type 2 plasmids 
A2.2.2.1 Assembly of pS27-2 and pS34-2 from HiSeq sequencing 
 
The contigs matching RepAci6 plasmids in the draft genomes of S27 and S34 were retrieved, 
analysed (Table A2.2) and tiled to the type 2 backbone. 
 
Table A2.2 Contigs matching RepAci6 plasmids in S27 and S34  
Isolate Contig 
number 
Contig 
length 
(bp) 
Kmer 
coverage  
Description Contig edges1 
 
Left Right 
S27 9 5,220 29.2 F2 R1 ISAba1 
 19 40,921 28.9 F1, tra region, repAci6 IRr of Tn6022 R1 
 26 4,675 29.1 F3 R2  R3 
 32 8,619 29.3 F2 ISAba125 R2 
 50 9,882 29.8 F1, trw genes R3 IRl of Tn6022 
 78 278 61.8 Repeat sequence   
S34 8 13,024 29.8 F1, repAci6 IRr of Tn6022  R1 
 22 37,778 30.1 F1, trw genes, res, 
 tra region 
R3  IRl of Tn6022 
 23 4,672 29.7 F3 R2  R3 
 32 13,669 30.1 F2 R1 R2 
  86 277 60.5 Repeat sequence   
2R1, R2 and R3 stand for repeat 1, 2 and 3, respectively.  
 
 
The contigs retrieved from the draft genome of S27 were mapped to the type 2 backbone (grey 
lines in Figure A2.3A). In addition to breaking at the repeat sequences (each of which were 
screened by PCR earlier) the assembly of pS27-2 also fragmented on a copy of ISAba1. Contig 
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9 and 32 each had a fragment of ISAba1 at one edge (Fig A2.3A) and examination of the 
sequence adjacent to the ISAba1 fragments revealed a matching 9 bp duplication (5` 
AAGTAGTGA 3`). New primers, RH2026 and RH2027, were designed to amplify this region 
and were predicted to amplify a 1,766 bp product. The amplicon generated was of the predicted 
size and was sequenced.  
 
Figure A2.3 Assembly of pS27-2 contigs. A. pS34-2 contigs tiled to the type 2 backbone. Arrows indicate the 
extent and orientation of genes and open reading frames. The repAci6 gene is blue, genes involved in conjugal 
transfer are red and the res and umuC genes are orange. Green boxes indicate the three repeat sequences. Grey 
lines above indicate the extent of different pS34-2 contigs. The black bars underneath show the primers used for 
assembly along with PCR amplicon size. Vertical arrows indicate the insertion location of AbaR4 and ISAba1. 
B. Assembly of AbaR4 in pS34-2. The oxa23 gene is magenta orange and the IR sequences of Tn6022 are shown 
in olive green. The blue box is ISAba1 and the internal arrows indicate the transposase orientation. The primers 
used to span AbaR4 are shown above by the black and pink bars, along with PCR amplicon size. The lines below 
indicate the transposons.  
 
The assembly also broke at the region following the trwC gene. Contig 50 and 16 both ended 
on the inverted repeats that bound Tn6022 and share a 5 bp target site duplication (5` CCATT  
3`) in the sequence adjacent to these repeats. This is the same target site duplication and 
location of AbaR4 in pA85-3. Hence, it was likely that pS27-2 also contained AbaR4 in this 
position. To confirm this, previously designed primers RH1391 and RH584 were paired and 
predicted to amplify a product 4,965 bp in size, while oxa23R and RH1392 used in the same 
reaction should produce an amplicon of 4,731 bp in size. In both cases, the amplicons generated 
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from S27 DNA appeared to be of the predicted sizes and were sequenced. As this is the second 
copy of AbaR4 in the genome of S27 (Chapter 4, Section 4.3.1), the internal AbaR4 PCR, 
RH910 and RH743 (pink in Fig A2.3B), was instead performed on a transconjugant. pS27-2 is 
87,530 bp in size.  
 
The contigs of S34 listed in Table A2.2 were tiled to the type 2 backbone and only one contig 
break in addition to the three repeats was present (Fig A2.4). Contig 22 and 8 both ended with 
the inverted repeats of Tn6022 and a 5 bp target site duplication (5` TCCAC 3`) was present 
in the sequence adjacent to the IRs. The primers, RH2028 and RH2029, were designed in the 
flanking plasmid backbone and were combined with internal AbaR4 primers RH584 and 
oxa23R, to produce an amplicon 5,034 bp and 4,569 bp in size, respectively (Fig A2.4B). The 
amplicons produced by both of these reactions using S34 DNA appeared to be on the correct 
sizes and were sequenced. S34 also contains another copy of AbaR4 in its genome (Chapter 4, 
Section 4.3.1) and therefore the internal PCR (pink in Fig A2.4B) was performed on a 
transconjugant. pS34-2 contains AbaR4 in a new location and is 86,366 bp in size.  
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Figure A2.4 Assembly of pS34-2 contigs. A. pS34-2 contigs tiled to the type 2 backbone. Arrows indicate the 
extent and orientations of genes and open reading frames. The repAci6 gene is blue, genes involved in conjugal 
transfer are red and the res and umuC genes are orange. Green boxes indicate the three repeat sequences. Grey 
lines above indicate the extent of different pS34-2 contigs. The black bars underneath show the primers used for 
assembly along with PCR amplicon size. Vertical arrows indicate the insertion location of AbaR4. B. Assembly 
of AbaR4 in pS34-2. The oxa23 gene is magenta orange and the IR sequences of Tn6022 are shown in olive green. 
The blue box indicates ISAba1 and the internal arrows are the transposases. The primers used to span AbaR4 are 
shown above by the black and pink bars, along with PCR amplicon size. The lines below indicate the transposons.  
 
A2.2.2.2 Assembly of pA85-3 plasmids using MiSeq sequencing data 
The contigs matching RepAci6 backbone in S22, S23, S25, S28, S32, S36 and S40 were 
retrieved, tiled on pA85-3 and were mostly completed by the same assembly PCRs as pS27-2 
(Table A2.3). The RepAci6 plasmids in S22, S23 and S40 were in one contig that had IRl and 
IRr of Tn6022 on the edges of the contig. The sequence adjacent to these two IRs was identical 
to that surrounding the AbaR4 position in pA85-3. PCR screening, as indicated in Table A2.3, 
revealed that pS22-2, pS23-2 and pS40-2 contain AbaR4 in the same position as pA85-3. S25 
and S28 had two contigs matching RepAci6 backbone (Table A2.3). One split was caused by 
the presence of AbaR4 in the same location as pA85-3, while the other was due to a copy of 
ISAba1 in the same position as pS27-2. The three screening PCRs listed in Table A2.3 were 
performed and successfully completed the assembly of pS25-2 and pS28-2. 
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Table A2.3 Contig/s matching RepAci6 backbone and assembly PCRs 
Isolate Contig/s1 AbaR4 position (pA85-3) ISAba1 (pS27-2 location) 
  RH1391-RH584 
(4,965 bp) 
oxa23R-RH1392 
(4,852 bp) 
RH2026-RH2027 (1,776 
bp) 
S22 1 (22) + + - 
S23 1 (20) + + - 
S25 2 (21, 31) + + + 
S28 2 (24, 33) + + + 
S32 2 (23, 44) - - - 
S36 2 (24, 43) - - - 
S40 1 (20) + + - 
1The contig numbers are in the parentheses.  
 
Contig 23 and 44 in S32 and contig 24 and 43 in S36 matched RepAci6 backbone, but they 
had not fragmented at a copy of AbaR4 or ISAba1. Instead, there appeared to be an error in the 
assembly as left of repeat 2 was sequence from F2 and to the right of this repeat was sequence 
from F1 (Fig A2.5). The sequence of F3 was in a separate contig in both isolates. This issue 
was easily resolved by sequencing the products previously amplified over repeat 1, 2 and 3 
from Chapter 8; Section 8.1.  
 
 
Figure A2.5 Contig 23 and 44 of pS32-2 and contig 24 and 43 of pS36-2. Arrows indicate the extent and 
orientation of genes and open reading frames. The repAci6 gene is blue, genes involved in conjugal transfer are 
red and the res and umuC genes are orange. Green boxes indicate the three repeat sequences. The lines of three 
different colours above indicate fragment 1 (purple), fragment 2 (blue) and fragment 3 (yellow).  
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Primer tables 
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Table A3.1 Primer pairs used for the detection of resistance genes.  
Target Primer Sequence (5'-3') Amplicon Size (bp) Reference 
Sulphonamide resistance genes  
sul1 HS549 ACTAAGCTTGCCCCTTCCGC 1,100 (249) 
 HS550 CTAGGCATGATCTAACCCTCG  (249) 
sul2 sul2F GGCAGATGTGATCGACCTCG 407 (158) 
 sul2R ATGCCGGGATCAAGGACAAG  (158) 
Aminoglycoside resistance genes  
aacC1 RH935 GCAGTCGCCCTAAAACAAAG 457 Hall lab 
 RH936 CCCGTATGCCCAACTTTGTA  Hall lab 
aadA1/aadA2 RH522 GTGGATGGCGGCCTGAAGCCA 516 Hall lab 
 RH531 GGCAGCGACATCCTTCGGCGC  Hall lab 
aacA4 RH532 GTTAGGCATCACAAAGTACAGC 518 Hall lab 
 RH533 CATCTGGGGTGGTTACGGTACC  Hall lab 
aphA1b RH880 CAACGGGAAACGTCTTGCTC 454 (188) 
 RH881 ATTCGTGATTGCGCCTGAG  (188) 
strA-strB strA-F CTTGGTGATAACGGCAATTC 1,190 (76) 
 strB-R GGATCGTAGAACATATTGGC  (76) 
aphA6 aphA6F ATACAGAGACCACCATACAGT 234 (269) 
 aphA6R GGACAATCAATAATAGCAAT  (269) 
armA RH2012 TCCATTCCCTTCTCCTTTCC 508 This study 
 RH2013 GGGGGTCTTACTATTCTGCCTA  This study 
Tetracycline resistance gene  
tetA(B) tetBF TTGGTTAGGGGCAAGTTTTG 658 (186) 
 tetBR GTAATGGGCCAATAACACCG  (186) 
b-lactamase genes     
blaTEM RH605 TTTCGTGTCGCCCTTATTCC 690 Hall lab 
 RH606 CCGGCTCCAGATTTATCAGC  Hall lab 
oxa23 oxa23F GATCGGATTGGAGAACCAGA 501 (275) 
 oxa23R ATTTCTGACCGCATTTCCAT  (275) 
Others     
ISAba1 upstream of ampC RH581 TGATGATGCGTGGTGTAGGT 2,583 (95) 
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Table A3.2 Primer pairs used to detect Tn6022, AbaR4 and AbaR4∆  
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
tniB-tniE RH910 GCGATAGTGAACGGATTGAGA 3,4101 Hall lab 
 RH587 TTGCCCATTAAGCACAACAG  Hall lab 
tniB-Tn2006 RH910 GCGATAGTGAACGGATTGAGA 9,3632  Hall lab 
 RH743 GGCTTCTTGTGGATGCAACT  Hall lab 
sup gene RH2523 CCCACTTTAGGATCAACGCC 209 This project 
 RH2509 GTGGTGTAGTCGCTTGTGTG  This project 
1Predicted amplicon size based on Tn6022. For Tn6022∆1 it is 560 bp.  
2Predicted amplicon size based on AbaR4. For AbaR4∆1 it is 6,513 bp.  
 
 
 
 
 
 
 
 
 
 
 
 
 RH582 GAGCTGCCATATTGGGAAGA  (95) 
Tn2006 ISAba1B CATGTAAACCAATGCTCACC 1,369 (42) 
 oxa23R ATTTCTGACCGCATTTCCAT  (275) 
 oxa23F GATCGGATTGGAGAACCAGA 2,725 (275) 
 ISAba1B CATGTAAACCAATGCTCACC  (42) 
TnaphA6 RH577 ACATTCACCCTGGCAAAAAG 1,427 Hall lab 
 aphA6R GGACAATCAATAATAGCAAT  (269) 
 aphA6F ATACAGAGACCACCATACAGT 1,745 (269) 
 RH576 AAACAACGGATCGCTTCAAC  Hall lab 
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Table A3.3 Primer pairs used for mapping AbGRI1-1 
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
comM-sup1 RH791 TGCTGCAATGAGCTGAAAGT 6,288  Hall lab 
 RH771 TGTAAAATCTGGTGGTCGTAC  Hall lab 
tniB-tetA(B)1 RH910 GCGATAGTGAACGGATTGAGA 7,120  Hall lab 
 tetBF TTGGTTAGGGGCAAGTTTTG  (186) 
tetA(B)-strB tetBR GTAATGGGCCAATAACACCG 4,616 (186) 
 strBout AGAGGAGCAACGCGATCTAGC  (201) 
strA-comM strAout AACCAGTCAGAATGCGATTCA 2,942  (201) 
 RH1366 CAGATTTGCCCAAAGATGGT   Hall lab 
1Predicted size based on Tn6022∆1. 
 
Table A3.4 Primer pairs used for mapping AbGRI1-3  
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
comM-sup1 RH791 TGCTGCAATGAGCTGAAAGT 6,288  Hall lab 
 RH771 TGTAAAATCTGGTGGTCGTAC  Hall lab 
sup-orf2 RH772 GCAGCCATAGGAATGACTTTTA 4,768  Hall lab 
 RH596 GGGCGGCAAATATAAAGGTT  Hall lab 
orf5-sul2 RH597 TTTGAAGAAATTGAGCATGAGG 5,586 Hall lab 
 RH955 GAAACTGTCCGAGGTTATGTTGAC  Hall lab 
sul2-uspA2 RH603 ACTTCATCCGCACACACGAG 8,423 Hall lab 
 RH934 TCGGAAATCCGAATAGTGAAA  Hall lab 
tniD-tetA(B) RH583 TCCTGTCTCTCGTGTAGCAAT 8,074  Hall lab 
 tetBF TTGGTTAGGGGCAAGTTTTG  (186) 
tetA(B)-strB tetBR GTAATGGGCCAATAACACCG 4,616 (186) 
 strBout AGAGGAGCAACGCGATCTAGC  (201) 
strA-comM strAout AACCAGTCAGAATGCGATTCA 2,942  (201) 
 RH1366 CAGATTTGCCCAAAGATGGT   Hall lab 
1Predicted size based on Tn6022∆1. 
2Predicted size based on Tn6022. 
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Table A3.5 Primer pairs used for mapping AbGRI1-4  
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
comM-sup1 RH791 TGCTGCAATGAGCTGAAAGT 6,288 Hall lab 
 RH771 TGTAAAATCTGGTGGTCGTAC  Hall lab 
sup-orf2 RH772 GCAGCCATAGGAATGACTTTTA 4,768  Hall lab 
 RH596 GGGCGGCAAATATAAAGGTT  Hall lab 
orf5-sul2 RH597 TTTGAAGAAATTGAGCATGAGG 5,586 Hall lab 
 RH955 GAAACTGTCCGAGGTTATGTTGAC  Hall lab 
sul2-uspA2 RH603 ACTTCATCCGCACACACGAG 8,423 Hall lab 
 RH934 TCGGAAATCCGAATAGTGAAA  Hall lab 
oxa23-tetA(B) oxa23R ATTTCTGACCGCATTTCCAT 5,205 (275) 
 tetBF TTGGTTAGGGGCAAGTTTTG  (186) 
tetA(B)-strB tetBR GTAATGGGCCAATAACACCG 4,616 (186) 
 strBout AGAGGAGCAACGCGATCTAGC  (201) 
strA-comM strAout AACCAGTCAGAATGCGATTCA 2,942  (201) 
 RH1366 CAGATTTGCCCAAAGATGGT   Hall lab 
1Predicted size based on Tn6022∆1. 
2Predicted size based on Tn6022. 
 
Table A3.6 Primer pairs used for mapping AbGRI1-5 
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
comM-sul21  RH791 TGCTGCAATGAGCTGAAAGT 5,099 (tniA recombination) Hall lab 
 sul2R ATGCCGGGATCAAGGACAAG  (158) 
sul2-uspA2 RH603 ACTTCATCCGCACACACGAG 8,423 Hall lab 
 RH934 TCGGAAATCCGAATAGTGAAA  Hall lab 
tniD-tetA(B) RH583 TCCTGTCTCTCGTGTAGCAAT 8,074  Hall lab 
 tetBF TTGGTTAGGGGCAAGTTTTG  (186) 
tetA(B)-strB tetBR GTAATGGGCCAATAACACCG 4,616 (186) 
 strBout AGAGGAGCAACGCGATCTAGC  (201) 
strA-comM strAout AACCAGTCAGAATGCGATTCA 2,9423  (201) 
 RH1366 CAGATTTGCCCAAAGATGGT   Hall lab 
1tniA-tniAb recombination. 
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2Predicted size based on Tn6022. 
34,130 bp in AbGRI1-5b.  
 
Table 3.7 Primer pairs used for mapping AbGRI1-6 
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
comM-sup1 RH791 TGCTGCAATGAGCTGAAAGT 6,288 (∆) Hall lab 
 RH771 TGTAAAATCTGGTGGTCGTAC  Hall lab 
Tn2006-tetA(B) oxa23R ATTTCTGACCGCATTTCCAT 5,016 Hall lab 
 tetBF TTGGTTAGGGGCAAGTTTTG  (186) 
tetA(B)-strB tetBR GTAATGGGCCAATAACACCG 4,616 (186) 
 strBout AGAGGAGCAACGCGATCTAGC  (201) 
strA-comM strAout AACCAGTCAGAATGCGATTCA 2,942  (201) 
 RH1366 CAGATTTGCCCAAAGATGGT   Hall lab 
1Predicted size based on Tn6022∆1. 
 
Table A3.8 Primer pairs used for mapping AbGRI1-7 
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
comM-sup1 RH791 TGCTGCAATGAGCTGAAAGT 6,288  Hall lab 
 RH771 TGTAAAATCTGGTGGTCGTAC  Hall lab 
Tn2006-orf2 oxa23R ATTTCTGACCGCATTTCCAT 7,720 (275) 
 RH596 GGGCGGCAAATATAAAGGTT  Hall lab 
orf5-sul2 RH597 TTTGAAGAAATTGAGCATGAGG 5,586 Hall lab 
 RH955 GAAACTGTCCGAGGTTATGTTGAC  Hall lab 
sul2-uspA2 RH603 ACTTCATCCGCACACACGAG 8,423 Hall lab 
 RH934 TCGGAAATCCGAATAGTGAAA  Hall lab 
oxa23-tetA(B) oxa23R ATTTCTGACCGCATTTCCAT 5,205 (275) 
 tetBF TTGGTTAGGGGCAAGTTTTG  (186) 
tetA(B)-strB tetBR GTAATGGGCCAATAACACCG 4,616 (186) 
 strBout AGAGGAGCAACGCGATCTAGC  (201) 
strA-comM strAout AACCAGTCAGAATGCGATTCA 2,942  (201) 
 RH1366 CAGATTTGCCCAAAGATGGT   Hall lab 
1Predicted size based on Tn6022∆1. 
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2Predicted size based on Tn6022. 
 
Table A3.9 Primer pairs used for mapping AbGRI1-8 
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
comM-sup1 RH791 TGCTGCAATGAGCTGAAAGT 6,288  Hall lab 
 RH771 TGTAAAATCTGGTGGTCGTAC  Hall lab 
sup-orf2 RH772 GCAGCCATAGGAATGACTTTTA 4,768  Hall lab 
 RH596 GGGCGGCAAATATAAAGGTT  Hall lab 
orf5-sul2 RH597 TTTGAAGAAATTGAGCATGAGG 5,586 Hall lab 
 RH955 GAAACTGTCCGAGGTTATGTTGAC  Hall lab 
sul2-uspA2 RH603 ACTTCATCCGCACACACGAG 8,423 Hall lab 
 RH934 TCGGAAATCCGAATAGTGAAA  Hall lab 
tniD-tetA(B) RH1310 TTGCTCAAGTGTACCCCTTTG 5,823 Hall lab 
 tetBF TTGGTTAGGGGCAAGTTTTG  (186) 
tetA(B)-strB tetBR GTAATGGGCCAATAACACCG 4,616 (186) 
 strBout AGAGGAGCAACGCGATCTAGC  (201) 
strA-Tn2006 strAout AACCAGTCAGAATGCGATTCA 2,517 (201) 
 oxa23R ATTTCTGACCGCATTTCCAT   (275) 
Tn2006-comM RH743 GGCTTCTTGTGGATGCAACT 5,023 Hall lab 
 RH1366 CAGATTTGCCCAAAGATGGT  Hall lab 
1Predicted size based on Tn6022∆1. 
2Predicted size based on Tn6022. 
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Table 3.10 Primer pairs used for mapping AbGRI2-1 
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
ABA1_011911-tnpR1 RH1315 AGGAGATCTTCTTGGCAGTCA 1,051 (188) 
 RH539 CCAGCCCTTCCCGATCTGTTG  (188) 
blaTEM-tnpA1000 RH605 TTTCGTGTCGCCCTTATTCC 2,650 (188) 
 RH759 GCCAGCTCATTTACCTTGCCGA  (188) 
tnpR5393c-aphA1b RH520 CATGGCCCAGCGCGATACTTCAG 2,297 (188) 
 RH880 CAACGGGAAACGTCTTGCTC  (188) 
aphA1b-sul1 RH881 ATTCGTGATTGCGCCTGAG 2,712 (188) 
 RH751 GCGGAACTTCACGCGATC  (188) 
tnpA-ABA1_01225 RH668 CACCAGAACCGCCTGCTCAA 1,219 (188) 
 RH1316 CATCTGCCATCCAGTTTGTG  (188) 
5`-CS-3`CS RH754 CGGCATCGAGCGGGATTTCCTT 4,5312 Hall lab 
 R1 AAGCAGACTTGACCTGAT  (159) 
1GenBank accession number CP010781. 
2Predicted size based on the cassette array aadA1-orfQ-orfP-orfP-aacC1. For the aadA1-orfQ-orfP-aacC1 cassette array it is 3,993.  
 
Table 3.11 Primer pairs used for mapping AbGRI2-12 
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
TE32_131401-tnpR1 RH1563 ATAGATCGGCTTCGGACTCA 1,046 Hall lab 
 RH539 CCAGCCCTTCCCGATCTGTTG  (188) 
blaTEM-tnpA1000 RH605 TTTCGTGTCGCCCTTATTCC 2,650 (188) 
 RH759 GCCAGCTCATTTACCTTGCCGA  (188) 
tnpR5393c-aphA1b RH520 CATGGCCCAGCGCGATACTTCAG 2,2972 (188) 
 RH880 CAACGGGAAACGTCTTGCTC  (188) 
aphA1b-ABA1_012283 RH881 ATTCGTGATTGCGCCTGAG 1,5814 (188) 
 RH2008 TGATGACTTCCATTAAAGCCTGT  This project 
1GenBank accession number CP010779. 
2Predicted size without IS26∆.  
3CP010781 
4Predicted size based on AbGRI2-12a. For AbGRI2-12b it is 1,772.  
 
 335	
 
Table 3.12 Primer pairs used for mapping AbGRI2-13 
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
ABA1_011891-tnpA1000 RH2009 GATAAGTTCGCACCGCATTT 1,223 This project 
 RH781 TCACCAGACCCAGAGCACCGA  Hall lab 
tnpR5393c-intI1 RH520 CATGGCCCAGCGCGATACTTCAG 1,881 (188) 
 RH935 GCAGTCGCCCTAAAACAAAG  Hall lab 
tnpA-ABA1_01225 RH668 CACCAGAACCGCCTGCTCAA 1,219 (188) 
 RH1316 CATCTGCCATCCAGTTTGTG  (188) 
 
Table 3.13 Primer pairs used for mapping AbGRI2-14 
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
ABA1_011911-tnpR1 RH1315 AGGAGATCTTCTTGGCAGTCA 1,051 (188) 
 RH539 CCAGCCCTTCCCGATCTGTTG  (188) 
blaTEM-tnpA1000 RH605 TTTCGTGTCGCCCTTATTCC 2,650 (188) 
 RH759 GCCAGCTCATTTACCTTGCCGA  (188) 
tnpR5393c-intI1 RH520 CATGGCCCAGCGCGATACTTCAG 1,881 (188) 
 RH935 GCAGTCGCCCTAAAACAAAG  Hall lab 
tnpA-ABA1_012251 RH668 CACCAGAACCGCCTGCTCAA 1,219 (188) 
 RH1316 CATCTGCCATCCAGTTTGTG  (188) 
1GenBank accession number CP010781. 
 
Table 3.14 Primer pairs used for mapping those isolates with only IS26 in the AbGRI2 region 
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
IS26 (1)     
ABA1_011911-
ABA1_01230 
RH1315 AGGAGATCTTCTTGGCAGTCA 1,048  (188) 
RH2007 ACTTTTGGCATCGTCGGTAT  This project 
IS26 (2)     
TE32_131402-
TE32_12895 
RH1563 ATAGATCGGCTTCGGACTCA 1,850 Hall lab 
RH2548 GGATTACGTTCGATGGTCTGC  This project 
1GenBank accession number CP010781. 
2GenBank accession number CP010779. 
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Table 3.15 Primer pairs used for AbGRI3 assembly 
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
AbGRI3-1i     
∆atr RH2001 GGAGTTGGTTTTGGTACAGCA 1,323  This project 
repAciN RH2002 TATAAGCCACCTCGCTCACC  This project 
intI1 RH2003 GCCTTGATGTTACCCGAGAG 1,193 This project 
∆asr RH2005 CACTGATCTGCTGGCTTTCA  This project 
atr∆ RH2015 CCCAGCAATCCATTCGTAGT 1,524 This project 
asr∆ RH2006 TGACGAGCTTTGTTTAGGTGTG  This project 
AbGRI3-1     
intI1 RH2003 GCCTTGATGTTACCCGAGAG 1,566 This project 
atr∆ RH2015 CCCAGCAATCCATTCGTAGT  This project 
∆asr RH2005 CACTGATCTGCTGGCTTTCA 1,151 This project 
asr∆ RH2006 TGACGAGCTTTGTTTAGGTGTG  This project 
AbGRI3-2i     
∆atr RH2001 GGAGTTGGTTTTGGTACAGCA 1,323  This project 
repAciN RH2002 TATAAGCCACCTCGCTCACC  This project 
intI1 RH2003 GCCTTGATGTTACCCGAGAG 1,943 This project 
aphA1b RH880 CAACGGGAAACGTCTTGCTC  (188) 
aphA1b RH831 TATACCCATATAAATCAGCATCC 1,203 Hall lab 
∆asr RH2005 CACTGATCTGCTGGCTTTCA  This project 
atr∆ RH2015 CCCAGCAATCCATTCGTAGT 1,524 This project 
asr∆ RH2006 TGACGAGCTTTGTTTAGGTGTG  This project 
AbGRI3-2     
aphA1b RH831 TATACCCATATAAATCAGCATCC 1,576 Hall lab 
atr∆ RH2015 CCCAGCAATCCATTCGTAGT  This project 
∆asr RH2005 CACTGATCTGCTGGCTTTCA 1,151 This project 
asr∆ RH2006 TGACGAGCTTTGTTTAGGTGTG  This project 
AbGRI3-3i     
∆atr RH2001 GGAGTTGGTTTTGGTACAGCA 1,605  This project 
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ISAba24 RH2010 TTTCGTGACACTCTCGCTTG  This project 
aacA4 RH2011 CATAGAGCATCGCAAGGTCA 1,007 This project 
∆asr RH2005 CACTGATCTGCTGGCTTTCA  This project 
atr∆ RH2015 CCCAGCAATCCATTCGTAGT 1,398 This project 
asr∆ RH2006 TGACGAGCTTTGTTTAGGTGTG  This project 
AbGRI3-3     
aacA4 RH2011 CATAGAGCATCGCAAGGTCA 1,380 This project 
atr∆ RH2015 CCCAGCAATCCATTCGTAGT  This project 
∆asr RH2005 CACTGATCTGCTGGCTTTCA 1,025 This project 
asr∆ RH2006 TGACGAGCTTTGTTTAGGTGTG  This project 
AbGRI3-4     
∆atr RH2001 GGAGTTGGTTTTGGTACAGCA 1,323  This project 
repAciN RH2002 TATAAGCCACCTCGCTCACC  This project 
armA RH2012 TCCATTCCCTTCTCCTTTCC 1,934 This project 
asr∆ RH2014 CCAAATACCGCCCACTCAAC  This project 
AbGRI3-5i     
∆atr RH2001 GGAGTTGGTTTTGGTACAGCA 2,146 This project 
ISAba24 RH2010 TTTCGTGACACTCTCGCTTG  This project 
intI1 RH2003 GCCTTGATGTTACCCGAGAG 1,943 This project 
aphA1b RH880 CAACGGGAAACGTCTTGCTC  (188) 
aphA1b RH831 TATACCCATATAAATCAGCATCC 1,203 Hall lab 
∆asr RH2005 CACTGATCTGCTGGCTTTCA  This project 
orf∆ RH2016 GCAGCCTCAAAGTGGAAAAC 1,173 This project 
asr∆ RH2006 TGACGAGCTTTGTTTAGGTGTG  This project 
AbGRI3-5     
aphA1b RH831 TATACCCATATAAATCAGCATCC 1,351 Hall lab 
orf∆ RH2016 GCAGCCTCAAAGTGGAAAAC  This project 
∆asr RH2005 CACTGATCTGCTGGCTTTCA 1,025 This project 
asr∆ RH2006 TGACGAGCTTTGTTTAGGTGTG  This project 
AbGRI3-6     
∆atr RH2001 GGAGTTGGTTTTGGTACAGCA 1,232 This project 
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repAciN RH2547 AATCAGCCACGCATTCAGTC  This project 
repAciN RH2002 TATAAGCCACCTCGCTCACC 2,638 This project 
ISAba24 RH2048 TCTGTCGCTACTGACTCGTC  This project 
aacA4 RH2011 CATAGAGCATCGCAAGGTCA 1,147 This project 
asr∆ RH2006 TGACGAGCTTTGTTTAGGTGTG  This project 
AbGRI3-7 (D86)     
ACICU_01435∆1 RH2049 CTTGCTGATATGGCGGGTTG 1,333 This project 
∆atr RH2001 GGAGTTGGTTTTGGTACAGCA  This project 
ISAba24 RH2047 CTTGATGTGCCCCAGGTCTA 1,568 This project 
∆ACICU_014351 RH2050 CCGTTCTGCTGCTATTCTGG  This project 
repAciN RH2002 TATAAGCCACCTCGCTCACC 1,293 This project 
ISAba24 RH2048 TCTGTCGCTACTGACTCGTC  This project 
1GenBank accession number CP000863.  
 
 
Table 3.16 Primer pairs used assembly of RepAci6 plasmids 
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
RepAci6     
repAci6 
repAci6 
RH2045 AAGGTGACAGCAAGTACGTG 482  This project 
RH2046 CGTGCGCCTCATTTCAACAT  This project 
Repeats     
CBI29_044211 
CBI29_044221 
RH1398 TTTGACGTTGCTCTTGTTGC 9872/9913/3,3784 (97) 
RH1399 TTCTCCCAAGTGGTCAGGTC  (97) 
CBI29_044411 RH1320 TTTACGATAATTGCATGGATGT 1,5252/1,5243 (192) 
CBI29_044431 RH1394 TGGTTGGCAGAACAAGATGA   (97) 
CBI29_044501 RH1397 CCATGTTCTTTTCCACATGC 1,5762/1,7743 (97) 
CBI29_044481 RH1503 GAAGATCCAGAAGCGGGATA  (97) 
TnaphA65 assembly     
CBI29_044851 RH1502 TTGCTTTAATCGGTGGTTCC  2,540 (97) 
aphA6 aphA6F ATACAGAGACCACCATACAGT  (269) 
aphA6 aphA6R GGACAATCAATAATAGCAAT 1,930 (269) 
 339	
CBI29_044831 RH1501 CTTGAGGAAGGGATGGTTGA  (97) 
pS24-1     
CBI29_044341 RH2024 TGTTGTTAGCTTGGATCGTGTC 4,831 This project 
tniD RH584 TCAATATGCCTCGCTCCACT  Hall lab 
oxa23 oxa23R ATTTCTGACCGCATTTCCAT 4,683 (275) 
CBI29_044401 RH2025 TGCAAAAGCAAAATCTTCGTCA  This project 
pS26-1/pS29-1     
CBI29_044871 RH2019 CGTGTAGCAACCATCCAAAA 4,938 This project 
tniD RH584 TCAATATGCCTCGCTCCACT  Hall lab 
oxa23 oxa23R ATTTCTGACCGCATTTCCAT 4,307 (275) 
CBI29_044871 RH2020 CATGAATGCCGTAGAGATCG  This project 
orf RH2030 TCATCATAGCACATCGTCCAG 1,069 This project 
CBI29_044221 RH1399 TTCTCCCAAGTGGTCAGGTC  (97) 
pS27-2, pS25-2, pS28-2    
CBI29_044261 RH2026 GAAACAAAACTTCACTGCTATGC 1,766 This project 
CBI29_044281 RH2027 AGACATACCGAAAAGTCCGAA  This project 
CBI29_04460 RH1391 ATGCGAGGCTTCTTGGTCTA 4,965 (99) 
tniD RH584 TCAATATGCCTCGCTCCACT  Hall lab 
oxa23 oxa23R ATTTCTGACCGCATTTCCAT 4,731 (275) 
CBI29_04460 RH1392 CCTTAACGCTCAGTCTTTTGG  (99) 
pS22-2, pS23-2, pS40-2    
CBI29_044601 RH1391 ATGCGAGGCTTCTTGGTCTA 4,965 (99) 
tniD RH584 TCAATATGCCTCGCTCCACT  Hall lab 
oxa23 oxa23R ATTTCTGACCGCATTTCCAT 4,731 (275) 
CBI29_044601 RH1392 CCTTAACGCTCAGTCTTTTGG  (99) 
pS34-2     
CBI29_045111 RH2028 ACCATGTGCCGTAATAGCCT 5,034 This project 
tniD RH584 TCAATATGCCTCGCTCCACT  Hall lab 
oxa23 oxa23R ATTTCTGACCGCATTTCCAT 4,569 (275) 
CBI29_045121 RH2029 ACAAATGAAGATACGTGCCTGA  This project 
pS21-2     
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CBI29_044601 RH1391 ATGCGAGGCTTCTTGGTCTA 2,367 (99) 
CBI29_044811 RH2021 TGTGTGCAGTTGGAATTAAAGC  This project 
CBI29_045121 RH2022 CCGACTCTTCAGGTGCTTCA 5,171 This project 
tniD RH584 TCAATATGCCTCGCTCCACT  Hall lab 
oxa23 oxa23R ATTTCTGACCGCATTTCCAT 4,757 (275) 
CBI29_045131 RH2023   This project 
pS30-2     
oxa23 oxa23R ATTTCTGACCGCATTTCCAT 2,101 (275) 
CBI29_04441 RH1320 TTTACGATAATTGCATGGATGT  (192) 
1GenBank accession number CP021787. 
2Size for the Type 1 backbone. 
3Size for the Type 2 backbone. 
4Product size for Type 3 and 4 backbones. 
5G7 location. 
 
Table A3.17 Small plasmid assembly 
PCR Primer Sequence (5`-3`) Amplicon size (bp) Reference 
pAb-G7-1 backbone RH2035 CCTGACAACTTCCACACAGC 328 This project 
pAb-G7-1 backbone RH2036 ACAGCAAGCCGATCGTATTG  This project 
pD72-1 backbone RH2037 CTTTGGTACGCTCTCTTGCC 263 This project 
pD72-1 backbone RH2038 GTTGTCGGGGTATTGGGGA  This project 
pS32-1     
tonB RH2505 TTACCTCCTGCTCGTTTGGG 2,728 This project 
Tn2006 internal RH743 GGCTTCTTGTGGATGCAACT  Hall lab 
oxa23 Oxa23R ATTTCTGACCGCATTTCCAT 2,317 (275) 
pAb-G7-1 backbone RH2506 AGAGTTACTGCCACACTGCT  This project 
pS21-1     
pD72-1 backbone RH1348 CACATTGTGGACAGGTTGGA 1,847 Hall lab 
aphA6 aphA6F ATACAGAGACCACCATACAGT  (269) 
aphA6 aphA6R GGACAATCAATAATAGCAAT 1,624 (269) 
pD72-1 backbone RH1322 ATTGCCGATGGAATGAAGAT  Hall lab 
pS30-1      
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 RH2502 AACAGGGATGTTCGGGCTAT 1,918 This project 
tet39 Tet39R GCCTTTTGCGTTGTTACCAT  (98) 
 RH2503 TGTCGCTTTGAGAGTTAGGC 2,508 This project 
 RH2504 TCGTATTGGTTCGCTCGGTA  This project 
 
 
 
